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Figure 1. Examples of immunoassay concepts. (A) Heterogeneous two-site assay immunometric 
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complex. The fluorescent label in the detection antibody allows quantification of the binding.  
(B) Heterogeneous competitive assay based on target binding antibody and a labeled competitor. 
The competition for a limited number of binding sites results in a signal intensity which correlates 
inversely to the concentration of the analyte. (C) Homogeneous competitive immunoassay based on 
energy transfer from labeled antibody to labeled competitor. In the presence of the target analyte, 
the distance between the two labels increases and no energy transfer is observed. (D) Homogeneous 
quenching assay based on competitor labeled with a fluorescent dye and antibody labeled with a 
quencher. In the presence of the target analyte, the fluorescence is recovered due to the larger 
distance between the label and the quencher. ............................................................................... 38 
Figure 2. The antibody formats most commonly in biosensors include the conventional antibody (IgG), 
the recombinant antibody fragments Fab (fragment antigen binding), scFv (single-chain fragment 
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Figure 3. Examples of mycotoxin analysis based on different recognition elements and detection 
schemes. (A) Non-competitive HT-2 toxin assay based on the anti-immune complex Fab and HT-2 
specific primary antibody. In the presence of the toxin, FRET (Förster resonance energy transfer) can 
occur due to the short distance between the two fluorophores. A, acceptor (Alexa Fluor); D, donor 
(europium dye). (B) Localized surface plasmon resonance (LSPR) sensor using aptamer-modified 
gold nanorods chemically attached to an optical fiber core. OTA binding to the aptamer induces an 
LSPR peak shift. (C) Detection of AFB1 by DNA aptamer -based fluorescent assay using graphene 
oxide (GO) nanosheets to bind the labeled aptamer in the absence of the toxin and quench the 
fluorescence. Signal amplification was achieved using DNase I for regeneration. (D) Anti-idiotypic 
nanobody was used in a phage-based real-time immuno-PCR for the detection of aflatoxin. Figures 
adapted from A, Arola et al. (2016);136 B, Lee et al. (2018);111 (C) Zhang et al. (2016);212 and (D) Lei 
et al. (2014).243 ................................................................................................................................. 51 
Figure 4. (A) The structure of filamentous phage M13 which consists of a protein coat made of the 
major coat protein (pVIII) and the minor coat proteins (pIII and pVI in one end and pVII and pIX in the 
other). The genomic DNA encoding for the coat proteins is enclosed within the protein coat. By 
introducing modified segments into the genomic DNA, the phage can be engineered to display foreign 
peptides or proteins as a fusion with one of the coat proteins, most commonly pIII. (B) Construction 
of phage-displayed libraries includes generation of the DNA library encoding for the different variants 
and introduction of the variable sequences in the phage DNA (typically phage vector or phagemid 
system). After transforming the DNA to bacteria, phages are amplified and will display individual 
protein or peptide variants outside the virion. ................................................................................ 54 
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Figure 5. Selection of affinity binders from a phage-displayed library. (A) The selection process 
consists of binding, washing, elution, and amplification steps which are usually repeated to  
3–5 times to enrich target-specific binders. (B) Target specificity of individual clones can then be 
determined by screening the monoclonal clones from single colonies in ELISA, and the positive 
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Figure 6. Schematic representation of partial Fusarium IGS region and location of the primers and 
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species complex: F. verticillioides (accession number AJ880005.1); F. saccharii (AJ879944.1); 
F. fujikuroi (AJ879945.1); F. proliferatum (AJ879946.1); F. subglutinans (AJ879947.1);  
F. thapsinum (AJ879948.1); F. nygamai (AJ879949.1) and F. circinatum (AJ879950.1). The 
sequences corresponding the species-specific probes and PCR primers common for both  
F. verticillioides and F. proliferatum (as well as most of other Fusarium species) are marked with 
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Figure 12. Optimization of the hybridization time using the synthetic target DNA and HRP detection.
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Figure 13. Calibration curves with enzymatic detection. The equations for allometric fittings for 
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biotin-peptide A2 (closed symbols) and background binding to a non-related peptide F11 (open 
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Figure 18. Selection of target binding phages. (A) Enrichment of target binding phage-peptides in the 
pannings was monitored by phage-based ELISA after five consecutive selection rounds. (B) Phage-
based ELISA with monoclonal phage clones A2 and D1 showed specific binding to the target, whereas 
low background was observed with a non-related phage clone F11. Light grey bars present the 
specific binding to the target antibody and dark grey bars the background binding to the wells without 
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Figure 19. Molecular dynamics trajectory analysis. [A] Total energy (ET) of the system as a function 
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phosphatase-1. (A) Docking of fumonisin B1 (green sticks) to protein phosphatase-1 (PP-1c, skyblue 
cartoon), a well-known inhibitor of several toxins including fumonisin B1.47,58 The peptide-protein 
docking model predicts that the interaction of the peptides A2 (red sticks) and D1 (yellow sticks) with 
PP-1c takes place in the same region as for fumonisin B1. (B) The non-related peptide F11 (magenta 
sticks) showed lower binding affinity to PP-1c as well as a different binding site. .................... 104 
Figure 22. Cross-reactivity of the phage-based ELISA. Response in the competitive phage-based 
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the best max/min ratio was selected for subsequent experiments. .......................................... 130 
Figure 38. Assay kinetics with 17-nm AuNPs. Measurements were repeated after 5 min (black),  
10 min (red), 15 min (blue), 20 min (magenta), 30 min (green), and 45 min (orange) incubation. 
Signal-to-background ratios (A) improved with longer incubation as fluorescence quenching 
increased. However, the shorter the incubation time the better sensitivity was observed, as can be 
seen in the normalized signals (B). An incubation time of 20 min was chosen for further experiments 
as it provided the required sensitivity but better reproducibility than shorter times. Error bars indicate 
the standard error of the mean (n = 3). A four-parameter logistic fit (OriginPro 9.0) was used to 
calculate the IC50 values. ............................................................................................................... 130 
Figure 39. Specificity of the homogeneous assay assessed by testing different mycotoxins. 
Fumonisins FB1 and FB2 showed almost identical calibration curves (A; FB1 black, FB2 red), whereas 
other mycotoxins such as T-2 toxin, HT-2 toxin, deoxynivalenol (DON), ochratoxin A (OTA), zearalenone 
(ZEA), or alternariol (AOH), did not give any response in the assay when tested at 100 ng mL–1 
concentration as the fluorescence signals (B) were comparable to the background signal of the blank 
without any toxin. Error bars indicate the standard error of the mean (n =3). A four-parameter logistic 
fit (OriginPro 9.0) was used to calculate the IC50 values. Structures of the tested mycotoxins are 
depicted on the right side. ............................................................................................................. 132 
Figure 40. Principles of the competitive immunoassays based on magnetic beads and mimotopes 
either in (a) phage-displayed (A2-phage), (b) synthetic (A2-bio), or (c) recombinant formats (A2-YFP). 
Abbreviations: bio, biotin; FB1, fumonisin B1; HRP, horse-radish peroxidase; YFP, yellow fluorescent 
protein. ............................................................................................................................................ 143 
Figure 41. Mimotope assays on magnetic beads using the A2-phage (black circles), synthetic A2-bio 
(red diamonds), or recombinant A2-YFP (blue triangles). The normalized signals are depicted as the 
average of three replicates ± standard error of the mean (n = 3). The response was fitted to a four-
parameter logistic curve fit (Origin 9.0). ....................................................................................... 144 
Figure 42. Kinetic analyses by surface plasmon resonance (SPR). (a) Analysis with the A2-phage did 
not show a measurable signal with the anti-FB1 (red) although successful immobilization of the phage 
could be confirmed with the anti-phage antibody (green). (b) Binding of the anti-FB1 antibody  
(0–500 nM) to the immobilized synthetic mimotope A2-bio, and (c) the recombinant A2-YFP  
(0–500 nM) to the immobilized anti-FB1. Sensorgrams of seven different concentrations (red) are 
shown in for each mimotope together with the data fitted (black) to a 1:1 binding model. ..... 146 
Figure 43. (A) Main features of the expression vectors (pRP006 and pRP010) used for mimotope-
GLuc fusion protein production in E. coli. (B) SDS-PAGE analysis of A2-GLuc purification: lane 1, cell 
lysate before purification; 2–3, flow-through and wash fractions of the amylose purification; 4–12, 
eluted MPB-mimotope-GLuc fusion (64 kDa); 13, actor Xa cleavage reaction with MBP (43 kDa) and 
mimotope-GLuc (21 kDa; red arrow) which was further purified by Ni-NTA; M, molecular marker 
(Precision Plus Protein Dual Color Standard). .............................................................................. 157 
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Figure 44. Selection of zearalenone mimotopes and tests with phage-based ELISAs. (A) Polyclonal 
phage-based ELISA after each selection rounds showed specific binding to the target antibody (red) 
and low non-specific binding to background wells coated with BSA (blue). Likewise, enrichment of 
the phages was seen in the phage titers after each selection round (blue diamonds; right y-axis). (B) 
Monoclonal phage-based ELISA with 15 individual clones. High specific binding to the target antibody 
(red) was seen with all except one clone, and low signals were measured in the background wells 
(blue) and in the presence of free zearalenone (green). (C) Schematic of the competitive phage-based 
ELISA using the phage (M13) -displayed mimotopes and anti-M13 conjugated to HRP. (D) 
Comparison of the competitive binding curves of the phage-displayed mimotopes GW (gray) and SF 
(red). The results are shown as normalized means ± the standard error of the mean (n = 3). A four-
parameter logistic fit (OriginPro 9.0) was used to calculate the IC50 values. ............................. 159 
Figure 45. GLuc-based immunoassays. (A) Schematic of the competitive bioluminescent 
immunoassay using the GLuc-tagged mimotopes. (B) ZEA calibration with SF-GLuc and (C) FB1 
calibration with A2-GLuc. The results are shown as normalized means ± the standard error of the 
mean (n = 3). A four-parameter logistic fit (OriginPro 9.0) was used to calculate the IC50 values.160 
Figure 46. (A) Regions of fungi ribosomal DNA (rDNA) which consists of repeated sequences encoding 
for the ribosome subunits. The genes are flanked by the internal transcribed spacers (ITS1 and ITS2) 
and the intergenic spacer (IGS). Figure modified from Weider et al.320 (B) Sequence alignment of the 
IGS sequence of representative strains of Fusarium fujikuroi species complex. Partial 28S gene is 
shown in blue, the location of the species-specific detection and capture probes for F. proliferatum 
and F. verticillioides are shown in dark red. DNA sequences on the partial 28S rRNA gene and the 
IGS region were collected from GenBank and aligned and visualized using CLC Sequence Viewer 
(http://www.clcbio.com/). .............................................................................................................. 167 
Figure 47. Detection of F. proliferatum using SA-HRP as a label and fluorescent (black) or 
chemiluminescent (blue) substrates. Normalized signals are depicted as the average of the analysis 
of replicate samples ± the standard error of the mean (n = 3). Allometric fits (OriginPro 9.0) were 
used to calculate the lower detection limits (blank + 3 × SD of blank). ..................................... 169 
Figure 48. Detection of F. proliferatum synthetic target using one (black) or two (orange) detection 
probes and SA-HRP with the fluorescent substrate for the detection. (A) More intense fluorescence 
signals were measured with two detection probes, but normalized signals (inset) did not show any 
improvement compared to a single detection probe. Signals are depicted as the average of the 
replicate samples ± the standard error of the mean (n = 3) and fitted with the allometric fit (OriginPro 
9.0). (B) Scheme of the assay using two detection probes (green) instead of just one to bind to the 
target DNA (red) simultaneously with the capture probe (blue). ................................................. 170 
Figure 49. Analysis of fragmented genomic DNA. (A) Genomic DNA was extracted from a maize 
sample contaminated with Fusarium fungi after which the crude genomic DNA was analyzed with the 
genosensor, directly or after enzymatic digestion. (B–C) Genosensor response for different 
concentrations of the genomic DNA with (green diamonds) and without (black circles) fragmentation. 
Significant variations were observed between replicates and analyses done on different days (B–C). 
The fluorescence signals are shown as the average of the replicate analysis of the samples (n = 3) 
± the standard error of the mean. ................................................................................................. 171 
Figure 50. (A) Schematic of the IGS region with the common primer pair (orange arrows) used to 
amplify the genomic rDNA of most of the species in the Fusarium fujikuroi species complex. (B) 
Analytical gel electrophoresis was used to confirm successful PCR amplification using as a template 
a maize sample contaminated with F. proliferatum. PCR product (746 bp) was seen when using KOD 
Xtreme Hot Start DNA Polymerase (lane 1) although KAPA HiFi HotStart DNA Polymerase (lane 2) 
could not amplify the target from the same sample. Lane M shows the molecular marker, GeneRuler 
1kb. .................................................................................................................................................. 173 
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Figure 51. Chip design for the integrated genosensor. (A) Chip in the Micronit clamping system which 
provides the connections for the fluidic (syringe pump), electric (integrated heater), optical (CMOS 
detector) structures of the system. (B) Microfluidic chip (dimensions 15 × 45 mm) designed for fungi 
detection. (C) CMOS detector (on the green support) placed under the capture chamber to measure 
the luminescence signals. Figure copyright Sandro Meucci/Micronit Microtechnologies. ....... 174 
Figure 52. Microfluidic approach for Fusarium detection. (A) Chip with the hybridization channel (blue 
dye solution indicates the fluidic path) with a total volume of 6 μL (300 μm × 100 μm). (B) Open 
reservoir as the inlet allowed to add each reagent manually. (C) The outlet was connected to a syringe 
pump and was preceded with the (D) detection chamber (600 μm × 600 μm) where an external 
magnet was used to capture the microbeads. An integrated heater (indicated with red arrows in  
A–B) made of conductive silver paste was used as the heating element to reach the required 
hybridization temperature. Figure copyright Sandro Meucci/Micronit Microtechnologies........ 175 
Figure 53. Fluorescent detection on the integrated genosensor showed intense emission from the 
detection chamber after addition of the substrate (Amplex UltraRed). High non-specific binding of SA-
HRP to the uncoated surface was seen in the absence of the target (right graph) but coating the 
microchannels with Pluronic (0.5%, w/v) was seen to improve the background and decrease the 
irreproducibility observed with the uncoated chip. ...................................................................... 176 
Figure 54. Preliminary results with the integrated approach for Fusarium detection. (A) On-chip DNA 
hybridization was tested using a direct F. proliferatum detection probe which was flowed through the 
microfluidic channel with the detection probe functionalized beads using the integrated heater set 
to +60°C. Afterward, the beads were collected from the chip, and the fluorescence signals were 
measured after adding the fluorescent substrate (Amplex UltraRed). The response of the on-chip 
hybridization was then compared to the off-chip hybridization doing the assay in microcentrifuge tube 
at +60°C. (B) Chemiluminescent measurement using the integrated CMOS detector. The hybridized 
sandwich complex was captured on the chip using an external magnet, and the CMOS detector was 
used to measure the luminescence signals from the beads in the detection chamber after adding 
the chemiluminescent substrate. Response from a control reaction without the target (green) was 
compared to the signals obtained when using 1 nM ssDNA target in the reaction (in two replicates; 
red triangles and yellow circles). The dashed line at 70 s indicates the time point where the flow of 
the substrate was stopped, and a decrease in the signals is seen. ........................................... 177 
Figure 55. Map of the Ph.D. (M13KE) vector. The library insert (red; 12 amino acids in the case of 
Ph.D.-12) has been introduced as N-terminal fusion to pIII (yellow). A short spacer (GGGS-linker) is 
included between the randomized segment and the pIII. The lacZα in the vicinity of the (+)-origin of 
replication (M13 ori) permits blue–white screening to detect contamination with wild-type phages.
 ......................................................................................................................................................... 179 
Figure 56. Results of the ELISA with the polyclonal phage pools after each selection round for 
zearalenone (ZEA) mimotopes with (A) and without (B) a pre-selection step. Binding of the phages 
was tested to the background (blue) and the immobilized target anti-ZEA antibody (red). Likewise, 
enrichment of the phages could be depicted as increasing phage titers after each selection round 
(blue diamonds; right y-axis). ......................................................................................................... 182 
Figure 57. Results of the ELISA with the polyclonal phage pools after each selection round of T-2 
toxin mimotopes (A) selection on the plate (i), and (B) selection on magnetic beads (ii). Binding of the 
phages was tested to the background (blue) and the immobilized target anti-T2 antibody (red).183 
Figure 58. Results of the ELISA with the monoclonal T-2 toxin mimotopes from the selection on (A) 
plate (i), and (B) magnetic beads (ii). Binding to the background (blue) and the anti-T2 antibody (red) 
was tested, and the clones with the best signal-to-background ratios were identified by DNA 
sequencing. .................................................................................................................................... 184 
Figure 59. Competitive phage-based ELISA with T-2 toxin mimotopes (A) F5, (B) F11, (C) G5, (D) H5, 
(E) H9, and (F) H11 from the first (i) selections. Normalized signals are depicted as the average of 
the replicate measurements ± the standard error of the mean (n = 3) and fitted with the four-
parameter logistic fit (OriginPro 9.0). Each assay was repeated three times on different days (blue, 
green, red) to test the inter-day variation. .................................................................................... 185 
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Figure 60. (A) Competitive phage-based ELISA with the monoclonal T-2 toxin mimotopes F11 (red), 
H11 (blue), and T13 (green). Normalized signals are depicted as the average of the replicate 
measurements ± the standard error of the mean (n = 3) and fitted with a four-parameter logistic fit 
(OriginPro 9.0). (B) Cross-reactivity with different mycotoxins (1 µg mL–1) and (C) binding to the 
background or other anti-toxin antibodies. Signals are normalized to the signal obtained in the 
absence of the toxin with the anti-T2 antibody. ............................................................................ 186 
Figure 61. The frequency of amino acids observed in the original Ph.D.-12 library338 and among the 
sequenced clones (Table 16) after 3–5 selection rounds for fumonisin B1 (FB1), T-2 toxin, and 
zearalenone (ZEA) mimotopes. ...................................................................................................... 188 
Figure 62. Scheme of the non-competitive immunoassays with the anti-immune complex peptide. 
Such antibody–analyte–peptide trivalent interaction allows the development of noncompetitive 
sandwich-type assays for small molecule detection..................................................................... 188 
Figure 63. Selection of anti-immune complex peptides for (A) FB1, (B) T-2 toxin, and (C) ZEA. Binding 
of the polyclonal phage pools to the background (blue), the anti-toxin antibody (red), and the anti-
immune complex (green; antibody together with the corresponding toxin, 300 ng mL–1 FB1 or T-2 
toxin, or 1000 ng mL–1 ZEA) were determined after each round. For ZEA, the phage titers after each 
round are indicated with blue diamonds in the right y-axis. ........................................................ 190 
Figure 64. Map of the DAb phagemid vector (pR2-VH) with the most important features. The VH 
sequence (DAb, 12 kDa) has been introduced as N-terminal fusion to pIII. The amber stop codon 
located between the VH and pIII is suppressed by the strain used for phage amplification (TG1) and 
is introduced as a glutamine. ......................................................................................................... 192 
Figure 65. Selection of domain antibodies for T-2 toxin. (A) The ratio between the input phages (pfu) 
and output phages (pfu) after each selection round. Pannings against T2–HSA (red) showed 
enrichment after three selection rounds (the bar of the first round is not visible in the scale used). A 
control panning (green) against the wells without the target in the second and third round showed 
some enrichment in the background binders as well. (B) ELISAs with the polyclonal phage pools after 
each round. Binding was tested to the target T2–HSA (red), HSA (yellow), and wells blocked with 5% 
milk (green). The commercial anti-T2 monoclonal antibody (MAb) was used as a positive control. The 
signal-to-background ratios (red diamonds, right y-axis) were calculated from the signal from T2–HSA 
coating divided with the background signals from the non-coated wells. (C) ELISAs with monoclonal 
phages. Binding was tested similarly to the target T2–HSA (red), HSA (yellow), and wells blocked with 
5% milk (green). .............................................................................................................................. 193 
Figure 66. Selection of domain antibodies for FB1. (A) Output phage (pfu) after each round for the 
target (FB1–BSA, yellow) and control pannings (BSA, green). (B) ELISA with the polyclonal phage pools 
after each round. Binding was tested to the target FB1–BSA (yellow), and BSA (green). In the first and 
second rounds the elution was done with trypsin, and in the third round the elution with trypsin and 
free FB1 (toxin) was compared. ...................................................................................................... 195 
Figure 67. Selection of domain antibodies for FB1. (A) ELISA with monoclonal phages from the second 
and third rounds. Binding was tested to BSA (red) and the target FB1–BSA in the absence (yellow) 
and presence of 2 µg mL–1 FB1 (green). (B) Competitive assay with selected monoclones with an 
overnight pre-incubation step with the toxin. As a control (dark green) no FB1 was used, or  
5 µg mL–1 (green), 10 µg mL–1 (light green), or 25 µg mL–1 FB1 (yellow). (C) Schematic of the 
hypothesized binding of the phage-displayed DAb which recognized the FB1–BSA only in the context 
of the protein-conjugate. ................................................................................................................ 196 
Figure 68. Competitive phage-based immunoassays for ZEA. (A) Optimization of the amount of the 
phage in the bead-based immunoassay in the absence of free ZEA (blue) and in the presence of  
3 ng mL–1 ZEA (green). Best signal-to-background ratio (red diamonds, right y-axis) was obtained with 
4 × 108 pfu mL–1, and it was used for the toxin calibration. (B) ZEA calibration using as the solid 
phase a microtiter plate (blue) or magnetic microbeads (red). Normalized signals are depicted as the 
average of the replicate samples ± the standard error of the mean (n = 3) and fitted with a four-
parameter logistic fit (OriginPro 9.0). ............................................................................................ 199 
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Figure 69. Optimization of the peptide (A2-bio and F11-bio) spotting. (A) The array was spotted with: 
(a) 1× PBS (pH 7.2), 0.01% sodium-deoxycholate; (b) 1× PBS (pH 7.2), 0.005% CHAPS, 0.01% BSA; 
or (c) 1× PBS (pH 7.2). Then, binding of different antibody concentrations to the peptides spotted 
with spotting buffer was tested (b). (B) Specific binding of anti-FB1 to A2-bio; and (C) non-specific 
binding to F11-bio. (D) Non-specific binding of anti-T2 to A2-bio; and (E) specific binding to F11-bio. 
Both peptides were spotted with (orange, purple, blue) neutravidin and without (green, red, light blue) 
in three different concentrations, 0.10  mg mL–1 (purple, green); 0,25 mg mL–1 (orange, red); or 
0.75 mg mL–1 (blue, light blue). The fluorescence signals are depicted as the average of three 
replicate spots in three replicate arrays ± standard error of the mean (n = 9). ........................ 200 
Figure 70. Optimization of the F11-bio spotting. (A) Binding inhibition curves with the peptide 
immobilized at a concentration of 0.25 mg mL–1, (blue) 0.50 mg mL–1 (orange), or 0.75 mg mL–1 
(red). (B) Binding inhibition curves with 0.25 mg mL–1 immobilized peptide F11 at different 
neutravidin concentrations, 1:4-molar ratio (blue), 1:6-molar ratio (orange) or 1:8-molar ratio (red). 
Results are shown as normalized mean signals ± the standard error of the mean (n = 9). A four-
parameter logistic fit (OriginPro 9.0) was used for the curve fitting. .......................................... 201 
Figure 71. (A) Optimization of T-2 toxin antibody concentration in the microarray. Anti-T2 toxin was 
used at 250 ng mL–1 (red), 40 ng mL–1 (orange), and 10 ng mL–1 (blue). Results are shown as mean 
fluorescence signals ± the standard error of the mean (n = 9). A four-parameter logistic fit (OriginPro 
9.0) was used for the curve fitting. (B) Scheme of the duplex microarray where A2-bio and F11-bio 
are spotted on the same array and FB1 and T-2 toxin can be detected simultaneously using an anti-
IgG secondary antibody labeled with AlexaFluor (AF). ................................................................. 202 
Figure 72. Duplex microarray assay for the detection of FB1 and T-2 toxin. A2-bio and F11-bio were 
spotted onto the same array, and the signals were measured from both spots (A and C, A2-bio 
250 µg mL–1; B and D, F11-bio 250 µg mL–1) in the presence of anti-FB1 (blue), anti-T2 (purple), or 
both antibodies (orange, red, and green). Different concentrations of one or both toxins were tested 
(blue and red, only FB1; green and purple, only T-2 toxin; orange both toxins simultaneously). Results 
are shown as the mean fluorescence signals ± the standard error of the mean (n = 9). A four-
parameter logistic fit (OriginPro 9.0) was used for the curve fitting. .......................................... 204 
Figure 73. (A) Main features of the expression vector for fusion proteins consisting of the mimotope 
(A2 or F11) and fluorescent protein ZsYellow, mOrange, or EmGFP. (B) Fluorescence emission 
spectra and emission maxima of the purified fusion proteins, A2-ZsYellow (yellow), A2-mOrange (red), 
and F11-EmGFP (green). The dashed lines represent the emission spectra reported in the literature. 
Excitation wavelengths were 472 nm, 490 nm, and 520 nm for EmGFP, ZsYellow, and mOrange, 
respectively. (C) Purification of the F11-EmGFP by HisTrap was monitored by SDS-PAGE analysis. 
Lane 1 unpurified lysate; 2, HisTrap flow-through; 3, Elution; M, molecular marker. ............... 206 
Figure 74. Binding of the fluorescent fusion proteins to their target antibody (200 ng of anti-FB1 or 
anti-T2 per well) and background binding (dark green) to the plate in the absence of the antibody.  
(A) A2-ZsYellow (anti-FB1-coating yellow; excitation at 490 nm), (B) A2-mOrange (anti-FB1-coating 
orange; excitation at 520 nm), (C) F11-EmGFP (anti-T2 coating green; excitation at 475 nm). 207 
Figure 75. Binding of the fluorescent fusion proteins to their target antibody in the microarray. 
Binding of different concentrations of A2-ZsYellow to (A) the target anti-FB1 antibody and (B) the non-
target anti-T2 antibody. Binding of different concentrations of F11-EmGFP to (C) the non-target anti-
FB1 antibody and (D) the target anti-T2 antibody. Different concentrations of the antibodies were 
spotted onto the microarray, 500 µg mL–1 (purple), 250 µg mL–1 (orange), 100 µg mL–1 (blue),  
50 µg mL–1 (green), and 20 µg mL–1 (red). The signals are depicted as the average of three replicate 
spots in three replicate arrays ± standard error of the mean (n = 9). ........................................ 208 
Figure 76. Microarray-based competitive immunoassays using fluorescent proteins (A) A2-ZsYellow 
and (B) F11-EmGFP for the detection of FB1 and T-2 toxin, respectively. Binding of the fluorescent 
fusion proteins to their target antibody in the microarray in the presence of the target mycotoxin. The 
anti-toxin antibodies (500 ng mL–1) were spotted onto the same microarray and binding of the 
mimotope-tagged fluorescent protein (green 2.5 µg mL–1, red 5 µg mL–1, or blue 10 µg mL–1) was 
tested with different toxin concentrations. The signals are depicted as the average of three replicate 
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spots in three replicate arrays ± standard error of the mean (n = 9) and fitted with a four-parameter 
logistic fit (OriginPro 9.0). ............................................................................................................... 209 
Figure 77. Optimization of the homogeneous quenching immunoassay with A2-YFP. Experiments 
were completed with (A) different reaction volumes, 60 µL (red), 80 µL (green), or 100 µL (violet),  
(B) with a prior blocking of the plate with Starting block (blue) or Protein free blocking buffer (green), 
in comparison with wells without blocking (red and violet, with and without pre-incubation before 
adding the gold, respectively), (C) at different temperatures, +26°C (red), +30°C (green), or +37°C 
(violet), (D) using different assay buffers, 10 mM phosphate buffer, pH 8, with 0.1% BSA (red), 0.5% 
BSA (violet), or 0.1% BSA and 0.05% Tween-20 (green), (E) in a 96-well plate (violet) or 384-plate 
(green) at a total reaction volume of 60 µL in both cases, and (F) alternative blockings of the 
AuNP:protGs either with 0.1% BSA (red), or 0.1% PEG-6000 (blue). .......................................... 210 
Figure 78. Fluorescence quenching with different sizes of AuNPs (A) Generation 0; 17 nm,  
(B) Generation 1; 27 nm, (C) Generation 2; 30 nm, (D) Generation 3; 36 nm, (E) Generation 4;  
54 nm, (F) Generation 6; 74 nm. Signals measured in the absence of FB1 (red) and in the presence 
40 µg mL–1 FB1. The ratio (Max/min) between these two signals is shown in the right y-axis (blue 
diamonds). The fluorescence signals are depicted as the average of replicate samples ± the standard 
error of the mean (n = 3). ............................................................................................................... 211 
Figure 79. Calibration curves with all AuNP generations, 0 (red), 1 (orange), 2 (yellow), 3 (green), 
4 (blue), and 6 (violet). The fluorescence signals are depicted as the average signal-to-background 
ratio ± standard error of the mean (n = 3) and fitted with a four-parameter logistic fit (OriginPro 9.0).
 ......................................................................................................................................................... 211 
Figure 80. Binding of the GLuc-fusion protein to their target antibody and background binding to BSA-
coated wells (blue squares). (A) A2-GLuc binding to immobilized anti-FB1 (red), (B) SF-GLuc and  
(C) GW-GLuc binding to anti-ZEA (green), (D) T13-GLuc and (E) F11-GLuc binding to anti-T2 (orange).
 ......................................................................................................................................................... 213 
Figure 81. Checkerboard titration with A2-GLuc (A) without (red) and (B) with 5 ng mL–1 FB1 (blue). 
Various concentrations of the immobilized antibody (50–400 ng/well) and A2-GLuc  
(0.125–1 µg mL–1) were tested in both conditions and those resulting in the highest signal-to-
background ratios were selected for the subsequent experiments. ........................................... 214 
Figure 82. Checkerboard titration with (A–B) GW-GLuc and (C–D) SF-GLuc without (violet) and with 
1 ng mL–1 ZEA (green). Various concentrations of the immobilized antibody (50–100 ng/well) and 
mimotope-GLucs (0.04–0.52 µg mL–1) were tested in both conditions, and those resulting in the 
highest signal-to-background ratios were selected for the subsequent experiments. ............... 214 
Figure 83. Optimization of the ZEA assay. (A) Various antibody concentrations were tested in the 
assay (10–1000 ng/well) but the lowest concentrations (10–20 ng; red and orange) did not result 
in good signals. Best sensitivity was seen with 50 ng (blue) whereas higher concentrations resulted 
in higher absolute signals but lower sensitivity. (B) Comparison of the optimized assay with GW-GLuc 
(blue) and SF-GLuc (orange). The signals are depicted as the average of three replicate spots in three 
replicate arrays ± standard error of the mean (n = 9). A four-parameter logistic fit (OriginPro 9.0) was 
used to estimate the assay sensitivity. .......................................................................................... 215 
Figure 84. Checkerboard titration with F11-Gluc (A) without (blue) and (B) with 1000 ng mL–1 T-2 
toxin (brown). Various concentrations of the immobilized antibody (50–400 ng/well) and F11-GLuc 
(0.1–2 µg mL–1) were tested in both conditions and those resulting in the highest signal-to-
background ratios were selected for the subsequent experiments. ........................................... 215 
Figure 85. (A) Optimization of T-2 toxin assay with the immobilized anti-T2 and F11-GLuc without 
(blue) and with 2000 ng mL–1 T-2 toxin (red) using different blocking buffers. PFBl, Protein-free 
blocking buffer, StartBl, Starting block; SuperBl, SuperBlock (all from ThermoScientific)  
(B) Competitive T-2 toxin assay with F11-GLuc in StartingBlock (green triangles), 1% BSA  
(red diamonds), or in 0.1% BSA (violet squares). ......................................................................... 216 
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Abstract 
New optical biosensing strategies for the analysis of  
mycotoxins and toxigenic fungi in food 
Mycotoxins are a diverse group of low molecular weight compounds produced as secondary 
metabolites by numerous species of filamentous fungi. This assemblage is chemically and 
toxigenically rather heterogeneous, but generally these toxins are known to cause disease and 
death in human and other vertebrates even at low concentrations. Mycotoxigenic fungi grow on 
a wide range of conditions and they can produce mycotoxins into the matrices on which they 
grow, often food intended for human consumption or animal feed. As a result of the ubiquitous 
nature of mycotoxigenic fungi, particularly in temperate and tropical regions of the world, 
mycotoxin contamination is often inevitable, and some calculations have estimated that 
approximately 25–50% of world crops are contaminated with these toxins. Although the 
awareness related to the hazards of mycotoxins as food and feed contaminants is growing, there 
are no absolute measures available for eliminating mycotoxins from agricultural products. While 
mycotoxin occurrence in the field can be decreased by good agronomic practices and planting 
resistant varieties, in the end, analytical methods capable of detecting mycotoxins and toxigenic 
fungi even at low concentration are of key importance for ensuring food safety. 
Biosensors can provide rapid, sensitive, low cost, real-time, and on-site analysis with 
compact and low power devices, and owing to these appealing advantages they have emerged 
as one of most interesting approaches to overcome the limitations of many conventional 
methods, for example, for food safety applications. Biosensors and bioaffinity assays are based 
on the high specificity and sensitivity of biomolecular recognition which is subsequently 
transformed into an analytically useful signal by a transducer. Among the vast variety of different 
biosensors, major research efforts in the field together with advances in material sciences have 
enabled the development of sophisticated and miniaturized devices to answer to the increased 
need for novel analysis tools and biosensing strategies. The main objective of this thesis was to 
develop new methods for the analyses of mycotoxins and toxigenic fungi in food. To this aim, 
different assay concepts and formats were explored to assess the impact of the assay 
components on the performance of bioanalytical assays and biosensors. New recognition 
elements were designed or selected to guarantee sensitive and specific detection of these food 
contaminants with the objective of meeting the demands of simple, rapid and low-cost yet 
sensitive methods for food safety applications. 
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Among the most common and widely-spread fungi, genus Fusarium includes notorious 
producers of several mycotoxins and has been associated with plant diseases with virtually every 
plant family. In the first part of this thesis, species-specific DNA probes were designed on the 
basis of the intergenic spacer regions of the ribosomal DNA to enable the detection of highly 
similar fungal species, Fusarium proliferatum and Fusarium verticillioides. Based on species-
specific capture and detection probes sandwich hybridization assays were implemented and 
optimized. With enzymatic detection, the developed genosensors were able to detect the 
synthetic target DNA in the low picomolar range with no significant cross-reactivity between the 
two species. The sensors were also used to analyze natural fungal contamination in maize 
samples after amplification of the genomic DNA using a common primer pair. The sample 
analyses were in accordance with previous results obtained with PCR, and no cross-reactivity 
between F. verticillioides and F. proliferatum, or other fungi species tested, was observed. The 
developed biosensors can provide a valuable tool to evaluate the potential for mycotoxin 
contamination in conditions where detection of mycotoxins directly is challenging, and ongoing 
work aims to integrate the method to a microfluidic platform for improved analysis. 
The second and major part of the thesis focused on the development of various assay 
concepts for mycotoxin analysis. Epitope mimicking peptides, or mimotopes, which are capable 
of imitating the epitope of an antigen and thus bind to same antibody paratope, were selected 
from a phage-displayed peptide library for mycotoxins fumonisin B1, T-2 toxin, and zearalenone. 
Such peptides present an intriguing alternative to overcome some of the limitations of 
competitive immunoassays conventionally established using toxin-conjugates. As mimotopes 
bind to the same antibody paratope as the target, they can be used as the competitor instead 
of the toxin-conjugate thus avoiding the cumbersome conjugation step. In this work, we have 
applied the selected mimotopes to various mimotope-based immunoassays to develop new and 
simple methods for mycotoxin detection. The developed methods include assays using the 
phage-displayed mimotopes, as well as the synthetic and recombinant counterparts of the 
peptides in heterogeneous and homogeneous assay formats. The development of microarray-
based immunoassay and magnetic bead–based assay for fumonisin detection using the 
synthetic peptide with a biotin linker provided excellent detection limits and the necessary 
sensitivity to meet the regulatory limits set by the European Commission for fumonisins. On the 
other hand, the mimotopes were used to construct recombinant fusion proteins consisting of 
the mimotope with fluorescent or bioluminescent proteins Thus, the readily labeled mimotope-
fusion could be directly applied to the immunoassays without the need for further labeling or 
secondary antibodies. Heterogeneous immunoassays using the mimotopes tagged with a yellow 
fluorescent protein (YFP) or Gaussia luciferase (GLuc) resulted in good analytical sensitivities in 
a rapid and simple assay concept. Moreover, the YFP-tagged fumonisin mimotope was used to 
develop a straightforward homogeneous fluorescence quenching immunoassay based on gold 
nanoparticles (AuNPs). 
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Resumen 
Nuevas estrategias para el desarrollo de biosensores ópticos 
aplicados al análisis de micotoxinas y hongos toxigénicos en alimentos 
Las micotoxinas son metabolitos secundarios tóxicos producidos por algunas cepas de hongos 
que contaminan alimentos, especialmente cereales y hortalizas. Estos compuestos de bajo 
peso molecular son químicamente y toxigénicamente heterogéneos; sin embargo, muchas de 
estas toxinas pueden originar enfermedades, y en ocasiones la muerte, tanto en humanos como 
en otros vertebrados. Los hongos toxigénicos crecen en muchas condiciones muy diversas, lo 
que puede dar lugar a la aparición de micotoxinas en los alimentos destinados tanto al consumo 
humano como al animal. Los hongos toxigénicos están ampliamente distribuidos por todo el 
mundo, particularmente en las regiones templadas y tropicales, por lo que la contaminación 
natural por micotoxinas es casi inevitable. De hecho, se estima que aproximadamente el 25–
50% de los cultivos mundiales están contaminados por estas toxinas, y la preocupación sobre 
los peligros asociados a su presencia en alimentos es cada día mayor. Actualmente, no existen 
alternativas viables para su eliminación en los productos agrícolas; aunque el empleo de 
buenas prácticas agrícolas o la plantación de variedades resistentes a los hongos, pueden 
ayudar a mejorar este problema. En cualquier caso, se requieren métodos analíticos sensibles 
y selectivos para la detección de micotoxinas y hongos toxigénicos, a bajas concentraciones, a 
fin de garantizar la seguridad alimentaria. 
Los biosensores son dispositivos que permiten la realización de análisis rápidos, 
sensibles, selectivos, en tiempo real, y en algunos casos “in situ”, empleando instrumentos 
compactos y de bajo coste. Dadas sus indudables ventajas, estos dispositivos permiten evitar 
algunas de las limitaciones de los métodos analíticos convencionales, de forma que su empleo 
para el control de la seguridad alimentaria se ha incrementado notablemente en los últimos 
años. Los biosensores se basan en la alta especificidad y sensibilidad del reconocimiento 
biomolecular que, posteriormente, se transforma en una señal analíticamente útil empleando 
un transductor adecuado (óptico, eléctrico, de masa, etc.). Los recientes avances en áreas como 
la ciencia de los materiales, el reconocimiento molecular, la biotecnología, la miniaturización o 
la microfluídica, entre otras, han favorecido el desarrollo de nuevos biosensores para la 
detección sensible y selectiva de micotoxinas y su aplicación el control de la seguridad 
alimentaria. 
El objetivo principal de esta tesis doctoral ha sido el desarrollo de nuevos biosensores 
para el análisis de micotoxinas y hongos toxigénicos en alimentos. Con este fin, se han 
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explorado diferentes estrategias y formatos de ensayo evaluándose su impacto sobre los 
dispositivos desarrollados. En todos los casos, se han diseñado o seleccionado nuevos 
elementos de reconocimiento para llevar a cabo la detección sensible, selectiva, rápida y a bajo 
coste de estos contaminantes. 
Entre los hongos toxigénicos, el género Fusarium es uno de los más comunes y 
ampliamente extendidos a nivel mundial. En la primera parte de esta tesis, se diseñaron sondas 
de ADN específicas para dos especies de Fusarium a partir de las regiones espaciadoras o 
intergénicas del ADN ribosómico. Esta aproximación permite distinguir entre especies hongos 
muy similares. Concretamente, se trabajó en la identificación de Fusarium proliferatum y 
Fusarium verticillioides, ampliamente distribuidos en regiones templadas. Para el desarrollo del 
genosensor se diseñaron sondas de captura y detección, que permitieron su identificación 
inequívoca, a concentraciones picomolares, en muestras de maíz contaminadas naturalmente 
con dichos hongos, empleando ensayos de tipo sándwich y detección enzimática con un 
sustrato fluorescente. Para ello el ADN genómico se amplificó mediante PCR utilizando un par 
de cebadores comunes. Los resultados obtenidos demuestran la selectividad de los 
biosensores desarrollados para F. verticillioides y F. proliferatum, y constituyen una valiosa 
herramienta para evaluar la contaminación de alimentos con hongos toxigénicos. Actualmente, 
estamos trabajando en la integración de este genosensor en un dispositivo microfluídico. 
En la segunda y principal parte de la tesis se han desarrollado inmunoensayos y 
plataformas biosensoras basados en medidas de luminiscencia para el análisis de micotoxinas. 
Concretamente, se han analizado fumonisina B1, toxina T-2 y zearalenona utilizando péptidos 
miméticos o mimopéptidos. Dichos mimopéptidos imitan el epítopo característico de un 
antígeno, uniéndose al mismo parátopo que éstos en el correspondiente anticuerpo selectivo. 
Su empleo evita los problemas asociados a la fabricación y utilización de conjugados tóxicos de 
las micotoxinas de los inmunoensayos convencionales. Para seleccionar los mimopéptidos se 
ha aplicado la técnica de despliegue de proteínas o péptidos sobre la superficie de fagos 
(“phage display”). Los dispositivos desarrollados emplean, alternativamente, los fagos que 
despliegan el mimopéptido de interés o el mimopéptido obtenido sintéticamente. Los péptidos 
sintéticos se han utilizado para el desarrollo de “microarrays” e inmunoensayos basados en el 
empleo de partículas magnéticas para la determinación de micotoxinas. Se han alcanzado 
límites de detección muy inferiores a los límites máximos de residuos establecidos por la Unión 
Europea. 
Por otra parte, se han diseñado y producido proteínas de fusión recombinantes 
compuestas por los mimopéptidos de las micotoxinas estudiadas y una proteína fluorescente 
(proteína fluorescente amarilla, YFP del inglés yellow fluorescent protein), o bioluminiscente 
(luciferasa Gaussia, GLuc del inglés Gaussia luciferase), que evita el empleo de anticuerpos 
secundarios, o de micotoxinas marcadas con una sonda luminiscente. Las proteínas 
recombinantes se han aplicado al desarrollo de dos tipos de ensayos. El primero se basa en un 
formato de tipo heterogéneo, empleando proteínas de fusión del péptido mimético y YFP, o 
GLuc, con el anticuerpo selectivo inmovilizado. En el segundo caso, la proteína recombinante 
se empleó en un ensayo de tipo homogéneo, utilizando nanopartículas de oro y medidas de 
desactivación de la fluorescencia. Este ensayo se realiza en una única etapa, sin la necesidad 
de lavados, reduciéndose el tiempo de análisis. La simplicidad y excelentes características 
analíticas de los métodos desarrollados son de gran utilidad para la determinación de 
micotoxinas en alimentos.
Mycotoxigenic fungi 
21 
1 Introduction 
1.1 Mycotoxigenic fungi 
1.1.1 FUNGAL SECONDARY METABOLISM 
Fungi are possibly the most diverse eukaryotic kingdom which has been estimated to comprise 
more than 1.5 million species including ubiquitous molds, yeasts, mushrooms, and polypores 
that are differentiated from plants and animals by their cell walls made of chitin and absorption 
as a mode of nutrition.1 Although fungi are most abundant in tropical regions they can be found 
worldwide, partly because they are versatile by virtue of their high degree of adaptability to a 
variety of conditions.2 Among the immense fungi kingdom there are several species which have 
served as important models for biomedical research, certain molds have become utterly 
renowned as producers of drugs, such as antibiotics, while others have been used in the 
production of cheese or in the fermentation of wine for centuries.1 At the same time, many fungal 
species also present severe threats to human health. Fungal infections can have lethal 
consequences on human and animals, as well as in crops where fungal contamination causes 
more economic damage than any other group of microorganisms.3 Fungi can also produce a 
range of toxic natural products which may pose severe health risks to humans and animals if 
they enter into the food chain. 
Most fungi can grow in a wide variety of different habitats, including soil and water, 
frequently as symbionts or endophytes with other organisms, including bacteria, plants, algae, 
and animals, and become essential to their survival.4,5 While some fungi obtain their nutrients 
from living hosts,5 others have been forced to develop different lifestyles and modes of 
interaction with their hosts, such as killing the host and living off the dead organism, or growing 
fast on the plant surface preventing the survival of other competitors.6,7 Fungi have also 
developed a number of strategies for protection and communication, one of which is the 
production of different types of secondary metabolites.1 
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Filamentous fungi, or molds, are multicellular organisms which grow by apical extension 
of their filaments.6 These species are recognized as producers of many interesting secondary 
metabolites with a remarkable bioactive nature. In fact, more than half of such isolated 
compounds have been reported to display antibacterial, antifungal or antitumor activity.8 
Secondary metabolites are usually produced late in the growth of the fungi, often upon entering 
the stationary or resting phase,9 and they are mainly synthesized by polymerization of primary 
metabolites by dedicated enzymes.8 The transcriptional activation of the genes encoding for 
these enzymes depends on the developmental stage of the fungi and is often a consequence of 
environmental stimuli, such as temperature, light, and nutritional input. Unlike primary 
metabolites which are essential for normal growth, development, or reproduction, the role of 
secondary metabolites is less obvious. Although secondary metabolites are not directly involved 
in any fundamental metabolic processes, they exhibit a variety of biological activities which can 
contribute to the survival of the fungi in its environment, be crucial in fungal development, or 
actively shape the interactions with other organisms.1 
The wide variety of bioactive secondary metabolites produced by filamentous fungi range 
from beneficial drugs and antibiotics to harmful toxins, and only a small fraction of them have 
been subjected to detailed analyses or have a commonly known biological function.5 In fact, the 
total number of fungal secondary metabolites has been estimated to be from 2000 to as many 
as 3 million unique secondary metabolites.10 Many of them have been found as the cause of 
intoxications, others are known for their antibacterial or pharmaceutically beneficial properties, 
whilst some remain simply as laboratory curiosities. Renowned secondary metabolites include, 
for example, natural pigment melanin which has been shown to have a protective role against 
ultraviolet (UV) damage and is required for the spore survival.9 Other secondary metabolites 
function as weapons for the fungi defense, although at physiologically relevant concentrations, 
these metabolites have also been suggested to act as signaling molecules rather than as 
toxins.8 Probably, the most prominent fungal secondary metabolites are antibiotics, such as 
penicillin, cephalosporin and other β-lactams, which have virtually revolutionized the treatment 
of infectious diseases. Other pharmaceutically important fungal secondary metabolites include 
immunosuppressive drugs, such as cyclosporin and mycophenolic acid which have an enormous 
clinical significance in organ transplantation.11 Some secondary metabolites, such as the 
gibberellins, are infamous for their role as plant growth hormones, or for their insecticidal 
properties like in the case of peramine and lolines.12 In fact, some toxic metabolites have been 
shown to protect the infected plants against insects suggesting their production as a possible 
manner for the fungi to limit competition for its food supply.13 Certain toxins, known as 
mycotoxins, which are toxic to vertebrates in distinction from other metabolites, such as 
antibiotics, which affect only prokaryotes or other eukaryotes,14 include a vast array of toxic and 
carcinogenic molecules which pose a severe threat to human and animal health.3
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1.1.2 MYCOTOXIN PRODUCTION BY FILAMENTOUS FUNGI 
Fungi that produce mycotoxins are referred to as mycotoxigenic fungi which include a wide 
variety of diverse fungal species which, in general, are not aggressive pathogens. The most 
important mycotoxins are produced primarily by three genera, Aspergillus, Penicillium, and 
Fusarium. Also, the genus Alternaria includes several mycotoxigenic species which play an 
important role in plant pathogenesis.15 Many mycotoxins are produced by several species in one 
genus, but some toxins can be produced by species in phylogenetically different genera  
(Table 1). Whether the production of related mycotoxins in different genera is caused by 
horizontal gene transfer or by parallel evolution is not yet known.16 Curiously, some strains are 
also known to produce different compounds or even produce the same compounds by different 
biosynthetic pathways.17 
Aspergillus genus is the main producer of aflatoxins, and it commonly affects corn, cotton, 
peanuts, and certain tree nuts. Although the genus is not considered to be a major cause of 
plant diseases, it has a huge agricultural impact due to the high toxicity of the mycotoxins 
produced. Certain species in this genus produce not only harmful but also beneficial 
metabolites, such as drugs, and they are widely used in biotechnology, for example for the 
production of hydrolytic enzymes.15,18 Species of the genus Alternaria are ubiquitous and 
abundant in the atmosphere as well as in soil, seed, and agricultural commodities. The genus is 
widely distributed in the environment and can infect more than 4000 host plants. These species 
are not only pathogenic to plants, causing spoilage and significant economic losses, but they 
also produce a wide variety of toxic secondary metabolites, mainly phytotoxins.15,19 The genus 
Penicillium has its claim to fame as the producer of the first antibiotics discovered nearly a 
century ago, although some species of the genus are also renowned plant pathogens or 
mycotoxin producers. Penicillium fungi are typically associated with the storage of crops and the 
production of mycotoxins such as ochratoxin.10 This complex genus, in terms of the number of 
species and range of habitats, is of great economic importance primarily as a cause of food and 
feed spoilage.19 
Genus Fusarium is an extensively studied and widely-spread fungi. This genus has been 
associated as endophytes or with plant diseases with virtually every plant family, and thus 
Fusarium contamination can result in significant economic losses. Moreover, many Fusarium 
species are known to directly incite diseases in plants, humans, and domesticated animals, and 
they are notorious producers of several mycotoxins.20 Variety of diseases caused by Fusarium 
in plants include root and stem rots, cankers, wilts, fruit or seed rots, and leaf diseases. In small 
grains, such as wheat and barley, Fusarium produces Fusarium head blight, a disease which is 
mainly associated with temperate regions and leads to serious reductions in the grain quality.21 
While some Fusarium strains have a wide host range and can colonize a variety of different 
crops, others are more restricted, such as F. verticillioides which is associated only with maize 
that can be infected with Fusarium ear rot.17 Interestingly, Fusarium fungi can also grow as 
apparently symptomless endophytes under many conditions.20 Thus, although fungal infections 
in the field are primarily transmitted by airborne spores, also infected but asymptomatic seeds 
can spread the infection.22 Moreover, largely as a consequence of their ability to live without 
oxygen, species of Fusarium occur in almost every environment making them probably the most 
prevalent pathogen in maize and many other grains.14,23 
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Table 1. Examples of the most common mycotoxin-producing fungi and agricultural products commonly 
affected by these species.14–16,20,24 
Fungi species  Commodities affected Major mycotoxins produced 
Aspergillus   
 A. flavus Ubiquitous in foods, mainly maize, peanut, and cottonseed 
AFB1 and AFB2 
Cyclopiazonic acid 
Sterigmatocystin 
 A. parasiticus Peanut, maize, cotton, spices, walnut AFB1 and AFB2 AFG1 and AFG2 
 A. niger Grapes, maize, coffee, peanuts OTA FB2, FB4, FB6 
 A. carbonarius Grapes, coffee, spices OTA 
 A. ochraceus Maize, peanuts, cottonseed, rice, cereal grains, coffee, spices 
OTA, ochratoxins B and C 
Penicillic acid 
Penicillium   
 P. citrinum Cereals, foods, feedstuffs CIT 
 P. verrucosum Cereals, stored grains, cured meat, cheese 
OTA, CIT 
Cyclopiazonic acid 
Tenuazonic acid 
 P. expansum  Fruits, especially apples 
Patulin 
Tenuazonic acid 
CIT 
Fusarium   
 F. graminearum Maize, wheat, barley DON, nivalenol  ZEA, zearalanone, zearalanol 
 F. culmorum Cereals 
DON, nivalenol 
HT-2 toxin 
ZEA, zearalanone 
 F. oxysporum Several crops, such as bean, cotton, potato, tomato, and banana 
FB1, FB2, FB3  
Enniatins 
 F. proliferatum Maize, wheat, sorghum, mango, asparagus 
FB1, FB2, FB3, FB4 
Moniliformin 
Beauvericin 
 F. verticillioides Maize 
FB1, FB2, FB3 
DON 
Zearalanone 
 F. sporotrichioides Maize, small grains 
T-2 toxin 
HT-2 toxin 
Beauvericin 
Alternaria   
 A. alternata Tomato, pear, apple, strawberry Alternariols 
 A. tenuissima Tomato, grapevine, strawberry Alternariols Tenuazonic acid 
Abbreviations: aflatoxin B1/B2, AFB1/2; aflatoxin G1/G2, AFG1/2; citrinin, CIT; deozynivalenol, DON; fumonisin B1–6, 
FB1–6; ochratoxin A, OTA; zearalenone, ZEA. 
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As a genus, Fusarium lacks certain morphological characters that can be used to easily 
differentiate the species, which has led to a somewhat confusing nomenclature among this 
family.20 When the genus was first introduced in 1809, the primary character of Fusarium was 
the presence of a distinctive canoe- or banana-shaped conidia, but to date many Fusarium 
species have been poorly defined and characterized, and different biologies of morphologically 
similar strains have complicated the study of Fusarium.20 Among the Fusarium genus, 
F. verticillioides and F. proliferatum, are among the most significant producers of toxic 
mycotoxins.25 F. proliferatum is known to cause diseases worldwide in many crops, most 
important one being maize,20 and it has been reported to produce a wide variety of mycotoxins 
often at high levels. The wide host range of this fungus has resulted in recovering these toxins 
from seemingly unlikely sources, such as asparagus or garlic.20 The macroconidia of 
F. proliferatum is similar to other species in Fusarium fujikuroi species complex (formerly known 
as the Gibberella fujikuroi species complex), and in fact, F. proliferatum is easily confused with 
F. fujikuroi, F. oxysporum, F. thapsinum, and F. verticillioides. Another important mycotoxin 
producer, F. verticillioides, formerly known as F. moniliforme, is one of the most prevalent seed-
borne fungi associated with maize worldwide,26 and it is known not only as a mycotoxin producer 
but also for being allergenic to human and capable of infecting cancer.20 
Due to the wide diversity of mycotoxin-producing fungi in a wide variety of crops both 
before and after the harvest, it is difficult to make general statements about the occurrence of 
the mycotoxigenic fungi. Some toxigenic species, mainly from Fusarium and Alternaria genera, 
are often classified to as “field fungi” because they require very high moisture content, whereas 
“storage fungi,” such as Aspergillus and Penicillium, can also grow in low moisture 
environments.19 More commonly these species occur in temperate regions, and climate change 
due to global warming has been estimated to alter the incidence of toxigenic fungi and even 
modify host resistance and host–pathogen interactions.15 In addition to crops and plants, 
certain mycotoxigenic fungi, for example some species of Fusarium and Aspergillus, have been 
found in moisture-damaged buildings.27 
Furthermore, the occurrence of mycotoxigenic fungi and subsequent mycotoxin 
contamination are affected by numerous external factors. Some are related to the susceptibility 
of crops, plant stress, harvesting practices, and storage of grains. First of all, fungal growth itself 
depends on favorable environmental conditions, and therefore, their occurrence varies among 
geographical areas and is strain-specific.28 For example, infection and ear rot by F. verticillioides 
and F. proliferatum, along with subsequent mycotoxin contamination, are more common in 
warm and dry weather, and, although not conclusive in all crops, high temperatures seem to 
play a role for example in aflatoxin contamination.10 Additionally, some microenvironmental 
factors are known to be a factor in mycotoxin production. For instance, the nitrogen and carbon 
sources that the fungi utilize as well as the pH of the environment are known to modulate 
mycotoxin production at the cellular level. Moreover, many epigenetic factors and 
environmentally activated genes have been identified to be relevant at the genomic level for 
certain mycotoxins. Production of mycotoxins also depends on when the infection occurs and 
on the host environment.29,30 For example, insect damage is known to play a large role in 
mycotoxin contamination in several species.15 
Although it is widely acknowledged that mycotoxins are usually produced to protect the 
fungi against other organisms, it still remains partly unanswered when and how fungi produce 
these toxins.21 Proper harvesting practices and storage conditions are known to be a factor in 
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the initiation of fungal contamination and mycotoxin production.29 Fungal contamination can be 
prevented by correct harvesting techniques, such as harvesting at the appropriate time after 
maturation of plants and inspecting of the harvesting equipment and storage facilities before 
the harvest.29 Nevertheless, for the detection of a fungal infection and the potential for 
mycotoxin contamination, it is essential to develop methods to determine the presence of these 
mycotoxigenic species. 
1.1.3 CONVENTIONAL METHODS FOR FUNGAL ANALYSIS 
In order to detect mycotoxins or prevent their formation, it is essential to identify their producers. 
However, it has been a difficult task because the taxonomy of mycotoxigenic fungi is complicated 
and many taxonomical concepts have changed over the last centuries. Moreover, although the 
identification methods have rapidly evolved, many laboratories working with mycotoxins lack the 
required equipment for the most sophisticated analyses. As a result, there exists a number of 
misidentifications and incorrect connections between fungal species and mycotoxin 
production.16 
Conventionally toxigenic fungi have been identified mainly based on morphological and 
cross-fertility criteria. However, recognition of the morphological characters is not always enough 
to accurately identify fungal isolates at the species level. In fact, these analyses are time-
consuming and demand expertise in taxonomy and physiology of the fungi.21 Accurate 
morphological characterization requires that the fungus is subcultured and handled with care, 
and moreover, growing fungus in a media that is appropriate for the morphological features to 
develop can take several weeks.20 At the same time, the taxonomy of mycotoxigenic fungi is 
intricate, especially within the genera Penicillium, Aspergillus, Alternaria, and Fusarium, and the 
classification is still in a state of flux and new species continue to be described.16 For these 
reasons, molecular diagnostics can offer interesting alternatives, although differentiation of 
some closely related species remains challenging.20 
The availability of next-generation sequencing in the 21st century has significantly changed 
the concepts of fungal identification. As the genes responsible for the most important fungal 
contaminants have been identified, with alpha taxonomy and reliable sequence databases the 
presence of fungi in crops can be identified.31 Thus, the development of methods for fungal 
detection based on polymerase chain reaction (PCR) has arisen as an alternative for culture-
based methods. Since PCR-based methods are not dependent on the morphology and 
cultivability of the fungi, they can provide more reliable results and offer the possibility for 
multiplexing. PCR allows ampliﬁcation of speciﬁc DNA fragments even from complex samples, 
and the amplified PCR products can be observed after gel electrophoresis and staining with DNA 
binding dyes.21 More advanced technologies, such as real-time PCR, also known as quantitative 
PCR (qPCR),32 have enabled monitoring DNA amplification in real time by using fluorescent 
reporter molecules. The fluorescence produced by the reporter increases as the reaction 
proceeds proportionally to the accumulation of the PCR product after each amplification cycle, 
which allows fast detection, identification, and quantification of the target. On the other hand, 
PCR has been combined with different technologies, such as restriction fragment length 
polymorphism, denaturing gradient gel electrophoresis, single-strand conformation 
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polymorphism, microsatellite length polymorphism, or enzyme-linked immunosorbent assays 
(ELISA).16 
Some recommendations for identifying fungal species involve initial recognition of the 
fungal genus using morphological criteria and subsequent validation using molecular methods. 
Thus, in practice, fungal isolates are grown on a battery of indicative media and identified based 
on a combination of morphological, physiological, nutritional, and chemical data. For example, 
Fusarium isolates can be identified on Specifikke nutrient-arme agar (SNA), potato dextrose agar 
(PDA) and yeast extract sucrose (YES) agar.20 Confirmatory analyses are often achieved by a 
BLAST (basic local alignment search tool) search of the DNA sequence of specific house-keeping 
genes, such as β-tubulin and calmodulin genes which usually provide good resolution at the 
species level.16 
PCR can also target conserved functional genes or regions of taxonomical interest, or 
alternatively, focus on the genes involved in mycotoxin production.16 For example, the 
biosynthetic pathway of fumonisins has been extensively studied and is known to be linked to 
17 fumonisin biosynthetic (FUM) genes. The FUM gene cluster has been described in several 
fumonisin producers, and primer pairs designed for these sequences, mainly to FUM1, FUM6, 
and FUM8, have been used to detect fumonisin-producing Fusarium strains by PCR.16 Real-time 
reverse-transcriptase (RT) PCR assays have been used to correlate the expression levels of 
FUM1 and FUM19 and fumonisin production in F. verticillioides. Moreover, specific primers 
designed on the FUM1 and FUM19 have enabled differentiation of closely related species, such 
as F. verticillioides and F. proliferatum.33,34 On the other hand, the ribosomal genes include 
highly conserved parts, the 18S, 5.8S, and 28S units, which are separated from each other by 
two internal transcribed spacer regions (ITS1 and 2), and the repeated modules are linked by 
internal spacer regions (IGS). These spacer regions include high variability between different 
species and can be used to distinguish even closely related species. Furthermore, the multi-
copy nature of ribosomal DNA is beneficial when quantifying small quantities of DNA. In 
comparison to assays using single-copy genes, the sensitivity can be more than 100 times 
better.16,35 
Undoubtedly, novel molecular technologies have made significant contributions to the 
identification, characterization, and detection of fungal species. Moreover, the available 
databases of genomic DNA sequences and the increasing understanding of fungal epigenetics 
have simplified the design of new assays. Various methodologies and platforms reported in 
recent years for the detection of mycotoxin-producing fungi in food commodities have been 
established as an important tool for environmental and food safety. In this regard, the 
development of molecular technologies have also had a substantial influence on research in 
plant pathology, the management and control of plant disease.16
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1.2 Mycotoxins 
1.2.1 ORIGIN AND NATURE 
The word mycotoxin, a combination of the Greek word for fungi or mold, mykes, and the Latin 
word toxicum meaning poison,36 was originally established in 1962, after an unprecedented 
veterinary crisis in England, during which nearly 100 000 turkeys died of a mysterious “Turkey X” 
disease.37 The incident was linked to the intake of moldy feed contaminated with toxic secondary 
metabolites from Aspergillus flavus and prompted the research on the toxicity and prevalence 
of these compounds identified as aflatoxins marking the beginning of what is often considered 
as modern mycotoxicology.10,18 Despite the relatively short history of the word mycotoxin, the 
appearance of these toxins in food and feed has been suggested to origin back to the early 
stages of agricultural history for up to 10 000 years ago when cultivation and storage of crops 
began thus creating a new ecological niche for fungal growth.31 
Mycotoxins are defined as low molecular weight products which are produced as 
secondary metabolites by filamentous fungi. This assemblage is chemically and toxigenically 
rather heterogeneous, but generally these toxins are known to cause disease and death in 
human and other vertebrates.38 As secondary metabolites mycotoxins are not directly involved 
in fundamental metabolic processes, and they have no necessary function in the life cycle of the 
producer cells. Nonetheless, secondary metabolites usually have a role in a range of cellular 
processes such as transcription, development, and intercellular communication,39 and although 
the complete function of mycotoxins is not understood, they are believed to display different 
biological activities which contribute to the survival of the fungi possibly by eliminating 
competing microorganisms from their growth environment.1,14 Although all mycotoxins are of 
fungal origin, not all toxic compounds produced by fungi are classified as mycotoxins. Fungal 
products which are mainly toxic to bacteria, such as penicillin, are called antibiotics, whilst 
products toxic to plants are called phytotoxins.38 On the other hand, mycotoxicoses, i.e., 
diseases caused by mycotoxins, do not include mushroom poisonings which result from 
intentional consumption of mushrooms as food.17 
Mycotoxins are usually very stable molecules which are produced by several genera, the 
most important ones being Penicillium, Aspergillus, and Fusarium species. Major crops 
commonly infected by these fungal species include cereals, cocoa, coffee, nuts, fruits, and 
beans.1 Mycotoxins are heat-stable, and thus they are not destroyed by normal industrial 
processing or cooking and cannot be eliminated entirely without damaging the food.14,23 
Essentially, mycotoxin contamination is often inevitable due to the widespread of mycotoxigenic 
fungi, particularly in temperate and tropical regions of the world, and some calculations have 
estimated that approximately 25–50% of world crops are contaminated with mycotoxins,40 
making mycotoxins a major problem in food safety.
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1.2.2 MYCOTOXINS AND FOOD SAFETY 
More than 200 diseases, ranging from diarrhea to cancers, are related to food contaminated 
with natural toxins, harmful bacteria, viruses, parasites or other chemical substances, and the 
World Health Organization (WHO) has estimated that annually the death of 2 million people can 
be linked to unsafe food.41 Food contamination can occur at any point during production, 
storage, distribution or preparation of foodstuffs, and thus it is essential that the entire 
production chain, from producer to consumer, is aware of the risks of unsafe food and the 
regulations set by the authorities to guarantee food safety. 
A particular concern is related to low molecular weight food contaminants, such as 
mycotoxins, which are often hard to detect owing to their small size. The occurrence of 
mycotoxins in food can have major consequences, including fatal health effects and serious 
economic implications due to losses of food and feedstuff and diminished animal production.16 
Several severe incidents caused by mycotoxin contamination leading to intoxications in both 
human and animals are known throughout history.1 The oldest recognized mycotoxicosis in 
humans occurred in the medieval times when an epidemic of ergotism, known as St. Anthony 
fire, arose as a consequence of fungal contamination in grains and was traced back to infection 
by the fungus Claviceps purpurea.10 Several similar incidents have been reported, for example, 
cardiac beriberi in Japan during the 19th and 20th centuries which was connected to moldy rice 
contaminated with Penicillium, or the alimentary toxic aleukia, described in particular in the 
Soviet Union during World War II, which was associated with consuming grains contaminated 
with Fusarium.31 Despite the increasing knowledge on mycotoxins as well as the actions for their 
detection and prevention, still in the 21st century some incidents of severe mycotoxicoses have 
been reported, such as aflatoxin poisoning in Kenya in 2004 leading to death of 125 people,42 
and aflatoxicosis in dogs after exposure to contaminated commercial dog food in the USA in 
2005.43 
Mycotoxins can be acutely or chronically toxic, or both at the same time, depending on the 
type of mycotoxin in question, the extent and duration of the exposure, the health and age of 
the exposed individual, as well as many other poorly understood synergistic effects involving 
genetics, dietary status, and interactions with other toxins.14,38,40 Exposure to mycotoxins occurs 
mostly by ingestion of contaminated food, although it can also follow dermal contact or 
inhalation of toxicogenic molds containing mycotoxins.14,40 Regardless of the way they get in 
contact with humans or animals, mycotoxins generally cause lowered performance, sickness, or 
even death already at very low concentrations.31,38 Their range of actions include cytotoxic, 
nephrotoxic, hepatotoxic, teratogenic, mutagenic, carcinogenic, immunosuppressive, or 
estrogenic effects (Table 2).1,40 Generally, the toxic effects of mycotoxins, are better understood 
in animals than in humans since the experimental studies appear more reliable.14 While the 
health effects count for the most significant risk of mycotoxin contamination also the economic 
losses caused by mycotoxins and fungal contamination are worth mentioning. The economic 
consequences are diverse and can be associated with a reduction of food quality, reduction in 
animal production due to diseases or feed refusal, as well as increasing medical costs of 
mycotoxicosis treatments.29,31 
Several national and international institutions and organizations, such as WHO, the 
European Commission (EC), the US Food and Drug Administration (FDA), and the Food and 
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Agriculture Organization (FAO) of the United Nations, have recognized the potential risks posed 
by mycotoxin contamination and addressed this problem by adopting laws and regulatory limits 
for major mycotoxin classes and selected individual mycotoxins.44 For example, the European 
Food Safety Authority (EFSA) has been established to scientifically evaluate and communicate 
on the risks associated with the food chain with a central goal to protect consumer health by 
guaranteeing a high level of food safety. A key element of this is testing foodstuffs for the 
presence of various chemical and biological hazards and setting up regulatory limits to 
guarantee safe food for the consumer.45 European Commission regulations and 
recommendations have established maximum residue limits (MRLs) for the major mycotoxins, 
including aflatoxins, ochratoxin A, patulin, deoxynivalenol, zearalenone, fumonisins, T-2 and 
HT-2 toxins, citrinin, and ergot alkaloids in food and feeds.46–52 
Although the awareness related to the hazards of mycotoxins as food and feed 
contaminants is growing, there are no absolute measures available for eliminating mycotoxin 
contamination. While mycotoxin occurrence in the field can be decreased by good agronomic 
practices and planting resistant varieties, in the end, analytical methods capable of detecting 
mycotoxins even at low concentration are of key importance for ensuring food safety. Despite 
the efforts, as yet, many countries still lack appropriate guidelines to protect the consumers 
from the harmful effects of mycotoxins. Moreover, although the regulations in many countries 
are based on worldwide recommendations, there still remains a need for the regulations to be 
harmonized from country to country especially where trade contracts exist. Also, some concern 
has been raised about the regulatory levels becoming more strict as a response to the 
development of more sensitive detection methods rather than basing them on realistic health 
effects.10,17 
1.2.3 OVERVIEW OF THE MOST ABUNDANT MYCOTOXINS 
Following the discovery of aflatoxins in the 1960s, numerous other mycotoxins have been 
identified and nowadays far more than 400 compounds, produced by some 350 fungal species, 
have been described in the literature.14 Currently, approximately 30 mycotoxins are considered 
a threat to human and animal health due to their toxic effects.38 The major classes of mycotoxins 
are aflatoxins, ochratoxins, fumonisins, trichothecenes, zearalenone, and ergot alkaloids  
(Table 2). The classification of mycotoxins can be considered challenging due to their diverse 
chemical structures and biological effects. Whilst mycologists classify mycotoxins by the fungi 
that produce them, organic chemists have tried to classify them by structure, physicians and 
clinicians by the illness they cause or by the organ they affect, and biochemists according to 
their biosynthetic origin.38 
Aflatoxins (AF), produced mainly by Aspergillus flavus and Aspergillus parasiticus in grains 
and legumes, are the most dangerous mycotoxins worldwide due to the widespread human 
exposure to high levels of aflatoxins and their carcinogenic properties. The naturally occurring 
aflatoxins are AFB1, AFB2, AFG1, and AFG2, for which “B” and “G” refer to the blue and green 
fluorescent colors produced by these compounds under UV light, among which AFB1 is the most 
abundant and toxic.1 In fact, AFB1 is recognized as one of the most efficient inducers of liver 
cancer, and the International Agency for Research on Cancer (IARC) has included naturally 
occurring aflatoxins in group 1 carcinogens, considering the high degree of risk of this toxin to 
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human health.53 In addition to the chronic effects, aflatoxin exposure may cause acute 
aflatoxicosis with vomiting, abdominal pain, hepatitis, and even death.54 
Ochratoxins were the first group of mycotoxins identified after the discovery of aflatoxins.14 
Ochratoxin A (OTA), which is mainly produced by Aspergillus ochraceus, Aspergillus carbonarius, 
and Penicillium verrucosum, is a common mycotoxin because of the widespread of these fungal 
species which can grow in a wide range of conditions in both warm and cool climates.1,29 
Ochratoxins have been frequently isolated from cereal crops, meat products, and cheese 
varieties. The toxic mechanisms of OTA include inhibition of protein synthesis and disruption of 
hepatic microsomal calcium homeostasis.14 OTA has been classified as a possible human 
carcinogen (group 2B) by IARC.53 
Fumonisins, a group of polyketide mycotoxins produced mainly by Fusarium verticillioides 
and Fusarium proliferatum, were discovered in 1988 as a result of many years of studying the 
moldy corn poisoning in horses, known as equine leukoencephalomalacia.55,56 These toxins 
were recognized to be highly hepatotoxic and cardiotoxic in rats and were also linked to porcine 
pulmonary edema in pigs.57 Later studies have identified fumonisins as the cause a variety of 
diseases in animals,58 including both liver and kidney tumors in rodents,25 and they have been 
linked to human carcinogenesis59 and neural tube defects,60 as well as plant diseases.61 At least 
15 different fumonisins have been identified,26 among which fumonisin B1 (FB1) is the most 
prevalent and toxic. Based on animal studies and cases of human esophageal cancer, IARC has 
categorized FB1 as possibly carcinogenic to humans (group 2B).53 FB1 bears a similar structure 
as cellular sphingolipids, and the toxicity of fumonisins appears to be a result of the interference 
in the metabolism of sphingolipids by inhibiting the enzyme ceramide synthase.1,26 Fumonisins 
are common contaminants in maize but can also occur, for example, in wheat, sorghum, barley, 
soybean, and black tea. Because of the similar growth conditions of the toxigenic fungal species, 
fumonisins often co-occur with aflatoxins, especially in maize.29 Fumonisins differ from most 
known mycotoxins by their hydrophilic nature which makes them difficult to study and potentially 
more harmful to human health, as they can remain undetectable most of the time. Moreover, it 
raises the specter that there might be many other mycotoxins yet to be discovered due to their 
hydrophilic nature.38,40 
Trichothecenes are a large class of mycotoxins produced by several fungal genera, mainly 
Fusarium. They are nonvolatile low molecular weight compounds which share a common 12,13-
epoxytrichothene skeleton that is responsible for their toxicological activity which is due to 
inhibition of protein or DNA synthesis or inhibition of the mitochondrial electron-transport 
system.14,29. Among the trichothecenes, deoxynivalenol (DON), produced mainly by Fusarium 
graminearum and Fusarium culmorum, is the most common and most widely studied, although 
also amongst the least toxic.38 Type B trichothecene DON occurs mostly in grains such as wheat, 
barley, oats, rye, and maize throughout the world, and its capacity to provoke vomiting episodes 
in various species including humans clarifies its commonly used nickname “vomitoxin”.1 
Highly similar T-2 and HT-2 toxins are type A trichothecene mycotoxins which are closely 
related epoxy-sesquiterpenoids produced by several Fusarium species. Both of these toxins 
have been found in grains, such as wheat, maize, oats, barley, rice, and beans.25 HT-2 toxin and 
T-2 toxin, which is often rapidly metabolized to the former, are relatively stable withstanding 
grain processing, baking, and cooking, and in some cases, these toxins can even be enriched in 
cereal by-products.62 The toxic effects of T-2 and HT-2 toxin include the inhibition of protein 
synthesis which also affects the synthesis of immunoglobulins and the humoral immunity.25,62 
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Zearalenone (ZEA) is produced by different species of Fusarium fungi which are 
pathogenic to cereal crops worldwide. Production of ZEA takes place mainly in temperate 
conditions before harvesting, but might also occur during or after harvest if the crops are not 
handled or dried properly.1 The classification of zearalenone as mycotoxin is somewhat 
controversial; while it is biologically potent, the effects are hardly toxic, and in fact, it resembles 
17β-estradiol and has thus been suggested to be classified rather as a nonsteroidal estrogen 
or mycoestrogen.38 
Citrinin is a mycotoxin commonly found in maize, wheat, rye, barley, oats, and rice, and it 
is recognized mainly for its nephrotoxicity. Citrinin was first extracted from a culture of 
Penicillium citrinum but has been later found to be produced by species from Penicillium, 
Aspergillus, and Monascus genera. Interestingly, citrinin displays antibiotic activity against 
Gram-positive bacteria and has been described as a promising insecticide, although its 
application as a drug has been limited because of the high toxicity.14 
Other well-known mycotoxins include for example ergot alkaloids which are the cause of 
ergotism, one of the oldest recognized mycotoxicoses, produced primarily by several species of 
plant pathogenic Claviceps, and patulin which is commonly found in apples and apple products, 
and occasionally in other fruits.1 Additionally, the so-called “emerging mycotoxins” have raised 
concern in recent years. This group includes, for example, fusaproliferin, beauvericin, enniatins, 
and moniliformin. At the moment there is little available knowledge available on these toxins, 
but recent research efforts are focusing on determining their toxicity and occurrence.29 
Moreover, the presence of toxin precursors, metabolites, degradation products, or the so-called 
masked mycotoxins also represents a potential threat to consumer safety. The presence of 
these compounds may increase the toxicity of food commodities with an apparently low 
concentration of the parental toxin. Besides, their detection is in many cases still in its infancy. 
Such metabolites and masked mycotoxins have been reported at least for trichothecenes, 
fumonisins, ochratoxins and zearalenone.25 
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Table 2. Most abundant and toxic mycotoxins and their toxic effects.1,14,38,53,63–66 
Mycotoxin Structure Mechanisms  of toxicity Effects 
Aflatoxins (AF) 
    AFB1, AFB2 
    AFG1, AFG2 
      AFM1 
 
DNA damage by 
the metabolized 
8,9-epoxide 
form of AFB1 
Acutely toxic, 
carcinogenic, 
immunosuppressive 
mutagenic, 
hepatotoxic, 
teratogenic 
Citrinin (CIT) 
 
 
Inhibition of RNA 
and DNA 
synthesis, 
induction of 
oxidative stress 
Cytotoxic and 
nephrotoxic 
Deoxynivalenol 
(DON) 
 
 
Inhibition of 
protein 
synthesis by 
binding to 
ribosomes 
Cytotoxic and 
genotoxic, causes 
nausea, vomiting, 
and diarrhea 
Fumonisins 
     FB1 
     FB2 
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sphingolipid, 
phospholipid 
and fatty acid 
metabolism 
Hepatotoxic, 
carcinogenic, 
teratogenic 
Ochratoxin     
     OTA 
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Carcinogen, 
nephrotoxic, 
teratogenic, 
immunosuppressive 
Patulin 
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apoptosis 
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T-2 toxin 
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1.2.4 CONVENTIONAL METHODS FOR MYCOTOXIN ANALYSIS 
As the presence of mycotoxins is presently unavoidable, management strategies have been 
implemented to prevent the contaminated commodities from entering into the food chain. In 
2003, the Council for Agricultural Science and Technology stated that the development of new 
technologies for mycotoxin analysis and improvement of detection (with specificity) of 
mycotoxins in prepared foods should be one important area of research that needs to be 
addressed in order to provide a safer food and feed supply in the 21st century.10 Moreover, the 
requirement to meet the regulatory limits set by national and international authorities has 
prompted the development of a vast number of analytical methods for the identification and 
quantification of mycotoxins.25 
Mycotoxins comprise a variety of different structures and occur in varying concentration 
ranges in a wide range of agricultural commodities, foodstuffs, and biological samples, and 
therefore, it is rather impossible to develop a single standard protocol for their analysis and 
detection. Thus, most methods target only individual mycotoxins, or at best a group of closely 
related mycotoxins. In principle, the detection methods can be divided into chromatographic 
methods, which are based on separation and detection of the toxins by different detectors, and 
bioanalytical assays or biosensors which rely on specific biorecognition elements capable of 
recognizing the target mycotoxin. The method chosen for each particular application should 
consider the sensitivity required, available instrumentation and expertise of the person 
performing the analysis, as well as the cost and analysis time.25,67 
On the other hand, mycotoxin monitoring includes not only the analysis or quantification 
step but also the sampling and sample preparation.16 Sampling refers to all the operations that 
are applied to a lot of an agricultural product and lead to a laboratory sample. This step specifies 
the size of the sample and how it is selected or taken from the lot, and it is often a major source 
of variability in mycotoxin analysis. Sample preparation includes grinding, homogenizing and 
sub-sampling in order to obtain an analytical portion for the actual analysis. This test portion is 
further solvent-extracted, most commonly with organic solvents, such as methanol, acetonitrile 
or acetone, depending on the physical properties of the analyte, and finally, the sample is 
analyzed to determine the mycotoxin concentration.16,25 
Thin-layer chromatography (TLC) was the first chromatographic method to be applied to 
mycotoxin detection, and although nowadays it has been mainly replaced by more advanced 
techniques, TLC is still routinely used to some extent, for example, in developing countries. 
Additionally, TLC methods have been approved as AOAC International official methods for 
several mycotoxins, such as aflatoxins, OTA, DON, ZEA, and patulin. Improvements to the basic 
TLC include the use of high-performance TLC plates, two-dimensional and bi-directional TLC, 
quantification by fluorescence densitometry, or combined with surface-enhanced Raman 
spectroscopy.16,68,69 
The predominant chromatographic method for mycotoxin detection is high-performance 
liquid chromatography (HPLC). The small size and polarity of most mycotoxins make them ideally 
suited for separation by reverse-phase HPLC using a variety of mobile phase compositions made 
up of water, methanol and acetonitrile or mixtures of these.16 Most commonly HPLC separation 
is coupled with UV and fluorescence detectors which use either the natural UV absorption or 
fluorescence of the analyzed mycotoxins or suitable derivatization methods. For example, 
fumonisins and type A trichothecenes which naturally lack a UV absorption band require 
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derivatization before HPLC analysis.16 Coupling of HPLC to mass spectrometry (MS) detection 
has enabled the development of analytical methods for the simultaneous quantification of 
mycotoxins, and it is considered as the reference method for unequivocal mycotoxin 
identification.16,70 Recent developments in this field have provided interesting alternatives for 
the simultaneous detection of multiple mycotoxins, and moreover, MS-based detection has also 
contributed to the discovery unknown mycotoxins.16,71,72 Also, some methods based on gas 
chromatography (GC) have been introduced, mainly for trichothecenes,73,74 but the application 
of this technique for mycotoxin analysis is limited by the polarity of mycotoxins and often requires 
derivatization before injection into the GC column.16 Chromatographic methods are useful for 
the separation and quantification of highly similar compounds, such as different analogs of 
aflatoxins or fumonisins. However, they usually require labor-intensive sample preparation, for 
example using immunoaffinity columns (IAC)75,76 or solid-phase extraction sorbents (SPE).77,78 
Moreover, despite the high sensitivity and specificity that can be achieved with these methods, 
they require expensive and bulky instrumentation and skilled personnel to perform the 
analysis.69 
Biosensors and bioanalytical assays are usually more appropriate for applications where 
fast and simple analysis are preferred, perhaps with the cost of slightly lower sensitivity. 
Immunochemical methods which rely on the high sensitivity and specificity achieved by 
mycotoxin-specific antibodies might not reach the accuracy and precision of chromatographic 
methods but have several advantages, such as simplicity, speed, and applicability to analyses 
in field conditions.25 For example, widely used ELISAs, in contrast to chromatographic methods, 
do not usually require profound sample clean-up but can be combined with fast extraction step 
in aqueous methanol or acetonitrile followed by dilution of the extract to avoid the matrix 
effect.16 Moreover, the speed and low cost usually make ELISA a superior option over HPLC 
when a large number of samples are screened for a single mycotoxin. In their simplest format, 
ELISAs can be based on visual detection or colorimetric readers, but higher sensitivity can be 
achieved with fluorescent or chemiluminescent detection, and the development of biosensors 
can also offer real-time readout and even perform the entire process automatically.67,79  
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1.3 Biosensors for mycotoxin monitoring 
1.3.1 GENERAL CONCEPTS AND DEFINITIONS 
The importance of monitoring and regulating various biologically significant molecules in many 
different disciplines, such as clinical chemistry, environmental protection, drug discovery, 
forensics, and food industry, has provoked the development of reliable analytical devices 
capable of accurate analysis.80–85 Biosensors can provide rapid, sensitive, low cost, real-time, 
and on-site analysis with compact and low power devices, and owing to their appealing 
advantages they have emerged as one of most interesting approaches to overcome the 
limitations of many conventional methods, for example, for environmental monitoring and point-
of-care medical applications.86 
A chemical sensor, a device which is capable of transforming chemical information into 
an analytically useful signal, conventionally contains two components, a receptor which is 
responsible for the chemical or molecular recognition and a physicochemical transducer which 
subsequently transforms the recognition event to a measurable signal.87 A chemical sensor 
becomes a biosensor when the recognition system is based on a biochemical mechanism.88,89 
The high specificity and sensitivity of biomolecular recognition, which is typically driven by a 
concert of many weak interactions, is the cornerstone of a wide range of diagnostic and synthetic 
technologies, such as biosensors.90 Biosensors come in all shapes and sizes, so to say, and 
whilst several factors affect their performance, the receptor and the transducer account for the 
most crucial elements. The essence of the specific target recognition relies on the receptor 
which is capable of binding to the target analyte with sufficient specificity and sensitivity. 
Biosensors can be classified according to the type of the receptor or recognition element, for 
example as immunosensors or aptasensors when based on antibodies and aptamers, 
respectively. On the other hand, the transducer generates an output signal and thus provides a 
means to measure the biorecognition event. In terms of the transducer properties, biosensors 
can be classified as electrochemical, electrical, optical, mass sensitive, thermometric, 
micromechanical, or magnetic sensors.89,91,92 
Within the scope of biosensors or bioaffinity assays, various concepts have been 
developed for analyte detection. Direct methods are capable of measuring direct binding of the 
target analyte to a usually immobilized recognition element. However, frequently the 
biorecognition is based on non-competitive or competitive assay formats. Figure 1 represents a 
schematic of the most common assay formats used in immunoassays although the same 
concepts can be further applied to other biosensors or bioaffinity assays using different 
recognition elements. Non-competitive assays are most often based on two recognition 
elements which bind simultaneously to the target and are used in excess (Figure 1A). The 
competitive, or reagent-limited, assays in turn are based on the competition of the target analyte 
with a labeled analyte analog for a limited number of binding sites (Figure 1B). Thus, the labeled 
analyte, also referred to as the tracer, provides a means of assessing the amount of the free 
and bound analyte.93 This competitive principle, where the signal intensity correlates inversely 
to the concentration of the analyte, formed the basis for the very first immunoassays 
described,94 and since then it has been widely used in various applications, even though the 
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format shows some fundamental limitations. Firstly, competitive affinity assays are inherently 
less sensitive than non-competitive ones, partly because the sensitivity of a competitive assay 
is mainly governed by the equilibrium constant of the recognition element and alternative assay 
designs or label technologies are not able to provide as significant improvements as in non-
competitive ones.93 Moreover, labeling of the analyte can be challenging or result in randomly 
cross-linked or unstable molecules, which can affect the biorecognition. Nevertheless, small 
molecules which are not capable of binding more than one recognition element at a time 
conventionally must be detected using a competitive assay format. 
On the other hand, bioaffinity assays can also be classified as heterogeneous or 
homogeneous, regardless of being competitive or non-competitive. Heterogeneous assays rely 
on a solid surface where one of the assay components is immobilized (Figure 1A–B) and washing 
steps are used to remove the unbound reagents. The separation step and high binding capacity 
of the solid surface can have significant effects on the assay performance. Most frequently used 
solid phases range from microparticles to microtiter plates where the immobilized compound, 
be it the recognition elements or the competitor, can be merely absorbed by non-specific 
interactions or immobilized by different covalent or site-specific coupling methods. Although the 
physical coupling of the recognition element often restricts its movement to some extent and 
affects the reaction kinetics, it should not disturb the target binding remarkably.93 Commonly, 
multiplexing in heterogeneous systems can be achieved, for example, by printing separate spots 
for different analytes in an array.95,96 
In homogeneous assays, a change or modulation of the signal is observed as a result of 
analyte binding, for example, based on energy transfer from one labeled molecule to another 
(Figure 1C–D). Such assays do not require a separation step of the unbound reagents, and 
therefore, they are usually simple mix-and-measure methods. Kinetics are usually fast in the 
homogeneous format making the entire assay protocol shorter and more straight-forward than 
in heterogeneous assays because the time-consuming incubation and washing steps can be 
avoided. However, at the same time the incorporation of washing steps have some advantages 
for improving the assay sensitivity, such as minimizing the effects of non-specific binding, and 
at least theoretically, the heterogeneous format is more sensitive than the homogeneous one.97 
The repertoire of methods based on these basic concepts and other assay schemes is 
vast and impressive. Significant research efforts in the field, together with recent advances in 
the material sciences, have enabled the development of sophisticated and miniaturized devices 
to respond to the growing need for novel analysis tools and new methods for medical sciences 
as well as for environmental and food safety.86 Simultaneously, the intentions to create easy-to-
use systems have provoked the development of home tests and new point-of-care devices which 
fully take advantage of the idea of biosensors to be simple and accessible to conditions outside 
well-equipped laboratories. The following paragraphs introduce briefly the most commonly used 
reporter systems in optical biosensors and the available recognition elements. Particular focus 
will be given to different applications for mycotoxin detection. Selected examples of recently 
reported methods using different recognition elements and transducers are collected in  
Table 3. In this context, various bioaffinity assays are described in the same section, albeit 
biosensors in their strictest definition do not include assays which require additional processing 
steps, such as reagent addition, and are not capable of continuous and reversible 
measurements.92,98 
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Figure 1. Examples of immunoassay concepts. (A) Heterogeneous two-site assay immunometric 
assay based on two antibodies which bind simultaneously to the target (red) forming a sandwich 
complex. The fluorescent label in the detection antibody allows quantification of the binding.  
(B) Heterogeneous competitive assay based on target binding antibody and a labeled competitor. 
The competition for a limited number of binding sites results in a signal intensity which correlates 
inversely to the concentration of the analyte. (C) Homogeneous competitive immunoassay based 
on energy transfer from labeled antibody to labeled competitor. In the presence of the target 
analyte, the distance between the two labels increases and no energy transfer is observed.  
(D) Homogeneous quenching assay based on competitor labeled with a fluorescent dye and 
antibody labeled with a quencher. In the presence of the target analyte, the fluorescence is 
recovered due to the larger distance between the label and the quencher. 
1.3.2 OPTICAL DETECTION 
Optical biosensors, which often bring together the fields of optics, fluidics, electronics, and 
biochemistry, have become a powerful detection and analysis tool during the last decades with 
vast applications in biomedical research, healthcare, food safety, pharmaceutical, and 
environmental analysis.99 By definition, optical biosensors are based on measuring an optical 
phenomenon, such as light absorption, fluorescence, luminescence, total internal reflection, 
surface plasmon resonance (SPR), or other optical properties, upon the biorecognition event to 
detect and identify the target molecules. Optical detection is particularly attractive as it can be 
applied to multiplexed applications, and moreover, optics can be easily miniaturized at a 
relatively low cost, as cheap and sophisticated light sources and detection devices have become 
available in the last decades.91 
 Label-free and label-based methods 
Generally, optical detection can be divided into label-based and label-free methods. Label-based 
methods rely on labels, such as fluorescent dyes or nanoparticles, which provide a measurable 
component for the biorecognition event. Label-free systems are capable of monitoring the 
recognition event directly having the biomolecules in their natural forms, i.e., unlabeled and 
unmodified, with the significant advantage that no laborious labeling process is required. 
Therefore, this type of detection is, in a certain way, easy and cheap to perform, and it can 
provide information about the reaction kinetics and the thermodynamics of the molecular 
recognition events. Nevertheless, label-free methods require sophisticated and complex 
instrumentation, and they possess some intrinsic limitations especially for the analysis of small 
molecules.100 The third review article (publication VIII) entitled “Optical biosensors for label-free 
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detection of small molecules”100 included in Annex I of this thesis provides further insights and 
discussion on applications of label-free optical biosensors for small molecule detection. 
Surface plasmon resonance (SPR) has been established as a landmark label-free 
biosensing platform in the last decades.101 SPR measures the changes in the refractive index at 
the surface of a metal film where electromagnetic waves, known as surface plasmons, 
propagate upon illumination. Surface plasmons are highly dependent on environmental 
parameters and the geometry of the plasmonic structure, and thus, upon the target binding onto 
the surface, a change in the plasmon mode can be observed.102 Prism couplers are most 
commonly used for the optical excitation, but also waveguide coupling, fiber optical coupling, 
and grating couplings have been employed.99,103 Antibody-based SPR-platforms have been 
applied to mycotoxin detection in the competitive assay format by immobilizing a protein-
conjugated mycotoxin onto the sensor surface, for example, for the detection of DON and 
nivalenol.104,105 Alternatively, direct toxin detection has been established using aptamers and 
molecularly imprinted polymers as the recognition element for the detection of AFB, OTA, and 
citrinin.106–108 
An interesting characteristic of some optical label-free platforms is their compatibility with 
label-based methods. Labels can be used to enhance or amplify the signal making them more 
versatile than other types of sensing platforms where only label-free detection can be 
implemented.99 Numerous examples have demonstrated that metallic or magnetic 
nanoparticles, fluorophores, and quantum dots can be used to enhance SPR signals.100,109 
Although one could argue that after incorporating a label to the sensor configuration the method 
is no longer genuinely label-free, such approaches have shown significant improvements, 
especially for small molecule detection. For example, detection of OTA by SPR using a nanogold-
enhanced assay was 10 times more sensitive than the non-enhanced one.110 Other label-free 
mycotoxin detection methods include, for example, OTA detection using an optical fiber-based 
localized surface plasmon resonance (LSPR) aptasensor (Figure 3B),111 or a planar waveguide 
operating on the polarization interferometry principle.112 
Despite the increased number of label-free methods reported in the literature, which can 
largely be attributed to the availability of sophisticated commercial instruments, for example, 
SPR platforms such as BIAcore, label-based methods continue their reign in many disciplines. 
In comparison with label-free methods, label-based analyses inherently rely on the use of labels 
and thus require conjugation of the label of choice to one of the assay components, often the 
recognition element. Thus, high-quality recognition element and labels alone are not sufficient 
to guarantee reliable analysis, but the methods used for labeling or conjugation are of great 
importance. In some cases, the labeling reaction proves difficult as a consequence of a lack of 
appropriate reactive groups for the conjugation, low reaction yields, or the formation of 
heterogeneous mixtures of conjugated molecules. Occasionally, the conjugation can alter or 
even abolish the recognition event leading to inconclusive results.113 A wide variety of different 
labeling strategies has been reported in the literature, including conventional covalent 
conjugation, for example, in the case of proteins using the primary amine groups of lysine 
residues, and novel biorthogonal or chemoselective conjugation methods, such as the so-called 
click-chemistry,114 or various protein tags designed from modified enzymes and their synthetic 
ligands.115,116 
Luminescent labels, including fluorescent, phosphorescent, as well as chemi- and 
bioluminescent molecules, are widely used reporters in optical sensing. The measurements can 
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be based on for example fluorescence intensity, decay time, anisotropy, quenching efficiency, 
or energy transfer using a variety of optical instruments ranging from smartphone cameras to 
highly sophisticated devices.92 While classical spectroscopic instrumentation usually provides 
high sensitivity, the devices are often bulky, expensive, and require a powerful power supply 
unit. The tremendous progress in miniaturized and integrated sensor devices have introduced 
alternative light sources and detectors, for example, planar waveguides, optical fibers, and 
complementary metal-oxide-semiconductor (CMOS) imagers, which have been widely applied to 
develop portable and integrated instruments.117,118 
 Optical reporters 
The main requirement of the reporter, or the label, is to provide a measurable signal using a 
detection system which allows detection of the label above the background noise.93 In principle, 
the higher the signal from the label, the easier and more sensitive the detection will be.118 The 
very first immunoassays were based on radioactive reporters, such as 125I, but they were later 
replaced with other systems due to the problems associated with safety and stability of the 
radiolabeled reagents. Commonly used reporters include enzymes, fluorescent dyes, 
luminescent proteins, and nanoparticles. Several factors can affect the choice of the label, 
including the molar absorptivity, quantum yield, optimal excitation and emission wavelengths, 
the Stokes’ shift, fluorescence lifetime, and photostability. 
Enzymes are one of the most used labels, in particular for immunoassays. Owing to their 
catalytic properties enzymes are capable of generating colored, fluorescent, or luminescent 
compounds from colorless or non-fluorescent substrates. Enzymes are usually measurable at 
very low concentrations because a single enzyme molecule can convert several substrate 
molecules, and the signal generating reaction progresses until the substrate of the enzyme runs 
out. However, enzymes might suffer from poor stability and short shelf-life which might affect 
their performance. Enzyme-based systems are also susceptible to interferences and variations 
in the assay conditions (pH, temperature, inhibitors, etc.) during the signal generation step, and 
in some cases, the reaction requires addition of specific cofactors.93 
Nevertheless, enzymes are versatile labels which can be applied to different measuring 
schemes by simply changing the substrate. The simplest measurements rely on colorimetric 
substrates which can be observed visually in a qualitative manner or quantitatively using a 
spectrophotometer. The simplicity of colorimetric substrates comes with some cost in the 
sensitivity which is limited by the working range of the spectrophotometer.93 Fluorescent 
substrates can usually provide sensitivities even several orders of magnitude higher than 
colorimetric ones, partly because fluorescent compounds can be repeatedly excited.93 
Alternatively, luminogenic substrates can be used for improved sensitivity. As chemiluminescent 
detection does not require an excitation light source, simple detectors can be used and provided 
that the incident light is efficiently isolated excellent sensitivities can be obtained.97 
Bioluminescence is a special type of chemiluminescence found in biological systems which has 
also been applied for detection to some extent.119 Despite the high sensitivity, 
chemiluminescent and bioluminescent reactions are often complete within a few seconds, and 
the signal measurement must be rapid enough for quantification purposes. For this kind of fast 
reactions with flash-type kinetics, automatic reagent injectors may be required to obtain 
accurate and reproducible results.97 
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Horse-radish peroxidase (HRP), one of the most widely used enzymes for 
chemiluminescence measurements. It is a glycosylated hemoprotein which can function as an 
oxidoreductase with a wide variety of hydrogen donors to reduce hydrogen peroxide. HRP can 
be used in combination with different substrates to generate colored, fluorescent, or 
luminescent derivatives.93 Various examples of HRP-based mycotoxin detection include mostly 
competitive assays using HRP-labeled secondary antibodies or HRP-conjugated toxins and 
colorimetric or chemiluminescent substrates.120–123 Another common enzymatic label, alkaline 
phosphatase (AP), is a dimeric glycoprotein which can be easily conjugated to different 
molecules through its large number of free amino groups without loss of enzyme activity. AP 
catalyzes the hydrolysis of phosphate esters of alcohols, phenols, and amines.97 This enzyme 
has been widely used to generate heterologous fusion proteins which consist of the recognition 
element, such as an antibody fragment, and the enzyme which can provide a way to measure 
the antibody binding. Production of such fusion proteins in Escherichia coli is rather straight-
forward and results in readily conjugated recognition elements. For example, antibody 
fragments against OTA, FB1, and HT-2 toxin have been expressed as AP-fusions and used for the 
toxin detection with colorimetric substrates.124–126 
Fluorescence and phosphorescence, which refer to the emission of light from 
electronically excited states, are dominant methodologies in many disciplines, including 
biotechnology, medical diagnostics, forensics, and sensing.127 Fluorescent reporters, which 
upon excitation, typically in the UV-range, emit light at a wavelength characteristic to the 
individual label, have been extensively used in optical sensors owing to many advantageous 
characteristics. These reporters, including directly fluorescent reporters as well as substrates 
which are converted to fluorescent products, exhibit high specific activity because one molecule 
can provide many photons of emitted light, since the cycle of excitation and fluorescence can 
be repeated many times for a single molecule during the measurement period.97 Thus, high 
sensitivities down to a single molecule or a single photon detection can be achieved. Moreover, 
fluorescent assays are usually inexpensive, robust and many fluorophores have very long shelf 
lives. Conventional fluorescent reporters might suffer from high background signals because of 
light scattering which can arise from particulate matters in the sample or the solid phase and 
cause an increase in the background signal, but they continue to be routinely used in a variety 
of applications.93,97 Organic dyes are widely used due to their availability and low price, and they 
offer tremendous diversity in terms of structures, spectroscopic properties, and chemical 
reactivities. Most widely used families of organic dyes include, for example, fluorescein, 
rhodamines, Alexa, BODIPY, and cyanine dyes, which can be used in a variety of measurement 
schemes.118 
Fluorescence polarization, or anisotropy, is based on excitation of fluorophores by 
polarized light and can be used to measure the apparent size of a labeled complex.127 Thus, 
fluorescence polarization measurements can provide information on the binding of small 
molecules, with fast Brownian rotation and low polarization, to larger molecules with slower 
rotation and higher polarization values. This principle has been used to detect small molecules 
by competitive immunoassays where the binding of a labeled competitor to the significantly 
larger antibody biomolecule is observed as changes in fluorescence anisotropy.128 For example, 
fluorescein-labeled FB1, ZEA, and T-2 toxin have been used in homogeneous fluorescence 
polarization assays for mycotoxin detection.129–131 The use of dyes with distinguishable spectra 
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has been further applied to measure several toxins simultaneously in a universal multi-
wavelength fluorescence polarization immunoassay.132 
On the other hand, fluorescent proteins which have revolutionized cell biology by enabling 
visualization of intramolecular interactions and events also present an intriguing option for 
biosensors. The green fluorescent protein (GFP), a naturally fluorescent protein derived from 
jellyfish Aequorea victoria, contains a fluorophore structure which essentially resembles an 
organic dye and is formed within the folded protein structure. Mutations in GFP have given rise 
to new fluorescent proteins with different colors and nowadays these mutants cover nearly the 
entire visible range, starting from blue and extending into the near-infrared.133 In addition, GFP-
like fluorescent proteins have been obtained from different sources demonstrating the broad 
evolutionary and spectral diversity of this protein family.118 For example, phycobiliproteins, 
intensely fluorescent proteins from blue-green and red algae, have been widely used because 
of their high quantum yields and excellent stability.127 The possibility of co-expressing 
fluorescent proteins as heterologous fusions with other proteins of interest has served as a 
unique tool in molecular biology and cellular imaging. Applications of fluorescent proteins 
include biological labeling to track and quantify individual or multiple protein species inside the 
cell, the study of protein–protein interactions or intracellular events, as well as the detection of  
different target molecules.118,134 Fluorescent proteins have also been used to develop 
biosensors both in vivo and in vitro, for example, to monitor the intracellular pH taking advantage 
of pH-sensitive GFP variants. Fluorescent proteins are remarkably stable, and they can be used 
and manipulated in multiple ways for different sensor applications.134 
Organic fluorophores and fluorescent proteins almost always display short lifetimes, 
generally between 1 and 10 ns, which limits the dynamic information available. Long-lifetime 
probes can be used to overcome these limitations and avoid autofluorescence and scattering 
effects. Lanthanides are uniquely fluorescent metals which, when incorporated into chelating 
complexes, possess some exceptional features, such as long luminescence lifetime, narrow 
emission peaks, and large Stokes’ shift.118,127 Lanthanides have found widespread use in 
bioanalytical assays, including mycotoxin detection. For example, a structure-switching aptamer 
in combination with magnetic beads and Tb3+ has been applied to the detection of OTA. In the 
absence of OTA, the aptamers were free to enhance the emission of Tb3+ leading to a dramatic 
increase in the signal.135 
Förster resonance energy transfer (FRET), which occurs when the emission spectrum of a 
donor fluorophore overlaps with the absorption spectrum of the acceptor molecule, is an 
extensively used phenomenon in sensing.127 As the extent of energy transfer is determined not 
only by the extent of spectral overlap but also by the distance between the donor and acceptor, 
it can be used to measure binding events of two labeled molecules and has become a widely 
applied method in homogeneous assays using organic dyes, lanthanide chelates, or 
nanoparticles. For example, a time-resolved fluorescence resonance energy transfer (TR-FRET) 
assay for the detection of HT-2 toxin allowed detection of the toxin in a homogeneous format 
within only 10 min using europium and Alexa Fluor–labeled antibody fragments (Figure 3A).136 
On the other hand, the development of new and better nanomaterials has favored the use 
of nanoparticles with unique size-dependent physical and chemical properties as optical 
reporters. Owing to their exceptional optical properties, nanomaterials, ranging from the original 
sphere-shaped nanoparticles to a broad variety of nanomaterials in diverse shapes and 
structures, such as nanotubes, nanowires, and quantum dots (QDs), have been considered 
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rather ideal for biosensor development.137–139 Metal nanoparticles, particularly gold 
nanoparticles (AuNPs) have been used as labels for decades, and they continue to be one of the 
most widely used labels. AuNPs are relatively simple and rapid to synthesize, and their surface 
can be efficiently modified by thiols and other bioligands.140 AuNP-labeled antibodies have been 
widely used in immunochromatographic tests using simple visual detection. The inherent 
physical characteristics of AuNPs also enable measuring these particles with surface-enhanced 
Raman spectroscopy (SERS) or LSPR.140 AuNPs have also been used to amplify the signals 
obtained by SPR, for example for the detection of OTA and AFB1.109,110 Furthermore, AuNPs are 
exceptionally efficient fluorescence quenchers,141,142 a phenomenon that has been attributed 
to various mechanisms, including FRET, nanometal surface energy transfer (NSET),143,144 and 
dipole-to-metal particle energy transfer (DMPET).145,146 
Dye nanoparticles or dye-doped nanoparticles, in which large quantities of dye molecules 
are trapped inside a polymer or silica matrix, can offer high optical intensity and excellent 
luminescent properties over conventional organic dyes.138 For example, a rapid 
immunochromatographic assay for AF was developed based on time-resolved fluorescence 
measurements of europium nanospheres in which the lanthanide chelates were embedded 
inside polystyrene nanoparticles.147 Moreover, inorganic lanthanide-doped nanoparticles, such 
as upconverting nanoparticles (UCNPs), have gained particular interest because of their 
extraordinary photochemical ability to convert infrared radiation to emission at visible 
wavelengths by sequential absorption of two or more photons. Despite their low quantum yields 
and quenching effects by water, UCNPs benefit from nearly complete elimination of 
autofluorescence and scattering effects. For example, homogeneous quenching assays based 
on luminescence resonance energy transfer (LRET) with UCNPs have shown excellent 
sensitivities for the detection of OTA.148,149 
Semiconductor nanoparticles, commonly known as quantum dots (QD), exhibit many 
exceptional optical features, including high quantum yield, low photobleaching, high 
photochemical stability, size-tunable emission, and broad excitation spectra.137 QDs have been 
widely used for biosensing, in particular as energy donors in combination with other dye 
acceptors in FRET-based detection schemes.150 For instance, detection of OTA and fumonisins 
has been established with QDs and colloidal nanoparticles in different assay schemes.151,152 
The variety of choices for optical reporters is extensive, and the aforementioned examples 
for mycotoxin detection represent only a fraction of the methods reported in the literature. 
Undoubtedly, the choice of the reporter has a direct effect on the sensitivity of the method, but 
yet, perhaps the most crucial element of all biosensors and bioaffinity assays is the recognition 
element which is responsible for the specific detection of the target analyte. 
1.3.3 RECOGNITION ELEMENTS IN BIOSENSORS 
The receptor, or the recognition element, is of key importance in biosensor development as its 
binding properties have a direct effect on the specificity and sensitivity of the method.90,153 The 
recognition element of choice must be able to detect the target analyte even at low 
concentrations, and moreover it ought to differentiate it from other similar molecules which 
might be present in the sample simultaneously. Additionally, the availability, compatibility, 
stability, shelf-life, and cost can contribute to the choice of the receptor.154 
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The first developed biosensors were based on enzymes as recognition elements,89 but 
later they have been accompanied and partly replaced with other alternatives, such as 
polyclonal and monoclonal antibodies, nucleic acids, and a variety of other protein binders. 
Generally speaking, biocatalytic sensors are based on a reaction catalyzed by macromolecules, 
mainly enzymes, whole cells, or tissues, whereas bioaffinity sensors are based on interactions 
of the analyte with the receptor. Although strictly speaking biosensors by definition88 are based 
on recognition elements of biological origin, also synthetic and artificial materials have been 
widely used in their replacement in bioinspired or biomimetic sensors. These alternative 
receptors, including nanomaterials or membrane structures, molecularly imprinted polymers 
(MIPs), aptamers, various binding proteins, and phage-displayed or synthetic peptides, have 
been reported to overcome some of the limitations of natural biorecognition elements, mainly 
because these materials are usually robust, more stable and cheaper to produce than many 
natural receptors.16 
 Biorecognition elements 
Glucose oxidase was the recognition element used in the very first biosensors, and since then 
enzyme-based biosensors have been used in various applications, perhaps most notably for 
glucose monitoring in blood.89 These biosensors rely on the efficient biocatalytic properties of 
enzymes and their ability to specifically recognize their substrates. Such sensors for toxin 
detection are usually based on the inhibition of the enzyme immobilized on the sensor surface, 
and they often monitor the total toxicity of the sample but generally are not able to identify the 
toxin.16 Development of modified enzyme receptors by genetic engineering for improved 
performance has been reported, but their analytical applications are still limited because the 
enzymes are usually not able to discriminate various toxic compounds from each other in the 
same sample.155,156 
Acetylcholinesterase (AChE) obtained from electric eel is one of the most commonly used 
enzymes in biosensors for the detection of pesticides, heavy metals, and toxins.155 AChE is a 
crucial enzyme for the transmission of nerve impulses to the cholinergic synapses, and its 
function is inhibited by nerve agents, organophosphorus, and certain toxins, such as AFB1.157,158 
Based on the inhibition of AChE, various biosensors have been reported for the detection of AFB1 
with different measurement schemes.159–162 Due to the reversible inhibition characterized by 
non-covalent interactions between AFB1 and AChE, the degree of inhibition is not dependent on 
the incubation time or the amount of the enzyme, and the use of large quantities of the enzyme 
makes it possible to shorten reaction times even further.159 
Whole-cell biosensors use living organisms, such as bacteria, yeast, algae, or tissue culture 
cells as the recognition elements by measuring their general metabolic status. Whole-cell 
biosensors often suffer from poor sensitivity compared to in vitro detection, but they can be 
suitable for initial screening and can be modified by simple genetic engineering methods for 
detecting a series of complex responses within a living cell.163,164 Cell-based biosensors have 
been reported, for example, for evaluating the individual or combined toxicities of DON, ZEA, and 
aflatoxins.165–167 
Antibodies are among the most widely used recognition elements in biosensors, not to 
mention their wide use in virtually all branches of biotechnology and biomedicine. Antibody-
based biosensors, or immunosensors, and immunoassays rely on the exceptional ability of 
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antibodies to recognize their target analyte. Naturally, antibodies, or immunoglobulins (Ig), are 
produced by the immune system in the B-cell lymphocytes to bind and inactivate foreign or 
harmful pathogens. The vast recognition variety of antibodies is achieved by a high sequence 
variation on the amino acid level which is introduced during the transcription process of the B-
cells by combinatorial assembly of the gene fragments, and further, by additional mutations 
after the primary recognition.168 The conventional and most widely used IgG antibody 
(approximately 150 kDa, Figure 2) is composed of two identical heavy (50 kDa) and two light 
polypeptide chains (25 kDa) which are linked to each other by disulfide bonds. Both chains, the 
light and the heavy, have one variable domain (VL and VH, respectively) and additionally, the light 
chain has a single constant domain (CL), whereas the heavy chain contains three or four 
constant domains (CH). The two antigen-binding fragments (Fabs) are responsible for binding to 
the target, whereas the highly conserved Fc-region (fragment crystallizable) interacts with 
effector molecules and cells.168,169 From the analytical point of view, the most relevant region is 
the antigen-binding site, or paratope, which is rather small compared to the size of the whole 
antibody. The antigen-binding site is composed of six complementary determining regions 
(CDRs), or hypervariable regions, which are responsible for the target recognition. 
Antibodies produced for biosensing and biotechnological applications are generally either 
polyclonal, monoclonal, or recombinant antibodies. Polyclonal antibodies can be purified from 
the sera of an immunized animal,170 whereas monoclonal antibodies are produced by hybridoma 
cell lines.171 The fact that polyclonal antibodies are a mixture of different antibody clones and 
susceptible to batch-to-batch variation limits their use in biosensing, although they often have 
better specificity than monoclonal antibodies and they are generally cheaper and faster to 
produce. Hybridoma technology allows producing large quantities of monoclonal antibodies with 
defined specificity and affinity, and they are usually the preferred option over polyclonal 
antibodies that are always a mixture of antibodies and suffer from poor reproducibility.90,93 
First polyclonal antibodies against mycotoxins were described more than 40 years ago172 
and were soon after complemented with monoclonal antibodies.173,174 Monoclonal antibodies 
continue to be the most widely used biorecognition element for mycotoxin detection, and during 
the last decades numerous immunoassays and immunosensors have been described with new 
intriguing characteristics in applications beyond the traditional ELISA, such as methods with 
improved separation steps using magnetic beads,175–177 or novel detection schemes, including 
new label-based132,178,179 and label-free approaches.109,180–182 The availability of commercial 
antibodies has for its part facilitated the development of new methods, although some 
commercial antibodies have been demonstrated to have high cross-reactivity which limits their 
application to real samples where several toxins can be present simultaneously.183,184 
Polyclonal and especially monoclonal antibodies have been the cornerstone of antibody-
based detection methods during the past decades, but despite their wide use, they possess 
some intrinsic limitations mostly related to high cost and low stability, for example, at high 
temperatures or in stringent conditions.185 The high specificity of antibodies can be partly 
attributed to their complex structure, but at the same time, it makes them susceptible to 
denaturation, degradation, or aggregation. Moreover, the large size of antibodies can cause 
steric hindrance, and the Fc-region often promotes non-specific binding.153 Production of 
polyclonal and monoclonal antibodies is inherently dependent on animal immunization, and 
despite the uttermost significance of hybridoma technology, it is usually expensive and time-
consuming.93,185 In addition, small analytes, such as mycotoxins, are too small to be recognized 
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by the immune system and thus require conjugation to a carrier molecule for antibody 
production. The use of such conjugates complicates the process to some extent, and 
unfortunately, on occasion results in antibodies that recognize the target only in the context of 
the conjugate.93 
 
Figure 2. The antibody formats most commonly in biosensors include the conventional 
antibody (IgG), the recombinant antibody fragments Fab (fragment antigen binding), scFv 
(single-chain fragment variable), and VH single domain antibody. 
On the other hand, nucleic acids, renowned as the carriers of genetic information and 
fundamental materials in all living organisms, including viruses and pathogens, present an 
exciting option for biosensing. Hybridization of nucleic acids by exceptionally strong base pairing 
with their complementary strand is the foundation of all types of DNA-based sensors, also known 
as genosensors.90 DNA is particularly suitable as a molecular target, as it is a very stable 
molecule that can be isolated relatively simply even from complex biological samples.90 
Synthesis of short oligonucleotide probes is fairly straight-forward and can be used to include 
reactive groups or labels to allow probe immobilization or detection. The selected target DNA 
sequence should be unique in the organism in question and provide sufficient variability to other 
similar species. Ideally, the target should be present in the cell at a relatively high copy number, 
although PCR and other DNA amplification methods can provide powerful target amplification.90 
The conventional end-point PCR, which usually relies on agarose gel–based detection, is limited 
by the lack of specificity in the detection step which is susceptible to subjective band 
identification.186 Real-time PCR (qPCR) combines PCR with fluorescently labeled probes allowing 
real-time monitoring of the amplification reaction. This robust, highly reproducible and sensitive 
method is widely used for pathogen identification, although it requires more complex 
instrumentation than the conventional PCR. Both end-point and qPCR methods have been 
reported for the detection of most common mycotoxigenic fungal species, such as 
F. proliferatum, F. verticillioides, and F. oxysporum.187–191 
 Bioinspired recognition elements 
During the last two decades, various alternatives for natural recognition elements have arisen 
to complement the conventional bioreceptors. Such bioinspired or biomimetic recognition 
elements can be of synthetic or semi-natural origin, or be based on modified chemical structures 
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or materials which have the potential to overcome some of the limitations related to the 
conventional biorecognition elements.192 Although it is unlikely, as well as unnecessary, that 
bioinspired recognition elements would completely replace the conventional biorecognition 
elements, they can be considered as a complementary option which might be more appropriate 
for some applications. For example, while antibodies and enzymes often suffer from poor 
stability, bioinspired recognition elements could be able to provide a means for developing 
robust, low-cost, or simple alternatives suitable for instance for high-throughput screening or 
low-resource settings.193 Detailed discussion on bioinspired recognition elements for mycotoxin 
detection is presented in the second review article (publication VII) entitled “Bioinspired 
recognition elements for mycotoxin sensors”193 included in Annex I of this thesis. 
The advancements in recombinant DNA technology and protein engineering during the 
last few decades have made it possible to modify existing proteins or design new ones with 
selected properties. The rise of recombinant antibodies which possess several advantageous 
characteristics, such as smaller size and easy production, while preserving the target specificity 
of the intact antibody, is an excellent example of such progress. The best-known antibody 
fragments are the Fab fragment (50 kDa) and the even smaller scFv (single chain fragment 
variable; 25 kDa) which consists only of the VH and VL domains which are joined by a synthetic 
polypeptide linker (Figure 2).194 The small size of recombinant antibody fragments has several 
advantages, including the decrease of nonspecific binding, often caused by the Fc-region of the 
intact IgG and the possibility to immobilize the antibodies at higher density.194 Moreover, 
recombinant antibody technology has the potential to bypass the immune system and, at least 
theoretically, select new antibodies within a couple of weeks without animal immunization. 
Unlike full-length antibodies, recombinant antibody fragments can be propagated in bacteria, 
such as E. coli, which significantly lowers the cost of production as no specialized cell culture 
facilities for hybridoma cell lines are needed.154,195 
Several recombinant antibodies have also been reported against mycotoxins. 
Recombinant antibodies which have been derived directly from monoclonal antibodies by 
cloning the gene fragments from the hybridoma cell lines and expressing them in E. coli have 
been described, for example, for DON,196,197 AFB1,198 and FB1.199 However, the fragments 
isolated directly from hybridoma cell lines often demonstrate lower affinity than the parental 
monoclonal antibody, and thus, more frequently recombinant antibodies are selected from 
recombinant libraries (see 1.4.3 Phage-displayed libraries) which moreover can avoid the initial 
production of monoclonal antibodies.200 
For an even further reduced size of the recognition element, peptides present an 
interesting alternative since they still share the same fundamental chemical structure as 
proteins or antibodies. Small peptides are easy to synthesize and stable in a wide range of 
conditions.201 Peptide binders can be derived from natural sources, for example from naturally 
occurring peptide hormones, or they can be selected from recombinant or chemical libraries. 
Both molecular biology and chemical techniques are available for identifying new peptide 
binders, and advances in bioinformatics and computational modeling have also made it possible 
to design peptide receptors in silico. As chemical synthesis has access to a wider diversity of the 
starting components, combinatorial peptide libraries can be constructed not only using natural 
compounds but also with unnatural amino acids or pseudo-peptide bonds.202 Despite the 
appealing features, actually only a few peptides have been successfully used as recognition 
elements, and they often lack the required affinity for biosensor development. The limited 
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examples of peptide-based recognition of mycotoxins found in the literature include, for 
example, the development of an OTA binding peptide NFO4 which was based on a specific region 
of human oxidoreductase.120,203 Peptides against OTA and aflatoxins have also been designed 
by computational modeling,204 or by combinatorial synthesis.205,206 On the other hand, peptides 
can be used as epitope mimics which can replace toxin-conjugates in competitive 
immunoassays (see 1.3.4 Particularities of small molecule detection). 
Alternatively, specially designed DNA or RNA molecules can be raised against virtually any 
target. Aptamers are relatively short (usually from 15 to 50 nucleotides) single-stranded RNA or 
DNA that can bind specifically various targets including ions, peptides, proteins, cells, 
antibodies, and organic molecules. Similarly, aptazymes (RNAzymes and DNAzymes) are 
engineered aptamers with allosteric properties which combine a target-binding strand and an 
enzyme strand. These bioinspired recognition elements can be obtained for specific targets by 
screening oligonucleotide libraries (1014–1015 variants) through the process of systematic 
evolution of ligands by exponential enrichment (SELEX).207 Biosensors using aptamers as 
biorecognition elements, also referred to as aptasensors, were first described more than twenty 
years ago and have since then been used in various sensing applications. Aptamers can provide 
high stability and affinity, as well as simplicity, low cost, and excellent batch-to-batch 
reproducibility. For mycotoxin detection, application of various aptamers has been reported 
using different transduction schemes.208 In particular, aptamers have been used in combination 
with metal and carbon nanostructures, such as AuNPs, graphene oxide (GO), single-walled 
carbon nanotubes (SWNTs), MoS2 flakes or TiO2 tubes, taking advantage of the strong quenching 
of fluorescent aptamer conjugates adsorbed on these surfaces.209–211 For example, aptasensors 
for OTA and AFB1 detection used single-walled carbon nanohorns (SWCNHs)210 or nano-
graphene oxides (Figure 3C),212 respectively, to quench the fluorescence of labeled aptamers 
when unfolded. Improved sensitivity was obtained by a self-amplifying cycle where the target-
bound aptamer was digested liberating the toxin for rebinding to a new aptamer. An alternative 
method for signal amplification in an electrochemical aptasensor was achieved using rolling 
circle amplification (RCA) to amplify the aptamer in the absence of target mycotoxin. Target 
binding to the aptamer inhibited the RCA, yielding a reduction of the redox signal.213 
Moving even farther away from the natural biorecognition elements or the 
abovementioned approaches which rely on engineered or modified natural structures, MIPs are 
an example of an entirely synthetic approach. These bioinspired or biomimetic materials, also 
known as plastic antibodies, are prepared in the presence of the target analyte, or template, by 
polymerization of functional monomers and cross-linkers. Upon removal of the template, a three-
dimensional network is retained with specific recognition cavities which are complementary in 
size, geometry, and arrangement of functional groups to the target.214 MIPs have been described 
as artificial antibodies or artificial enzymes,215 and in comparison with their biological 
counterparts, they show numerous advantages for sensor development including their low cost 
and ease of preparation, high physical and chemical stability, robustness, compatibility with 
organic solvents, and reusability.216 However, in comparison with antibodies MIPs typically have 
lower affinity and specificity as well as slower binding kinetics than those of biological receptors. 
Several MIP-based sensors have been described for mycotoxins, for example, using MIPs 
functionalized with AuNPs in an electrochemical sensor,217 or with QDs which were quenched in 
the presence of the target toxin.218 In a different approach, citrinin was detected by 
Biosensors for mycotoxin monitoring 
49 
functionalizing disposable fiber optic sensors219 or quartz crystal microbalance electrodes220 
with the MIPs. 
1.3.4 PARTICULARITIES OF SMALL MOLECULE DETECTION 
Small molecules, often defined as low molecular weight organic molecules typically less than 
1000 Da in size, include of a wide variety of different chemical compounds, of either natural or 
pharmaceutical origin, many of which are biologically, pharmacologically, or environmentally 
relevant molecules. Myriad of different biosensors and bioanalytical assays have been reported 
for the diverse group of small molecule analytes, including mycotoxins, although owing to their 
small size they are often challenging analytes. To begin with, small molecules might be 
problematic targets for many recognition elements, in particular for antibodies.93 While large 
analytes, such as proteins, can be detected with two-site or sandwich immunoassays, small 
molecules that inherently are not capable of binding two antibodies simultaneously must be 
conventionally analyzed using a competitive assay format. The important role of the recognition 
element is particularly eminent in such assay format because the recognition depends 
exclusively on the specificity of a single binder, and the sensitivity of the system is mainly defined 
by the equilibrium constant of the recognition element.93,221 Moreover, the competitive assay 
format requires conjugation of the target to a carrier molecule or a label to enable immobilization 
or detection of this competitor. Synthesis of these conjugates can be challenging and time-
consuming or result in randomly cross-linked or unstable molecules. Labeling of the analyte may 
also alter the epitope reducing or even abolishing the biorecognition event, which can 
compromise the assay sensitivity. Moreover, lot-to-lot variations of the conjugates, or even false 
positives caused by the release of the analyte moiety from the conjugate, are known to affect 
the assay reproducibility and accuracy.93,222,223 
Instead of using the analyte-conjugate as the competitor, the so-called epitope mimics have 
been introduced as an intriguing alternative. The exceptional ability of these molecules to mimic 
the epitope of the analyte, and thus bind to the same antibody paratope, has been witnessed in 
several fields, including immunotherapy, epitope mapping, and allergy treatment.224,225 For 
biosensor development, epitope mimics can provide significant advantages as they can replace 
the analyte-conjugate and thus overcome the limitations related to target conjugation.193 
Antibodies themselves, known as anti-idiotypic antibodies,226 or short peptides, also called 
mimotopes, have been widely used for the detection of small molecules, mycotoxins in 
particular.193,222 
Reported mimotopes, for example for the detection of DON,227 FB1,228–230 OTA,121,231–234 
and ZEA,235 vary in length and structure; use of linear 7-mer121,231 and 12-mer230 peptides, as 
well as cyclic mimotopes,228 has been described. After the discovery of mimotopes from phage-
displayed libraries, the phage-borne peptides have been used directly in ELISAs with 
colorimetric231 and chemiluminescent234 detection, as well as in dipstick234 and dot-
immunoassays.236 Alternatively, the phage-borne peptides can be replaced with their synthetic 
or recombinant counterparts, thus avoiding the use of the phage in the assay. Short peptides, 
which are relatively simple and cheap to synthesize chemically, have been used in various 
immunoassays, for example for the detection OTA121 and FB1.228,230 Interestingly, recombinant 
proteins, on the other hand, which can be produced in bacteria cost-effectively even in large 
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quantities, can be constructed of the mimotope in fusion with a protein ideal for coating, such 
maltose-binding protein (MBP),229,233 or for detection, for example, fluorescent237,238 or 
bioluminescent proteins.239 
Nanobodies are the most widely used form of anti-idiotypic antibodies for mycotoxin 
detection. This special class of antibodies is derived from naturally occurring heavy chain 
antibodies in camelids and sharks and is renowned for the complete lack of the light chain. 
Hence, the antibody paratope is formed by a single VHH domain with three hypervariable loops, 
as opposed to six in the IgG.169,240 The small size of nanobodies and their high stability to harsh 
conditions have gained significant attention in the field of biotechnology and biosensing.169,241 
Mostly because of their unsuitability for small molecule detection as a consequence of the 
special paratope, the majority of applications using nanobodies for mycotoxin detection employ 
them as epitope mimics. In fact, the exceptional convex-like structure of the paratope is known 
to bind well to clefts and cavities, making them highly suitable for molecular mimicry of 
haptens.93,242 Detection of mycotoxins, including aflatoxin (Figure 3D),243 citrinin,244,245 DON,246 
FB1,124,242 and OTA,247 using anti-idiotypic nanobodies has been reported to increase the 
sensitivity, at best 20-fold in comparison with the conventional assays using the toxin-
conjugates. 
On the other hand, since non-competitive immunoassays are usually considered superior to 
the competitive assays because of their higher sensitivity and specificity, novel methodologies 
have been implemented in order to benefit of these properties also in applications for small 
molecule detection. For such, non-conventional antibodies developed by recombinant antibody 
technology have been reported for small molecule detection. For example, the open sandwich 
immunoassay (OS-IA) is based on the association of separated VH and VL chains in the presence 
of the analyte and has been reported to outperform competitive assay in terms of sensitivity, 
working range, and assay time.248 OS-IAs have been reported for the detection of ZEA using the 
VH and VL chains of a monoclonal anti-ZEA antibody. The non-competitive assays showed 
superior performance compared to the competitive assay,249 although OS-IA in which the 
recognition still relies on only one antibody can suffer from cross-reactivity.248,250 Alternatively, 
non-competitive immunoassays for small molecules have been reported using two antibodies, 
one of which, known as the anti-immune complex or anti-metatype antibody, binds to the primary 
antibody only when it is in complex with the target analyte. Such non-competitive immunoassays 
based on anti-immune complex antibodies have the added advantage of increased specificity 
due to the use of two antibodies instead of one. For example, anti-immune complex antibodies 
for the detection of HT-2 were selected from phage display libraries, and the developed 
immunoassays showed superior performance in comparison with the competitive ELISA  
(Figure 3A).125,136 
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Figure 3. Examples of mycotoxin analysis based on different recognition elements and detection 
schemes. (A) Non-competitive HT-2 toxin assay based on the anti-immune complex Fab and HT-2 
specific primary antibody. In the presence of the toxin, FRET (Förster resonance energy transfer) 
can occur due to the short distance between the two fluorophores. A, acceptor (Alexa Fluor); D, 
donor (europium dye). (B) Localized surface plasmon resonance (LSPR) sensor using aptamer-
modified gold nanorods chemically attached to an optical fiber core. OTA binding to the aptamer 
induces an LSPR peak shift. (C) Detection of AFB1 by DNA aptamer–based fluorescent assay using 
graphene oxide (GO) nanosheets to bind the labeled aptamer in the absence of the toxin and 
quench the fluorescence. Signal amplification was achieved using DNase I for regeneration. (D) 
Anti-idiotypic nanobody was used in a phage-based real-time immuno-PCR for the detection of 
aflatoxin. Figures adapted from A, Arola et al. (2016);136 B, Lee et al. (2018);111 C, Zhang et al. 
(2016);212 and D, Lei et al. (2014).243
  
Table 3. Examples of biosensors and bioaffinity assays for mycotoxin detection. 
Target toxin Recognition element Assay Solid phase Label Measurement LOD LR Samples Ref. 
OTA MAb Competitive (mimotope) Microtiter plate HRP CL 0.005 ng mL
–1 0.006–0.245 ng mL–1 
Coffee 
Corn 
Rice 
234 
AF MAb Competitive (AI-Nb) Microtiter plate TaqMan PD-IPCR 0.02 ng mL
–1 n.d. 
Corn 
Rice 
Peanut 
243 
HT-2 toxin Fab Non-competitive (IC) – Eu + AF647 FRET 0.38 ng mL
–1 n.d. Wheat 136 
AFB1 Nb Competitive (AFB1–BSA) Microtiter plate HRP A n.d. 0.117–5.676 ng mL
–1 
Corn 
Rice 
Peanut 
251 
OTA Aptamer (RCA) Direct Gold electrode MB CV 0.065 ppt 0.1 ppt–5 ppb Wine 213 
FB1 Aptamer Direct Microcantilever – Cantilever deflection 33 ng mL
–1 100–40000 ng mL–1 – 252 
OTA Aptamer Direct GNR on optical fiber – LSPR 0.006 ng mL
–1 5.1–50718 ng mL–1 Grape juice 111 
AFB1 AChE Direct SPE – A 468 ng mL–1 625–62500 ng mL–1 Olive oil 162 
AFB1 MIP Direct Gold electrode – LSV 0.3 fg mL–1 1 fg mL–1–1 μg mL–1 – 217 
ZEA MIP Direct – QD F 0.64 ng mL–1 9.55–99330 ng mL–1 
Corn 
Rice 
Wheat flour 
253 
Abbreviations: A, amperometry; AChE, acetylcholinesterase; AF, AlexaFluor; AI-Nb, anti-idiotypic nanobody; BSA, bovine serum albumin; CL, chemiluminescence; CV, cyclic voltammetry; 
F, fluorescence; FRET, Förster resonance energy transfer; GNR, gold nanorod; HRP, horse-radish peroxidase; IC, immune complex; LOD, limit of detection determined the blank + 3 × 
standard deviation of the blank; LR, linear range; LSPR, localized surface plasmon resonance; LSV, linear sweep voltammetry; MAb, monoclonal antibody; MB, methylene blue; MIP, 
molecularly imprinted polymer; Nb, nanobody; n.d., not determined; QD, quantum dot; PD-IPCR, phage display mediated immuno polymerase chain reaction; RCA, rolling circle 
amplification; SPE, screen-printed electrode. 
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1.4 Phage display for biosensor development 
1.4.1 FILAMENTOUS BACTERIOPHAGES 
Bacteriophages, or phages for short, are bacterial viruses which are ubiquitous in nature but 
harmless to humans. Their role as the main regulators of the microbial balance among the 
diverse variety of bacteria existing in the ecosystem makes them naturally eminent but owing to 
many interesting characteristics phages have also become an exceptional tool for many 
biotechnological applications.90 The Greek origin of the name bacteriophage describes them as 
“bacteria-eaters,”90 although perhaps more aptly they can be defined as parasites which are 
capable of infecting bacteria and multiplying within the bacterial host.254 Upon infection, the 
phage takes over the biosynthetic machinery of the host cell to replicate its genetic material and 
subsequently produce over a thousand identical phage particles.255 
Naturally, a myriad of different phages exist but generally, each phage particle, or virion, 
encloses its genome of DNA or RNA in a protein coat, or capsid.256 Phages, while being abundant 
in nature and highly specific to bacteria, are extremely robust and can withstand even harsh 
conditions.90 They can be classified based on their morphology, and further depending on their 
life cycle and propagation ways.90 Lytic or productive phages, such as T4, T7, T3, and MS2 
phages, are only capable of replicating their genome, assembling the phage virions, and 
releasing them by lysing and killing the host cell.256,257 Lysogenic or temperate phages, such as 
λ phage, can multiply via lytic cycle or incorporate their genome into the host cell genome where 
it will produce a quiescent state.257 Filamentous phages, distinct for their long rod-like shape, 
are lysogenic phages which do not lyse their host cell but secrete the newly assembled virions 
and continue the process. Filamentous phages can infect a wide variety of Gram-negative 
bacteria, for example, E. coli, and the most used phages include M13, fd, and f1 phages, all 
belonging to the Ff class, so named because they infect the bacterial host via the tip of the F 
conjugative pilus.258 
M13, one of the most used phages, consists of a circular single-stranded DNA (ssDNA) 
genome packaged within the phage particle, a somewhat flexible protein cylinder of about 
930 nm in length and 6.5 nm in diameter.257 The filamentous capsid consists of the phage 
structural proteins, including the major coat protein (pVIII), which appears in approximately 
2700 copies alongside the virion, and the minor coat proteins, capping both ends of the phage, 
pVII and pIX at one end and pIII and pVI in the other (Figure 4A).257,259 The pIII is the largest and 
structurally most complex of the phage proteins, and it is essential for the infectivity, because 
of its role in the binding to the bacterial pilus, and necessary for the termination of viral 
assembly. The remaining six phage proteins are involved in viral replication and assembly.258 As 
described previously, M13 can infect E. coli by attachment of the pIII to the pilus which is 
encoded by the bacterial genes carried on the F-factor. After phage binding, the pilus retracts 
until the phage reaches the bacterial surface and pIII can bind to the membrane proteins and 
transfer the phage genome into the host cell. The infecting phage disassembles, and the coat 
proteins are inserted into the bacterial membrane. Once inside the bacterial cell, the phage 
genome is converted to double-stranded DNA (dsDNA) by bacterial enzymes and the synthesis 
Introduction 
54 
of new phage proteins begins. Newly synthesized proteins finally assemble around the ssDNA 
genome and extrude from the bacterium. As a non-lytic phage, M13 does not kill the host cell, 
but the infected host can continue to grow and divide.257,259 
The phage structure and its mode of replication have contributed to making phages a 
valuable tool for biological research.257 Because of the natural assembly of phage virions they 
are simple and rapid to produce even in large quantities in bacteria, and they are relatively easy 
to purify in high yields.258 Modifying the phage genome is relatively straight-forward as foreign 
DNA sequences can be easily inserted into the nonessential regions of the genome, making it a 
useful cloning vehicle in biotechnology. 
 
Figure 4. (A) The structure of filamentous phage M13 which consists of a protein coat made of the 
major coat protein (pVIII) and the minor coat proteins (pIII and pVI in one end and pVII and pIX in 
the other). The genomic DNA encoding for the coat proteins is enclosed within the protein coat. By 
introducing modified segments into the genomic DNA, the phage can be engineered to display 
foreign peptides or proteins as a fusion with one of the coat proteins, most commonly pIII. (B) 
Construction of phage-displayed libraries includes generation of the DNA library encoding for the 
different variants and introduction of the variable sequences in the phage DNA (typically phage 
vector or phagemid system). After transforming the DNA to bacteria, phages are amplified and will 
display individual protein or peptide variants outside the virion. 
1.4.2 PRINCIPLES AND APPLICATIONS OF PHAGE DISPLAY 
Phage display refers to the expression of peptide or protein variants on the surface of the phage 
virion by cloning the gene encoding for it as a fusion with one of the phage coat proteins.257,260 
This technique has been recognized as a powerful tool to screen and select binders on the basis 
of molecular recognition from phage-displayed libraries, assemblies of up to about 10 billion of 
phage clones each harboring a different variant of the displayed entity (Figure 4B).258 
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Filamentous phages are the most common ones used for phage display because they are 
rather ideal for inserting various-length DNA segments into the genome which is relatively small 
in size and accommodates well such modifications. Moreover, cloning and construction of 
fusions are facilitated by the possibility of isolating both ssDNA and dsDNA. Being non-lytic, 
filamentous phages do not kill the host cell but can be amplified in high quantities.261 On the 
other hand, one of the drawbacks of using M13 for phage display is that, owing to the non-lytic 
propagation, all the compounds of the virion must be exported through the bacterial inner 
membrane before the phage assembly. On occasion, this has been a limitation for displaying 
large proteins whose size, sequence, or folding might prevent the translocation or disrupt the 
integrity of the capsid. In principle, this limitation can be obviated by using lytic phages, such as 
icosahedral T4 and especially T7, which assemble entirely in the cytoplasm.262,263 
Nevertheless, based on filamentous phages, numerous display systems have been 
developed, using different coat proteins for the display together with phage or phagemid vectors. 
These phage display systems can be more specifically classified according to the arrangement 
of the coat protein genes which in the end affects the display valence, i.e., whether the foreign 
peptide or protein is displayed on all or only part of the copies of the coat proteins.254 The  
N-terminus of pIII was the first location used for the display of a foreign peptide,264 and it is still 
the most commonly used, although all five capsid proteins have been employed for display.258,261 
The major coat protein, pVIII, can be used for both N- and C-terminal fusions, but only short 
peptides (6–8 residues) can be displayed without disturbing the phage’s ability to replicate. 
Fusion with the major coat protein pVIII will normally lead to multivalent display with even 
thousands of copies whereas lower valencies, usually 1–5 copies per phage, are obtained with 
pIII fusions. 
Commonly phage display is based on operating either on phage or phagemid vectors.265 
In the phage vector display, the foreign DNA sequence to be displayed is introduced to the phage 
genome fused with the gene of one of the coat proteins. As a result, the phage will express the 
foreign entity, peptide or protein, as a fusion with the coat protein. In some cases, for example, 
if the size of the target is too large, such display may interfere with phage assembly, and the 
phagemid system is preferred. Phagemids are phage-derived vectors which do not encode for 
all the structural and functional proteins of the phage but carry only the necessary replication 
origins and one kind of coat protein which is used for the display. Phagemid usually contains an 
antibiotic resistance gene and two origins of replication, a plasmid replication origin that allows 
them to replicate in high copy number in the host cell and a filamentous phage replication origin 
which is activated once the phagemid-bearing cell is superinfected with the helper phage. Thus, 
the phagemid by itself can replicate within a bacterial cell and maintain itself as a plasmid, but 
it is not able to finish the assembly of phage particles independently. Only when a helper phage 
vector containing also the genetic elements for phage packing is present, and thus, the host cell 
harbors both the phagemid and helper phage genome, phage particles can be produced. In fact, 
the superinfection results in two types of infective virions, particles carrying the helper phage 
DNA and particles with the phagemid DNA.258,266 
Generally, the phagemid vectors are preferred especially when displaying entire proteins 
or antibody fragments. As the size of the phagemid is considerably smaller than the phage 
vector, they are easier to manipulate, maintain and propagate, and they usually allow higher 
transformation efficiencies and improved genetic stability. Moreover, the cloning is relatively 
simple in comparison with phage vectors which have a somewhat complex structure with 
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overlapping genes, promoters, and terminators.261 In addition, the phagemid system is required 
if monovalent display is desired. Nevertheless, the phagemid system requires an additional 
infection with a helper phage to provide all the proteins needed to make ssDNA and new virion 
particles.259 Helper phage usually has a modified packing signal to favor the packing of the 
phagemid,267 and further modifications can allow, for example, multivalent display or inhibition 
of wild-type phage infection with trypsin-cleavable pIII display.268,269 The tryptic helper phage 
(KM13) is sensitive to trypsin and loses its infectivity when incubated with this protease. Trypsin 
treatment after the selection can, therefore, eliminate the majority of the helper phages that do 
not display the foreign peptide of interest. In other words, only those phages carrying the fusion 
protein can maintain their infectivity and continue to propagate in the bacterial host.257,258 
Wild-type or genetically modified phages, as well as individual phages displaying a 
particular protein or peptide of interest, are an interesting option to be used as recognition 
elements, and phage display has contributed to the widespread application of phages in a 
myriad of phage-based biosensors.270 Advances and recent applications of phages to biosensor 
development have been reviewed in the first review article (publication VI) entitled “Application 
of bacteriophages in sensor development”271 included in Annex I of this thesis. Nevertheless, by 
far the most renowned and intriguing application of phage display is the construction and use 
of phage-displayed libraries which can be used to select specific affinity binders against virtually 
any target. Such in vitro selection, also referred to as directed evolution, has established phage 
display as a valuable and remarkably versatile tool in many disciplines for selecting affinity 
binders and exploring interactions between proteins, peptides, and small-molecule ligands, 
making significant contributions to the study of molecular recognition.257,258 
1.4.3 PHAGE-DISPLAYED LIBRARIES 
 Peptide libraries 
Phage-displayed libraries are made of billions of phage clones, each one carrying a different 
foreign DNA insert and therefore displaying a unique peptide or protein sequence on its surface. 
Importantly, each unique phage can replicate upon bacterial infection.254 The foreign DNA 
sequence coding for the displayed protein or peptide can derive from a natural source, or it can 
be deliberately designed and synthesized chemically.258 
The use of peptide libraries is perhaps inferior to antibody libraries, but nevertheless, they 
have been widely used for various applications, for example, for diagnostics, epitope mapping, 
vaccine development, and protein–protein interaction studies. Moreover, peptides can provide 
information about interactional motifs, epitopes or binding sites of antibodies and other 
proteins. Phage-displayed peptides can also be useful intermediates in the development of 
small-molecule drugs.272 Remarkably, peptides can be isolated against almost any protein target 
including, for example, antibodies, enzymes, receptors, transcription factors, and protein 
interaction domains.258 Experience has shown that peptides identified by phage display 
commonly bind to protein functional sites rather than randomly or non-specifically to the surface. 
Such binding sites are often grooves or depressions in the protein surface with exposed 
hydrophobic groups making them suitable for specific target binding.258 If the peptide binds to 
the functional site of the target protein, it will also most likely inhibit binding of others to the 
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same site. Taking advantage of this feature peptides have been used as surrogate ligands in a 
variety of competition-based assays for drug discovery.258 Similarly, antibody binding peptides 
have been applied as epitope mimics in competitive immunoassays. 
Many peptide libraries are made by joining the DNA sequences coding for the peptide 
directly into the phage genome at or near the N-terminus of gIII. As a result, potentially five 
copies of peptide–pIII fusions are displayed at one end of the phage particle. Fusion to the gVIII 
can result in more than 2000 copies of the peptide per phage. Thus, the multivalent nature of 
the display will have significant avidity effects, and potentially low-affinity binders might end up 
selected due to the high avidity.272 The size of the peptide is limited in such systems but can be 
increased if a phagemid system is used. Moreover, the phagemid system allows reducing the 
avidity effects by a monovalent display. The size of peptide libraries in terms of the number of 
distinct peptide sequences is usually limited by bacterial transformation efficiency. Typically, 
peptide library sizes vary between 107 and 109 phages. Thus, the size of completely randomized 
peptides (e.g., 20 different codons, at n different positions) is limited to n = 6–8. Despite these 
limitations also longer peptides, although incomplete in terms of nucleotide randomization, have 
been used to construct libraries with sufficient variety.254,272 
Random peptide libraries can be derived by oligonucleotide-directed mutagenesis from 
”degenerate” oligonucleotides which are synthesized chemically by adding mixtures of 
nucleotides to a growing nucleotide chain.254,258 Random peptide libraries can be described as 
naïve in the sense that they are designed to be as unbiased as possible, and thus, they can 
provide specific binders for many different targets. However, selections from naïve libraries 
often result in binders with low or mediocre affinities, especially if the size of the library is not 
sufficient.273 Randomness in the sequence can be introduced at nucleotide level varying all the 
nucleotides of the codons (”NNN”) resulting in highly biased diversity since some amino acids 
are represented by several codons and furthermore three codons are stop codons. Thus 
generally, degeneracy at the codon level is preferred as it gives a less biased representation of 
the amino acids. In fact, even less redundant diversity where only the third position of the codon 
is allowed to vary either as G/C or G/T (”NNK” or ”NNS”) is sufficient to cover all the 20 amino 
acids.258 
In some cases, the randomization is restricted to certain regions thus creating a 
constrained library opposed to an unconstrained one. In general, constrained peptide libraries 
present less three-dimensional shapes than an unconstrained library, and therefore, the 
probability for target binding is reduced. However, those with appropriate conformations may 
possess far higher affinities than any unconstrained peptide because the loss in entropy on 
target binding is likely lower than for unconstrained peptides.254,273 A common constraint on 
displayed peptides is a disulfide bond between two cysteine residues at fixed positions in an 
otherwise random sequence resulting in cyclic peptides. Similarly, coordination bonds between 
histidine residues and metal ions can constrain peptides.254,273 Alternative, constrained 
peptides can be presented in the context of a protein scaffold, such as α-helices, β-sheets, or 
other secondary structure elements. In a sense, antibody libraries actually entail a protein 
scaffold where specific regions responsible for the antigen binding have been randomized. 
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 Antibody libraries 
Although the first use of phage display focused on peptides, antibody libraries have been 
arguably the most successful use of this technology and have led to the discovery of antibodies 
with affinities comparable to those obtained by hybridoma technology.260,274 In fact, alongside 
with the development of monoclonal antibodies using hybridoma technology171 and the isolation 
and cloning of antibody genes to enable expression of antibody fragments in bacteria,275,276 the 
generation of antibody libraries by phage display can be considered as one of the 
groundbreaking methods for the antibody discovery. 
Antibody libraries can be constructed from natural sources by isolating the B-cells of a 
source animal which has been immunized with the target antigen and using the isolated 
antibody genes to create the antibody library.277 This kind of immunized libraries have a strong 
bias towards the antigen, and even a modest-sized library can be sufficient to isolate specific 
binders. However, construction of a separate immunized library is needed for each antigen, 
although immunization with several antigens simultaneously is also possible.278 Most 
immunized libraries are produced from mouse,279–283 but also other animals, such as rabbit,278 
chicken,284 sheep,285 monkey,286 camel,287 and shark,288 have been used. Additionally, 
immunized human libraries have been made using blood from patients naturally infected with 
virus or parasites.257,289 
On the other hand, naïve antibody libraries can be constructed completely in vitro resulting 
in non-immunized,290 synthetic,291 or semi-synthetic libraries.292 The use of synthetic repertoires 
bypasses the need to isolate antibody genes and allows generating sequences with predefined 
properties or using optimal framework sequences.293 Non-immunized libraries are a result of 
rearranged antibody genes isolated from B-cells of healthy individuals that have not been 
intentionally immunized. Semi-synthetic and combinatorial libraries combine natural and 
synthetic sequences. Such libraries are usually constructed by introducing synthetic diversity 
into a naïve library by PCR assembly of germline genes, or by recombination of in vivo formed 
CDRs.260 Synthetic libraries are constructed entirely in vitro, using oligonucleotides to introduce 
diversity into the CDRs. While antibodies with mediocre affinities are readily screened from 
relatively small naïve or synthetic libraries, in general, for isolating high-affinity binders the 
diversity of the library becomes significant.260 In fact, studies have shown a linear correlation 
between the library size and the highest affinity that has been isolated, meaning that, in 
particular in the case of naïve or synthetic libraries, the size of the library must be large enough 
to increase the probability of finding a given antibody and enhance the quality of the antibody.294 
1.4.4 SELECTION OF BINDERS FROM PHAGE-DISPLAYED LIBRARIES 
Individual clones from phage-displayed libraries theoretically can be directly screened for target 
binding, for example by immunoassays, in a manner resembling the screening of synthetic or 
chemical libraries which must be screened compound by compound. However, screening of 
libraries consisting of millions to billions of different clones is limited by the number of clones 
that can be examined.260 In order to efficiently isolate specific binders the library needs to be 
coupled to a technology which provides a means to carry out selections from these repertoires. 
In vitro display technologies, which basically mimic the natural in vivo process of antibody 
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production, have enabled such proficient enrichment and selection of binders in a rapid and 
controllable manner. The essence of the display technologies resides in the physical linkage 
between the phenotype of the phage displaying the protein or peptide on the surface and the 
genotype encoding for that entity, packaged as the genetic information within the same phage 
particle. This link enables selection of phage-displayed libraries and powerful enrichment by 
selective propagation of the individual with the desired properties.260 Thus, a single displayed 
entity, be it a peptide, protein or antibody fragment, of the desired trait, can be captured from a 
pool of billions of variants, its gene can be amplified and used for another selection round or 
whatever downstream purpose might be desired.259 
Although phage display is the most renowned technique for screening libraries,264,295 also 
other display methods, including cell surface display using bacteria,296 yeast,297 or mammalian 
cells,298 as well as cell-free systems, such as ribosome display,299 have been successfully 
applied to screening antibody libraries. Although less popular than phage display technology, 
these methods present some advantages, such as the ability of yeast cells to express complex 
proteins which require post-translational modifications, or the possibility to create larger 
libraries using cell-free methods which are not restricted by the bacterial transformation 
efficiency.300  
The process of in vitro selections, whether it is based on phage or other display systems, 
commonly includes: (I) the generation of genotypic diversity by constructing protein or peptide 
libraries which consist of millions or billions of different variants, (II) the display method which 
creates a physical link between the expressed protein variant and the gene coding for it, (III) the 
application of selective pressure to screen for target-specific binders, and finally, (IV) 
amplification of the selected variants.260 Remarkable features of in vitro selection technologies 
include the possibility of defining the selection conditions carefully, the potential for high 
throughput applications, and further improvement of selected binders by various protein 
engineering methods, for example, to achieve better affinity or stability, reduce unwanted cross-
reactivities, or add tags for purification or immobilization.93,169,301 These systems provide 
immediately the genes and corresponding DNA sequences of the clones selected against the 
specific target. Simple sub-cloning can allow presenting modifications or adding functionalities, 
such as purification tags or fusions to enzymes or fluorescent proteins.301 Moreover, also 
conventionally challenging targets, including toxic or non-immunogenic molecules, have been 
successfully used.302,303 
The screening process of phage-displayed libraries, commonly known as panning, 
includes introducing the phage-displayed library to the target captured to a solid surface, 
washing to remove the unbound and nonspecifically bound phages, elution of the bound phages, 
and amplification of the eluted phages through bacterial infection (Figure 5A). Ideally, only one 
round of selection is required, but as nonspecific binding limits the enrichment in one selection 
round, in most cases, 3–5 iterative rounds of selection and amplification are performed to select 
individual binders. A variety of modifications in the panning protocol and details for improved 
selections have been described for selecting high-affinity binders from phage-displayed libraries. 
Generally, the experiment can be designed to maximize either phage capture or affinity 
discrimination. While effective capture is best used for the first selection round, the conditions 
can be modified in the later rounds to produce better affinity discrimination.257 
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Figure 5. Selection of affinity binders from a phage-displayed library. (A) The selection process 
consists of binding, washing, elution, and amplification steps which are usually repeated to 3–5 
times to enrich target-specific binders. (B) Target specificity of individual clones can then be 
determined by screening the monoclonal clones from single colonies in ELISA, and the positive 
clones can be identified by DNA sequencing. 
The early rounds of selection are usually the most important ones. Any bias or loss of diversity 
during the first round will be amplified in the subsequent rounds. Moreover, since the number 
of potential binders is low among the highly diverse library, efforts should be made to maximize 
the capture of all interesting clones. When enrichment of selective clones is achieved, and the 
diversity is reduced in the later rounds, stringency can be increased by decreasing the target 
concentration or increasing the number or time of the washes.258 The amount of background or 
nonspecific binders in the phage pool is significant, especially in the first round when the 
proportion of specific clones is still low. Certain additives, such as glycerol and surfactants, can 
be used to reduce the non-specific binding of the phage, but they can also reduce the specific 
binding. The probability of enriching unwanted binders against the solid phase, the blocking 
agents, or the carrier protein, can also be reduced by pre-selecting the library before the actual 
selection. 
The selection is commonly carried out in solution or at solid phase. Most frequently the 
target is directly immobilized on a solid support, such as immunotube, beads or microtiter plate, 
which enables the separation of bound and unbound phages by simply washing the support.258 
Small molecules which cannot be directly immobilized are often conjugated to a carrier protein 
or chemically conjugated to a linker such as biotin. For binding in solution, a biotinylated target 
is incubated with the phages in solution, after which the target bound phages are captured by 
streptavidin, for example, using magnetic beads.257 Because binding is an equilibrium reaction 
where the amount of the binder–target complex formed is determined by the affinity and the 
concentrations of the binder and the target, the amount of the target used for the selections is 
one of the critical factors in the process. Theoretical models suggest that high-affinity binders 
should be selected with the target concentration lower than the dissociation constant (KD), but 
often a target excess is used in particular in the first rounds to allow capture of a higher fraction 
of the phage population and decrease the risk of losing the rare high-affinity binders.304 
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However, by using limited and decreasing amounts of the target in the later rounds, the selection 
favors high-affinity binders.260 Additionally, if multivalent display is used, avidity will play a 
significant role in the binding and seemingly good binders with actually low affinity might be 
selected due to avidity effects. When selection of high-affinity binders is desired, monovalent 
display is thus preferred,258 although the use of a controlled density of the target during the 
selections can reduce the avidity effects favoring one-to-one binding interactions, even with 
multivalent displays.272 
On the other hand, also the washing steps are of great importance. Typically, affinity, in 
terms of the KD which is the ratio of the association (kon) and dissociation rates (koff), can be 
improved by removing phages with fast dissociation rates in the washing step. The number and 
length of the washings can be thus optimized to select high-affinity binders. Short incubation 
times, short washes, low target concentration, and decreased number of input phage might 
favor the selection of clones with fast binding.260,305 
In the elution step, bound phages are typically eluted by addition of an acid or a base to 
break the binding interaction. If such elution step is not efficient enough, it will result in the loss 
of high-affinity binders. On the contrary, too harsh conditions might affect the infectivity of the 
phage and have consequences in the amplification step. Alternatively, elution can be done by 
competition, i.e., by adding an excess of the free target to the selections, or by cleavage of 
phages which include a specific protease cleavage site between the phage and the displayed 
binder.257 It should be also noted that the amplification step is susceptible to artifacts, such as 
biased production of clones which are capable of growing faster than an average clone.258 Thus, 
clone enrichment is not only determined by the affinity of the binder but also the toxicity of the 
specific clones to the bacterial host, solubility, folding efficiency, and stability may contribute to 
the outcome of phage display. 
In the end, the outcome of any selection process is a mixture of clones with different 
target-binding properties. Screening of individual clones, typically by phage-based ELISAs, is 
needed to evaluate their target-binging capabilities. Finally, DNA sequencing of selected clones 
can be used as a guideline to define at what stage to screen the library (Figure 5B).260 Recent 
developments in automation of the selection process have enabled rapid screening, for 
example, for several targets simultaneously. Moreover, screening robots enable testing of 
thousands of different binders,260 and protein microarrays can prove useful for high-throughput 
analysis of the specificity and affinity.306 
In continuation of mimicking the natural selection process, similarly to affinity maturation 
in vivo in which the immune response is capable of producing antibodies with increased 
affinity,168 a variety of in vitro techniques can be used to improve the affinity and specificity of 
the binders. The process, known as in vitro affinity maturation, comprises a variety of 
mutagenesis strategies which have been used to construct second-generation libraries based 
on desired characteristics of the parental peptide or antibody with some fixed or biased 
sequences. Diverse techniques used include random mutagenesis using DNA modifying 
enzymes or error-prone PCR, introduction of mutations to certain areas or residues of the 
antibody, usually in the variable region and the hypervariable loops, for example by 
oligonucleotide-directed mutagenesis. Also DNA recombination, including the use of natural 
evolution or recombination of the target gene, can be used to recombine homologous segments 
to emphasize the desired property, or to shuffle heterologous genes to create new 
diversity.258,307
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1.4.5 PHAGE DISPLAY AND MYCOTOXINS 
Small molecules, or haptens, are challenging targets for many binders because of their size. 
Because haptens are not immunogenic, for immunization, they need to be conjugated to a 
carrier protein. Alike, for phage display, small molecules are usually conjugated to a carrier 
protein, or chemically modified with biotin or reactive groups which enable their immobilization. 
As a result, the isolated antibodies from both natural and in vitro selections may also recognize 
part of the linker or carrier protein, and the soluble target is recognized less efficiently. Despite 
the inherent limitations of small molecules, many examples of applications of phage display for 
mycotoxin detection have been reported. In fact, the libraries can be designed taking into 
account specific prerequisites so as to find antibodies, for example, against haptens.308 In 
addition, the selection conditions in phage display can be strictly controlled, and the library can 
be for example pre-selected against the carrier protein to avoid background binders, or to favor 
binding of the free target, the bound phages can be eluted in the presence of the soluble 
one.309,310 
Various mycotoxin-specific antibodies have been selected from phage-displayed libraries 
and used for immunoassay or biosensor development. However, only a few examples of 
antibodies originating from naïve or synthetic libraries have been reported. For example, an 
AFB1-specific scFv has been selected from a synthetic human scFv library (Tomlinson J) showing 
an excellent KD of 1.2 × 10–12 M,311 although other examples, such as FB1-specific scFv selected 
from a naïve library showed only rather low affinity, with a KD of 4.08 × 10–7 M.312 In fact, 
immunized libraries which are already biased towards the target, have been more widely used, 
perhaps because they often, although not necessarily, result in binders with higher affinities. 
Phage-displayed scFv-libraries have been constructed from immunized mice, at least against 
FB1,279 OTA,280 and ZEA.281 Kinetic analysis by SPR showed excellent affinities in the nanomolar 
range for the anti-OTA and anti-ZEA antibody fragments demonstrating the advantage of using 
immunized libraries. Alternatively, so-called positive phage-display libraries have been 
constructed by randomly recombining the VH and VL gene fragments from hybridoma cell lines 
which secrete a specific monoclonal antibody. Such libraries have been reported at least against 
AFB1200 and FB1,313 both of which resulted in an scFv with improved affinity compared to the 
parental monoclonal antibody. Also, the use of nanobodies (VHH) has been reported for example 
for the detection of OTA. Nanobody Nb28 was selected from an alpaca-derived VHH-library and 
showed excellent performance in various assay schemes, including phage display-mediated 
immuno-polymerase chain reaction which provided one of the lowest detection limits reported 
so far for OTA,314 direct competitive fluorescence enzyme immunoassay using a recombinant 
fusion of the same nanobody with alkaline phosphatase,315 and ELISA with the soluble 
nanobody.316  
Alternatively, phage display has been used to select epitope mimics which can replace 
toxin-conjugates in competitive assays, as discussed before (1.3.4 Particularities of small 
molecule detection). Both peptide and synthetic antibody libraries have been used to select 
binders against anti-toxin antibodies. The exceptional feature of phage display to search for 
binders, even without any prior knowledge about the antibody paratope, proves particularly 
useful in this application. Antibody–antigen interactions are usually a complex combination of 
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hydrogen bonds, electrostatic bonds, or Van der Waals forces, and unless the antibody paratope 
and antigen binding are extremely well characterized, rational design or computational modeling 
of epitope mimics would be challenging. Nonetheless, despite the lack of any of this information, 
phage display can be used to select binders for these antibodies. Moreover, whilst the selections 
for the primary binder, i.e., the toxin-specific antibody, exquisitely look for high-affinity binders 
to provide excellent sensitivity in the final application, epitope mimics do not necessarily require 
such high affinity. In fact, a slightly lower affinity of the epitope mimic in comparison with the 
target toxin can be advantageous as weaker affinity indicates less amount of the analyte needed 
to participate in the competition leading to higher sensitivities.242,247 Thus, naïve or synthetic 
libraries which might not have enough diversity to find high-affinity binders can be used to search 
for epitope mimics. For example, a naïve alpaca nanobody library, which was originally 
constructed for the screening of DON-specific nanobodies,317 has been used to select anti-
idiotypic nanobodies for the detection of several mycotoxins, including citrinin,244,245 DON,246 
FB1,124,242 and OTA.247 
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2 Aims of the study 
 
The overall objective of this thesis was to develop new methods for the detection and 
quantification of mycotoxins and toxigenic fungi in food. To this aim, various assay concepts and 
formats were explored to assess the impact of different assay components on the performance 
of bioanalytical assays and biosensors. New recognition elements were designed or selected to 
achieve specific detection of these food contaminants with the objective of meeting the 
demands of simple, rapid and low-cost yet sensitive methods for the detection of mycotoxins or 
toxigenic fungi in agricultural products. The selected recognition elements were applied to the 
development of biosensors where the effect of the reporter and affinity binders were evaluated 
in both homogeneous and heterogeneous assay formats. More specifically, the aims of this 
Ph.D. thesis work were: 
1) Development of species-specific DNA probes for the detection and differentiation of 
highly similar fungal species, Fusarium proliferatum and Fusarium verticillioides, and 
the development, optimization and application of the genosensors for the detection of 
these fungi in cereals. 
2) Identification of mycotoxin mimicking peptides, or mimotopes, for mycotoxins 
fumonisin B1, zearalenone and T-2 toxin from a phage-displayed peptide library. 
3) Development of immunoassays for mycotoxin detection based on the use of the 
synthetic mimotopes in a microarray format and their application to the analysis of 
fumonisin B1 in maize and wheat samples. 
4) Construction and expression of recombinant fusion proteins consisting of the 
previously identified mimotopes and fluorescent or bioluminescent proteins. 
5) Development of heterogeneous and homogeneous immunoassays based on the 
recombinant mimotope fusion proteins for mycotoxin detection in cereals. 
6) Comparison of the different assay formats developed using the phage-borne, 
synthetic, and recombinant mimotopes. 
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3.1 Detection of mycotoxigenic fungi 
 
The genus Fusarium is one of the most common producers of mycotoxins and species within 
this genus are among the most abundant fungi found in agricultural products, such as maize, 
wheat, and barley. Although the presence of the fungi does not guarantee mycotoxin 
contamination, assessment of these fungi species is essential to prevent it and identify the 
mycotoxin producers in crops. F. proliferatum and F. verticillioides belong to the Fusarium 
fujikuroi species complex which causes a variety of devastating disease in plants and produce 
a range of menacing mycotoxins. A prerequisite for understanding the ecological behavior of the 
fungi in this species complex, or to evaluate the potential mycotoxin contamination, is the 
development of robust and reliable methods for their identification at the species level. 
Conventional methods for fungal detection are based on culturing the fungi in specific 
media which inevitably takes several days and is challenging if the species have similar 
morphologies, as do F. proliferatum and F. verticillioides. This publication aimed to develop 
species-specific DNA probes, which would allow detection and discrimination of these closely 
related species, and to apply the developed of genosensors based on these probes to the 
detection of fungal contamination in maize samples. The work included targeting an intergenic 
spacer region of rDNA (IGS) which allowed differentiating both Fusarium spp., the design of 
capture and detection oligonucleotide probes for this specific region, optimization of the assay 
protocol using the designed DNA probes as the recognition elements, and finally, application of 
the develop method to fungi analysis in contaminated maize samples. The main advantages of 
the genosensors presented in this work over conventional culture-based methods include more 
sensitive and specific analysis, faster and less labor-intensive protocol resulting in a 
straightforward identification of the targets at the species level.
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3.1.1 SPECIES-SPECIFIC OPTICAL GENOSENSORS FOR THE DETECTION 
OF FUSARIUM FUNGI IN FOOD SAMPLES 
Reproduced from: Analytica Chimica Acta 2016, 935, 231–238 
Copyright ® 2016, with permission from Elsevier. 
Abstract 
Plant-pathogenic Fusarium species, Fusarium verticillioides and Fusarium proliferatum, are the 
major producers of fumonisins which are one of the most common mycotoxins found in maize. 
Herein, we report the development of specific and sensitive genosensors for detecting these two 
closely related Fusarium species in food samples. The sensors are based on species-specific 
capture and detection probes, which bind to the intergenic spacer region of rDNA (IGS). 
Oligonucleotide functionalized magnetic microbeads are used to capture the target DNA which 
is then detected using biotinylated detection probes and a streptavidin-coupled label. The 
developed genosensors had detection limits of 1.8 pM and 3.0 pM for F. proliferatum and 
F. verticillioides, respectively, using synthetic DNA targets. Furthermore, the biosensors were 
used to analyze natural fungal contamination of commercial maize samples. After amplification 
of the genomic DNA, the sensors detected the presence of the fungi, in accordance with previous 
results obtained with PCR. No cross-reactivity between F. verticillioides and F. proliferatum, or 
other fungi species tested, was observed. The developed biosensors can provide a valuable tool 
to evaluate the potential for mycotoxin contamination in conditions where detection of 
mycotoxins directly is challenging. 
 Introduction 
Fumonisins, a group of secondary metabolites produced primarily by Fusarium species, are one 
of the major food-borne toxins found in maize worldwide. Fumonisin B1, the most abundant and 
toxic of fumonisins, has been reported to be neurotoxic, hepatotoxic, and nephrotoxic in animals, 
and it has been classified as a possible carcinogen to humans.1–3 The European Union has set 
maximum residue limits (MRLs) for fumonisins and other mycotoxins, including aflatoxins, 
ochratoxin A, zearalenone, deoxynivalenol, T-2 and HT-2 toxin, patulin, and citrinin in food and 
feedstuff to ensure a high level of food safety.4–6 In order to prevent food contamination it has 
also become important to identify the mycotoxin producers in food and feed, as it can elucidate 
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the mycotoxigenic potential of the analyzed samples.7,8 Although the presence of the fungi does 
not guarantee mycotoxin contamination, several studies have shown a correlation between 
Fusarium and mycotoxin levels.9–11 Thus, early detection of mycotoxigenic fungi can be a useful 
tool for food and feed quality control. 
Mycotoxin-producing fungi species are frequently found in agricultural commodities, and 
they can grow on a wide range of substrates under a wide range of environmental conditions. 
The Fusarium fujikuroi species complex (formerly known as the Gibberella fujikuroi species 
complex) includes several closely related species in the genus Fusarium and is considered to 
be one of the main contaminants of crops. Fusarium verticillioides and Fusarium proliferatum 
are often found in this complex, and they have highly similar morphology and are 
phylogenetically close to each other.12,13 These species are the major producers of fumonisins 
in maize, even in plants with no signs of infestation. While F. proliferatum is known to colonize 
a wide range of hosts, including maize, wheat, barley, pine trees, asparagus, and palm trees, 
F. verticillioides is mainly restricted to maize. For this reason, a remarkable effort has been made 
during the last two decades to distinguish unambiguously these toxigenic strains.14–16 
Conventionally toxigenic Fusarium species have been identified with culture-based 
techniques and morphological classification using methods that are often laborious, time-
consuming, and require taxonomical expertise in Fusarium species. More recently molecular 
diagnostic methods based on specific detection of fungal DNA have emerged to replace the 
cumbersome microbiological analysis.17–21 Ribosomal DNA (rDNA) is the most commonly used 
target for the molecular identification of plant pathogenic fungi.22 The nuclear rDNA consists of 
the internal transcribed spacer (ITS) and the intergenic spacer (IGS) regions. The ITS region is 
the most widely used and sequenced DNA region in molecular ecology of fungi, and it has been 
recommended as the universal fungal barcode sequence,23 whereas the IGS region is less used. 
Nevertheless, the IGS region is known to have the highest variability between species, and it is 
considered to be the most rapidly evolving spacer region. This allows differentiating even 
genetically closely related species, such as F. verticillioides and F. proliferatum. Also, the multi-
copy nature of the rDNA region can enhance the assay sensitivity compared to methods that are 
based on single-copy sequences.10,24 
Direct detection of Fusarium species is challenging because the fungi often exist in 
species complexes, or at very low concentrations in clinical and natural environments. Different 
molecular genotypes or varieties can also exist within the species, and they may have different 
pathogenic profiles and virulence levels to the host.25 PCR amplification of the target DNA offers 
a sensitive high-throughput method for identifying pathogens in complex mixtures even when 
they are no longer viable, and several PCR protocols have been developed for the detection of 
mycotoxigenic Fusarium species, such as F. verticillioides11,26 and F. proliferatum.10,27 
Nevertheless, conventional end-point PCR has several limitations. Lack of specificity of 
the agarose gel–based detection of the amplified target DNA can lead to false positive results. 
This may be due to the challenges in determining the exact amplicon size, subjectivity in band 
identification, and the potential occurrence of amplification artifacts with similar size as those 
of the real PCR product.28,29 To overcome these problems, traditional PCR-based methods have 
evolved to quantitative approaches such as qPCR – also called real-time PCR – or, more recently, 
digital PCR,30 and single molecule arrays (SimoaTM).31 Some Fusarium species as well have been 
detected with qPCR showing satisfactory results.32,33 However, despite their inherent sensitivity, 
quantitative PCR techniques are not yet standard tools for the analysis of nucleic acids since 
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they require costly chemicals and consumables, complex instrumentation and qualified 
personnel. In addition, the simultaneous detection of several different pathogens with multiplex 
qPCR is difficult, as it requires complex primer design and careful optimization of the reaction 
conditions to allow specific and efficient target amplification. Furthermore, multiplexing based 
on the use of fluorescent dyes is limited by the availability of dyes with distinguishable 
spectra.34,35  
PCR-enzyme-linked immunosorbent assays (PCR-ELISA) combine the high selectivity of 
the amplification-based DNA methods with the sensitivity of ELISA. Also, PCR-ELISA allows 
processing a large number of samples in a short time using only standard laboratory equipment, 
which demonstrates its suitability for the implementation of integrated screening methods for 
pathogen detection in food.36 For example, a PCR-ELISA with a biotinylated capture probe has 
been used to detect the amplified PCR fragment of fumonisin-producing Fusarium species.37 
However, traditional ELISA-based methods have some limitations, such as large sample 
amounts required, recurrent non-specific adsorption of DNA, and reduced multiplexing 
capabilities.38 
In response to these limitations, the combination of PCR and DNA biosensors – also called 
genosensors – is considered an attractive alternative for pathogen detection due to their 
simplicity, low cost, and the possibility of multiplexing, together with exquisite specificity 
attributable to the use of sequence-specific probes.36 In particular, genosensors based on 
magnetic microbeads and PCR amplification, have been broadly used in clinical applications 
and food analysis because of their excellent sensitivity, reproducibility, reduced time of analysis, 
high sample throughput, and easy automation with minimum consumption of the sample and 
reagents.39,40 To the best of our knowledge, only a few genosensors, mainly microarrays, have 
been developed for fungal pathogen screening and identification. One of the first was reported 
by Leinberger and coworkers who implemented a microarray platform which included capture 
probes of 16–24 bases for the fungal rRNA target genes. The method allowed the identification 
of 12 common pathogenic Candida and Aspergillus species in clinical isolates.41 
Here we describe the development of new genosensors that combine the end-point PCR 
with magnetic microbead–based sensors for the simultaneous and accurate detection of both 
F. proliferatum and F. verticillioides for agro-food safety applications. This combination benefits 
from the advantages of the IGS region for designing one common primer pair for generating a 
PCR product for fumonisin producing Fusarium species, and two pairs of novel species-specific 
DNA probes that target either F. proliferatum or F. verticillioides. A bead-based sandwich 
hybridization assay is performed by incubating the sample, containing the common PCR 
amplicon, and magnetic microbeads coupled to capture probe and biotinylated detection probe. 
The assay protocols, including a selection of the optical reporter, are optimized to allow 
enhanced sensitivity and specificity. Finally, we demonstrate the suitability of the genosensors 
for the analysis of Fusarium contamination in natural maize samples, postulating this novel 
screening method as the basis of further implemented platforms with the multiplexing 
capabilities necessary to distinguish the wide range of fumonisins-producing fungi species.42,43 
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 Materials and methods 
Materials 
LodeStars 2.7 Carboxyl paramagnetic beads with an average diameter of 2.7 µm were 
purchased from Agilent Technologies, Inc. (Santa Clara, CA, USA). Streptavidin  
R-phycoerythrin conjugate (SAPE), Pierce™ Streptavidin Poly-HRP (SA-poly-HRP), Qdot® 655 
Streptavidin Conjugate, Dynabeads® Oligo(dT)25, Amplex UltraRed reagent together with bovine 
serum albumin (BSA), 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC), 
BupH™ MES buffered saline and phosphate-buffered saline (PBS), Tris-EDTA (100× solution), 
and Blocker™ solution (casein in PBS) were purchased from Thermo Fisher Scientific (Waltham, 
MA, USA). Saline-sodium citrate buffer (SSC, 20× concentrate), sodium dodecyl sulfate solution 
(SDS, 20%), Tween-20, and betaine solution (5 M) were from Sigma-Aldrich (St. Louis, MO, USA). 
Black polypropylene 384-microplates were obtained from Eppendorf (Hamburg, Germany) and 
all oligonucleotides (Table 4) were from Integrated DNA Technologies, Inc. (San Diego, CA, USA). 
The NZY Plant/Fungi gDNA extraction kit was acquired from by NZYtech (Lisboa, Portugal) and 
Sabourad dextrose broth + chloramphenicol was from Conda (Madrid, Spain). For the PCR 
amplification, the KOD Xtreme Hot Start DNA Polymerase and dNTPs were purchased from 
Merck Millipore (Darmstadt, Germany). The assay incubations were performed in Digital shaking 
dry bath from Thermo Scientific (Waltham, MA, USA).  
Design of species-specific oligonucleotide probes and primers 
Species-specific capture and detection probes were designed to bind to the IGS region of 
F. proliferatum and F. verticillioides. Also, PCR primers were selected to bind to sequences that 
are common for both Fusarium species, which allowed amplification of both targets with the 
same primer pair in one reaction. The probes and primers were designed on the basis of 
sequence alignments of the IGS region of more than one hundred Fusarium strains (ten of those 
belonging to F. verticillioides and forty belonging to F. proliferatum) from different origins and 
other related species and genera obtained previously in our laboratory or retrieved from 
databases. Sequences were edited and aligned by ClustalW method using the MegAlign program 
of DNASTAR software (Lasergene, WI, USA). Figure 11 in the supplementary material shows the 
partial alignment of the IGS sequence of representative strains of Fusarium fujikuroi species 
complex which includes F. proliferatum and F. verticillioides, and the primers and probes 
designed in this work. Schematic presentation of the primers and probes within the IGS region 
is presented in Figure 6. 
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Figure 6. Schematic representation of partial Fusarium IGS region and location of the 
primers and probes designed in this work. 
The oligonucleotide probe and PCR primer sequences are presented in Table 4. The capture 
probes included an amino modification in 5’-terminus for coupling, and the detection probes 
had a 3’-terminal biotin for labeling. The direct detection probe, that was used as a positive 
control hybridized, directly to the capture probe without the target sequence. The synthetic 
targets for both species included the complementary sequences of both the capture and 
detection probes. 
Table 4. Oligonucleotide sequences of the species-specific probes for F. proliferatum and 
F. verticillioides (FP and FV, respectively) and PCR primers which amplify both of the species.  
Name Sequence (5’ 3’) 
Capture probe FP 5’ Amino modifier C12 – CGG CCA CCA GAG GAT GTG 
Capture probe FV 5’ Amino modifier C12 – GAG TTT CCA GTC TCG CCG CTG ATG GA 
Detection probe FP GAC CAG AGC GAA CGT GGT C – 3’ Biotin 
Detection probe FV TGT GGT CTG GTG GCC GCG – 3’ Biotin 
Direct detection probe FV 5' Biotin – TCC ATC AGC GGC GAG ACT GGA AAC TC 
Synthetic target FP GAC CAC GTT CGC TCT GGT CCA CAT CCT CTG GTG GCC G 
Synthetic target FV CGC GGC CAC CAG ACC ACA TCC ATC AGC GGC GAG ACT GGA AAC TC 
Forward primer GTC CTG TAA GCA GTA GAG 
Reverse primer CTC GCG GGC CAC TTT TGA 
Coupling of capture probes to magnetic particles  
The capture probes FP and FV were conjugated from their terminal amino group to the 
carboxylated magnetic microbeads. First, the beads (1 mg) were washed twice with 0.01 M 
NaOH, followed by three washes with the coupling buffer (0.1 M MES, pH 5.7; 0.01% SDS) 
according to manufacturer’s instructions. Next, the carboxyl surface was activated by adding 
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150 μL of 525 mM EDC in coupling buffer together with 5 nmol of amino-modified DNA to reach 
the total reaction volume of 500 µL. The reaction tube was incubated for 30 minutes at room 
temperature in slow shaking. Another 150 µL of 525 mM EDC solution was added, and the 
incubation was continued for 30 minutes as before. Finally, the beads were washed with 1x Tris-
EDTA buffer three times and stored at +4 °C in the same buffer. The DNA coupling efficiency 
and the capture probe density on the bead surface was determined by measuring the amount 
of DNA remaining in the solution phase after immobilization, as previously reported.44 
Sample preparation 
Five maize samples from commercial fields in Spain were kindly supplied by the Insect-plant 
Interaction Group from CIB-CSIC (Madrid, Spain). The samples were previously analyzed for 
fungal contamination by PCR assays. Briefly, the seeds (15–20 g) were ground with a grinder 
and sieved by a 0.1 mm screen to obtain a subsample of 0.08 g that was subsequently 
subjected to DNA extraction. Total DNA (120–200 ng) was used in PCR assays10,18,26,45–49 to 
determine the presence of the fungi in the samples. 
In parallel, the samples were tested with the genosensors. First, to extract the genomic 
DNA 3 g of ground maize sample was incubated in 50 mL Sabourad dextrose broth for 24 h at 
+28 °C, 120 rpm. The culture was filtered and homogenized in liquid nitrogen with mortar and 
pestle. Then, the genomic DNA was extracted from homogenized samples with NZY Plant/Fungi 
gDNA kit according to the manufacturer’s instructions. The IGS region of the fungal DNA was 
amplified using PCR primers designed on the conserved regions of the Fusarium species. The 
PCR reaction contained 0.3 µM forward and reverse primers, 0.4 mM dNTPs, 0.7 M betaine, 
0.02 U µL–1 of KOD Xtreme Hot Start DNA Polymerase, and 1x Xtreme buffer. The total volume 
of the reaction was 50 µL. The thermal cycling of the PCR consisted of 2 min initial denaturation 
at +94 °C followed by 30 cycles of +98 °C for 10 s denaturation, +50 °C for 30 s annealing, 
and +68 °C for 1 min extension steps.  
Assay protocol 
One-step sandwich hybridization assay was performed by mixing the capture probe coupled to 
the magnetic beads, the target DNA, and the biotinylated detection probe. First, to reduce the 
nonspecific binding the microcentrifuge tubes were blocked with BlockerTM for 1 h at +37 °C. 
Then, the target DNA (0–0.5 pmol of the synthetic target or 10 µL of sample in three replicates, 
except 6 replicates for the blank) was mixed with 0.5 pmol of detection probe and heated to 
+95 °C for 5 min to denature the DNA. After cooling the mixture on ice for 5 min, 6.5 µg of beads 
(approximately 5×105 beads), were added to reach the total reaction volume of 100 µL. All 
dilutions were made in hybridization buffer (5× PBS with 0.1 M betaine), and the reaction was 
incubated for 1.5 h at +60 °C with slow shaking (600 rpm). The beads were then washed three 
times with washing buffer A (2× SSC, 0.02% Tween-20) and 50 µL of SAPE (10 µg mL–1), SA-QD 
(5 nM) or SA-poly-HRP (200 ng mL–1) in hybridization buffer was added to each reaction tube. 
After 30 min incubation in shaking at room temperature, the beads were washed three times 
with washing buffer B (0.1% BSA, 0.02% Tween-20). Next, they were resuspended in 12 µL of 
hybridization buffer and transferred to the wells of a 384-microtiter plate. The SAPE and 
quantum dot reactions were directly measured with CLARIOstar microplate reader from BMG 
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Labtech (Ortenberg, Germany) after short shaking. For the enzymatic reaction, Amplex UltraRed 
reagent was mixed with hydrogen peroxide according to the manufacturer’s instructions, and 
50 µL of the substrate solution was added to each well to develop the fluorescent signal. The 
fluorescent signals were measured with the microplate reader using excitation/emission 
wavelengths of 490/578 nm for SAPE, 320/655 nm for quantum dots, and 510/590 nm for 
Amplex UltraRed. 
 Results and discussion 
Probe design and assay optimization  
The intergenic spacer region (IGS) of the ribosomal DNA is one of the most rapidly evolving 
sequences in the genome. The IGS region of Fusarium was chosen as the target DNA for 
developing species-specific genosensors since it has sufficient variability to discriminate closely 
related species, such as F. verticillioides and F. proliferatum. On the other hand, the use of IGS 
region to develop specific probes, instead of single-copy genes (either constitutive or toxin 
biosynthetic genes), enhances the sensitivity of the assay due to its multi-copy character.24 The 
PCR primers were designed to hybridize to the conserved regions of the IGS so that the same 
primer pair will amplify both F. proliferatum and F. verticillioides DNA, as well as other Fusarium 
species, F. saccharii, F. fujikuroi, and F. nygamai within the Fusarium fujikuroi species complex 
(Figure 11 in the supporting information). In this way, we could avoid the complex primer design 
and PCR reaction optimization that is required for developing multiplex PCR assays. 
Furthermore, the sequence variations within the PCR amplicon were exploited to identify and 
distinguish F. proliferatum and F. verticillioides by designing the species-specific capture and 
detection probes on these sequences. 
Figure 7 shows a schematic illustration of the target DNA detection by the genosensors. 
The sandwich complex is formed when the target DNA hybridizes with the species-specific 
detection and capture probes. The capture probes are coupled from their 5’-terminus to 
magnetic beads which allow efficient separation of the target even from complex mixtures. 
Biotin in the 3’-terminus of the detection probe allows detection of the hybridized complex in a 
flexible way using any streptavidin-coupled label. 
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Figure 7. Schematic of the assay principle. Target DNA (red) is recognized by the capture 
probe (blue) coupled to magnetic microbeads and the biotinylated detection probe (green). 
Hybridized sandwich complex is then detected using SA-poly-HRP and Amplex  
UltraRed substrate. 
After oligonucleotide coupling, the capture probe density on the bead surface was determined 
by measuring the amount of DNA remaining in the solution phase after immobilization. The 
optimized coupling protocol resulted in 268 pmol of oligonucleotides/mg of beads which is in 
accordance with the surface binding capacities reported for commercially available magnetic 
microbeads.50 Due to the complexity of the genomic DNA the first experiments with the 
genosensors were done with synthetic target DNA that was complementary to the capture and 
the detection probes. The sandwich assay can be performed either in two steps, adding first the 
bead-coupled capture probes, washing and then adding the detection probe, or in one step 
where both probes and the target DNA are hybridized in one incubation step. We observed that 
both assay formats resulted in similar signal levels, but the 1-step format allowed higher 
reproducibility (RSD < 16% ) (Figure 8A), which is most likely due to the lower number of washing 
steps required in this setup. The optimal hybridization time was defined as 1.5 h, as it resulted 
in higher fluorescence signal intensities than shorter incubation times. However, longer 
incubation did not show further improvement in the assay (Figure 8B; Figure 12 in the supporting 
information). As the GC-content of the IGS-region and the probes is rather high (55–75%), 
hybridization requires high temperatures for optimal binding. At +60 °C the signals obtained 
from the assay were best for both species, and this temperature was selected for assay 
development (Figure 8C). The effect of temperature was more evident for F. verticillioides, and 
it could be traced back to the higher GC-content, and higher Tm, of the probes. 
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Figure 8. Optimization results: (A) one-step or two-step hybridization assay, (B) hybridization 
time, and (C) hybridization temperature, light grey F. proliferatum and dark grey 
F. verticillioides (n = 3). 
Selection of the most sensitive label 
To increase the sensitivity of the assay, alternative labels were tested for fungi detection. Instead 
of streptavidin-coupled R-Phycoerythrin (SAPE), which is an intensely bright phycobiliprotein, 
streptavidin-coupled quantum dots and SA-poly-HRP were evaluated as well. Calibration curves 
with different labels are presented in Figure 9. Quantum dots showed increased sensitivity 
compared to SAPE, but the best sensitivity was achieved with the SA-poly-HRP as the label. The 
use of enzymatic detection allows signal amplification since each HRP molecule can catalyze 
many cycles of conversions of substrate molecules to the fluorescent product, leading to an 
increment of the analytical signal. Moreover, the use of SA-poly-HRP as label further increases 
the amount of fluorescent molecules produced per binding event further enhancing assay 
sensitivity, as described before.51 
 
Figure 9. Comparison of different labels: Hybridized sandwich complex was detected 
using SA-poly-HRP (red), QD (blue) and SAPE (black) as a label. With four-parameter 
logistic fitting the EC50 values were 0.3 nM, 2.8 nM, and 6.1 nM for SA-poly-HRP, QDs 
and SAPE, respectively (n = 3). 
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Cross-reactivity and analytical sensitivity 
After the determination of optimal assay conditions, we performed the cross-reactivity studies 
between F. proliferatum and F. verticillioides to confirm species-specific recognition of the 
genosensors. The sandwich hybridization assays were carried out with the synthetic target using 
F. proliferatum specific probes with F. verticillioides target, and vice versa. No significant cross-
reactivity was observed since the signals from non-specific targets were at the level of the non-
target background (Figure 10). Mirete et al. (2013)43 have determined that the nucleotide 
sequence similarity of the IGS region between F. proliferatum and F. verticillioides is 85%, but 
the capture and detection probes of the genosensors were designed to bind to the regions with 
most variation. In this way, the high sequence variation of the IGS region was used to distinguish 
closely the related species, F. proliferatum and F. verticillioides. Using other targets, such as the 
genes involved in fumonisin biosynthesis, FUM1,11 or even the ITS region,37 this differentiation 
is not possible. 
 
Figure 10. Cross-reactivity of the genosensors was studied by testing the 
F. verticillioides probes (white columns) and F. proliferatum probes (grey columns) 
with both F. proliferatum (FP) and F. verticillioides (FV) targets. SA-poly-HRP was used 
as the label (n = 3). 
Analytical performance of the genosensors was evaluated using the SA-poly-HRP as a label in 
the optimized assay conditions. The calibration graphs corresponding to the linear response 
range for both species are presented in the supplementary material (Figure 13). The fitting 
equations were y = 2140.5[C]0.67 (R² = 0.9996) and y = 2360.0[C]0.74 (R² = 0.996) for 
F. proliferatum and F. verticillioides respectively (6 points per calibration in three replicates, 
except six replicates for the blank). The lower limit of detection was defined as the signal of the 
blank plus three times the standard deviation above the background, in this case 1.8 pM 
(corresponding to 4.0 pg/sample and equivalent to 1.81 × 108 copies of target DNA) and 3.0 pM 
(corresponding to 2.0 pg/sample and equivalent to 1.08 × 108 copies of target DNA) for 
F. proliferatum and F. verticillioides, respectively. The slightly higher detection limit obtained in 
the case of F. verticillioides might be due to the higher GC-content of the probes which could 
cause less efficient binding to the target. The linear range of the assay was approximately  
5–200 pM. Assay reproducibility was determined from fluorescence signals of three replicates 
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within the same day, or in three different days. The intra- and inter-assay relative standard 
deviations (RSD) using 30 pM synthetic target DNA were 6% and 14%, respectively, 
demonstrating the suitability of the genosensors for the qualitative detection of the fungi. 
Analysis of contaminated maize samples 
Finally, to demonstrate the potential use of the genosensors for food analysis we tested five 
maize samples for fungal contamination. The samples were previously analyzed with PCR for 
the presence of fungi.10,18,26,45–49 Two of the samples were not contaminated with Fusarium, 
sample 1 did not contain any fungi, and sample 2 was contaminated with Aspergillus flavus, 
another common fungus in maize. The other three samples were contaminated either with 
F. proliferatum or F. verticillioides, or both species as indicated in Table 5. The genomic DNA 
from these five maize samples was extracted using a commercial DNA extraction kit as 
described in Materials and methods. Since the genomic DNA is complex and difficult to use 
directly for hybridization assays the Fusarium IGS region was amplified by PCR with the primers 
that recognize both F. proliferatum and F. verticillioides. 
After the amplification, the PCR reaction was directly analyzed with the two genosensors 
without any further purification. The samples were heated at +95 °C to denaturate the double-
stranded PCR product and minimize secondary structures of the target DNA. The biotinylated 
detection probe was combined with 10 µL of the sample during heating to minimize the chance 
of rebinding of the complementary strands. To confirm the functionality of the assay and to 
assure that there was no significant interference from the PCR reaction we included a positive 
and negative control to the sample analysis. The negative control included magnetic microbeads 
with dT-oligo that does not bind to the target DNA, and the positive control was FV specific beads 
with a direct detection probe that binds to capture probe directly without the target DNA. The 
cut-off value was determined as previously reported for qualitative PCR-ELISA approaches52, 53 
as the mean signal of the negative controls plus three times the standard deviation of the 
negative controls. Samples that gave signals above this cut-off value were determined as 
positive. Table 5 shows the excellent agreement between the previous analysis and the 
genosensors. No fungi were detected from the two samples without Fusarium, and sample 2 
contaminated with Aspergillus flavus fungi showed no cross-reactivity neither with 
F. proliferatum nor F. verticillioides specific probes. Positive signals were obtained in the 
presence of either or both F. proliferatum and F. verticillioides, which confirmed the specificity 
and selectivity of the detection, as before observed with the synthetic target, as well as sufficient 
sensitivity for detecting the PCR amplicon. 
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Table 5. Results of the sample analysis. Five maize samples were analyzed with the genosensors 
for the presence of F. proliferatum or F. verticillioides. Positive and negative controls were included 
for each sample. 
Sample and fungal contamination 
according to previous PCR analysis 
Negative 
control 
Positive 
control F. proliferatum F. verticillioides 
1 – – + – – 
2 Aspergillus flavus – + – – 
3 F. proliferatum – + + – 
4 F. verticillioides – + – + 
5 F. proliferatum, F. verticillioides – + + + 
 Conclusions 
We have developed two optical genosensors for the selective detection of F. proliferatum and 
F. verticillioides, the major producers of fumonisins in maize. The system takes advantage of 
the IGS region of the fungal genomic DNA and two specific oligonucleotide probes, which allow 
highly specific detection of the two closely related species. The genosensors were able to detect 
the synthetic target DNA in the low picomolar range with no significant cross-reactivity between 
the two species, as well as identify the fungal contamination in maize samples using the 
amplified genomic DNA. A common primer pair was designed for the conserved sequences of 
the IGS region, which enabled amplification of both Fusarium species in one reaction. The same 
primer pair could also be used for other species in the Fusarium fujikuroi species complex, which 
will be a significant advantage when developing a multiplex sensor for several Fusarium species. 
In addition, the magnetic bead assay protocol implemented in this work could easily be 
automated providing a simple and robust method for the detection of mycotoxigenic Fusarium 
species in food samples.  
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 Supporting information 
 
Figure 11. Partial alignment of the IGS sequence with representative strains of Fusarium fujikuroi 
species complex: F. verticillioides (accession number AJ880005.1); F. saccharii (AJ879944.1); 
F. fujikuroi (AJ879945.1); F. proliferatum (AJ879946.1); F. subglutinans (AJ879947.1); 
F. thapsinum (AJ879948.1); F. nygamai (AJ879949.1) and F. circinatum (AJ879950.1). The 
sequences corresponding the species-specific probes and PCR primers common for both 
F. verticillioides and F. proliferatum (as well as most of other Fusarium species) are marked with 
boxes in the alignment. 
 
Figure 12. Optimization of the hybridization time using the synthetic 
target DNA and HRP detection. 
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Figure 13. Calibration curves with enzymatic detection. The equations for allometric 
fittings for (A) F. proliferatum and (B) F. verticillioides were y = 2140.5x0.67  
(R² = 0.9996) and y = 2360.0x0.74, (R² = 0.996), respectively (n = 3). 
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3.2 Mycotoxin detection 
 
The second and major part of the thesis focused on the development of methods for the 
detection of mycotoxins fumonisin B1 and zearalenone. Even though the presence of 
mycotoxigenic fungi has been shown to correlate with the mycotoxin levels, it is still crucial to 
detect the toxins themselves to guarantee food safety. The national and international 
regulations for the major mycotoxin classes have provoked the development of new methods 
for the detection and quantification of these compounds. Chromatographic methods continue 
their reign among the validated methods, but many biosensors and bioanalytical assays have 
been introduced as an alternative for fast screening or on-field applications. 
The work aimed to develop new immunoassays for mycotoxin detection based on epitope 
mimicking peptides, or mimotopes. The exceptional ability of mimotopes to bind to the same 
antibody paratope as the target analyte makes them an intriguing alternative to replace the 
toxin-conjugates in competitive immunoassays. We have selected mimotopes from synthetic 12-
mer peptide library by phage display using the mycotoxin-specific antibody as the target, anti-
FB1 in publication II and anti-ZEA in publication V. Later, the individual phages which showed the 
best performance in competitive phage-based immunoassays were identified by DNA 
sequencing. Thus, the identified mimotopes could be applied to the immunoassays without the 
phage which itself might not be an ideal component in the assay due to its immense size and 
biologically active nature. 
As an alternative for the phage-borne mimotopes, two strategies were tested and 
compared. In publications II and IV, the synthetic counterpart of the FB1-mimotope was used as 
a competitor in immunoassays in a microarray or magnetic bead format. The synthetic peptide 
was designed with a biotin-linker which enabled simple coupling of the mimotope to the solid 
surface, the array or magnetic beads, using neutravidin. In a different approach, recombinant 
fusion proteins were constructed of the same mimotopes together with fluorescent or 
bioluminescent proteins. The recombinant fusion proteins could be expressed in bacteria and 
used directly as the tracer in the immunoassays. Thus, no additional labeling steps or secondary 
antibodies were required, which simplified the assay protocol and shortened the time needed 
to perform the assay. Publications III–V report the development of such recombinant fusion 
proteins for FB1 and ZEA detection using a yellow fluorescent protein and bioluminescent 
Gaussia luciferase as the fusion partner and tracer. The work includes optimization and 
comparison of different assay concepts, including plate-based and bead-based heterogeneous 
immunoassays, as well as a homogeneous quenching immunoassay based on the fluorescent 
fusion protein and gold nanoparticles.  
Publication IV presents a comparison of the various assays based on different mimotope-
formats, including the phage-borne, synthetic, and recombinant fusion proteins. As the 
immunoassay performance is dependent on many factors, including the used solid phase and 
label, a direct comparison of the different mimotope-formats was performed by surface plasmon 
resonance (SPR) in order to determine how the structural context of the mimotope affects the 
binding kinetics. 
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3.2.1  MICROARRAY-BASED IMMUNOASSAY WITH SYNTHETIC 
MIMOTOPES FOR THE DETECTION OF FUMONISIN B1 
 
Reproduced from: Analytical Chemistry 2017, 89, 6216–6223. 
Copyright ® 2017, with permission from ACS Publication. 
Abstract 
Mimotopes, or epitope mimics, can be applied to competitive immunoassays, for the detection 
of low molecular weight natural toxicants, as an alternative to toxin-conjugates. In this work, we 
report the development of a microarray-based immunoassay for the detection of fumonisin B1 
using a novel mimotope selected by phage display technology. Fumonisin-specific antibody was 
used to isolate mimotopes from a 12-mer peptide library in successive selection rounds. 
Enrichment of antibody binding phages was observed after three panning rounds, and sequence 
analysis of randomly selected monoclonal phages revealed two conserved peptide sequences. 
Clone A2, with peptide sequence VTPNDDTFDPFR, showed the best response in enzyme-linked 
immunosorbent assay (ELISA) in terms of sensitivity and reproducibility and was selected for 
microarray development. A biotinylated synthetic derivative of this mimotope was immobilized 
onto epoxy-glass slides, and fumonisin B1 was detected in a competitive binding inhibition assay 
using the anti-fumonisin antibody and a labeled secondary antibody. The array showed an IC50 
value of 37.1 ± 2.4 ng mL–1 (n = 9), a detection limit of 11.1 ng mL–1, and a dynamic range from 
17.3 to 79.6 ng mL–1. Good specificity toward fumonisin B1 and its structural analog, 
fumonisin B2, was observed, together with negligible cross-reactivity for other mycotoxins 
produced by the same fungi species. The mimotope microarray was applied to the analysis of 
fumonisin B1 in spiked maize and wheat samples. The method enabled quantification of the 
mycotoxin at the levels set by European legislation and holds promise for future adaptation to 
include other mycotoxins for multiplex detection. 
 Introduction 
Fumonisins are a group of mycotoxins produced as secondary metabolites by Fusarium species. 
These fungal toxins are found worldwide, mainly in maize but have also been detected for 
example in wheat, rice, and soybean.1,2 Among the 15 different naturally occurring fumonisins 
reported so far, the most abundant and toxic one is fumonisin B1 (FB1). This compound has been 
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shown to cause a variety of toxic effects in animals and was classified as possibly carcinogenic 
to humans.3 The accumulation of fumonisins in food and feedstuff may pose severe 
consequences on animal and human health, and several international authorities, including the 
European Commission, have set maximum residue limits (MRLs) for these compounds in food.4,5 
The requirement to meet these regulations has motivated the development of novel analytical 
methods for the identification and quantification of fumonisins in various food commodities. 
Currently, analytical methods for the determination of fumonisins are based on liquid 
chromatography (LC) with a diode array (DAD), fluorescence (FLD), or mass spectrometric (MS) 
detection preceded by a sample clean-up step using solid-phase extraction or, in some cases, 
immunoaffinity columns.6–9 Though these methods provide excellent accuracy and 
reproducibility, they show some limitations, including high cost, long analysis times, and the 
requirement of highly skilled personnel and time-consuming sample preparation steps, which 
make them unsuitable for on-site analysis or high-throughput screening. The development of 
screening methods based on antibodies, or aptamers, in combination with novel detection 
techniques, has received much research attention lately.6 In comparison to other analytical 
methods for mycotoxin detection, immunoassays are particularly attractive due to their high 
specificity, good sensitivity, ease of manipulation, fast response times, and low cost. Thereby, 
their use has expanded from specialized laboratory analysis to home testing.10,11 Polyclonal12 
and monoclonal antibodies,13 as well as recombinant antibody fragments,14 have been applied 
to the development of immunoassays for fumonisins using different detection schemes, such 
as enzyme-linked immunosorbent assays (ELISAs), magnetic bead-based ELISAs,15 along with 
some rapid and low-cost immunochromatographic tests16,17 or fluorescence polarization 
assays.18 
Nevertheless, these approaches require conjugation of the competing toxin molecule 
either to a carrier protein or to a label, which can be considered as one major drawback of the 
competitive immunoassay format generally applied to the detection of fumonisins. Synthesis of 
the toxin-conjugates can be time-consuming and challenging or result in randomly cross-linked 
and unstable molecules which might reduce immunoassay sensitivity.19,20 Replacement of the 
toxin-conjugate for an epitope mimic, or mimotope, of the target mycotoxins as coating antigens 
has the potential to overcome such limitations. Mimotopes mimic the structure of the epitope 
and bind specifically to the same antibody paratope as the analyte eliciting a similar antibody 
response than the native epitope.21,22 Moreover, they can be immobilized at high density while 
preserving their stability and specificity,23 and their use avoids the risks associated with the 
manipulation of hazardous compounds. 
Phage display offers a powerful alternative to search for mimotopes, even when previous 
knowledge of the antibody–antigen interaction mechanisms is scarce. Several groups have 
developed phage-displayed mimotopes, mostly peptides or anti-idiotypic antibodies, for 
example, for the detection of aflatoxin,21 deoxynivalenol,24 ochratoxin,25 and zearalenone,26 as 
well as for fumonisins.27,28 
The majority of the mimotope assays described so far rely on the application of phage-
borne peptides. Excellent sensitivities have been reported using this approach, and the phage-
displayed mimotopes appear easy to produce. However, although biologically active phages are 
widely used in research, there exist some safety concerns and reluctance to use these bacterial 
viruses for diagnostic purposes.29,30 As an alternative, other approaches have been reported 
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using genetically engineered peptide-fusion proteins; for example peptide–maltose binding 
protein (MBP) fusions were directly used as coating reagents in ELISA.31,32 Nonetheless, genetic 
engineering required for the development of such fusion proteins, as well as expression and 
purification of the constructs, can be challenging due to problems associated with protein 
misfolding or degradation occasionally observed in the expression of heterologous fusion 
proteins.33 
Chemical synthesis of small peptides is a well-established and widely used method34 and 
could offer a simple alternative for using the phage-displayed mimotopes or the genetically 
engineered peptide-fusions. In fact, some studies have shown that the synthetic peptide alone 
is sufficient to act as the mimotope in competitive phage-free ELISAs.35,36 Due to their small 
molecular weight, chemically synthesized peptides are stable in a wide range of conditions and 
less prone to lose their activity. Furthermore, during their synthesis, a variety of targeted 
modifications can be added, including biotinylation, the introduction of specific reactive groups, 
or fluorescent and affinity tags.37 
Microarrays, also known as “microspot” assays, are renowned high-throughput tools 
mostly used for gene expression profiling, drug discovery, and protein–protein interaction 
studies due to their immense capabilities related to multiplexing, high sensitivity, enhanced 
reproducibility, reduced analysis time, and ease of automation, but the method is also an 
attractive alternative for immunoassay development.38–40 A few microarray-based methods have 
been reported for the detection of mycotoxins,41,42 some of them also for fumonisin analysis.43,44 
These approaches established simultaneous detection of several mycotoxins taking advantage 
of the multiplexing capacity of the microarray; however, in all cases, the toxin-conjugate was 
used in the competitive assay. 
In this work, we describe the development of a novel mimotope-based microarray for the 
detection of fumonisin B1 and its application to the analysis of the toxin in cereal samples. The 
mimotope was selected from a phage-displayed peptide library, and its epitope mimicking 
nature was confirmed by competitive ELISA. Following functionalization with a biotin linker, the 
peptide was spotted in an array format on a modified glass slide and binding of anti-fumonisin 
monoclonal antibodies was competitively inhibited by the target mycotoxin in the sample 
solution. The amount of antibody bound to the patterned mimotopes was revealed using a 
fluorescently labeled secondary antibody. Several parameters affecting immunoassay 
performance have been optimized, including the concentrations of the mimotope and the 
fumonisin-specific antibody, as well as the assay and spotting buffers. Finally, we have 
demonstrated the suitability of the microarray for fumonisin B1 detection in spiked maize and 
wheat samples. The novel screening method shows promise as the basis of further development 
of multiplex mycotoxin detection to fully embrace the vast potential of microarray technology.
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 Experimental section 
Materials 
Ph.D.-12 Phage Display Peptide Library Kit was purchased from New England Biolabs (Ipswich, 
MA, USA) and the fumonisin antibody was from BioTez (Berlin, Germany). Nunc MaxiSorp 96-
well plates, Amplex UltraRed reagent, o-phenylenediamine dihydrochloride (OPD), and 
NeutrAvidin Biotin Binding Protein were purchased from Thermo Fisher Scientific (Waltham, MA, 
USA). Mycotoxins fumonisin B1 (FB1), fumonisin B2 (FB2), T-2 toxin, and HT-2 toxin were from 
Fermentek Ltd. (Jerusalem, Israel), citrinin (CIT) from Thermo Fisher Scientific, alternariol (AOH) 
and tenuazonic acid (TeA) from Apollo Scientific (Bredbury, UK), deoxynivalenol (DON), 
cyclopiazonic acid (CPA), β-zearalenol (ZEL), zearalenone (ZEN), zearalanone (ZAN), and 
alternariol monomethyl ether (AME), as well as bovine serum albumin (BSA), CHAPS, and  
Tween-20 were from Sigma-Aldrich (St. Louis, MO, USA).  
The biotinylated peptide A2 (VTPNDDTFDPFRGGGSK (Bio)–NH2) and a non-related 
peptide F11 (GYGSILPFNPVFGGGSK (Bio)–NH2) were synthesized at Peptide Synthetics 
(Fareham, UK). The HRP-conjugated anti-M13 antibody was obtained from GE Healthcare Inc. 
(Chicago, IL, USA) and the Alexa Fluor 647 AffiniPure Goat Anti-Mouse IgG (H+L) from Jackson 
ImmunoResearch Inc. (West Grove, PA, USA). For microarray development, the chip platform 
was proprietary ARChip Epoxy slide developed at AIT (EP 02799374; US 10/490543). The blank 
wheat quality control material was purchased from Romer laboratories (Getzersdorf, Austria), 
and the maize sample was from Saatbau (Linz, Austria). 
Mimotope identification by biopanning 
Fumonisin epitope mimics, or mimotopes, were selected from the commercial dodecapeptide 
library (Ph.D.-12) by consecutive rounds of phage display selection (Figure 14) according to 
manufacturer’s instructions. Briefly, 96-well microtiter plate was coated, overnight at +4 °C, 
with the target monoclonal antibody (1 μg of antibody in 100 μL of PBS per well). The remaining 
protein-binding sites in the coated wells were then blocked with 5% (w/v) BSA in PBS (pH 7.2) 
for 1 h at +4 °C and washed six times with PBS-T [PBS (pH 7.2); 0.1% (v/v) Tween-20]. The 
phage library (1 × 1011 pfu) was added to the coated wells (two wells were used during rounds 
1 and 2, and one well during rounds 3–5, with 100 μL per well) and incubated with slow shaking 
for 1 h at room temperature. The wells were then washed ten times with PBS-T, and finally, the 
bound phages were eluted with 100 μL of 0.2 M glycine-HCl (pH 2.2) for 10 min, after which, 
the supernatant was collected and neutralized immediately with 10 μL of 1 M Tris-HCl (pH 9.1). 
The eluate was amplified by infecting E. coli ER2738, and the amplified phage was used for the 
subsequent panning rounds. After each panning round, the number of eluted and amplified 
phages was determined by tittering, and the number of input phages was kept constant in all 
rounds. After the second panning round, the concentration of Tween-20 in the washing buffer 
was increased from 0.1% to 0.5% (v/v) for more stringent washes. After the third, fourth and 
fifth selection rounds, individual plaques were picked from the LB/IPTG/X-gal plates and tested 
in the phage-based ELISA to select the positive clones binding to the target antibody. The amino 
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acid sequence of the peptide displayed by these phages was identified by sequencing using the 
primer –96 gIII (CCC TCA TAG TTA GCG TAA CG). 
Phage-based ELISAs 
To screen for the positive clones, the phage-displayed peptides were tested in direct phage-
based ELISA and the best clones, further in a competitive assay (Figure 15A). To that aim, 
microtiter well plates were coated with the capture antibody (200 ng in 60 μL of PBS) by 
overnight incubation at +4 °C. The wells were then blocked with blocking buffer (PBS, pH 7.2; 
2% (w/v) BSA) for 1 h at +4 °C and washed four times with PBS-T (PBS, pH 7.2; 0.1% (v/v)  
Tween-20). For the simple phage-based ELISA, the amplified phage stock was then added to the 
coated wells in 1:10- or 1:100-dilution, and for the competitive assay, the monoclonal phages 
(108 pfu mL–1) were incubated together with different fumonisin B1 concentrations 
(0–5000 ng mL–1) for 1 h. For the cross-reactivity studies, fumonisin B1 was replaced with other 
mycotoxins at the concentration of 500 ng mL–1. After washing the plate four times, anti-M13-
HRP (1/5000-dilution in blocking buffer) was added, and the incubation was continued for 1 h. 
All incubation steps were done in the total volume of 60 μL with slow shaking at room 
temperature. Finally, the plate was washed six times as described previously, and 60 μL of the 
substrate solution, either OPD or Amplex UltraRed, was added to each well according to the 
manufacturer's instructions. The absorbance (at 495 nm) or fluorescent signals (excitation at 
510 nm and detection at 590 nm) were measured using a CLARIOstar microplate reader from 
BMG Labtech (Ortenberg, Germany). 
 
Figure 14. Workflow of the panning rounds carried out to isolate the antibody specific binder 
peptides A2 and D1. 
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Microarray fabrication 
The synthetic mimotope A2 was used for the development of a microarray for fumonisin B1 
detection. Biotinylated peptide (0.25 mg mL–1 in printing buffer [PBS, pH 7.2; 0.005% (w/v) 
CHAPS; 0.01% (w/v) BSA]) was mixed with neutravidin in 1:4 molar ratio and arrayed onto 
ARChip Epoxy slides using Nanoprint Protein Microarrayer (Arrayit, Sunnyvale, CA, USA) equipped 
with SMP5 microspotting pin (Arrayit). Each probe was printed in triplicate in each array with 
350 μm spot-to-spot distance, and 12 identical arrays were printed per slide. After printing, the 
slides were kept at +4 °C at least for 3 days to ensure complete probe immobilization, and they 
were blocked before use with PBS-T (PBS, pH 7.2; 0.1% (v/v) Tween-20) for 30 min in continuous 
stirring to remove any unbound probes. Then, the slides were washed twice in PBS and dried 
with compressed air. 
Mimotope assay 
Mycotoxin detection was based on a competitive binding inhibition assay with the immobilized 
mimotope tagged with biotin (Figure 3C). The spiked samples, or the toxin standards in the range 
of 0 to 1500 ng mL–1, were first pre-incubated with 100 ng mL–1 fumonisin specific antibody in 
assay buffer (PBS, pH 7.2; 0.05% (v/v) Tween-20; 0.5% (w/v) BSA) for 30 min with slow shaking. 
To study the selectivity of the assay fumonisin B1 was replaced with other mycotoxins produced 
by the same Fusarium species (fumonisin B2, T-2 toxin, HT-2 toxin, deoxynivalenol, and 
zearalenone). Arrayit microarray hybridization cassette was used on the slides to form separated 
wells where 50 µL of the pre-incubated solution was applied in three replicates. The reaction 
was incubated with slow shaking for 2 h protected from light. After washing the wells twice with  
PBS-T, AF647-labeled anti-mouse IgG (1 μg mL–1 in 50 μL of assay buffer) was added to each 
well and incubated for 1 h with slow shaking. Finally, the slides were washed three times, first 
with PBS-T, then PBS, and finally rinsed with MQ water, and dried with compressed air. 
Microarray imaging and data analysis 
Fluorescence signals were measured with 633 nm excitation wavelength by an LS Reloaded 
microarray scanner from Tecan (Männedorf, Switzerland) and further analyzed with GenePix 
Pro 6.0 analysis software (Molecular Devices, Corp., Sunnyvale, CA, USA). The signals were 
background corrected, and non-valid spots, those given a flag “not found” by the image analysis 
software or excluded by an outlier test, were excluded. Mean values of remaining spots were 
used for down-stream data analysis. 
For the calibrations, toxin standards at different concentrations were tested by the 
microarray, and the fluorescence signals were analyzed with Origin Pro 9.0 software (OriginLab 
Corp., Northampton, MA, USA) using a four-parameter logistic regression (4-PL) model 
(equation 1): 
y = Amin+ (Amax − Amin)
1+ � xIC50
�
 b                   (1) 
where Amax is the asymptotic maximum (the signal in the absence of the analyte), b and IC50 are 
the slope of the curve and analyte concentration, respectively, at the inflection point, and Amin is 
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the asymptotic minimum. The limit of detection (LOD) was determined as the fumonisin 
concentration where the antibody binding to the immobilized peptide was inhibited by 10% and 
the dynamic range of the method as the toxin concentration from 20% to 80% inhibition, as 
previously reported.45 The cross-reactivity (CR) of the competitive assay was calculated based 
on the IC50 values using the following formula (equation 2): 
CR = 
IC50(FB1)
IC50(other mycotoxin)
×100%                  (2) 
Sample preparation 
Blank maize and wheat samples were spiked with fumonisin B1 and tested with the mimotope 
assay. The maize sample was ground with a mixer mill, and 5 g of the finely ground corn, or the 
blank wheat sample, was suspended in 10 mL of 60% (v/v) methanol in PBS and spiked with 
the toxin (200–4000 µg of FB1 per kg of the maize or wheat sample). The mixtures were 
incubated in shaking for 30 min at room temperature, then centrifuged (4500 g, 10 min) and 
filtered with 0.22 μm filter to remove any insoluble material. For the assay, the extracts were 
diluted 1:10 in the assay buffer resulting in final methanol concentration of 6%. 
 Results and discussion 
Selection and characterization of phage-displayed mimotopes 
A linear 12-mer phage display peptide library was subjected to successive rounds of selection 
to isolate antibody-specific binders (Figure 14). Efficient enrichment of antibody binding phages 
was observed after three rounds of panning as deduced from the increased phage titer during 
the panning rounds. Moreover, the signal-to-background ratios obtained with the entire phage 
pools in the phage-based ELISA increased after each panning round (Figure 18A in the 
supporting information). A total of 48 randomly selected phage plaques from the panning rounds 
3–5 were tested to identify the individual specific binders. Altogether, 73% of the screened 
clones showed good signal-to-background ratios in the assays indicating specific binding to the 
fumonisin antibody. Sequencing of the positive clones revealed two conserved peptide 
sequences, VTPNDDTFDPFR and RPLDLYPGSGQE (named A2 and D1, respectively), both of 
which showed excellent signal-to-background ratios in the corresponding ELISAs  
(Figure 18B in the supporting information). 
Three-dimensional structural models of these peptides were generated with different 
molecular modeling tools. Due to the lack of information on the structure of the commercial anti-
fumonisin antibody paratope, we decided to simulate by molecular docking46 the interaction of 
the selected mimotopes, A2 and D1, with the protein serine/threonine phosphatase-1  
(PP-1c), which is known to be inhibited by fumonisin B147 and compare the behavior of 
mimotopes and fumonisin B1 in such interaction. The description of the molecular dynamics 
simulation, the three-dimensional structural models, and the protein-peptide/mycotoxin docking 
analysis are included in the supporting information. In good agreement with the experimental 
results of the phage-based ELISAs, the models suggested that A2 and D1 mimotopes are 
structurally and energetically similar, and moreover, their interaction with the protein is 
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comparable to that of fumonisin B1 (Figure 19, Figure 20 and Figure 21 in the supporting 
information). Therefore, in principle, both A2 and D1 could be considered as excellent mycotoxin 
mimics for immunoassay development. 
In order to confirm their functionality as fumonisin B1 mimotopes, the phage-displayed 
peptides, A2 and D1, were further tested in competitive ELISAs (Figure 15A). Both clones 
showed inhibition by the mycotoxin with IC50 values of 38.7 ± 5.4 ng mL–1 and  
85.8 ± 8.3 ng mL–1 (n = 3) for A2 and D1, respectively (Figure 15B). Furthermore, the 
monoclonal antibody was proven to be specific towards fumonisins B1 and B2 as no cross-
reactivity was observed with other mycotoxins tested (T-2 toxin, HT-2 toxin, citrinin, alternariol, 
alternariol monomethyl ether, cyclopiazonic acid, β-zearalenol, zearalenone, zearalanone, and 
tenuazonic acid) (Figure 22 in the supporting information). The clone A2 showed the best 
response in terms of sensitivity and reproducibility, and it was selected for microarray 
development. 
Assay optimization and array characterization 
The phage-displayed mimotope was shown to compete against the toxin for the binding to the 
fumonisin-specific monoclonal antibody, but with a view to develop a robust method for 
fumonisin detection, we decided to replace the phage-borne peptide by its synthetic counterpart. 
The A2-mimotope was synthesized with C-terminal biotin which allows easy coupling of the 
peptide to, for example, a solid surface or a labeling molecule using the biotin–neutravidin 
binding interaction. The biotinylated peptide consisted of the mimotope sequence 
(VTPNDDTFDPFR) and a short linker (GGGS) connected to biotin that was coupled to the primary 
amine of the C-terminal lysine residue. The linker ensured sufficient space between the 
mimotope and biotin to avoid any steric hindrance for binding to the antibody. Furthermore, to 
mimic the structure of the phage-displayed peptide as closely as possible, the C-terminus of the 
synthetic peptide was amidated to avoid the free negatively charged carboxyl group that was not 
present in the phage during the panning selections. 
The biotinylated peptides were immobilized via neutravidin on epoxy-slides. Preliminary 
experiments had shown high non-specific binding when streptavidin was selected for the 
coupling; however, the use of neutravidin is known to minimize non-specific adsorptions due to 
its neutral isoelectric point.48, 49 Antibody binding to the immobilized biotin-mimotope was 
evaluated in direct binding assays at different antibody concentrations (25–2000 ng mL–1). The 
binding curve (Figure 16A) confirmed that the synthetic peptide binds the monoclonal antibody, 
even in absence of the phage. Low non-specific binding of the antibody to the microarray surface 
was confirmed by spotting a nonrelated peptide as negative control. 
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Figure 15. (A) Workflow of the competitive phage-based ELISA using anti-M13 conjugated to 
HRP with Amplex UltraRed substrate. (B) Comparison of the competitive binding curves of 
the phage-displayed mimotopes A2 (black) and D1 (red). The fluorescent signals were 
normalized to the mean maximum and minimum absolute signals and the results are shown 
as normalized means ± the standard error of the mean (n = 3). A four-parameter logistic fit 
(OriginPro 9.0) was used to calculate the IC50 values. 
Next, an on-chip binding inhibition assay was implemented for the detection of fumonisins B1 (  
Figure 16C). After a checkerboard type of assay where different concentrations of the 
immobilized peptide (100–750 μg mL–1) and neutravidin were exposed to increasing 
concentrations of the antibody (25–2000 ng mL–1), 250 μg mL–1 peptide, with a 1:4 molar ratio 
of neutravidin, and 100 ng mL–1 antibody were selected as the working conditions (Figure 23 in 
the supporting information). Figure 16B shows the competition inhibition curves obtained under 
the optimized conditions using fumonisin B1 standard solutions in the range of  
0–900 ng mL–1. The IC50 value and the LOD were 37.1 ± 2.4 ng mL–1 (n = 9) and  
11.1 ng mL–1, respectively. The dynamic range calculated from 20–80% inhibition was between 
17.3 and 79.6 ng mL–1. Reproducibility of the microarray-based assay was demonstrated by low 
relative standard deviations (RSD) of 9.2% in average for intra-day (n = 9) and 7.6 and 10.9% 
for inter-day assays, on three different days, for toxin concentrations of 30 and 40 ng mL1, 
respectively. 
Compared to previously reported microarrays for fumonisin detection using a toxin-
competitor (Table 8 in the supporting information), the mimotope-based method showed 
similar44 or superior43 performance in terms of sensitivity and reproducibility. Although other 
mimotope-based assays for fumonisin B127 have reported nearly 10-fold lower detection limits, 
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the microarray format benefits from the miniaturization capability of the array allowing lower 
reagent consumption with an automated and reproducible manner of manufacturing the array 
slides. For instance, the peptide ELISA based on synthetic peptide–BSA conjugate reported by 
Liu et al. (2013)27 required almost 30 μg of the peptide-conjugate for coating just one microtiter 
well plate, whereas only with 5 μg of the peptide one can easily spot onto 200 slides with 
12 arrays each. 
The specificity of the assay was tested with different mycotoxins (Table 6) and, in 
accordance with the previous experiments with the phage-based ELISA, negligible cross-
reactivity was observed with other mycotoxins produced by the same Fusarium species (T-2,  
HT-2, deoxynivalenol, and zearalenone). The monoclonal antibody was not able to distinguish 
fumonisin B1 from its structural analog, fumonisin B2, but similar IC50 values were observed for 
both with no statistical difference (confidence level 95%). 
  
Figure 16. (A) Direct binding of the fumonisin antibody in different concentrations to the 
immobilized biotin-peptide A2 (closed symbols) and background binding to a non-related 
peptide F11 (open symbols). (B) Binding inhibition assay with the mimotope microarray. 
Results are shown as mean signals ± the standard error of the mean (n = 9). A four-
parameter logistic fit (OriginPro 9.0) was used to calculate the IC50 values. (C) Schematic 
presentation of the microarray-based immunoassay for fumonisin detection with 
biotinylated mimotopes. 
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Effect of methanol and sample matrix 
Methanol is a commonly used solvent for mycotoxin extraction. However, high concentrations of 
this chemical are known to affect antibody–antigen binding, thus worsening the sensitivity of 
immunoassays.50 The effect of methanol on the mimotope assay was studied by spiking the 
assay buffer with different methanol concentrations (Figure 17A). There was no significant 
difference between the IC50 values obtained in the presence of 0–6% methanol; however, 
concentrations beyond 20% severely interfered with the assay. Moreover, antibody binding was 
decreased by more than half at values higher than 40%. Similar results of methanol effect on 
immunoassays have also been reported elsewhere.19,31 A final concentration of 6% methanol 
was selected for sample analysis. 
To evaluate the matrix effect, working standards for calibrations were prepared in maize 
or wheat blank matrix extracts, and the response was compared to that of the assay buffer. The 
comparison of the dose-response calibration curves obtained in these samples showed no 
statistically significant differences (confidence level 95%) (Figure 17B). 
Table 6. Cross-reactivity with other Fusarium mycotoxins. 
Toxin Chemical structure IC50 (ng mL–1) Cross-reactivity 
Fumonisin B1 
 
37.1 ± 2.4 100% 
Fumonisin B2 
 
28.7 ± 6.4 120% 
T-2 toxin 
     
> 1000 < 4% 
HT-2 toxin 
     
> 1000 < 4% 
Deoxynivalenol 
             
> 1000 < 4% 
Zearalenone 
          
> 1000 < 4% 
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Sample analysis 
Finally, the mimotope assay performance was evaluated with spiked samples using both maize 
and wheat matrices. Blank samples were spiked with the toxin standard in different 
concentrations, in the range of 200–2000 μg kg–1 for maize and 600–4000 μg kg–1 for wheat 
and measured using the developed microarray. The results (Table 7) showed mean recoveries 
of 73–122% in maize and 76–115% in wheat, with the corresponding coefficients of variations 
in the range of 5–12% and 3–10%. Thus, the method can be considered suitable for monitoring 
the total fumonisin concentration under the current regulatory limits of 4000 μg kg–1 set for 
unprocessed maize products.5 Wheat, which is not at the moment under the European 
Commission regulations, showed similar performance and could also be used as sample matrix 
to detect fumonisin in the selected concentration range. Further improvement of the sample 
analysis could possibly be achieved by optimizing the extraction procedure or using a 
preconcentration step to evaporate the methanol of the extract rather than diluting the sample. 
Table 7. Analysis of spiked maize and wheat samples (n = 3 replicates, 3 spots/replicate). 
Matrix 
Spiked FB1 Measured FB1 
Recovery CV 
(µg kg–1) (µg kg–1) 
Maize  
200 244.7 122% 5% 
400 290.7 73% 11% 
600 551.3 92% 9% 
1000 814.8 81% 12% 
2000 1506.3 75% 8% 
Wheat  
600 548.4 91% 10% 
1000 1148.6 115% 3% 
2000 1513.7 76% 10% 
4000 3915.2 98% 5% 
 Conclusions 
In this work, we reported the selection of a novel mimotope from a commercial peptide library 
using phage display technology, and furthermore, the development of mycotoxin microarray 
using the synthetic mimotope. By using the synthetic counterpart of the phage-displayed 
peptide, we could develop a robust method independent of the biologically active phage. The 
analytical characteristics, including sensitivity, specificity, and reproducibility, as well as the 
analysis of spiked maize and wheat samples demonstrated the suitability of the method as a 
tool to analyze fumonisins B1 in food. The reported detection limit of the method is sufficient to 
meet the current regulatory limits set by the European legislation and could be further improved 
by optimizing the sample extraction method so as to minimize the matrix effect caused by real 
samples. Compared to previously reported microarrays for fumonisin detection using a toxin-
competitor, the mimotope-based method showed similar or superior performance in terms of 
sensitivity and reproducibility. Moreover, the microarray format benefits from the miniaturization 
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capability of the array allowing lower reagent consumption with an automated and reproducible 
manner of manufacturing the array slides. Furthermore, the novel screening method presented 
here shows great promise as the first step for further development of multiplex mycotoxin 
detection tool that makes the most of the microarray technology. 
 
Figure 17. (A) Effect of methanol on the assay response. Calibration curves were repeated 
in 0% (black ▲); 5% (green ▼); 10% (red ■); 20% (blue ●); 30% (orange ♦); and 40% (dark 
grey ●) methanol concentration (v/v) in assay buffer. (B) Calibration curves in assay buffer 
(black ■), maize (red ▼), or wheat extract (blue ▲). Results are shown as mean signals ± 
the standard error of the mean (n = 9). A four-parameter logistic fit (OriginPro 9.0) was used 
to calculate the IC50 values. 
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 Supporting information 
Supporting information includes the description of the molecular modeling tools used to create 
three-dimensional structural models of the peptides and fumonisin B1, together with the results 
of the phage-based ELISA and microarray optimization. Comparison of the analytical 
characteristics of the developed microarray with other reported immunoassays for the detection 
of fumonisin B1 is reported in Table 8. 
Experimental part 
Molecular dynamics simulation. Molecular dynamics (MD) simulations were performed to 
estimate the three-dimensional structure of both mimotopes, A2 (VTPNDDTFDPFRGGGS) and 
D1 (RPLDLYPGSGQEGGGS), together with a non-related peptide F11 (GYGSILPFNPVFGGGS). 
The MD simulations were built with the tLEaP module of AMBER14, starting from an extended 
conformation (φ = ψ = ω = 180°). Subsequently, a simple structural refinement of full-atom was 
performed using "relax" application of Rosetta 3.2.51,52 The coordinates of the peptides, resulting 
from the “relax” application, were processed with tLEaP in order to generate suitable topologies. 
Each peptide was subjected to the following protocol: hydrogens and other missing atoms were 
added using the LEaP module with the parm99 parameter set, Na+ counterions were added to 
neutralize the system, then the structures were solvated in an octahedral box of explicit TIP3P 
model with water molecules localizing the box limits at a distance of 12 Å from the peptide 
surface. The total number of atoms in each simulated system ranged from 18196 to 25982, 
including the solvent molecules. 
The simulations were performed at 1 atm and 298 K, maintained with the Berendsen 
barostat and thermostat, using periodic boundary conditions and particle mesh Ewald sums 
(grid spacing of 1 Å) for treating long-range electrostatic interactions with a 10 Å cutoff for 
computing direct interactions. The SHAKE algorithm was used to satisfy bond constraints, 
allowing employment of a 2 fs time step for the integration of Newton’s equations as 
recommended in the AMBER package.53,54 Amber ff99SB force field parameters55,56 were used 
for all residues. The protocol consisted of performing an optimization of the initial structure, 
followed by 50 ps heating step at 298 K, 50 ps for equilibration at constant volume and 500 ps 
for equilibration at constant pressure. Three independent 20 ns MD simulations were 
performed. Frames were saved at 100 ps intervals for subsequent analysis. The analyses were 
conducted with cpptraj57 on the trajectory time intervals where the convergence criteria were 
met. The total energy of the system (including solvation) was monitored during the simulations, 
and the pairwise mass-weighted root means square displacement (RMSD) on backbone CA, C 
and N atoms was used as a metric.  
The structural model of fumonisin B1 was constructed using HyperChem 8 software and 
subsequently minimized using Gaussian 09, revision A.02 (Gaussian Inc., Wallingford, CT) at 
DTF B3LYP/3-21G level of theory. 
 
Protein-peptide docking. To compare the binding characteristics of fumonisin B1 and the 
mimotopes A2 and D1 we predicted docking of these molecules to protein phosphatase-1,58 an 
enzyme known to be inhibited by several toxins, including fumonisin B1.47 Docking of the toxin 
was constructed using the utilities implemented by AutoDockTools 1.5.4 
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(http://mgltools.scripps.edu/)59,60 and docking of the peptides was performed using the CABS-
dock web server which provides an interface for modeling protein-peptide interactions using a 
highly efficient protocol for the flexible docking of peptides to proteins.61 
Results and discussion 
 
Figure 18. Selection of target binding phages. (A) Enrichment of target binding phage-
peptides in the pannings was monitored by phage-based ELISA after five consecutive 
selection rounds. (B) Phage-based ELISA with monoclonal phage clones A2 and D1 showed 
specific binding to the target, whereas low background was observed with a non-related 
phage clone F11. Light grey bars present the specific binding to the target antibody and dark 
grey bars the background binding to the wells without the target coating. 
                                               B
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Figure 19. Molecular dynamics trajectory analysis. [A] Total energy (ET) of the system as a 
function of the time of each peptide (black = A2; red = D1; blue = F11). The total energy 
remained stable throughout the dynamics which indicated that the prediction of the folding 
was stable for this time interval. Comparing the energies of the peptides we could observe 
the following order of structure stability: A2 > D1 > F11. [B] The root mean square 
displacement (RMSD) as a function of time for each peptide. This parameter indicated the 
convergence of peptide folding from the extended structure to its conformation adopted 
during the MD. Peptides D1 and A2 reached their stable conformation after 5 and 15 ns, 
respectively, whereas for the non-related peptide F11 it required a longer time.  
 
Figure 20. Models of mimotopes A2 (A) and D1 (B), as well as a non-related peptide F11 (C) 
and fumonisin B1 (D). The peptides (A–C) consisted of 12 amino acids and a GGGS-linker, 
labelled in red in each structure. Molecular dynamics modelling indicated that peptides A2 
and D1 have similar structural and energetic properties which may suggest that they also 
maintain similar binding or activity properties. 
A                                               B
A B  
C D
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Figure 21. Comparison of the molecular docking of the peptides and fumonisin B1 to protein 
phosphatase-1. (A) Docking of fumonisin B1 (green sticks) to protein phosphatase-1 (PP-1c, 
skyblue cartoon), a well-known inhibitor of several toxins including fumonisin B1.47,58 The 
peptide-protein docking model predicts that the interaction of the peptides A2 (red sticks) 
and D1 (yellow sticks) with PP-1c takes place in the same region as for fumonisin B1. (B) The 
non-related peptide F11 (magenta sticks) showed lower binding affinity to PP-1c as well as 
a different binding site. 
 
Figure 22. Cross-reactivity of the phage-based ELISA. Response in the competitive phage-
based ELISA was studied with different mycotoxins, fumonisin B1 (FB1) and B2 (FB2), T-2 
toxin, HT-2 toxin, citrinin (CIT), alternariol (AOH), alternariol monomethyl ether (AME), 
cyclopiazonic acid (CPA), β-zearalenol (ZEL), zearalenone (ZEN), zearalanone (ZAN), and 
tenuazonic acid (TeA). Only fumonisins B1 and B2 showed a response in the concentration 
of 500 ng mL–1. Data present the signal-to-background ratios (background without any 
target) ± the standard error of the mean (n = 3), light grey bars A2-phage and dark grey bars 
D1-phage.  
A B  
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Figure 23. Microarray optimization. (A) Binding inhibition curves with the immobilized 
peptide in the concentration of 250 μg mL–1 (black ▲), 500 μg mL–1 (red ▼), or  
750 μg mL–1 (blue ▲). (B) Binding inhibition curves with 250 μg mL–1 immobilized peptide 
with different neutravidin concentrations, 1:4-molar ratio (black ▲), 1:6-molar ratio (red ▼), 
or 1:8-molar ratio (blue ▲). Results are shown as normalized mean signals ± the standard 
error of the mean (n = 9). A four-parameter logistic fit (OriginPro 9.0) was used for the curve 
fitting. 
.
A                                               B
  
Table 8. Comparison of the analytical characteristics of the developed microarray with other reported immunoassays for the detection of fumonisin B1. 
Assay type Label Measurement  IC50 and DR LOD  Sample Reference 
ELISA with immobilized FB1–OVA 
and recombinant scFv HRP Absorbance 
12.67 ng mL–1 
2.10–76.45 ng mL–1 
0.832 ng mL–1  
(8.32 μg kg–1) Spiked corn [14]
 
Peptide-ELISA with immobilized 
mimotope–BSA and McAb HRP Absorbance 
6.06 ng mL–1 
1.77–20.73 ng mL–1 1.18 ng mL
–1 Maize, feedstuff, and wheat [27] 
ELISA on ICG-strip with 
immobilized FB1–OVA and  
labelled PcAb 
Golloidal gold Visual – 5 ng mL–1 Maize, wheat, sorghum, and paddy [16] 
Microcantilever array with SAMs  
of FB1-specific aptamer – Cantilever deflection 
– 
0.1–40 μg mL–1 33 ng mL
–1 – [62] 
Magnetoimmunosensor on CSPE 
with immobilized McAb and   
FB1–HRP 
HRP Amperometry 2.86 ng mL
–1 
0.73–11.2 ng mL–1 0.33 ng mL
–1 Maize, beer [63] 
Multiplex suspension array 
immunoassay with immobilized 
McAb and FB1–OVA–biotin 
Phycoerythrin Fluorescence 41.5 ng mL
-1 
11.6−110.3 ng mL-1 6.0 ng mL
–1 Spiked corn, wheat, and feedstuff [21] 
Multiplex homogeneous 
immunoassay with labelled FB1 
and McAb 
AlexaFluor 647 Fluorescence polarization 
1918 μg kg–1  
587.0–6265 μg kg–1  
66.3 ng mL-1 
(331.5 μg kg–1) Maize [64] 
Microarray-based ELISA with 
immobilized FB1–BSA and PcAb AP Absorbance 
– 
– 43 ng mL
–1 – [43] 
Multiplex ELISA on reusable 
biochips with imobilized  
FB1–BSA and McAb 
HRP Chemiluminescence 644.8 μg kg
-1  
10.5–138.5 ng mL–1 
9.9 ng mL–1 
(159.0 μg kg–1) Oat, wheat, rye, corn [44] 
Microarray-based immunoassay  
with covalently immobilized 
mimotope and McAb 
AlexaFluor 647 Fluorescence 37.1 ng mL
–1 
17.3–79.6 ng mL–1 11.1 ng mL
–1 Spiked maize and wheat This work 
Abbreviations: McAb = monoclonal antibody; scFv = single-chain fragment variable antibody; PcAb = polyclonal antibody; OVA = ovalbumin; HRP = horse-radish peroxidase; BSA = 
bovine serum albumin; SAM = self-assembled monolayer; CSPE = carbon screen-printed electrode; DR = dynamic range; AP = alkaline phosphatase; ICG = immunochromatographic. 
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3.2.2 HOMOGENEOUS QUENCHING IMMUNOASSAY FOR FUMONISIN B1 
BASED ON GOLD NANOPARTICLES AND AN EPITOPE-MIMICKING 
YELLOW FLUORESCENT PROTEIN 
 
Reproduced from: ACS Nano 2018, 12, 11333–11342. 
Copyright ® 2018, with permission from ACS Publication. 
Abstract 
Homogeneous immunoassays represent an attractive alternative to traditional heterogeneous 
assays due to their simplicity, sensitivity, and speed. On the basis of a previously identified 
epitope-mimicking peptide, or mimotope, we developed a homogeneous fluorescence 
quenching immunoassay based on gold nanoparticles (AuNPs) and a recombinant epitope-
mimicking fusion protein for the detection of mycotoxin fumonisin B1 (FB1). The fumonisin 
mimotope was cloned as a fusion protein with a yellow fluorescent protein that could be used 
directly as the tracer for FB1 detection without the need of labeling or a secondary antibody. 
Furthermore, owing to the fluorescence quenching ability of AuNPs, a homogeneous 
immunoassay could be performed in a single step without washing steps to separate the 
unbound tracer. The homogeneous quenching assay showed negligible matrix effects in 5% 
wheat extract and high sensitivity for FB1 detection, with a dynamic range from 7.3 to 
22.6 ng mL−1, a detection limit of 1.1 ng mL−1, and IC50 value of 12.9 ng mL−1, which was 
significantly lower than the IC50 value of the previously reported assay using the synthetic 
counterpart of the same mimotope in a microarray format. The homogeneous assay was 
demonstrated to be specific for fumonisins B1 and B2, as no significant cross-reactivity with other 
mycotoxins was observed, and acceptable recoveries (86% for FB1 2000 μg kg−1 and 103% for 
FB1 4000 μg kg−1), with relative standard deviation less than 6.5%, were reported from spiked 
wheat samples, proving that the method could provide a valuable tool for simple analysis of 
mycotoxin-contaminated food samples. 
 Introduction 
Owing to their exceptional optical properties, nanomaterials are often considered ideal for 
biosensor development, and the vast progress in the field during the last decades has enabled 
development of ultrasensitive sensors.1−4 Especially gold nanoparticles (AuNPs) have received 
particular attention due to their optical and electronic properties. Considering their 
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straightforward synthesis, high stability and biocompatibility, high electron density, and strong 
absorption in the visible region, AuNPs continue to be one of the most used materials for 
different sensing schemes.5 The latter includes electrochemical,6 surface-enhanced Raman 
scattering (SERS),7 fluorescent,8 and colorimetric assays, as well as other disciplines, such as 
material sciences, bioimaging, and electronics.1,9,10 Furthermore, AuNPs are exceptionally 
efficient fluorescence quenchers,11,12 a phenomenon that has been ascribed to various 
mechanisms, including Fo ̈rster resonance energy transfer (FRET), nanometal surface energy 
transfer (NSET),13,14 and dipole-to-metal particle energy transfer (DMPET).15,16 Because of the 
high molar absorption coefficient of AuNPs compared to organic dyes and fluorescent proteins, 
broad energy bandwidth, as well as their tunable absorbance according to the nanoparticle size 
and geometry,5 AuNPs have been applied as quenchers in fluorescent homogeneous assays12 
based on organic dyes,17 polymers,18 quantum dots,16,19 as well as fluorescent proteins (FPs).20 
FPs, which are widely used as markers for gene expression analysis or protein tracking 
within cells or organelles, and have revolutionized molecular biology in the last decades, are 
able to emit strong, stable fluorescence, and they can be expressed as fusion proteins in 
recombinant hosts.21,22 Several FPs with enhanced fluorescence or different spectral 
characteristics have proven not only their excellence for studying biomolecular interactions but 
have also further expanded the scope of applications of these proteins, for example, for 
immunoassay development.23−25 Particularly, FRET-based FP probes have been established as 
an important tool for studying various intracellular molecules and events,23 demonstrating the 
tremendous potential of homogeneous sensing schemes for both in vivo and in vitro assays, 
where the bound and free tracers can be distinguished without the need of a separation step. 
Such homogeneous assay formats can result in significant cost and time savings by enabling 
simpler and faster protocols while, at least theoretically, being more sensitive than the 
heterogeneous assays.12,26 
The exceptional ability of epitope-mimicking peptides, or mimotopes, to imitate the 
epitope of an antigen and thus bind to same antibody paratope, has been witnessed in several 
fields including immunotherapy, epitope mapping, and allergy treatment.27,28 Furthermore, 
epitope-mimicking peptides and antibodies are an intriguing option to overcome some of the 
limitations of competitive immunoassays.29,30 As they bind to the same antibody paratope as 
the antigen and elicit a similar antibody response, epitope mimics can be used as the competitor 
instead of the labeled antigen in applications where the conjugation of the target to a carrier 
molecule is challenging, or it can cause toxicity to the user. Several mimotopes have been 
selected from phage-displayed peptide libraries for the detection of low molecular weight targets 
such as pesticides,31 neurotoxins,32 cancer drugs,33 mycotoxins,34−36 and other chemicals.37 
Phage-borne peptides have shown great potential for the development of small-molecule 
immunoassays, but considering the large size and the biologically active nature of phages these 
methods are not always ideal for immunoassay development.38,39 As an alternative, the 
synthetic counterparts of the phage-borne mimotopes40−42 or recombinant peptide−protein 
fusions43−45 have been suggested as phage-free options. Production of recombinant fusion 
proteins is an attractive alternative because of the low cost of producing recombinant proteins 
in bacteria and the variety of possibilities to design the protein tailored to the purpose, for 
example, including tags for purification or using an active enzyme as a fusion protein and later 
directly as the tracer.46 
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In this work, we present a simple and rapid immunoassay for fumonisin detection based 
on a recombinant fluorescent fusion protein and fluorescence quenching by AuNPs. Fumonisins 
are mycotoxins produced by Fusarium fungi as secondary metabolites47 that can be found as 
natural contaminants commonly in maize but also in wheat, rice, sorghum, and beans.48 Owing 
to the hepatotoxic and carcinogenic effects of fumonisins,49 as well as the important economic 
consequences of mycotoxin contamination,50 detection of these toxins is of great importance. 
Several international authorities, such as the European Commission51,52 and the United States 
Food and Drug Administration,53 have set regulatory limits to ensure food safety. Although maize 
is currently the only foodstuff that falls under international regulations, other cereals are also 
commonly affected by mycotoxin contamination. For instance, wheat may be an important 
contributor to the exposure to fumonisins in areas where this cereal is an important source of 
food, and less maize is consumed.54,55 A recent study showed that the prevalence of fumonisins 
is very similar in stored wheat and stored maize,56 underlining the importance of fumonisin 
analysis not only in maize-products but also in other foodstuffs. Chromatographic methods for 
mycotoxin detection, mostly high-performance liquid chromatography (HPLC) coupled with diode 
array, fluorescence, or mass spectrometry detection, can offer high sensitivity but are usually 
expensive and require highly skilled personnel and tedious sample cleanup. In contrast, 
biosensors and bioanalytical assays are considered convenient for the rapid determination of 
these toxins, as they are usually low cost while maintaining the required sensitivity and 
specificity.57,58 In a previous paper, we reported the development of a microarray for the 
detection of fumonisin B1 (FB1), the most abundant and toxic of fumonisins, based on a synthetic 
mimotope.40 Here, the FB1-mimotope is produced recombinantly as a fusion with a yellow 
fluorescent protein (YFP), which, at the same time, functions as the tracer in the immunoassay. 
On the basis of a competitive immunoassay, the YFP-tagged FB1-mimotope is used as the tracer 
in a heterogeneous reference assay with immobilized antibody and, furthermore, in a 
homogeneous quenching assay, where the binding event is observed as fluorescence quenching 
by AuNPs. 
 Results and discussion 
Detection of low molecular weight analytes, such as mycotoxins, poses challenges for 
researchers, as direct detection of these molecules is difficult, and the conjugation or labeling 
needed for the competitive assay format is often challenging. Epitope mimics, which can replace 
the target conjugate and avoid the use of toxic compounds as assay30 by creating a recombinant 
fusion protein of the same FB1-mimotope and a YFP. Construction of such fluorescently tagged 
mimotope, which can be produced recombinantly in bacteria, allows developing simple 
immunoassays as neither labeling of the mimotope itself nor secondary antibodies are required. 
Furthermore, we report the application of the YFP-tagged mimotope to a homogeneous 
quenching immunoassay that employs AuNPs and enables detection and quantification of FB1 
in a simple, fast, one-step assay. 
Construction of the YFP-tagged mimotope 
The YFP-tagged FB1 mimopeptide was generated by cloning the FB1-mimotope VTPNDDTFDPFR 
(named A2)40 in fusion with Zoanthus sp. yellow fluorescent protein (YFP), ZsYellow,59,60 using 
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standard molecular biology techniques.61 In the mimotope-YFP fusion construct (Figure 24), the 
yellow fluorescent protein and A2-mimotope were separated by a glycine-serine (GS)-linker to 
ensure sufficient space for the mimotope binding, and a polyhistidine tag (His-tag) down-stream 
of YFP was used to purify the protein by affinity chromatography. To remove the His-tag after 
purification, a Tobacco Etch Virus (TEV) protease cleavage site was included between the YFP 
and the His-tag. Successful cleavage was confirmed because the fusion protein no longer bound 
to the nickel-nitrilotriacetic acid (Ni-NTA) matrix after the TEV-catalyzed reaction. The fluorescent 
excitation and emission spectra of the purified fluorescent fusion protein is shown in Figure 30 
in the supporting information. 
 
Figure 24. Scheme of the fusion protein construct and main features of the 
expression vector used for protein production in E. coli. 
Heterogeneous fluorescence immunoassay 
The epitope-mimicking nature of the YFP fusion protein and its functionality as a tracer was 
studied in a heterogeneous fluorescence immunoassay, where an anti-FB1 antibody is 
immobilized in microtiter wells, and competition between FB1 and the mimotope-YFP is shown 
as low fluorescence readings in the presence of high FB1 concentrations (Figure 25A). On the 
basis of the typical sigmoidal standard curve for a competitive heterogeneous assay26  
(Figure 25B) the half-maximal inhibitory concentration (IC50) was 6.8 ± 0.3 ng mL−1, and the 
lower limit of detection (LOD), determined as the average signal of the blank minus 3 times the 
standard deviation of the blank, turned out to be 3.5 ng mL−1. The dynamic range of the assay, 
calculated from the IC20 and IC80 values (Figure 25B), was from 3.2 to 14.8 ng mL−1. Although 
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the assay sensitivity was higher than those of the phage-based and synthetic peptide assays,40 
and the assay protocol was simplified because no secondary antibody was needed, the 
heterogeneous assay still required a few washing steps to remove the unbound reagents and 
overnight incubation to immobilize the capture antibody. 
 
Figure 25. (A) Schematic representation of the heterogeneous fluorescence immunoassay 
using the mimotope-YFP construct and an immobilized anti-FB1 antibody. (B) 
Dose−response curve of the competitive heterogeneous assay. Fluorescence readings 
(excitation at 500 nm, emission at 545 nm) are depicted as the average of the replicate 
samples ± the standard error of the mean (n = 3). A four-parameter logistic fit (OriginPro 
9.0) was used to calculate the IC values. 
Homogeneous quenching immunoassay 
The recognition principle of the homogeneous assay is based on fluorescence quenching of the 
mimotope-YFP construct. As shown in Figure 26, the assay uses protein G -coated AuNPs that 
quench the emission of light upon antibody binding to mimotope-YFP. In the presence of the 
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target FB1, competition between the latter and the mimotope prevents the fusion protein binding 
to the antibody, and fluorescence is recovered due to the larger distance from the AuNPs. Thus, 
the one-step assay allows distinguishing the antibody-bound tracer (mimotope-YFP) readily from 
the free tracer. In addition to the fast and straightforward protocol, which consist of only mixing 
the reagents and 20 min of incubation, the method benefits from the advantage of measuring 
a signal rise with increasing analyte concentrations in opposition to the heterogeneous 
reference assay. The low background signal in the absence of the target, due to the strongly 
quenched fluorescence, makes it easier to detect even small changes in the readout, as 
generally, it is considered better to measure a large signal against low background than to 
measure the difference between two large signals.26 
 
Figure 26. Schematic representation of the homogeneous quenching immunoassay based 
on the mimotope-YFP and an anti-FB1 antibody immobilized on AuNP/protein G-conjugates. 
Upon mimotope-YFP binding to the antibody, the AuNP efficiently quenches the intrinsic 
fluorescence of YFP. In the presence of FB1, the mimotope-YFP is not bound to the antibody, 
and its fluorescence is no longer turned off.  
Since the efficiency of fluorescence quenching by the AuNP depends not only on the distance 
from the fluorophore but also on the nanoparticle size,62 we tested the performance of different 
AuNPs in the homogeneous quenching immunoassay. Citrate-stabilized gold nanoparticles were 
prepared by a step-by-step growing procedure,63 and their average diameters were determined 
to be 17.1 ± 2.0, 36.1 ± 3.3, and 72.4 ± 7.1 nm by transmission electron microscopy (TEM; 
Figure 31 in the supporting information). The UV−vis absorption spectra of the AuNPs showed 
the typical plasmon band peaking at 519, 530, and 546 nm for the 17, 36, and 72 nm AuNPs, 
respectively (Figure 27). Furthermore, dynamic light scattering (DLS) was used to evaluate the 
average hydrodynamic diameter and polydispersity of the nanoparticles (Figure 32 in the 
supporting information). 
His-tag-mediated conjugation of recombinant protein G to the citrate-capped AuNPs 
allowed simple and flexible preparation of the protein-decorated AuNPs. First, a flocculation test 
was performed to determine the amount of protein required to stabilize the AuNPs. Aggregation 
Scientific publications 
116 
of bare AuNPs was observed upon addition of 10% (w/v) NaCl, whereas the protein-decorated 
AuNPs retained their typical plasmon band under the same conditions, confirming a successful 
protein coating (Figure 33 in the supporting information). Moreover, the presence of a protein 
overlayer was observed by TEM (Figure 34 in the supporting information), and the amount of 
immobilized protein was determined by hydrolysis and high-performance liquid chromatography 
(HPLC) analysis (Figure 35 and Table 9 in the supporting information). AuNPs might also have 
been directly coupled to antibodies by nonspecific absorption;64,65 however, protein G -mediated 
linkage allows a more controlled coupling. Because the antibody is directly added to the assay 
reaction rather than to the coupling reaction, the exact amount of antibody in the final assay 
can be determined more precisely, and it is not subject to variations among the different batches 
prepared. Moreover, in this way, the antibodies would bind to the protein G -coated AuNPs in an 
oriented manner, ensuring that the antigen binding sites are available and not hindered, which 
might be (at least partially) the case for nonspecifically bound antibodies. Since AuNP-based 
surface energy transfer (SET) quenching is known to overcome the established distance limits 
of FRET,14,66 the additional increase in the distance between AuNPs and the fluorescent protein 
produced by the protein G overlayer is not as critical as in energy-transfer assays based on 
organic dye acceptors that quench the donors’ fluorescence. 
 
Figure 27. Normalized UV−vis absorption spectra of the 17 nm (black dashed line), 36 nm 
(red solid line), and 72 nm (blue dotted line) AuNPs prepared. Absorption maximums were 
519, 530, and 546 nm, respectively. 
The feasibility of the assay principle was evidenced by observing a strong fluorescence 
quenching upon the fusion protein binding to the antibody-conjugated AuNPs (Ab-AuNPs).  
Figure 28 shows the variation of the mimotope-YFP fluorescence (0.5 μg mL−1) with the 
concentration of AuNPs ranging from 0 to 4 nM for the 17, 36, and 72 nm sizes of the latter. 
Control experiments in the absence of the nanoparticle-bound antibody (Figure 28) confirmed 
that the fluorescence quenching was predominantly due to the specific binding of the mimotope-
YFP to the anti-FB1 Ab-AuNPs (1.5 μg mL−1 of Ab) and not due to the (trivial) phenomena of light 
scattering, absorption of the excitation light (at 500 nm), and of the fluorescence (at 545 nm) 
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by the AuNPs themselves. Furthermore, in the presence of 100 ng mL−1 FB1, competition 
between FB1 and epitope-mimicking mimotope-YFP resulted in fluorescence signals that were 
similar to the background levels without the antibody on the nanoparticles. 
The higher SET efficiency of the smallest AuNPs of the three sizes tested has been 
rationalized previously in terms of quenching of the fluorophore occurring within the near field 
of the AuNP by formation of an image dipole of the former at the nanoparticle surface, once the 
size-dependent changes in the complex dielectric function and the absorptivity of the AuNPs are 
factored in.67 The light scattering effect prevails for nanoparticles larger than 20 nm diameter, 
effectively decreasing the specific fluorescence quenching by SET. The maximum quenching 
efficiency (86%), determined from Figure 28 data as [1 − (I/I0)] × 100, was obtained with 1 nM 
17 nm antibody-decorated particles when 0.5 μg mL−1 mimotope-YFP was used. Higher 
concentrations of AuNPs led to increased levels of quenching even in the absence of FB1, 
indicating nonspecific binding of mimotope-YFP or rather the effect of the very strong absorption 
and scattering caused by the AuNPs, taking into account the minimal concentration of the 
fluorescent molecule. For the larger AuNPs, in particular, the nonspecific quenching was 
observed already at relatively low nanoparticle concentrations (2 pM). 
 
Figure 28. Fluorescence quenching produced by the 17 (A), 36 (B), and 72 nm (C) AuNPs in 
the presence of a constant mimotope-YFP concentration of 0.5 μg mL−1. The effect of the 
AuNP concentration (0−4 nM) on the fluorescence signal was measured for the antibody- 
AuNP conjugates (1.5 μg mL−1 of Ab) both in the absence (red circles) and in the presence 
(green triangles) of 100 ng mL−1 of FB1, or without the antibody (black diamonds). The 
fluorescence signals (excitation at 500 nm, emission at 545 nm) are shown as the average 
values of replicate samples ± the standard error of the mean (n = 3). 
To check the observed maximum efficiency of the nanoparticle SET on the 17 nm AuNPs against 
the predicted one,67 we estimated the distance from the AuNP surface to the YFP chromophore. 
Taking into account the 3.2 nm protein G coating of the nanoparticle (from TEM, Figure 34 in 
the supporting information) supporting the oriented antibody (9.5 nm from top to bottom)66 and 
the 4 nm YFP with the chromophore buried approximately in the middle of the protein,68,69 we 
can roughly estimate a fluorophore–surface distance of 15 nm. This value assumes that the 
mimotope has an insignificant effect. Theory predicts an 86% emission quenching efficiency at 
18 nm from the surface of a 16.5 nm (diameter) AuNP,67 a value that is very close to the 
estimated distance considering the approximations involved in our calculation. Furthermore, the 
efficient SET process between the fluorophore and the AuNP was shown to be of static nature: 
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single-photon timing fluorescence decay measurements are identical in the absence and in the 
presence of the antibody-decorated metal nanoparticles (a fluorescence lifetime of 3.60 ± 
0.01 ns was determined for the free and AuNP-bound mimotope-YFP, Figure 36 in the 
supporting information), yet the fluorescence intensity at the detector is ca. 6 times larger in the 
absence of the AuNPs. 
For the further assay development, AuNP concentrations with best signal-to-background 
ratios calculated from maximal and minimal fluorescence signals without or with FB1, 
respectively, were selected. To determine the optimum concentrations of mimotope-YFP and the 
antibody, a checker-board-type titration was performed with different dilutions. Increasing the 
mimotope-YFP concentrations obviously resulted in an increase in the fluorescence signals, but 
high concentrations exhibited also increased nonspecific binding in the presence of FB1  
(Figure 37 in the supporting information). Therefore, 0.5 and 1.5 μg mL−1 mimotope-YFP and 
antibody concentrations, respectively, were chosen for subsequent measurements. 
In the homogeneous format, the assay kinetics are usually extremely fast, since slow 
diffusion does not limit the rate of the binding reaction to a surface as in heterogeneous 
assays.26 In fact, already after 5 min of incubation, the specific fluorescence quenching could 
be observed in our assay (Figure 38 in the supporting information). Somewhat further increase 
of the quenching was obtained after 45 min of incubation yielding an improved signal-to-
background ratio (Figure 38A in the supporting information). However, after signal 
normalization, similar or better sensitivities (expressed as the IC50 values) were found with 
shorter incubation times (Figure 38B in the supporting information). Therefore, a 20 min 
incubation was selected for further optimization, as it provided the required sensitivity but better 
reproducibility than still shorter incubation times. Then, the specificity of the immunoassay was 
evaluated by determining the cross-reactivity with other mycotoxins. The assay did not 
distinguish the structurally related FB1 and FB2 fumonisins, since the antibody is not specific to 
either of the isotopes. Nevertheless, negligible cross-reactivity toward other mycotoxins was 
observed (Figure 39 in the supporting information). 
On the basis of the optimized conditions, we applied the developed quenching assay to 
quantification of FB1 using the various-sized AuNPs. Standard FB1 solutions of different 
concentrations were mixed with fixed antibody, mimotope-YFP, and AuNP concentrations, and 
after 20 min of incubation, the fluorescence of the solutions was measured. Figure 29A shows 
the dose–response plots of the measured signal-to-background fluorescence ratios as a 
function of the FB1 concentration. Typical sigmoidal calibration curves were obtained with all the 
AuNPs, but the larger the nanoparticle size, the lower the signal-to-background ratio resulted in 
agreement with the overall effects discussed above. 
To investigate the effect of a real sample matrix, the analysis with 17 nm AuNPs was 
performed in either the assay buffer, that is, 10 mM phosphate buffer (pH 8.0) containing 0.1% 
(w/v) bovine serum albumin (BSA), or in wheat extracts diluted with the assay buffer. High 
concentrations of the sample extract interfered with the assay and resulted in lower maximum 
signals; however, 5% wheat extract in the final reaction volume showed negligible interference 
(Figure 29B). The calibration curve in this medium showed excellent reproducibility with an 
average intra-assay relative standard deviation (RSD) of 4.6% and an IC50 value of 12.9 ± 
1.0 ng mL−1. The assay dynamic range (IC20−IC80) was from 7.3 to 22.6 ng mL−1, and its limit of 
detection (LOD) was calculated to be 1.1 ng mL−1, which was 10-fold better than previously 
reported with the synthetic peptide40 and slightly lower than that of the heterogeneous reference 
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assay. The advantage of the homogeneous assay format with a low background signal in the 
absence of the target could be demonstrated by comparing its analytical performance to that of 
the heterogeneous assay: while the IC50 of the heterogeneous assay (6.8 ± 0.3 ng mL−1) was 
almost twofold better than that of the homogeneous assay, the LOD of the homogeneous assay 
was better than that of the heterogeneous one (LOD 3.5 ng mL−1) due to the lower background 
signals and thus lower absolute and relative errors of the background. Compared to other 
bioanalytical assays reported in the literature (Table 10 in the supporting information), similar 
and lower LODs for FB1 detection have been described, but the homogeneous quenching assay 
benefits from significantly shorter assay time, and, due to the simple one-step protocol, the 
method would be ideally suited to multiplexing and automation. 
Finally, two wheat samples spiked with FB1 were analyzed with the homogeneous assay. 
Sample extracts were diluted in assay buffer, and recoveries of 86% (RSD 6.2%) and 103% (RSD 
3.2%) were obtained for samples spiked with 2000 or 4000 μg kg−1 FB1, respectively. Current 
European regulation on fumonisins covers only maize-based products, and the maximum 
residue limit for unprocessed maize products is 4000 μg kg−1. Therefore, the reported 
homogeneous quenching assay might be used as a reliable and accurate method even with real 
samples. 
 
Figure 29. (A) Calibration curves for FB1 obtained with AuNPs of different sizes: 17 nm (black 
squares), 36 nm (green triangles), and 72 nm (red circles). Signal-to-background ratios were 
calculated by dividing the fluorescence in the presence of FB1 by the signal obtained in the 
absence of FB1. (B) Comparison of the dose−response curves in assay buffer (black 
squares) and in 5% sample extract (blue circles) using 17 nm decorated AuNPs; 
fluorescence values were normalized to the mean maximum and minimum absolute signals, 
and the results are shown as normalized means ± the standard error of the mean (n = 3). A 
four-parameter logistic fit (OriginPro 9.0) was used to calculate the IC values. 
 Conclusions 
This work demonstrates the applicability of epitope mimics to sensitive immunoassays. The 
homogeneous quenching assay for the quantification of FB1 mycotoxin based on gold NPs 
demonstrated superior analytical features, including lower detection limit and a more 
straightforward assay protocol than the heterogeneous reference assay. Notably, the 
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homogeneous assay based on fluorescent mimotope-YFP fusion protein we have developed is 
more sensitive than the previously reported immunoassay based on the synthetic mimotope. 
Because the fluorescent fusion protein was directly used as the tracer, there was no need for a 
further labeling reaction or secondary antibodies in contrast to other reported AuNP quenching 
immunoassays.17,64 Recombinantly produced fusion proteins guarantee a fixed stoichiometry 
between the fusion partners and avoid issues related to batch-to-batch variations or 
heterogeneous conjugates that are often observed as the product of chemical conjugation 
reactions. The superb fluorescence quenching efficiency of AuNPs via nanoparticle surface 
energy transfer is an attractive feature for homogeneous assay development, and the use of 
His-tag-mediated AuNP coating provides a flexible and facile manner to create protein-
conjugated AuNPs that can readily be used with different antibodies. Overall, the simplicity and 
analytical performance of the quenching assay provides an elaborated yet powerful tool for rapid 
analysis of mycotoxins in food samples. 
 Experimental section 
Materials 
pZsYellow vector was obtained from Clontech Laboratories, while the expression vector pQE-
T2−2 together with the Ni-NTA (nickel-nitrilotriacetic acid) magnetic agarose beads were from 
Qiagen. Chemically competent Escherichia coli One Shot BL21 Star (DE3) cells, Phusion HF DNA 
polymerase, restriction enzymes, and Pierce BCA protein assay kit were from Thermo Fisher 
Scientific. Oligonucleotides were obtained from Integrated DNA Technologies. HisTrap FF and 
PD-10 columns were from GE Healthcare. Bacterial cell lysis buffer and BSA were purchased 
from NZYTech. Amicon Ultra Centrifugal filters were from Merck Millipore, and Packard HTRF 96-
well black plates were from Nunc. Protease inhibitor cocktail and TEV protease, together with 
sodium citrate (+99%) and tetrachloroauric(III) acid trihydrate (HAuCl4∙3H2O, +99.9%), were 
purchased from Sigma-Aldrich. Recombinant protein G with His-tag was obtained from Abcam. 
The monoclonal antifumonisin antibody was purchased from BioTez. Mycotoxins 
fumonisin B1 (FB1), fumonisin B2 (FB2), T-2 toxin, and HT-2 toxin were from Fermentek; alternariol 
(AOH) was from Apollo Scientific, while deoxynivalenol (DON) and zearalenone (ZEA) were from 
Sigma-Aldrich. The blank wheat quality control material was purchased from Romer laboratories. 
Construction of fluorescent fusion proteins  
For the expression of YPF-tagged mimotope A2, plasmid pPA031 was constructed. The ZsYellow 
gene was polymerase chain reaction (PCR)-amplified from vector pZsYellow by Phusion HF DNA 
polymerase with oligonucleotides RP08Fw and PA09Rv. The sense primer RP08Fw (5′-TTC GAG 
CTC ATG GTT ACT CCG AAT GAT GAT ACG TTT GAT CCT TTT CGG GGT GGA GGT TCG GCT CAT TCA 
AAG CAC GGT CTA-3′) contained a 5′-overhang composed of the DNA sequence encoding for the 
mimotope A2 (underlined) to generate the translational fusion A2-YFP. The antisense primer 
PA09Rv (5′-GCT GGT ACC TGG CCC TGA 474 AAA TAC AGG TTT TCG GCC AAG GCA GAA GGG AAT 
GC- 475 3′), hybridizing to the 3′-end of the ZsYellow, was used to add a TEV cleavage site 
between the 10xHis-tag and the C-terminus of YFP. The PCR product was subcloned at the SacI 
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and KpnI sites of pQE-T7-2 to generate pPA031. Successful cloning was confirmed by DNA 
sequence analysis. 
Fusion protein expression and purification 
For the over-expression of the mimotope-YFP fusion protein, plasmid pPA031 was transformed 
into E. coli One Shot BL21 Star (DE3) cells and selected on LB agar plates with 50 μg/mL 
kanamycin. A single colony harboring the plasmid was used to inoculate 15 mL of preculture (LB 
medium supplemented with 50 μg/mL kanamycin), which was grown overnight at +30 °C. The 
cell growth was spectrophotometrically monitored, and, the following day, preculture in the 
exponential growth phase was used to inoculate a main culture of 250 mL (LB medium 
supplemented with 50 μg/mL kanamycin) to an optical density at 600 nm (OD600) of 0.05. The 
main culture was grown at +37 °C with shaking until an OD600 of 0.6 was reached, and 
isopropylβ-D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 500 μM to 
induce fusion protein expression. The cultivation was then continued at +37 °C for 5 h. After 
that, the cells were collected by centrifugation (10 min at 5 000g at +4°C) and resuspended in 
10 mL of lysis buffer supplemented with protease inhibitor cocktail. The cells were lysed by 
sonication on ice for 3 min, after which the resultant cell debris was removed by centrifugation 
for 20 min at 15 000g at +4 °C. Successful expression of the fluorescent protein was confirmed 
by analyzing the fluorescence emission of the soluble and insoluble fractions as well as the 
culture media. 
The fluorescent fusion protein was purified from the cell lysate by HisTrap column 
according to the manufacturer’s instructions.70 First, the clarified lysate was diluted (1:3 v/v) in 
binding buffer (20 mM phosphate buffer pH 7.2, 500 mM NaCl and 20 mM imidazole) to ensure 
optimal binding conditions for the purification. After the sample was loaded into the HisTrap 
column, the latter was washed with 30 mL of the binding buffer, and, finally, the His-tagged 
proteins were eluted by elution buffer (20 mM phosphate buffer pH 7.2, 500 mM NaCl, and 
500 mM imidazole). Presence of the fluorescent protein in the elution fractions was followed 
spectrophotometrically, and the fluorescent fractions were pooled. The buffer was exchanged 
to 50 mM Tris buffer (pH 7.75) containing 150 mM NaCl with PD-10 according to manufacturer’s 
instructions70 and concentrated using Amicon Ultra 3K Centrifugal Filter Units.71 The 
concentration of the stock was determined by BCA kit,72 and to remove the C-terminal His-tag, 
4 μg of TEV protease was added to 100 μg of the fusion protein (in 100 μL of 50 mM Tris buffer 
pH 7.75 containing 150 mM NaCl). After overnight incubation at +4 °C, the cleaved His-tag and 
the His-tagged TEV protease were removed by adding 50 μL of Ni-NTA magnetic agarose beads 
to the reaction. The beads were captured with an Nd magnet after 15 min, and the supernatant 
was collected. Successful His-tag cleavage was confirmed by observing the fluorescence 
emission in the fraction that did not bind to Ni-NTA beads. Finally, the protein concentration of 
the purified mimotope-YFP without His-tag was determined with a BCA assay kit, and its purity 
was verified by SDS polyacrylamide gel electrophoresis (PAGE). The fluorescent excitation and 
emission spectra of the purified fluorescent fusion protein are shown in Figure 30 in the 
supporting information. 
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Heterogeneous fluorescence immunoassay 
The heterogeneous fluorescence immunoassay with mimotope-YFP (Figure 25A) was performed 
in 96-well black plates by coating the wells with capture antibody (100 ng in 60 μL of 0.2 M 
sodium carbonate/bicarbonate, pH 9.4) by overnight incubation at +4°C. The wells were then 
blocked with blocking buffer (PBS pH 7.2; 3% (w/v) BSA) for 3 h at room temperature and 
washed twice with PBS-T (PBS pH 7.2; 0.05% (v/v) Tween-20). Toxin standards in the range from 
0 to 250 ng mL−1 (in three replicates) were added to the coated wells together with the 1 μg mL−1 
mimotope-YFP in assay buffer (PBS, pH 7.2; 0.05% (v/v) Tween-20; 0.1% (w/v) BSA) in a total 
reaction volume of 60 μL. After incubation of 1.5 h at slow shaking, the wells were washed four 
times with PBS-T. Finally, 60 μL of PBS was added to each well, and fluorescence signals 
(excitation at 500 nm; detection at 545 nm) were measured using a BMG Labtech CLARIOstar 
microplate reader. 
Gold nanoparticle (AuNP) synthesis and characterization 
The effect of the gold nanoparticle size on the fluorescence quenching was evaluated by 
preparing the metal colloids following a step-by-step growing procedure described elsewhere,63 
with minor modifications. First, 97 mg (0.33 mmol) of trisodium citrate dihydrate was dissolved 
in 150 mL of Milli-Q water (used immediately after collection from the system, 18.2 MΩ cm at 
+25 °C, pH 7.33) in a 250 mL two-necked round-bottom flask attached to a condenser. A 
25 mM HAuCl4 stock solution was prepared by dissolving 246 mg of gold(III) chloride trihydrate 
in 25 mL of Milli-Q water. Once the solution containing sodium citrate boiled (+110 °C), 1 mL of 
the gold solution was rapidly injected under vigorous stirring, obtaining in this way citrate-capped 
AuNPs after ca. 10 min. The reaction mixture was cooled to +90 °C, and two consecutive 
injections of 1 mL of 560 HAuCl4 solution were performed every 30 min. Then, 30 min after the 
second addition, 55 mL of the suspension was extracted, centrifuged (at 12 857g for 2 h) and 
resuspended into the same amount of Milli-Q water to yield the “generation 0” (Gen0) 
suspension. Then, 53 mL of Milli-Q water was added to the remaining mixture in the round-
bottom flask and kept under stirring for 15 min, until the temperature reached +90 °C. 
Separately, a 60 mM sodium citrate stock solution was prepared (441 mg in 25 mL of Milli-Q 
water), and 2 mL of this stock solution was added to the reaction mixture to yield the seed 
solution for the following generation. In this case, three consecutive injections of 1 mL HAuCl4 
solution were incorporated at 30 min intervals. After 30 min of the third addition, 55 mL of the 
suspension was extracted and treated as described previously to obtain “generation 1” (Gen1). 
The procedure was repeated in an iterative fashion until “generation 6” (Gen6) was reached. 
For the assay optimization, samples of Gen0, Gen3, and Gen6, corresponding to 17, 36, and 
72 nm nanoparticles, respectively, were used. 
TEM images were acquired using a JEOL JEM-1400PLUS instrument operating at 120 kV, 
with a LaB6 electron source and a GATAN US1000 CCD camera (2k × 2k). The diameter of at 
least 150 particles was determined from these TEM images using ImageJ software (United 
States National Institutes of Health) to characterize the size distribution of the nanoparticles. 
The absorption spectra of the AuNPs were measured on a Varian Cary 3-Bio UV–vis 
spectrophotometer. Their concentration was determined from the UV−vis spectra using the 
reported absorption coefficients at 450 nm (ε450) for AuNPs of different sizes,73 namely,  
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3.24 × 108, 3.52 × 109, and 2.93 × 1010 M−1 cm−1 for 17, 36, and 72 nm AuNPs, respectively. 
Hydrodynamic diameter and zeta potential measurements were conducted on a CGS-8 (ALV) 
instrument equipped with an Ar-ion laser (Coherent I300, 514.5 nm). 
Recombinant protein G with His-tag was conjugated to citrate-stabilized AuNPs as 
previously described with minor modifications.74 Initially, the protein concentration required to 
stabilize AuNPs was tested by flocculation tests with NaCl.65 Briefly, 150 μL of AuNPs (2.5 nM) 
and different concentrations (0−7.8 μg mL−1) of protein G in 10 mM phosphate buffer (pH 8.0) 
were mixed in an AuNP/protein mole ratio ranging from 1:0 to 1:120. After 15 min of incubation 
at room temperature, 50 μL of 10% NaCl solution was added to the above mixture, and the 
stability of the gold was monitored by its color and by the absorbance of the mixture. On the 
basis of the flocculation test, for the self-assembly of the AuNP-protein G conjugates, 
6.5 μg mL−1 (250 nM) protein G was added to a microcentrifuge tube containing a AuNP 
suspension (2.5 nM of 17 nm AuNPs, 0.4 nM of 36 nm AuNPs, or 0.04 nM of 72 nm AuNPs) in 
10 mM phosphate buffer (pH 8.0). After incubation for 45 min at +4 °C, the suspension was 
washed twice by centrifugation at 12 000g for 20 min, and, finally, the AuNP-protein G 
conjugates were resuspended in 10 mM phosphate buffer (pH 8.0) with 0.1% (w/v) BSA, using 
1/10 of the original reaction volume to achieve stocks of a higher concentration. Quantification 
of the protein G coverage was performed by hydrolysis of the protein immobilized onto the AuNPs 
and classical amino acid HPLC analysis of the hydrolysates, following the strategy described by 
Liu et al. (2017)75 (see supporting information for method details). 
Homogeneous quenching immunoassay 
The homogeneous quenching immunoassay with mimotope-YFP and protein G-coupled AuNPs 
(Figure 4) was performed in black 96-well plates in one step by mixing the assay components in 
10 mM phosphate buffer (pH 8.0) containing 0.1% (w/v) BSA in a total reaction volume of 60 μL. 
After a checkerboard-type titration of the antibody and mimotope-YFP to determine their optimal 
concentrations, 1.5 μg mL−1 anti-FB1 antibody and 0.5 μg mL−1 mimotope-YFP were used and 
mixed with the toxin standards in the range from 0 to 250 ng mL−1 (in three replicates). For the 
optimization of AuNP-protein G conjugates, concentrations ranging from 0.001 to 4 nM were 
studied, but, for the calibration curves, 1 nM (17 nm AuNP), 0.6 nM (36 nm AuNPs), or 0.06 nM 
(72 nm AuNPs) concentrations were used. After 10−45 min of incubation at room temperature, 
fluorescence signals (excitation at 500 nm; detection at 545 nm) were measured using the 
CLARIOstar microplate reader. 
Sample preparation and analysis of spiked samples 
A blank wheat reference material was used to confirm the functionality of the homogeneous 
assay with a real sample matrix. According to a previously described protocol for FB1 
extraction,43 5 g of the blank wheat sample was suspended in 25 mL of PBS or, for the spiked 
samples, 2 or 4 μg of FB1 was added to 1 g of wheat suspended in 5 mL of PBS (2000 or 
4000 μg kg−1 of FB1). Suspensions were ultrasonically extracted for 15 min and centrifuged at 
15 000g for 15 min. The supernatant was filtered with a 0.22 μm nylon filter to remove any 
insoluble material and diluted in the assay buffer. 
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Data analysis 
For the toxin dose−response plots, the fluorescence signals were analyzed with OriginPro 9.0 
software (OriginLab Corp.) using a four-parameter logistic regression (4-PL) function  
(equation 1): 
y = Amin+ (Amax − Amin)
1+ � xIC50
�
 b                   (1) 
where Amax is the asymptotic maximum, b and IC50 are the slope of the curve and the analyte 
concentration, respectively, at the inflection point, and Amin is the asymptotic minimum. The limit 
of detection (LOD) was determined using the average blank signal ± 3 × the standard deviation 
of the blank, while the dynamic range of the assay was defined as that corresponding to the 
20% to 80% inhibition (IC20−IC80). 
 Supporting information 
Excitation and emission spectra of the purified fluorescent fusion protein 
 
Figure 30. Excitation and emission spectra of the epitope-mimicking yellow 
fluorescent protein in 10 mM PBS (pH 8.0)/0.1% (w/v) BSA buffer. 
Characterization of gold nanoparticles 
Citrate-stabilized gold nanoparticles (AuNPs) were prepared by a step-by-step growth 
procedure62 as described in the Experimental section. Average diameters of the different 
generations were determined by transmission electron microscopy (TEM) to be 17.1 ± 2.0 nm, 
36.1 ± 3.3 nm, and 72.4 ± 7.1 nm (Figure 31). Furthermore, dynamic light scattering (DLS) was 
used to evaluate the average hydrodynamic diameter and polydispersity of the particles  
(Figure 32). 
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Figure 31. The diameter of at least 150 particles of each generation was determined from 
TEM images to characterize the size distribution of the particles (A). Average sizes of 17.1 ± 
2.0 nm (black), 36.1 ± 3.3 nm (red), and 72.4 ± 7.1 nm (blue) were measured for 
generations 0, 3, and 6, respectively. Typical TEM images for AuNPs of different sizes are 
shown in figures B (17 nm AuNPs), C (36 nm AuNPs), and D (72 nm AuNPs). The scale bars 
correspond to 100 nm. 
 
Figure 32. Plots of the normalized intensity distribution of the hydrodynamic diameters of 
17 nm (black), 36 nm (red), and 72 nm AuNPs (black) measured by dynamic light scattering 
(DLS). Average mean hydrodynamic particle diameters (Z-average) of 26.8 nm, 45.0 nm, 
and 79.8 nm, and polydispersity indexes (PDI) of 0.251, 0.324, and 0.164 were measured 
for the 17 nm, 36 nm, and 72 nm AuNPs, respectively. 
Conjugation of protein G to AuNPs 
Citrate-capped AuNPs were conjugated to recombinant protein G by His-tag-mediated self-
assembly. Initially, a flocculation test was performed to determine the amount of protein 
required to stabilize AuNPs. Aggregation of bare AuNPs was observed upon addition of 10% 
(w/v) NaCl, whereas protein-coated AuNPs retained their typical plasmon band under these 
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conditions, confirming the successful protein coating (Figure 33). Furthermore, analysis of 
protein-conjugated AuNPs by TEM confirmed the presence of the protein coat (Figure 33). 
 
Figure 33. Evaluation of the minimum amount of protein required to stabilize the conjugates 
against salt-induced flocculation. Bare AuNPs (i.e., without added protein) aggregated upon 
addition of 10% (w/v) NaCl (black line) whereas high protein concentrations (AuNP/protein 
mole ratios above 1:100, cyan curve) remained colloidally stable, and no changes in the 
absorbance were observed. The arrow indicates the variation observed in the absorption 
spectra with increasing concentration of protein G (0–7.8 μg mL–1, corresponding to mole 
AuNP/protein ratios from 1:0 to 1:120). 
 
Figure 34. AuNPs (17 nm) with (right) and without (left) protein G coating were analyzed by 
TEM. Negative staining was performed using neutral phosphotungstic acid (3% solution 
buffered to pH 7 with sodium hydroxide). The size of the protein coat was measured to be 
3.0 ± 0.2 nm from the TEM images, which was in agreement with theoretical calculations of 
the size of protein monolayer on the gold surface (assuming a globular protein, the diameter 
of the 26 kDa protein G was estimated to be 3.2 nm).  
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Quantification of protein G on AuNPs 
Quantification of protein coverage on gold nanoparticles was performed following the strategy 
described by Liu et al. (2017)75 with some changes. The method is based on the hydrolysis of 
the protein immobilized onto gold nanoparticles and classical amino acid analysis of the 
hydrolysate. 
Briefly, the AuNP-protein G conjugates were prepared following the protocol described in 
the Experimental Section, but the concentrated stocks were obtained using 10 mM phosphate 
buffer (pH 8.0), avoiding the presence of BSA. For the hydrolysis, an aliquot of 12.5 µL of the 
concentrated AuNP-protein G conjugate was diluted to 50 µL with phosphate buffer (10 mM, 
pH 8). Then, the dilute solution was mixed with 50 µL of 12 M hydrochloric acid and kept at 
+110 °C for 24 h. The digested sample was evaporated to dryness in order to remove the acid, 
and the solid residue was dissolved in 100 µL of borate buffer (0.2 M, pH 8.5). The obtained 
hydrolysis product was immediately diluted with 700 µL of borate buffer (0.2 M, pH 8.5) and 
200 µL of 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) derivatization reagent 
(3 mg mL–1 in anhydrous acetonitrile). The reaction mixture was kept in a shaker at 800 rpm 
and +55 °C for 10 min. Finally, the amino acids-AQC derivatives were analyzed in triplicate by 
HPLC-FLD (high-performance liquid chromatography with fluorescence detection). 
Chromatographic separation of the amino acids-AQC derivatives was performed on a 
ZORBAX® SB-C18 (150 mm × 4.6 mm, 3.5 μm) HPLC column from Agilent (Torrance, CA). A 
gradient program was used with the mobile phase, combining solvent A (Milli-Q water 
supplemented with 0.1% trifluoroacetic acid (TFA)) and solvent B (acetonitrile supplemented 
with 0.1% TFA) as follows: 1–8% B (12 min), 8–11% B (13 min), 11% B (2 min), 11–20% B 
(2 min), 20% B (10 min), 20–100% B (8 min) and finally the initial condition, 1% B, was 
recovered in 8 min. Analyses were performed at a flow rate of 0.8 mL min–1, and the column 
temperature was kept at +40 °C. The injection volume was 80 μL, and all the compounds eluted 
within 45 min. The excitation and emission wavelengths of the FLD detector were set at 254 nm 
and 395 nm, respectively. Calibration was carried out using protein G as the standard. Thus, 
protein G was hydrolyzed and derivatized following an identical protocol to that described above 
for the AuNPs-protein G conjugate samples. 
Quantification was performed measuring the peak area at a retention time of 34 min that 
was previously identified as AQC-glycine derivative by comparing the retention time with a single 
glycine amino acid-AQC standard injection. The chromatograms of hydrolyzed protein G in 
amounts ranging from 0 to 100 ng are shown in Figure 35. 
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Figure 35. The chromatograms of protein G-based calibrants after hydrolysis and AQC 
derivatization. 
The binding efficiency (B, %) was calculated according to (eq 2), 
B(%) = �  Bound protein G
Total protein G
 �×100 (2) 
where Bound protein G is the amount of protein immobilized on the AuNPs analyzed and the 
Total protein G is the amount of protein G in the reaction mixture. The results summarized in 
Table 9 are in agreement with those obtained by other authors using a similar quantification 
methodology.2 
Table 9. Summarized results of the protein G binding efficiency and surface coverage on AuNPs. 
Sample Total protein G (µg) Bound protein G (µg) B (%) 
17 nm AuNPs 3.25 1.57 ± 0.07* 48 ± 2 
26 nm AuNPs 3.25 2.1 ± 0.1 64 ± 3 
72 nm AuNPs 3.25 2.1 ± 0.3 66 ± 8 
*Confidence interval for n = 3 calculated as ± 𝑡𝑡𝛼𝛼,𝜐𝜐 𝑠𝑠 √𝑛𝑛�  where α is the significance level set at 0.05 and ν, 
degrees of freedom. 
Mycotoxin detection 
129 
Mimotope-YFP antibody emission decays  
 
 
Figure 36. Mimotope-YFP antibody emission decay in 10 mM PBS (pH 8.0), 0.1% (w/v) BSA buffer 
in the absence (A) and in the presence (B) of 17 nm gold nanoparticles (Au-NPs) decorated with 
protein G and the oriented anti-FB1 antibody in the same buffer after 20 min incubation. Excitation 
was performed with a 463-nm <1-ns laser diode pulsed at 900 KHz through a 465-nm band-pass 
interference filter; emission was monitored at 538 nm through a 500-nm blazed double 
monochromator, with a Hamamatsu R928P photomultiplier tube. In both cases, 30000 counts 
were collected at the peak channel, but (B) required 6 times as much time as (A). 
A 
B 
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Assay optimization 
 
Figure 37. Optimization of the mimotope-YFP concentration in the homogeneous quenching 
immunoassay with 1 nM AuNP and 1.5 µg mL–1 antibody. Maximal fluorescence signals without 
added FB1 (red circles) and minimal signals with 100 ng mL–1 FB1 (black diamonds), and the ratio 
of the maximal to minimal signals (blue triangles, right y-axis) after 20 min incubation. Error bars 
indicate the standard error of the mean (n = 3). A mimotope-YFP concentration of 0.5 µg mL–1 with 
the best max/min ratio was selected for subsequent experiments. 
 
Figure 38. Assay kinetics with 17-nm AuNPs. Measurements were repeated after 5 min (black), 
10 min (red), 15 min (blue), 20 min (magenta), 30 min (green), and 45 min (orange) incubation. 
Signal-to-background ratios (A) improved with longer incubation as fluorescence quenching 
increased. However, the shorter the incubation time the better sensitivity was observed, as can be 
seen in the normalized signals (B). An incubation time of 20 min was chosen for further 
experiments as it provided the required sensitivity but better reproducibility than shorter times. 
Error bars indicate the standard error of the mean (n = 3). A four-parameter logistic fit (OriginPro 
9.0) was used to calculate the IC50 values. 
 
  
Table 10. Comparison of the analytical characteristics of the novel homogeneous quenching immunoassay with other reported assays for the detection of FB1. 
Preparation refers to preliminary steps required such as reagent immobilization, labeling, coating, etc. Assay time is the sum of assay incubation steps without taking 
into account the washing steps or measurement time. Washing steps refer to the total amount of washes during the entire assay protocol. The calculation method for 
the limit of detection (LOD) has been marked with † if the LOD was determined from 3SD of the blank, or with ‡ if 90% inhibition was used. Dynamic range (DR) is 
defined from the IC20 and IC80 values. 
Assay and 
measurement type 
Recognition  
element Label IC50 and DR LOD  
Preparative 
steps 
Assay 
time 
Washing 
steps Sample Ref. 
ELISA (A) 
Immobilized  
FB1–OVA 
Recombinant scFv 
HRP 12.67 ng mL
–1 
2.10–76.45 ng mL–1 
0.832 ng mL-1  
(8.32 μg kg-1) 
(†) 
FB1–OVA 
immobilization 
overnight 
2 h 14x Spiked corn [76] 
Peptide-ELISA (A) 
Immobilized 
mimotope–BSA 
McAb 
HRP 6.06 ng mL
–1 
1.77–20.73 ng mL–1 1.18 ng mL
-1 
Conjugate 
immobilization 
overnight 
2 h 12x 
Maize, 
feedstuff, and 
wheat 
[77] 
Magnetoimmuno-
sensor on CSPE (Am) 
Immobilized McAb 
FB1–HRP HRP 
2.86 ng mL–1 
0.73–11.2 ng mL–1 0.33 ng mL
-1 (‡) – 3 h 13x Maize, beer [78] 
Multiplexed  
homogeneous 
immunoassay (FP) 
Labeled FB1 
McAb AF 647 
1918 μg kg–1  
587.0–6265 μg kg–1  
331.5 μg kg–1 
(66.3 ng mL–1) 
(†) 
FB1 labeling 5 min – Maize [79] 
Microarray-based 
immunoassay (F) 
Immobilized 
synthetic mimotope 
McAb 
AF 647 37.1 ng mL
–1 
17.3–79.6 ng mL–1 11.1 ng mL
–1 (‡) Microarray printing 3.5 h 7x 
Spiked  
maize and 
wheat 
[40] 
Homogeneous 
immunoassay (FQ) 
McAb 
Mimotope-YFP 
YFP 
AuNP 
12.9 ng mL–1 
7.3–22.6 ng mL–1 1.1 ng mL
–1 (†) 
AuNP coating and 
washing 1 h 30 
min 
20 min – Spiked wheat This work 
Abbreviations: A, absorbance; AF, AlexaFluor; Am, amperometry; AuNP, gold nanoparticle; BSA, bovine serum albumin; CSPE, carbon screen-printed electrode; DR, dynamic range; F, 
fluorescence; FP, fluorescence polarization; FQ, fluorescence quenching; HRP, horse-radish peroxidase; McAb, monoclonal antibody; OVA, ovalbumin; scFv, single-chain fragment variable 
antibody; YFP, yellow fluorescent protein. 
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Figure 39. Specificity of the homogeneous assay assessed by testing different mycotoxins. 
Fumonisins FB1 and FB2 showed almost identical calibration curves (A; FB1 black, FB2 red), whereas 
other mycotoxins such as T-2 toxin, HT-2 toxin, deoxynivalenol (DON), ochratoxin A (OTA), 
zearalenone (ZEA), or alternariol (AOH), did not give any response in the assay when tested at 100 
ng mL–1 concentration as the fluorescence signals (B) were comparable to the background signal 
of the blank without any toxin. Error bars indicate the standard error of the mean (n =3). A four-
parameter logistic fit (OriginPro 9.0) was used to calculate the IC50 values. Structures of the tested 
mycotoxins are depicted on the right side. 
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Abstract 
Mycotoxins can be found as natural contaminants in many foods and feeds, and owing to their 
toxic effects, it is essential to detect them before they enter the food chain. An interesting 
approach for the analysis of mycotoxins by competitive immunoassays is the use of epitope 
mimicking peptides, or mimotopes, which can replace the toxin-conjugates traditionally used in 
such assays. Mimotopes can be selected from phage-displayed peptide libraries even without 
any prior knowledge of the antibody–antigen interaction, and after identifying the target specific 
clones, the individual clones can be efficiently amplified in bacteria and used directly in the 
immunoassay. Following such approach, we have previously selected and identified a 
dodecapeptide which functions as a mimotope for the mycotoxin fumonisin B1. In this work, we 
present the development and comparison of various immunoassays based on this mimotope, 
named A2, which has been used in the phage-displayed format in which it was selected, but also 
as a fluorescent recombinant fusion protein or as a synthetic peptide. The best sensitivity was 
obtained with the magnetic bead–based assay using the synthetic peptide and enzymatic 
detection which provided a detection limit of 0.029 ng mL–1. Analysis of the binding kinetics by 
surface plasmon resonance (SPR) further reinforced the suitability of the synthetic peptide for 
the competitive immunoassay as this mimotope showed a slightly lower affinity for the target 
antibody in comparison with the recombinant fusion protein. 
 Introduction 
The small size of many diagnostically or environmentally relevant molecules presents particular 
challenges for the development of rapid methods for their detection. Immunoassays for low 
molecular weight analytes, or haptens, which contain only one epitope and thus are not able to 
bind more than one antibody at the same time, are usually performed in the competitive assay 
format. A major limitation of this approach is the requirement to conjugate the target molecule 
either to a carrier protein or to a label which allows the immobilization or detection of this 
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competitor for immunoassay development.1 In some cases, the synthesis or chemical 
conjugation of these competitors can be problematic and time-consuming or result in a 
heterogeneous mixture of randomly cross-linked or unstable molecules which can reduce the 
immunoassay performance. Additionally, the analyte conjugation can unfavorably affect the 
antibody recognition, or the release of the analyte moiety from the conjugate might even cause 
false positive results.2–4 Epitope mimics are an intriguing alternative to overcome such 
limitations related to the competitive immunoassay format.2,5 Their exceptional ability to mimic 
the epitope of the analyte and thus bind to the same antibody paratope allows using epitope 
mimics as the competitor instead of the conjugated analyte itself. Several epitope mimicking 
antibodies, referred to as anti-idiotypic antibodies, as well as short peptides, known as 
mimotopes, have been described for various low molecular weight targets, including 
mycotoxins.5,6 
Mycotoxins are low molecular weight compounds produced as secondary metabolites by 
filamentous fungi, and they can be found as natural contaminants in many vegetal foods and 
feeds, including cereal grains, nuts, fruits, spices, and beans.7,8 Currently, approximately 400 
compounds are recognized as mycotoxins, and about 30 of them are considered as a threat to 
human and animal health due to their cytotoxic, nephrotoxic, hepatotoxic, teratogenic, 
mutagenic, carcinogenic, immunosuppressive, or estrogenic effects.7–9. Due to the natural 
character of these toxins and the widespread distribution of mycotoxin-producing molds 
mycotoxin contamination is often inevitable,9 and therefore, to guarantee food safety several 
national and international authorities, including the European Commission, have set maximum 
residue limits (MRLs) for the most common and toxic mycotoxins.10–13 Whilst the conventional 
mycotoxin detection methods, based on liquid chromatography coupled with diode array (DAD), 
fluorescence (FLD) or mass spectrometry (MS) detection, offer high sensitivity and 
accuracy,6,14,15 immunoassays and biosensors provide fast and low-cost alternatives. These 
simple features make them more suitable for multiplexed approaches as well as for field testing 
or low-resource settings, and can provide real-time readout and even fully automated 
processes.16,17 
The concept of epitope mimics has been widely recognized in the field of mycotoxin 
research, and mimotopes have been reported for the most common mycotoxins, including 
aflatoxin,18 deoxynivalenol (DON),19 fumonisin B1 (FB1),20–22 ochratoxin A (OTA),23–27 and 
zearalenone.28 Phage display29–31 is a powerful technique that enables the selection of 
mimotopes from phage-displayed peptide libraries. Phage-borne peptides for mycotoxin 
detection have been applied to different immunoassays, for example using colorimetric23 or 
chemiluminescent25 detection, or developing rapid methods based on dipsticks25 and dot-
immunoassays.28 Nevertheless, despite the wide use of phages in research, they might not be 
ideal components for immunoassay development due to their large size and biologically active 
nature.32,33 Alternatively, after identifying the mimotope sequence from a phage-displayed 
library, the phage-borne peptides can be replaced by their synthetic or recombinant 
counterparts. Taking advantage of the rather well-established and straightforward chemical 
synthesis of short peptides, synthetic mimotopes have been demonstrated to be an attractive 
alternative to develop phage-free mimotope assays.20,22,23,27 On the other hand, the vast 
possibilities of genetic engineering and the low cost of producing recombinant proteins in 
bacteria also make the use of recombinant mimotope-protein fusions an attractive option.21,26,34 
For example, for OTA and FB1 recombinant mimotope-fusions with maltose binding protein 
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(MBP) have been used as coating agents in ELISA,21,26 and recently, mimotopes tagged with 
bioluminescent35 or fluorescent reporter proteins36,37 enabled using the fusion protein directly 
as the tracer. 
Despite the various applications of mimotopes particularly for mycotoxin detection,5 the 
available information on comparing the alternative mimotope formats is still scarce. In this work, 
we have systematically compared the performance of seven different immunoassays using the 
phage-borne, synthetic, or recombinant mimotopes for the detection of FB1. A previously 
identified mimotope20 was produced in bacteria either by phage display or by expressing a 
recombinant fusion protein with a yellow fluorescent protein (YFP). The developed competitive 
immunoassays using these mimotopes were compared with the binding inhibition assay using 
the synthetic mimotope with a biotin linker. To further explore alternatives, to improve the assay 
sensitivity and working range, the immunoassays were transferred from the conventional 
microtiter plate–based format to magnetic beads with a large surface area available for the 
immobilization. Moreover, in order to study the differences in the binding kinetics of the 
interaction between the phage-borne, synthetic, or recombinant mimotopes with the anti-FB1 
antibody binding parameters, we performed kinetics analyses by surface plasmon resonance 
(SPR). This real-time and label-free analysis could provide a more accurate comparison of the 
mimotope binding to the target antibody independent of the used immobilization support, label, 
or secondary antibody. 
 Materials and methods 
Materials 
The monoclonal anti-fumonisin antibody was purchased from BioTez (Berlin, Germany) and 
fumonisin B1 (FB1) was from Fermentek Ltd. (Jerusalem, Israel). Biotinylated peptide (A2-bio 
with the sequence VTPNDDTFDPFRGGGSK(Bio)−NH2) was synthesized at Peptide Synthetics 
(Fareham, UK). The HRP-conjugated anti-M13 antibody, together with the BIAcore sensor chips 
CM5 and CM3, the mouse antibody capture kit and amine coupling kit were obtained from GE 
Healthcare Inc. (Chicago, IL, USA). The peroxidase-conjugated AffiniPure Rabbit Anti-Mouse IgG 
(H+L) and monoclonal mouse anti-biotin were from Jackson ImmunoResearch Inc. (West Grove, 
PA, USA). The M13 major coat protein antibody was from Santa Cruz Biotechnology (Dallas, TX, 
USA). LodeStars 2.7 Carboxyl paramagnetic beads with an average diameter of 2.7 mm were 
purchased from Agilent Technologies, Inc. (Santa Clara, CA, USA) and Dynabeads Protein G, 
NeutrAvidin Biotin Binding Protein and Amplex UltraRed reagent together with 1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC), StartingBlock (TBS) Blocking Buffer 
and Blocker solution (casein in PBS) were from Thermo Fisher Scientific (Waltham, MA, USA). N-
hydroxysulfosuccinimide (sulfo-NHS) was purchased from Fluorochem (Hadfield, UK). Black 
polypropylene 384-microplates were obtained from Eppendorf (Hamburg, Germany), black 
Packard HTRF 96-well plates from Nunc (Roskilde, Denmark) and clear Greiner polypropylene 
96-well plates from Sigma-Aldrich (St. Louis, MO, USA). The pZsYellow vector was obtained from 
Clontech Laboratories (Mountain View, CA, US) and the expression vector pQE-T2-2 was from 
Qiagen (Hilden, Germany). Chemically competent Escherichia coli One Shot® TOP10 and BL21 
Star (DE3) cells, the restriction enzymes, and Pierce™ bicinchoninic acid (BCA) protein assay kit 
Mycotoxin detection 
139 
were from Thermo Fisher Scientific. PCR primers were obtained from Integrated DNA 
Technologies, Inc. (San Diego, CA, USA), and KOD Xtreme Hot Start DNA Polymerase was 
purchased from Merck Millipore (Darmstadt, Germany). HisTrap FF and PD-10 columns were 
from GE Healthcare. Bacterial cell lysis buffer and bovine serum albumin (BSA) were purchased 
from NZYTech (Lisbon, Portugal), and protease inhibitor cocktail from Sigma-Aldrich. 
Preparation of phage-displayed mimotopes and fusion proteins 
Phage-displayed mimotopes (A2-phage) were prepared by infecting a 25-mL culture of E. coli 
ER2738 grown to the early-log phase (OD600 0.01–0.05) with the previously identified phage 
clone A2.20 The culture was incubated at +37 °C with vigorous shaking (250 rpm) for 5 h. Next, 
the culture was centrifuged for 15 min (12 000 g, +4 °C), and the phage containing supernatant 
was mixed with 1/6 volume of PEG/NaCl (20% PEG 6000 in 2.5 M NaCl). After 3 h incubation 
on ice, the precipitated phages were collected by centrifugation for (15 min at 12 000 g, +4 °C). 
The phage precipitate was resuspended in 1 mL of PBS (pH 7.4), and the precipitation with 
PEG/NaCl was repeated. Finally, the phage stock was incubated at +65 °C for 15 min to kill any 
residual E. coli, and the phage titer was determined by plating serial dilutions of the phage 
suspension with E. coli. 
Construction and expression of the recombinant mimotope fusion protein 
YFP-tagged FB1-mimotope (A2-YFP) was generated by cloning the FB1-mimotope A2 with the 
peptide sequence VTPNDDTFDPFR20 in fusion with Zoanthus sp. yellow fluorescent protein 
(YFP), ZsYellow,38,39 using standard molecular biology techniques. Plasmid pA2-YFP was 
constructed by amplifying the ZsYellow gene from vector pZsYellow by PCR using KOD Xtreme 
Hot Start DNA polymerase. The sense primer (5’–TTC GAG CTC ATG GTT ACT CCG AAT GAT GAT 
ACG TTT GAT CCT TTT CGG GGT GGA GGT TCG GCT CAT TCA AAG CAC GGT CTA–3’) hybridizing to 
the 5’-end of ZsYellow contained a 5’-overhang composed of the DNA sequence encoding for 
the mimotope A2 (underlined) to generate the translational fusion A2-YFP. The antisense primer 
(5’–GCT GGT ACC TCA GTG GTG GTG GTG GTG GTG GGC CAA GGC AGA AGG GAA TGC–3’), 
hybridizing to the 3’-end of the ZsYellow, was used to add a polyhistidine tag (His-tag) to the C-
terminus of the fusion protein. The PCR product was subcloned at the SacI and KpnI sites of 
pQE-T7-2, and successful cloning was confirmed by DNA sequence analysis. 
For the overexpression of the YFP-tagged A2, plasmid pA2-YFP was transformed into 
E. coli One Shot BL21 Star (DE3) cells and selected on LB agar plates with 50 μg/mL kanamycin. 
A single colony harboring the plasmid was used to inoculate 5-mL preculture (LB medium 
supplemented with 50 μg/mL kanamycin) which was grown overnight at +30°C. The cell growth 
was followed spectrophotometrically, and the following day, the preculture was used to inoculate 
a main culture of 150 mL (LB medium supplemented with 50 μg/mL kanamycin) to an optical 
density at 600 nm (OD600) of 0.05. The main culture was grown at +37 °C in shaking until an 
OD600 of 0.7 was reached, and IPTG (isopropyl β-D-1-thiogalactopyranoside) was added to a final 
concentration of 500 μM to induce fusion protein expression. The cultivation was then continued 
at +37 °C for 5 h. Thereafter, the cells were collected by centrifugation (10 min at 5 000g at 
+4 °C) and resuspended in 10 mL of lysis buffer supplemented with protease inhibitor cocktail. 
The cells were lysed by sonicating on ice, after which the resultant cell debris was removed by 
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centrifugation for 15 min at 15 000g at +4 °C. Successful expression of the fluorescent proteins 
was confirmed by analyzing the fluorescence emission of the soluble and insoluble fractions as 
well as the culture media. 
The fluorescent fusion protein was purified from the cell lysate by HisTrap column 
according to the manufacturer’s instructions. First, the clarified lysate was diluted (1:3, v/v) in 
binding buffer (20 mM phosphate buffer; pH 7.2, 500 mM NaCl and 20 mM imidazole) to ensure 
optimal binding conditions for the purification. After loading the sample in the HisTrap column, 
the column was washed with 30 mL of the binding buffer and finally the His-tagged proteins 
were eluted by adding elution buffer (20 mM phosphate buffer; pH 7.2, 500 mM NaCl and 500 
mM imidazole). The presence of the fluorescent protein in the elution fractions was followed 
spectrophotometrically, and the fluorescent fractions were pooled. The buffer was exchanged to 
50 mM Tris buffer (pH 7.75) containing 150 mM NaCl and 0.02% (w/v) NaN3 with PD-10 
according to the manufacturer’s instructions. Finally, the protein concentration of the purified 
A2-YFP was determined using the BCA assay kit. 
Protein coupling to magnetic beads 
For the magnetic bead assays, the anti-FB1 antibody or neutravidin were conjugated to 
carboxylated magnetic microbeads. First, the beads (1 mg for antibody coupling, 2 mg for 
neutravidin coupling) were washed twice with 0.01 M NaOH, followed by three washes with milli-
Q water and a final wash with buffer A (100 mM MES, pH 5.7; 0.01% SDS). Beads were 
resuspended in buffer A, and 79 mM EDC and 113 mM sulfo-NHS were added to a final reaction 
volume of 200 μL (1 mg beads) or 1000 μL (2 mg beads). The reaction was incubated for 2 h at 
room temperature in shaking after which the beads were washed three times with buffer B 
(10 mM phosphate buffered saline, pH 7.4; 0.01% SDS), and 20 μg of antibody or 175 μg of 
neutravidin in buffer B were added to reach the total volume of 100 μL or 530 μL, respectively. 
Incubation was continued for 4 h, and after aspiration of the buffer, the antibody-coupled beads 
were blocked in StartingBlock (TBS) Blocking Buffer and the neutravidin-coupled beads in 
Blocker Casein for 1 h. Finally, the beads were washed with the blocking buffer three times and 
stored at +4 °C in the same buffer. 
MB-ELISA with phage-displayed mimotope 
For the magnetic bead–based ELISA (MB-ELISA) using the phage-displayed peptide, antibody-
coupled magnetic beads (0.05 mg mL–1) were mixed with A2-phage (2×109 pfu mL–1) and the 
toxin standards in the range of 0–100 ng mL–1 (in three replicates) in microcentrifuge tubes 
previously blocked with the Blocker Casein. The assay buffer  was PBS, pH 7.4; 0.05% (v/v) 
Tween-20; 0.1% (w/v) BSA and the total reaction volume 100 μL. After 1 h  incubation with 
shaking at room temperature, the beads were washed twice with PBS-T (PBS, pH 7.4; 0.05% 
(v/v) Tween-20). Then, HRP-labeled secondary antibody (anti-M13-HRP) was added to each tube 
(1:5000-dilution), and the incubation was continued for 30 min. Finally, the beads were washed 
as described previously, resuspended in 50 μL of assay buffer and transferred to the wells of a 
black 96-well plate. Amplex UltraRed reagent was mixed with hydrogen peroxidase according to 
the manufacturer's instructions, and 50 μL of the substrate solution was added to each well. 
Mycotoxin detection 
141 
The fluorescence signals (excitation at 530 nm and detection at 590 nm) were measured using 
a CLARIOstar microplate reader from BMG Labtech (Ortenberg, Germany). 
MB-ELISA with the synthetic peptide 
The MB-ELISA with the synthetic peptide was performed in the wells of a clear Greiner 96-well 
plate previously blocked with Blocker Casein during 1 h at room temperature. For the 
competitive pre-incubation step, the synthetic peptide A2-bio (1 μg mL–1) together with the anti-
FB1 (100 ng mL–1) were first mixed with the toxin standards in the range from 0 to  
1000 ng mL–1 (in three replicates) in a total reaction volume of 200 µL in PBS-T (PBS, pH 7.4; 
0.05% (v/v) Tween-20). After 30 min incubation with shaking at room temperature, neutravidin-
coupled magnetic beads (6.5 µg in 10 µL) were added to each well and incubation was 
continued for another 30 min. The beads were washed three times using a plate washer with 
magnetic support (HydroFlex, Tecan, Switzerland) with the same buffer, and the HRP-labeled 
anti-IgG secondary antibody (0.26 µg mL–1 in a total volume of 200 µL per well) was added to 
each well followed by 30 min incubation at room temperature. Finally, the beads were washed 
three times as described previously, and the fluorescence signals were measured after addition 
of the Amplex UltraRed substrate as described before. 
Fluorescent protein immunoassay 
For the fluorescent protein A2-YFP assay on magnetic beads, 100 ng of anti-FB1 was mixed with 
200 ng of A2-YFP together with the toxin standards in the range of 0–100 ng mL–1 (in three 
replicates) in microcentrifuge tubes previously blocked with Casein in a total reaction volume of 
60 μL using the same assay buffer as reported previously. After 1 h incubation with shaking at 
room temperature, protein G -beads (10 μg in 40 μL) were added to each tube, and the 
incubation was continued for another 15 min. The beads were then washed three times with 
PBS-T and finally resuspended in 20 μL of assay buffer and transferred to the wells of a black 
384-well plate. Fluorescence signals (excitation at 500 nm; detection at 545 nm) from each well 
were measured with the microplate reader. 
Data analysis 
For the mycotoxin calibrations, the fluorescence signals were normalized to the minimum and 
maximum signals and analyzed with Origin Pro 9.0 software (OriginLab Corp., Northampton, MA, 
USA) using the four-parameter logistic regression (4-PL) model (equation 1): 
y = Amin+ (Amax − Amin)
1+ � xIC50
�
 b                   (1) 
where Amax is the asymptotic maximum, Amin the asymptotic minimum, and b and IC50 are the 
slope of the curve and analyte concentration, respectively, at the inflection point. For comparing 
the different assays, the sensitivity defined as the lower limit of detection (LOD) was determined 
as the concentration for which the antibody binding to the mimotope was inhibited by 10%, and 
the dynamic range was defined as the toxin concentrations leading to inhibition between 20% 
and 80% (IC20–IC80). 
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Affinity measurements by SPR 
Surface plasmon resonance (SPR) analysis on BIAcore X100 (GE Healthcare) was performed to 
determine the affinity constant and binding kinetics of the interaction between the phage-borne, 
synthetic, or recombinant mimotopes (namely A2-phage, A2-bio, and A2-YFP, respectively) and 
the target antibody. For the analysis, each ligand was captured by a covalently coupled antibody 
(anti-mouse IgG, anti-biotin IgG, or anti-phage IgG) to the surface of a sensor chip CM5, or CM3 
in case of the phage analysis. Covalent antibody immobilization of was carried out using the 
amine coupling kit by BIAcore following the manufacturer's instructions. Briefly, the carboxyl 
derivatized surface of the chip was first activated with EDC/NHS, afterwhich, the anti-mouse IgG 
(30 μg mL–1 in 10 mM sodium acetate pH 5.0), the anti-biotin IgG (100 μg mL–1 in 10 mM sodium 
acetate pH 5.0), or the anti-phage IgG (100 μg mL–1 in 10 mM sodium acetate pH 5.5) were 
immobilized with approximately 5000, 9000, and 4000 response units (RUs), respectively. After 
capture antibody injection, the remaining active sites on the chip were blocked by injecting 1 M 
ethanolamine. Both the reference and sample channels were treated equally on all the chips. 
For the A2-YFP analysis, the mouse anti-FB1 antibody (5 µg mL–1) diluted in the running 
buffer (20 mM phosphate buffer, pH 8.0; 200 mM NaCl; 0.1% Tween-20) was injected in the 
sample channel of the anti-mouse coupled CM5 chip, at a flow rate of 5 µL min–1 for 150 s 
leading to a response of approximately 350 RU. A2-YFP was then injected in running buffer at 
concentrations ranging from 0 to 500 nM, in both the reference and sample channels at a flow 
rate of 30 µL min–1 for 180 s. The chip surface was regenerated between cycles by injection of 
10 mM glycine-HCl pH 1.7 at a flow rate of 5 µL min–1 for 400 s. 
For the A2-bio analysis, the synthetic A2-bio (20 ng mL–1) was injected in the sample 
channel of the anti-biotin coupled CM5 chip in the same running buffer at a flow rate of  
5 µL min–1 for 180 s leading to a response of approximately 8 RU. Anti-FB1 was then injected in 
the running buffer at concentrations ranging from 0 to 500 nM, in both the reference and sample 
channels at a flow rate of 30 µL min–1 for 180 s. Between cycles, the surface was regenerated 
by injection of 10 mM glycine-HCl (pH 3.0) at a flow rate of 5 µL min–1 for 400 s. 
For the phage analysis, the A2-phage (1013 pfu mL–1) was coupled to the sample channel 
of the anti-phage functionalized CM3 chip in the running buffer, at a flow rate of 5 µL min–1 for 
180 s leading to a response of approximately 40 RU. The anti-FB1 antibody, at 1000 nM 
concentration in the running buffer, was then injected in both the reference and sample 
channels at a flow rate of 30 µL min–1 for 180 s. As no binding was seen, an anti-phage-HRP 
was injected as a control to confirm the successful capture of the phage. The binding data with 
A2-YFP and A2-bio were fit to a 1:1 Langmuir binding model for calculation of the kinetic 
parameters using the BIAcore evaluation software. The affinity constant (KD) values were derived 
from the kinetic constants by the quotient between the association rate (kon) and the 
dissociation rate (koff). 
 Results and discussion 
Phage-based immunoassays 
Phage display is a robust technique to search for epitope mimics even without prior knowledge 
of the antibody–antigen interactions. After identifying a novel epitope mimicking peptide, or 
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mimotope, using phage display, the most straightforward approach is probably the use of the 
peptide linked to the phage for the assay development. We have previously identified FB1-
mimotope, named A2, from the Ph.D.-12 commercial dodecapeptide library (New England 
Biolabs).20 After pannings, the epitope mimicking nature of A2 was demonstrated in a 
competitive immunoassay using the phage-displayed mimotope and the anti-FB1 antibody 
immobilized onto a microtiter plate. The lower detection limit (LOD) defined as the FB1 for which 
the antibody binding to the peptide was inhibited by 10%, was 7.47 ng mL–1 and the IC50 value 
38.7 ng mL–1, as previously reported.20 
The antibody immobilization procedure is evidently one of the crucial factors affecting the 
assay performance in all heterogeneous immunoassays which inherently rely on immobilizing 
one of the assay components.1 To further improve the detection limit we transferred the phage-
based FB1 ELISA to a magnetic bead–based assay format (MB-ELISA, Figure 40A) where the 
anti-FB1 was immobilized on magnetic beads rather than non-specifically on the surface of a 
microtiter plate. The MB-ELISA showed significantly improved sensitivity in comparison with the 
assay on the 96-well plate, which could be attributed to the increased surface area of the beads 
compared to the plate. The sensitivity in terms of the LOD and IC50 value was 0.87 ng mL–1 and 
2.70 ng mL–1, respectively (Figure 41). 
 
Figure 40. Principles of the competitive immunoassays based on magnetic beads and 
mimotopes either in (a) phage-displayed (A2-phage), (b) synthetic (A2-bio), or (c) 
recombinant fusion protein (A2-YFP), optimized in this work. Abbreviations: bio, biotin; FB1, 
fumonisin B1; HRP, horse-radish peroxidase; YFP, yellow fluorescent protein. 
Use of the synthetic mimotopes 
Despite their wide use in research, there exist some safety concerns to use phages, bacterial 
viruses, for diagnostic purposes.32 We recently showed how the phage-displayed mimotope for 
FB1 could be replaced by its synthetic counterpart for FB1 detection. The peptide-based 
immunoassay in a microarray format showed an LOD of 11.1 ng mL–1 and held promise for 
adaptation to a multiplexed immunoassay by including other mycotoxins in the same 
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microarray.20 The microarray-based immunoassay relied on the use of a fluorescently labeled 
secondary antibody, and in order to improve the sensitivity, this label was replaced by an 
enzyme,  horse-radish peroxidase (HRP), and applied in a magnetic bead assay format (MB-
ELISA) (Figure 40B). The use of an enzymatic label could improve the detection limits obtained 
in immunoassays because of the signal amplification achieved since each enzyme can catalyze 
many cycles of conversions of substrate molecules to the fluorescent product, leading to an 
increase in the analytical signal. In fact, the IC50 value (1.85 ng mL–1) obtained with the MB-
ELISA was 20-fold lower than with the microarray (37.1 ng mL–1). Moreover, since the magnetic 
beads allowed immobilization of a higher amount of peptide on their surface compared to the 
spots in the array, the dynamic range (0.13–25.6 ng mL–1) was also substrantially wider than 
for the microarray (17.3–79.6 ng mL–1). Unlike in the microarray where the peptide was spotted 
on the surface of the chip prior to the assay, the MB-ELISA format included a competitive pre-
incubation step where the peptide and FB1 were mixed together with the antibody and incubated 
in solution. Subsequently, the peptide-bound antibodies were captured by the neutravidin-
coupled MBs via the biotin-linker on the peptide (A2-bio). The solution-based competitive binding 
to the antibody provided faster kinetics and resulted in a lower sensitivity, with an LOD of 
0.029 ng mL–1 (Figure 41). 
 
Figure 41. Mimotope-based assays on magnetic beads using the A2-phage 
(black circles), synthetic A2-bio (red diamonds), or recombinant A2-YFP (blue 
triangles). The signals (normalized to the maximum and minimum values) are 
depicted as the average of three replicates ± standard error of the mean 
(n = 3). The response was fitted to a four-parameter logistic curve fit 
(Origin 9.0). 
Assays with the recombinant fusion mimotope 
The synthetic peptide–based assays showed improved analytical characteristics compared with 
the phage-based assay, but nevertheless, the use of synthetic peptides relied on chemical 
synthesis which is susceptible to batch-to-batch variations and can be costly if dependent on 
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commercial providers. To overcome such limitations, we further studied the possibility of using 
the mimotope as a fusion partner with a fluorescent protein. Such recombinant fusion proteins 
can be produced cost-effectively in bacteria even in large quantities, and the fusion protein can 
be designed by genetic engineering to include, for example, specific tags which will enable 
simple purification or immobilization. Moreover, by using a fluorescent protein as the second 
part of the fusion protein, the mimotope can be readily produced with a label and could be 
directly used as the tracer. Thus, neither separate labeling reactions with additional purification 
steps, nor secondary antibodies are required for the immunoassay. With these considerations 
in mind, we described previously the construction of a fusion protein of the mimotope A2 and 
the yellow fluorescent protein (YFP), ZsYellow. The fusion protein was expressed in E. coli, and 
after affinity purification using the C-terminal polyhistidine tag, the fusion protein was used 
directly in the immunoassay, either in a heterogeneous or a homogeneous assay format where 
the antibody was immobilized on a microtiter well plate or gold nanoparticles, respectively.37 
The main advantage of using YFP-tagged mimotope (A2-YFP) was the simplified assay 
protocol which consisted of only one incubation step, since no secondary antibody was needed. 
The LOD and IC50 values of the plate-based heterogeneous assay were 2.01 ng mL–1 and 
6.83 ng mL–1, respectively, which demonstrated not only that the novel YFP-tagged mimotope 
could function as the competitor in the assay but also that the assay format and the YFP as a 
label could provide good sensitivity. The homogeneous assay using gold nanoparticles and 
fluorescence quenching as the sensing mechanism resulted in a somewhat higher IC50 value 
(12.9 ng mL–1), the approach but could benefit from a more straightforward and faster assay 
protocol.37 
Considering the tendency of improving the assay sensitivity significantly bu using 
magnetic beads, also the heterogeneous A2-YFP assay was transferred to the MB format  
(Figure 40C). By using protein G–coupled beads to capture the antibody, the competition step 
between the mimotope and the mycotoxin for the antibody binding sites was performed in 
solution subsequently capturing the immunocomplex with protein G–beads. As anticipated, the 
MB-assay provided improved sensitivity with an LOD of 0.31 ng mL–1 and an IC50 value of 
1.72 ng mL–1 (Figure 41), which could be the result of not only the large surface area of magnetic 
beads but also the pre-incubation step in solution and the use of protein G for oriented antibody 
immobilization. Nevertheless, partly due to lower absolute signals in comparison with the plate-
based assay, the measurement of the fluorescence of the YFP on the MB surface was not as 
reproducible as the measurements from the bottom of the well plate, which resulted in higher 
within assay relative standard deviation (RSD) values from the MB-assay (9.4%) than from the 
plate assay (6.4%). However, by automating the magnetic bead handling or by exploring 
alternative measurement schemes for the beads instead of the microplate reader, we believe 
that the detection and reproducibility of the bead-based assay could be improved in the future. 
Analysis of binding kinetics 
In order to examine the mimotope binding to the target antibody more accurately, and above all, 
independently of the other assay components, SPR analyses were performed with a BIAcore 
instrument. Since the response in SPR is roughly proportional to the size of the analyte and due 
to the vast differences in the sizes of the different mimotopes (~14 MDa A2-phage; 29 kDa  
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A2-YFP; 2035 Da A2-bio), it was not feasible to measure all the interactions using in the same 
assay format. 
Despite the wide use of phage display for mimotope discovery, there are only a few studies 
reporting the binding kinetics of phage-displayed mimotopes.40 More often such analyses 
involve the expression of the displayed protein or peptide as a fusion in the absence of the 
phage itself. As in this case we were particularly interested in the kinetics of the mimotope 
binding in the context of the phage, the A2-phage was immobilized on the sensor surface with a 
covalently coupled anti-phage capture antibody. The anti-FB1 antibody was passed through the 
chip surface as the analyte. However, no binding was seen at the antibody concentrations tested 
(1000 nM) under the ligand capture conditions achieved, which suggests a poor accessibility of 
phage-displayed the mimotope for the selective binding sites. Successful immobilization of the 
phage was anyhow observed as the anti-phage-HRP was shown to bind specifically to the sample 
channel after the A2-phage immobilization (Figure 42A). 
 
Figure 42. Kinetic analyses by surface plasmon resonance (SPR). (A) Analysis with the A2-phage 
did not show a measurable signal with the anti-FB1 (red) although successful immobilization of the 
phage could be confirmed with the anti-phage antibody (green). (B) Binding of the anti-FB1 antibody 
(0–500 nM) to the immobilized synthetic mimotope A2-bio, and (C) the recombinant A2-YFP  
(0–500 nM) to the immobilized anti-FB1. Sensorgrams obtained for seven different concentrations 
(red) are shown in for each mimotope together with the data fitted (black) to a 1:1 binding model. 
Owing to the small size of the synthetic A2-bio, the peptide was bound to the sample channel 
via its biotin-linker using a sensor chip with a covalently coupled anti-biotin capture antibody. 
Different concentrations of the anti-FB1 antibody (0–500 nM) were then passed through the 
sensor surface as the analyte (Figure 42B). The binding association (kon) and dissociation (koff) 
rates could be measured leading to a KD of 170nM. Interestingly, the analysis of A2-YFP with the 
immobilized anti-FB1 antibody provided the best affinity values (KD 38 nM), as the measured kon 
was faster and the koff slower than than for the synthetic peptide (Figure 42C). A comparison of 
the binding parameters determined by SPR analyses is shown in Table 11. 
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Table 11. Calculated binding parameters from the SPR analyses (Figure 42) 
including the association (kon), dissociation (koff) and equilibrium dissociation 
(KD) constants. 
Mimotope KD kon (M–1 s–1) koff (s–1) 
A2-phage n.d. n.d. n.d. 
A2-bio 170 nM 2.27 × 104 3.85 × 10–3 
A2-YFP 38 nM 3.49 × 104 1.33 × 10–3 
Comparison of the FB1 immunoassay formats 
New technologies have spurred the development of novel methods for mycotoxin detection, and 
notably, the use of mimotopes has become an exciting alternative for mycotoxin immunoassays. 
Several research groups have reported various immunoassays using mimotopes, most 
commonly with the phage-borne peptide but more recently also with the synthetic counterpart 
of this peptide, or a recombinant fusion protein. We have previously selected a mimotope for 
mycotoxin FB1, and in this work, the mimotope was applied to various immunoassays using 
either the phage-borne, synthetic, or recombinant fusion mimotope. The assay with the synthetic 
peptide in a magnetic bead–based ELISA (MB-ELISA) provided the best sensitivity which could 
be attributed to a pre-incubation step in solution prior to the magnetic bead capture, the high 
surface area provided by the magnetic beads and the signal amplification by the enzymatic 
reaction. The effect of the bead-based format on the assay sensitivity was also observed using 
the phage-borne peptide and the recombinant YFP-tagged mimotope. Although the use of the 
YFP-tagged mimotope did not improve the the sensitivity of the assay in comparison with the 
synthetic peptide assay, its application can be regarded as a highly attractive alternative as no 
secondary antibodies or separate labeling reactions are required. 
A systematic comparison of the analytical characteristics of the immunoassays optimized 
using the different mimotopes and assay formats is presented in Table 12. Whilst the 
microarray-based method could be an advantageous tool for multiplexed mycotoxin analysis, in 
comparison with the other methods, it shows the highest detection limit for FB1, although the 
value is well belowe the EU regulatory levels.20 Moreover, microarray development requires the 
most complex instrumentation since a microarray printer and fluorescent scanner are needed. 
Nonetheless, the same assay format as in the microarray using the synthetic peptide shows 
great promise in the MB-ELISA. In particular, the wide dynamic range and low detection limit 
obtained with this approach demonstrate the advantages of using magnetic beads for the 
analysis. The major improvement in the sensitivity compared to the microarray is most likely due 
to, not only the use of magnetic beads, but also the enzymatic detection. As the MB-ELISA is 
based on the use of a secondary antibody labeled with an enzyme, instead of the AF647-label 
as in the microarray, signal amplification evidently leads to an increment of the analytical signal. 
Similarly, the use of the HRP-labelled secondary antibody in combination with the phage-based 
assays could be seen as a signal amplification method and possibly has great effect on the 
assay sensitivity. Moreover, since the HRP-labelled anti-phage antibody targets the phage major 
coat protein pVIII which is present in usually more than 2000 times in one phage, significant 
signal amplification can be achieved. Finally, perhaps a bit surprisingly, the YFP-tagged 
mimotope assays were able to compete with the enzyme-based methods in terms of sensitivity. 
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As discussed previously, the immunoassay sensitivity, which is inherently highly 
dependent on the affinity of the target-specific antibody,1 can be affected by the choice of the 
label and the immobilization support, among other factors. Moreover, the performance of a 
competitive immunoassay depends not only on the affinity of the target analyte but also on the 
affinity of the competitor. Often a slightly lower affinity of the competitor can be advantageous 
since a smaller amount of the analyte is needed for the competition, leading to higher 
sensitivities.27,41,42 With many factors changing among the immunoassays tested, the 
abovementioned assays with the phage-displayed, synthetic, or recombinant mimotopes do not 
actually provide sufficient information to draw conclusions about the affinity of the mimotopes. 
Therefore, we decided to perform kinetic analysis of the different mimotope formats by SPR in 
order to conclude if the differences in the sensitivities of the various immunoassays tested could 
arise from the variation of the binding affinities. Although the peptide sequence was the same 
in all cases, it is noteworthy that the presence of the fluorescent protein or the phage can affect 
the binding kinetics. The results of the SPR were not conclusive in all the aspects as the 
experiments with the phage-displayed peptide could not provide any numerical values of the 
affinity. Nevertheless, it could be concluded that the phage binds poorly to the antibody, perhaps 
due to the large size of the phage which might lead to the slow association. The phage-displayed 
peptide is expressed outside the phage virion as a fusion with the minor coat protein pIII which 
is present in the phage in five copies clustered at one end of the mature phage leading to 
pentavalent display of the peptides.43 Thus, in the immunoassay, the avidity also might have a 
significant effect in comparison to the synthetic peptide or fluorescently-tagged mimotope. As 
mentioned earlier, the substantial signal amplification of the HRP-labelled antibody in the phage-
based immunoassays could explain why the A2-phage with a seemingly poor binding is still 
performing mediocrely in the assay. 
In the case of the synthetic A2-bio and recombinant A2-YFP, the measured KD values were 
in the nanomolar range. Significant differences could be seen in both the association and 
dissociation phases; the synthetic peptide showed a slower association rate and a faster 
dissociation rate than A2-YFP leading also to a higher KD. These differences observed in the 
kinetic analyses suggest a more appropriate folding of the antibody epitope in the context of the 
recombinant fusion protein mimotope than for the synthetic peptide. When comparing the MB-
based immunoassays, both of these peptides showed a very similar sensitivity in terms of the 
IC50 value. However, the synthetic peptide provides a much wider dynamic range and lower 
detection limits, which we have previously attributed to the use of a pre-incubation step prior to 
the capture with the magnetic beads. Based on the kinetic analysis, we can also conclude that 
the lower affinity of the synthetic peptide to the antibody might also be an important feature for 
the improved sensitivity as a smaller amount of the toxin is required to compete with the 
mimotope. 
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Table 12. Comparison of the immunoassays using the FB1 mimotope A2 as phage-displayed (A2-phage), 
synthetic with a biotin linker (A2-bio) or recombinant format (A2-YFP). 
Mimotope Immobilization support IC50 (ng/mL) 
LOD* 
(ng/mL) 
Dynamic range** 
(ng/mL) 
Average 
RSD Ref. 
A2-phage 96-well plate 38.7 7.47 13.7–109 4.7 % [20] 
A2-phage MB 2.70 0.87 1.32–5.51 12.6 % This work 
A2-bio Microarray 37.1 11.1 17.3–79.6 9.2 % [20] 
A2-bio MB 1.85 0.029 0.13–25.6 9.5% This work 
A2-YFP 96-well plate 6.83 2.01 3.16–14.8 6.4% [37] 
A2-YFP – homogeneous 12.9 5.29 7.34–22.6 4.6% [37] 
A2-YFP MB 1.72 0.31 0.59–5.04 9.4% This work 
Abbreviations: MB, magnetic beads; RSD, relative standard deviation; YFP, yellow fluorescent protein. 
* LOD defined as the concentration in which the antibody binding to the mimotope was inhibited by 10% 
**Dynamic range defined between 20 and 80% inhibition, i.e., IC20–IC80 
 Conclusions 
In this work, we have developed immunoassays for FB1 detection based on mimotopes originally 
selected by phage display. A systematic comparison of various immunoassays based on the FB1-
mimotope, named A2, was conducted using the phage-displayed mimotope as well as a 
fluorescent recombinant fusion protein and a synthetic peptide with a biotin-linker. Furthermore, 
in order to improve the assay sensitivity and working range, immunoassays based on magnetic 
beads and enzymatic detection were established. Comparison of the assay performance showed 
the best sensitivity using the synthetic mimotope together with enzymatic detection and 
magnetic beads as the immobilization support which could be traced back to the large surface 
of the beads area available for the immobilization as well as the signal amplification by the 
enzyme and a solution-based competitive binding between the antibody its target. Moreover, 
analysis of the binding kinetics by SPR further reinforced the suitability of the synthetic peptide 
for the competitive immunoassay as this mimotope showed a slightly lower affinity for the target 
antibody in comparison with the recombinant fusion protein. Together these comparative results 
of the immunoassays and SPR can provide important insights for the development of novel 
mimotope-based immunoassays for various low molecular weight targets in the future. 
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Abstract 
Mimotopes, or epitope mimicking peptides, have been introduced as an interesting alternative 
to the analyte-conjugates for competitive immunoassays for the detection of low molecular 
weight molecules, such as mycotoxins. In this work, we report the development of recombinant 
fusion proteins based on bioluminescent Gaussia luciferase (GLuc), the smallest known 
luciferase, and mimotopes for mycotoxins zearalenone (ZEA) and fumonisin B1 (FB1). The newly 
identified mimotope for ZEA and a previously reported mimotope for FB1 were cloned as a fusion 
protein with GLuc that could be then used directly as the tracer for the toxin detection without 
the need of labeling or a secondary antibody. The bioluminescent immunoassays based on an 
immobilized antibody and the mimotope-GLuc fusions showed IC50 values of 0.35 and  
1.3 ng mL–1, detection limits of 0.091 and 0.21 ng mL–1, for ZEA and FB1, respectively. Both 
assays demonstrated superior sensitivity that is significantly better than, for example, a 
previously reported assay using the fumonisins mimotope cloned as a fusion protein with a 
yellow fluorescent protein. 
 Introduction 
Mycotoxins are low molecular weight natural contaminants produced as secondary metabolites 
by filamentous fungi.1 The genus Fusarium, mainly F. proliferatum, F. verticillioides, 
F: graminearum, and F. oxysporum, is a renowned mycotoxin producer and one of the most 
abundant fungal species commonly found in agricultural products, especially in maize.2,3 As a 
results of global warming, the geographic distribution of mycotoxigenic fungi can change as hot 
and dry conditions often favors the fungal infection and this can contribute to give rise to 
increased levels of mycotoxins in agricultural products.4,5 Among the wide variety of mycotoxins 
produced by Fusarium, fumonisins, trichothecenes, and zearalenone account for the most 
important ones.6 Fumonisins are common contaminants in maize but can also occur for example 
in wheat, sorghum, barley, soybean, and black tea. Among at least 15 different fumonisins 
identified,7 fumonisin B1 (FB1) is the most prevalent and toxic. Based on animal studies and 
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cases of human esophageal cancer, the International Agency for Research on Cancer (IARC) has 
categorized FB1 as possibly carcinogenic to humans (group 2B).8 FB1 bears a similar structure 
as cellular sphingolipids, and the toxicity of fumonisins appears to be a result of interference in 
the metabolism of sphingolipids by inhibiting the enzyme ceramide synthase.7,9 Zearalenone 
(ZEA) is produced mainly in temperate regions where Fusarium contamination is frequent, most 
commonly at the field before harvesting, but might also occur during or post-harvest if the crops 
are not handled or dried properly.9 ZEA is biologically potent and as its structure resembles 
sufficiently 17β-estradiol it is known for its estrogenic properties.1 
Owing to the toxic effects, as well as the significant economic consequences of mycotoxin 
contamination, several international authorities, such as the European Commission10,11 and the 
United States Food and Drug Administration,12 have set regulatory limits for the major 
mycotoxins in food and feed. Currently, many analytical methods for mycotoxin analysis combine 
liquid or gas chromatographic separation (LC or GC) with a diode array (DAD), fluorescence (FLD) 
or mass spectrometric (MS) detection. Though these methods can provide excellent accuracy 
and reproducibility, they are usually expensive and require highly skilled personnel and tedious 
sample cleanup. In contrast, biosensors and bioanalytical assays are considered convenient for 
the rapid determination of these toxins, as they are usually low cost while maintaining the 
required sensitivity and specificity.13,14 
Development of bioaffinity assays for small molecules, such as mycotoxins, poses some 
particular challenges mainly because they consist of only one epitope and thus usually must be 
detected in the competitive assay format.15,16 A major limitation of this format is the requirement 
to conjugate the target molecule to a carrier protein or a label which allows the immobilization 
or detection of this competitor.17 In some cases, synthesis or chemical conjugation of these 
competitors can be challenging and time-consuming or result in a heterogeneous mixture of 
randomly cross-linked or unstable molecules which in the worst case are not recognized by the 
antibody any longer. The exceptional ability of epitope-mimicking peptides, or mimotopes, to 
imitate the epitope of the analyte and thus bind to same antibody paratope, has been presented 
as an intriguing option to overcome these limitations in the competitive immunoassays.15 
Several mimotopes have been selected from phage-displayed peptide libraries for the 
detection of low molecular weight targets such as pesticides,18 neurotoxins,19 cancer drugs,20 
and mycotoxins.21–23 Phage display provides an elegant method to identify mimotopes from 
phage-displayed peptide libraries even without prior knowledge about the paratope of the 
antibody.24 Phage-borne mimotopes have shown great potential for mycotoxin detection, but 
considering the large size and the biologically active nature of phages, these methods are not 
always ideal for immunoassay development.25,26 Alternatively, the synthetic counterparts of the 
phage-borne mimotopes27–29 or recombinant peptide–protein fusions30–34 have been suggested 
as phage-free options. In particular, recombinant fusions either with fluorescent30,33 or 
bioluminescent34 proteins have shown great potential as the fusion can be used directly as the 
tracer without the need for secondary antibodies or further labeling. 
In previous work, we have reported the development of a microarray-based immunoassay 
for the detection of FB1 using a synthetic mimotope,27 and a homogeneous quenching assay 
using a recombinant mimotope tagged with a yellow fluorescent protein (YFP).30 The YFP-tagged 
mimotope provided improved sensitivity and a faster and simpler protocol compared to the 
assays based on the phage-displayed or synthetic mimotopes. With this in mind, we aimed to 
develop alternative recombinant fusions which could be used for mycotoxin detection in 
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mimotope-based immunoassays but with improved sensitivity as a result of the luciferase-
catalized light-emitting reaction. In this work, we describe the selection of ZEA mimotopes from 
a random dodecapeptide library and the use of the selected epitope mimics in a competitive 
phage-based ELISA. In continuation, the ZEA-mimotope and the previously identified FB1-
mimotope are used to construct recombinant fusion proteins with the bioluminescent Gaussia 
luciferase (GLuc). GLuc, isolated originally from copepod, Gaussia princeps, exhibits high 
luminescent emission and has emerged as a prominent reporter protein for bioluminescent 
detection applications.35,36 
 Experimental section 
Materials 
Ph.D.-12 Phage Display Peptide Library Kit, pMAL-c5X vector, NEB Express Competent E. coli, 
amylose resin, and Factor Xa were purchased from New England Biolabs (Ipswich, MA, USA). The 
monoclonal anti-zearalenone antibody was from Soft Flow Hungary Ltd (Pécs, Hungary) and the 
anti-fumonisin antibody from BioTez (Berlin, Germany). Clear and black MaxiSorp 96-well plates 
together with Pierce Centrifuge Columns and 1-Step Ultra TMB-ELISA Substrate Solution were 
purchased from Thermo Fisher Scientific (Waltham, MA, USA). Fumonisin B1 (FB1) and 
zearalenone (ZEA) were obtained from SantaCruz Biotechnology (Dallas, TX, USA), and the HRP-
conjugated anti-M13 antibody was obtained from GE Healthcare Inc. (Chicago, IL, USA). KOD 
Xtreme Hot Start Master Mix was from Millipore (Billerica, MA, USA) and Ni-NTA agarose from 
Qiagen (Valencia, CA, USA). ProBlock Gold Bacterial Protease Inhibitor Cocktail was purchased 
from Gold Biotechnology Inc. (St. Louis, MO, USA) and native coelenterazine was from NanoLight 
Technology (Pinetop, AZ, USA). 
Identification of mimotopes by phage display 
FB1 and ZEA mimotopes were selected from the commercial dodecapeptide library (Ph.D.-12) 
by three consecutive rounds of selections according to manufacturer’s instructions with minor 
modifications. Similarly to the previously described FB1 mimotope (named A2),27 ZEA mimics 
were identified from the phage-displayed library by consecutive selection rounds using the anti-
toxin antibody as the target. For each selection round, wells of a 96-well microtiter plate were 
coated with the target monoclonal antibody by an overnight incubation at +4 °C. For the first 
round, three wells were coated with 1 μg of antibody in 100 μL of 0.1 M sodium bicarbonate per 
well, whereas for the subsequent rounds the amount of antibody was reduced to 0.5 μg and 
0.25 μg per well, and the number of wells to two and one in the second and third rounds, 
respectively. Similarly, pre-selection wells were coated with 5 mg mL–1 bovine serum albumin 
(BSA). The following day, the remaining protein-binding sites in the coated wells were blocked 
with 3% (w/v) BSA in PBS (pH 7.2) for 2 h at room temperature in slow shaking and washed 
three times with PBS-T [PBS (pH 7.2); 0.1% (v/v) Tween-20]. For the first round, 100-fold 
representation of the library (2 × 1011 pfu) diluted in PBS with 0.05% Tween-20 and 0.1% BSA 
was added to the pre-selection wells and incubated with slow shaking for 1.5 h at room 
temperature. The solution was then transferred to the wells coated with the target antibody, and 
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the incubation was continued for another 1.5 h. The wells were then washed six times with  
PBS-T, and finally, the bound phages were eluted with 100 μL of 0.2 M glycine-HCl (pH 2.2) with 
0.01% BSA for 10 min, after which, the supernatant was collected and neutralized immediately 
with 40 μL of 1 M Tris-HCl (pH 9.1). The eluate was amplified by infecting E. coli ER2738, and 
the amplified phage was used for the subsequent panning rounds. After each panning round, 
the number of eluted and amplified phages was determined by titering, and the number of input 
phages (2 × 1011 pfu) was kept constant in all rounds. The incubation time in the pre-selection 
and target wells was reduced to 1 h in the second and third rounds while the number of washes 
was increased to ten and the concentration of Tween-20 in the washing buffer was increased 
from 0.1% to 0.5% (v/v) for more stringent washes. Moreover, in order to favor the elution of 
good ZEA mimics, a competitive elution step was used instead of glycine. After the washes,  
100 ng mL–1 of ZEA in the second round and 10 ng mL–1 of ZEA in the third round, was added 
to each well and incubated for 1 h after which the solution was collected and used to the infect 
the bacteria. After the three selection rounds, individual plaques were picked from the 
LB/IPTG/X-gal plates and tested in the phage-based ELISA to select the positive clones binding 
to the target antibody. Finally, to identify the peptide sequences, the selected clones were 
sequenced using the primer -96 gIII (5’–CCC TCA TAG TTA GCG TAA CG–3’). 
Phage-based ELISA 
The success of the pannings was evaluated in a phage-based ELISA using the immobilized anti-
ZEA antibody and HRP-labeled anti-HRP secondary antibody (Figure 44C). For the ELISA, 
microtiter well plates were coated with the anti-ZEA capture antibody (200 ng in 60 μL of 0.2 M 
sodium carbonate/bicarbonate, pH 9.4) by overnight incubation at +4 °C. The wells were then 
blocked with blocking buffer (PBS, pH 7.2; 3% (w/v) BSA) for 2 h at +4 °C and washed two times 
with PBS-T (PBS, pH 7.2; 0.1% (v/v) Tween-20). Next, the amplified phage stock was added to 
the coated wells in 1:30- or 1:100-dilution and incubated for 1 h. For the competitive assay, 
additionally different concentrations of ZEA (0–1000 ng mL–1) were added to the wells. After 
washing the plate four times, anti-M13-HRP (1/5000-dilution in blocking buffer) was added and 
the incubation was continued for 1 h. All incubation steps were done in the total volume of 60 μL 
with slow shaking at room temperature. Finally, the plate was washed four times as described 
previously, and 60 μL of TMB substrate solution was added to each well. After 1–5 min 
incubation, the reaction was stopped by adding 60 µL of 2 M sulfuric acid to each well, and the 
absorbance (at 450 nm) was measured using a CLARIOstar microplate reader from BMG 
Labtech (Ortenberg, Germany). 
Construction of bioluminescent fusion proteins 
For the expression of GLuc-tagged mimotopes, plasmids pRP006 and pRP010 were 
constructed. The GLuc gene was PCR-amplified from vector pColdI-GLuc using KOD Xtreme Hot 
Start Master Mix. The DNA sequence encoding for the mimotope (A2, VTPNDDTFDPFR; or SF, 
SFDYFLWDSTET) together with the GS-linker were added to the 5’-end and a polyhistidine tag to 
the 3’-end of GLuc in three sequential PCR-reactions using the primers listed in Table 13 (PCR I: 
Forward Primer 1 and Reverse Primer 1; PCR II: Forward Primer 2 and Reverse Primer 2; PCR III: 
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Forward Primer 3 and Reverse Primer 2). The PCR product from the third PCR-reaction was then 
subcloned at the NdeI and BamHI sites to pMAL-c5X expression vector (Figure 43A). 
Table 13. PCR primers used to create the mimotope-GLuc fusions. Forward primers 1–3 (A2/ZF2) were 
used to add the DNA sequence encoding for the mimotope (in bold) to the 5’ of the GLuc (underlined) by 
three sequential PCR reactions. Two universal reverse primers were used for both fusions to introduce a 
polyhistidine tag to the 3’ of GLuc. Restriction enzyme NdeI and BamHI (in cursive) were used to subclone 
the translational fusion to the pMAL-c5X expression vector. 
Primer name DNA sequence (5’→3’) 
Forward Primer A2-1 GAT CCT TTT CGG GGT GGA GGT TCG ATG AAA CCG ACC 
Forward Primer A2-2 GTT ACT CCG AAT GAT GAT ACG TTT GAT CCT TTT CGG 
Forward Primer A2-3  GGT GGA GGT TCG CAT ATG GTT ACT CCG AAT 
Forward Primer ZF2-1 TCT ACT GAG ACG GGT GGA GGT TCG ATG AAA CCG ACC 
Forward Primer ZF2-2 AGT TTT GAT TAT TTT CTT TGG GAT TCT ACT GAG ACG 
Forward Primer ZF2-3 GGT GGA GGT TCG CAT ATG AGT TTT GAT TAT 
Universal Reverse Primer-1 CTA ATG ATG ATG ATG ATG ATG ATC ACC ACC TGC 
Universal Reverse Primer-2 CGA ACC TCC ACC GGA TCC CTA ATG ATG ATG 
 
Fusion protein expression and purification 
For the overexpression of the mimotope-GLuc fusion proteins, plasmids pRP006 and pRP010 
were transformed into E. coli NEB Express cells and selected on LB agar plates with  
100 µg mL–1 ampicillin. A single colony harboring the plasmid was used to inoculate 5-mL 
preculture (LB medium supplemented with 100 µg mL–1 ampicillin), which was grown overnight 
at +37 °C, 250 rpm. The following day, overnight preculture was expanded into a main culture 
of 300 mL (LB medium supplemented with 100 µg mL–1 ampicillin) and the growth was 
continued at +37°C until the optical density at 600 nm (OD600) of 0.6 was reached. The protein 
expression was then induced by IPTG (isopropyl β-D-1-thiogalactopyranoside) at a final 
concentration of 1 mM followed by growth for 4 h at +16 °C. The cells were collected by 
centrifugation (10 min at 5000g at +4 °C) and resuspended in 10 mL of lysis buffer (50 mM 
Tris-HCl, pH 8.7; 150 mM NaCl) supplemented with protease inhibitor cocktail. Then, the cells 
were lysed by sonication on ice for 10 min, after which the resultant cell debris was removed by 
centrifugation for 20 min at 12,000g at +4 °C, and the supernatant was filtered by a syringe 
through a 0.45 μm filter. 
The clarified lysate was then incubated with amylose resin for 30 minutes, collected on a 
Pierce Centrifuge Column by gravity flow and washed with 10 column volumes of the lysis buffer. 
The protein was then eluted in 1 mL fractions with the lysis buffer supplemented with 10 mM 
maltose. The MBP-tag was cleaved by Factor Xa (2.5% (w/w)) during 6 h at room temperature. 
The cleaved product was then purified using Ni-NTA resin. After capturing the cleaved mimotope-
GLuc with C-terminal polyhistidine tag, the resin was washed with 10 column volumnes of the 
lysis buffer supplemented with 20 mM imidazole, and finally, the product was eluted with the 
lysis buffer supplemented with 250 mM imidazole in 1 mL fractions. The purifications were 
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followed by by SDS-PAGE analysis (Figure 43B), and the concentration of the purified protein 
stock was determined by BCA kit. 
 
Figure 43. (A) Main features of the expression vectors (pRP006 and pRP010) used for mimotope-
GLuc fusion protein production in E. coli. (B) SDS-PAGE analysis of A2-GLuc purification: lane 1, cell 
lysate before purification; 2–3, flow-through and wash fractions of the amylose purification; 4–12, 
eluted MPB-mimotope-GLuc fusion (64 kDa); 13, actor Xa cleavage reaction with MBP (43 kDa) 
and mimotope-GLuc (21 kDa; red arrow) which was further purified by Ni-NTA; M, molecular marker 
(Precision Plus Protein Dual Color Standard). 
Bioluminescent immunoassays 
The immunoassays with bioluminescent mimotope-GLuc fusions were performed in black  
96-well plates by coating the wells with capture antibody (50 ng in 60 µL of 0.2 M sodium 
carbonate/bicarbonate, pH 9.4) by overnight incubation at +4 °C. The wells were then blocked 
with blocking buffer (PBS pH 7.2; 3% (w/v) BSA) for 4 h at room temperature and washed twice 
with PBS-T (PBS pH 7.2; 0.1% (v/v) Tween-20). Toxin standards ranging from 0 to 250 ng mL–1 
(in three replicates) were added to the coated wells together with 1 µg mL–1 A2-GLuc (for FB1), 
or 40 ng mL–1 SF-GLuc (for ZEA) in assay buffer (PBS, pH 7.2; 0.05% (v/v) Tween-20; 0.1% (w/v) 
BSA) in a total reaction volume of 60 µL. After incubation of 1.5 h at slow shaking, the wells were 
washed four times with PBS-T. Finally, the bioluminescence intensity of each well was measured 
in the CLARIOstar by injecting 60 µL of native coelenterazine at a final concentration of 
2.0 μg mL–1 (in PBS). 
Data analysis 
The immunoassay data with different toxin concentrations were normalized to the minimum and 
maximum signals, and the normalized signals were analyzed with Origin Pro 9.0 software 
(OriginLab Corp., Northampton, MA, USA) using a four-parameter logistic regression (4-PL) model 
(equation 1): 
y =Amin+ 
(Amax-Amin)
1+ � xIC50
�
 b                   (1) 
where Amax is the asymptotic maximum (the signal in the absence of the analyte), Amin is the 
asymptotic minimum, and b and IC50 are the slope of the curve and the analyte concentration 
at the inflection point, respectively. The limit of detection (LOD) was determined as the toxin 
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concentration where the antibody binding to the peptide was inhibited by 10% and the dynamic 
range of the method as the toxin concentration from 20% to 80% inhibition. 
 Results and discussion 
Selection and characterization of phage-displayed zearalenone mimotopes 
Zearalenone (ZEA) mimotopes were selected from the linear 12-mer phage display peptide 
library (Ph.D.-12) in three successive rounds of panning. The first round was performed with high 
concentrations of the target antibody and gentle washes to maximize the capture of all 
interesting clones, whereas during the subsequent rounds the amount of the antibody was 
reduced, and the stringency of the washes was increased. Moreover, the elution step was 
performed by competition with the decreasing amounts of the free toxin instead of the 
nonspecific acid elution used in the first round. The use of these strategies for the mimotope 
selections allowed an efficient enrichment of antibody binding phages was observed after three 
rounds of panning. This observation was evidenced by the increased phage titers during the 
panning rounds and from the excellent signal-to-background ratios obtained in the ELISA using 
the entire phage pools after each panning round (Figure 44A). A total of 15 individual phage 
clones were randomly selected from the third panning round, amplified, and tested similarly in 
the phage-based ELISA. Altogether, 14 out of 15 clones showed good signal-to-background 
ratios in the assay indicating specific binding to the anti-ZEA antibody. Moreover, competition 
with the free ZEA (1000 ng mL–1) was seen with all the clones demonstrating successful 
selection of ZEA mimicking peptides (Figure 44B). 
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Figure 44. Selection of zearalenone mimotopes and tests with phage-based ELISAs. (A) Polyclonal 
phage-based ELISA after each selection rounds showed specific binding to the target antibody (red) 
and low non-specific binding to background wells coated with BSA (blue). Likewise, enrichment of 
the phages was seen in the phage titers after each selection round (blue diamonds; right y-axis). 
(B) Monoclonal phage-based ELISA with 15 individual clones. High specific binding to the target 
antibody (red) was seen with all except one clone, and low signals were measured in the 
background wells (blue) and in the presence of free zearalenone (green). (C) Schematic of the 
competitive phage-based ELISA using the phage (M13) -displayed mimotopes and anti-M13 
conjugated to HRP. (D) Comparison of the competitive binding curves of the phage-displayed 
mimotopes GW (gray) and SF (red). The results are shown as normalized means ± the standard 
error of the mean (n = 3). A four-parameter logistic fit (OriginPro 9.0) was used to calculate the IC50 
values. 
The DNA sequencing results showed two conserved peptide sequences, GWWGPYGEIELL and 
SFDYFLWDSTET (named GW and SF, respectively), which were further tested in the competitive 
ELISA with different toxin concentrations (Figure 44C). The ELISA with the representative phage 
clones GW and SF showed good sensitivities with IC50 values of 2.8 ± 0.2 ng mL–1 and 
3.5 ± 0.2 ng mL–1 for GW and SF, respectively (Figure 44D). Clone SF gave a better response in 
terms of reproducibility and was selected for further applications. 
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Bioluminescent immunoassay based on GLuc fusion protein 
Recombinant mimotope-fusions were constructed based on bioluminescent GLuc in fusion with 
the newly identified ZEA-mimotope SF and a previously studied FB1-mimotope A2.27 The epitope-
mimicking nature of the recombinant fusion proteins and their functionality as the tracer was 
confirmed in a competitive immunoassay, where the capture antibody was immobilized in 
microtiter wells, and competition between target toxin, FB1 or ZEA, and the mimotope-GLuc was 
shown as low luminescence readings in the presence of high toxin concentrations. On the basis 
of the typical sigmoidal standard curve for a competitive heterogeneous assay,3 (Figure 45) the 
half maximal inhibitory concentrations (IC50) were 0.35 ± 0.06 ng mL−1 and 1.3 ± 0.1 ng mL−1 
for ZEA and FB1, respectively. Comparison of the analytical characteristics of the bioluminescent 
immunoassay with other methods developed using the same mimotopes is presented in  
Table 14. 
 
Figure 45. GLuc-based immunoassays. (A) Schematic of the competitive bioluminescent 
immunoassay using the GLuc-tagged mimotopes. (B) ZEA calibration with SF-GLuc and (C) FB1 
calibration with A2-GLuc. The results are shown as normalized means ± the standard error of the 
mean (n = 3). A four-parameter logistic fit (OriginPro 9.0) was used to calculate the IC50 values. 
 Conclusions 
In this work, we reported the selection of a zearalenone mimotope from a commercial peptide 
library using phage display technology, and furthermore, the development of bioluminescent 
immunoassays using recombinant GLuc-fusion proteins based on zearalenone and fumonisins 
B1 mimotopes. The bioluminescent immunoassays offered simpler methodology compared to 
the phage-based assay as the GLuc-tagged mimotope could be directly used as the tracer, and 
no further labeling or secondary antibodies were required. Compared to the previously reported 
methods for fumonisin detection using the same mimotope and the phage-based zearalenone 
assay, the bioluminescent based assay offered higher or comparable sensitivity. 
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Table 14. Comparison of the immunoassays using the ZEA- and FB1 mimotopes as phage-displayed or 
recombinant fusion proteins. 
Mimotope Target IC50 (ng/mL) 
LOD* 
(ng/mL) 
Dynamic range** 
(ng/mL) 
Average 
RSD Ref. 
A2-phage FB1 38.7 7.5 13.7–109 4.7 % [27] 
A2-YFP FB1 6.8 2.0 3.2–14.8 6.4% [30] 
A2-GLuc FB1 1.3 0.21 0.41–4.1 6.1% This work 
SF-phage ZEA 3.5 2.3 2.7–4.6 12.0% This work 
SF-GLuc ZEA 0.35 0.09 0.15–0.80 9.0% This work 
Abbreviations: GLuc, Gaussia luciferase; FB1, fumonisin B1; RSD, relative standard deviation; YFP, yellow fluorescent 
protein; ZEA, zearalenone. 
*LOD defined as the concentration in which the antibody binding to the peptide is inhibited by 10% 
**Dynamic range defined between 20 and 80% inhibition, i.e., IC20–IC80 
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4 Results and 
discussion  
4.1 Fungal genosensors 
 
Fungal contamination is a common and widely spread problem which can lead to global health 
issues, environmental challenges, and important economic losses. Certain fungi species are 
renowned pathogens while others are harmful solely for their capacity to produce toxic 
secondary metabolites, mycotoxins. Among mycotoxigenic fungi, genus Fusarium is one of most 
the prevalent producers of common mycotoxins in the northern temperate regions, and species 
of this family are commonly found in cereal crops in America, Europe, and Asia making them a 
major agricultural problem.21 Some Fusarium species, such as F. verticillioides, have a very 
narrow host range, infecting predominantly certain cereals, whereas other species, such as 
F. proliferatum, are rather ubiquitous in grains and other plants. In publication I, we have 
developed species-specific genosensors for the detection of these two Fusarium species. Their 
distinction using conventional methods is challenging due to their highly similar morphologies, 
but the development of molecular methods has enabled specific and sensitive detection of 
these fungi. The following section discusses further the background and some additional 
aspects of the work presented in publication I. 
4.1.1 SELECTION OF SPECIFIC DNA PROBES FOR FUSARIUM 
In essence, biosensors, which have become the fastest growing technology for pathogen 
detection in recent years,90 are dependent on specific recognition elements capable of 
recognizing the target analyte and distinguishing it from other similar molecules. Biosensors, 
based on oligonucleotide probes, DNA or RNA, also known as genosensors, rely on the 
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exceptional specificity of base pairing and the immense sequence variety of nucleic acids. By 
designing specific probes, complementary to the chosen target nucleic acid, genosensors can 
be applied to the analysis of virtually any target ranging from infectious diseases to foodborne 
pathogens. The specificity of the interaction relies on selecting unique target sequences which 
differ sufficiently from other potential cross-reactive sequences, making the probe selection one 
of the most critical steps in the development of these devices. Ideally, a candidate target 
sequence should be present in the cell at a relatively high copy number, while being adequately 
heterologous at the sequence level to allow the distinction of the target at both genus and 
species level.90 
For fungal detection, various DNA sequences have been used as targets for characterizing 
the genetic variability among fungi families, or for detecting and quantifying specific species. 
Commonly used target genes include both nuclear and mitochondrial DNA regions. Widely used 
genes comprise translation elongation factors (tef-1α), calmodulin, and β-tubulin.21 On the other 
hand, in the case of mycotoxigenic fungi, some prefer to use the genes involved in the 
biosynthesis of mycotoxins as they have been presumed to relate with the amount of the toxin 
present in the sample. For example, FUM6 and FUM8 genes within the fumonisins biosynthetic 
cluster have been widely used to identify fumonisin-producers. However, although correlation 
between mycotoxin concentration and their biosynthetic genes has been found,318 other studies 
with different Fusarium species and different mycotoxins have shown distinct results.21,319 
Moreover, biosynthetic gene targets are usually not capable of providing the required selectivity 
for identifying fungi at the species level. 
On the other hand, ribosomal DNA (rDNA) is one of the most used target sequences for 
Fusarium detection and identification. The eukaryotic ribosome is composed of small and large 
subunits which are encoded by the genes 5.8S, 18S, and 28S. These three genes are generally 
found together, separated by internal transcribed spacers (ITS1 and ITS2), in a repetitive 
manner and separated by the intergenic spacer (IGS) (Figure 46A).320 A high degree of sequence 
homogeneity is seen among rDNA within different species even though variation among rDNA 
copies within species and even within individuals has been observed. This is due to the fact that 
while the core regions of rDNA are usually highly conserved, the spacer sequences, especially 
the IGS, tend to show a high level of variation even among closely related species.320,321 
Moreover, owing to the repetitive nature of rDNA, it can provide higher sensitivity as a target in 
comparison with single-copy genes. 
Fusarium fungi are widespread worldwide, and this large family of fungi has been found 
in a variety of agricultural products. The Fusarium fujikuroi species complex (formerly known as 
the Gibberella fujikuroi species complex) includes several closely related species in the genus 
Fusarium, most important ones being F. proliferatum, F. verticillioides, F. fujikuroi, and 
F. sacchari. The species within this complex are highly similar in terms of both morphology and 
phylogenetics, which makes distinguishing the individual species difficult. Above all, 
conventional methods based on morphological and cross-fertility criteria undergo difficulties in 
identifying fungal isolates at the species level. In the past decades, development of PCR and 
molecular biology methods for Fusarium detection, among others, have spurred the 
identification and detection of fungal species with the advantage of being independent of the 
fungal morphology and cultivability.21 
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Figure 46. (A) Regions of fungi ribosomal DNA (rDNA) which consists of repeated sequences 
encoding for the ribosome subunits. The genes are flanked by the internal transcribed spacers 
(ITS1 and ITS2) and the intergenic spacer (IGS). Figure modified from Weider et al.320 (B) Sequence 
alignment of the IGS sequence of representative strains of Fusarium fujikuroi species complex. 
Partial 28S gene is shown in blue, the location of the species-specific detection and capture probes 
for F. proliferatum and F. verticillioides are shown in dark red. DNA sequences on the partial 28S 
rRNA gene and the IGS region were collected from GenBank and aligned and visualized using CLC 
Sequence Viewer (http://www.clcbio.com/). 
Having recognized the pre-requisites for designing the recognition elements for the identification 
of F. proliferatum and F. verticillioides at the species level, in publication I, species-specific 
probes for these species were designed on the IGS region. Sequence alignment of the IGS region 
of more than one hundred Fusarium strains showed that it bears enough variability between the 
species within the Fusarium fujikuroi species complex to allow their differentiation (Figure 46B). 
Since such variability was observed in the sequences of such highly similar species, we assumed 
that also other species would provide at least similar differences. Species-specific capture and 
detection probes (marked in dark red in Figure 46B) for each species, F. proliferatum and 
F. verticillioides, were designed on the IGS region on those sections which showed enough 
variability. 
On the other hand, although previous studies have reported the development of specific 
primers for each fungal species using the IGS regions,187,188 in this work, we decided to use a 
single primer pair which could amplify all Fusarium species, and the species-specific 
identification would happen subsequently using the species-specific capture and detection 
probes. 
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4.1.2 SIGNAL AMPLIFICATION STRATEGIES 
 Choice of the label and detection method 
A magnetic bead–based sandwich hybridization assay (Figure 7) for F. proliferatum and 
F. verticillioides was established using two species-specific probes which together could provide 
a high level of specificity. The capture probe was immobilized onto magnetic microbeads which 
functioned as the solid support, while the detection probe was functionalized with biotin. The 
biotin-linker allowed flexibility when choosing a label for the system, because practically anything 
labeled with streptavidin (SA) or other biotin-binding protein could be used to generate a 
measurable signal. After the initial experiments using streptavidin-coupled R-Phycoerythrin 
(SAPE), an intensely bright phycobiliprotein, as the label, other options were studied in order to 
increase the sensitivity of the assay. Experiments with SA-coupled quantum dots and SA-poly-
HRP showed increased sensitivity. In particular, it was noted that the enzymatic detection using 
SA-poly-HRP led to a 20-fold higher sensitivity compared to SAPE (Figure 9). 
The use of an enzymatic label enabled not only enhanced sensitivity but also provided 
further flexibility in the measurement scheme. The wide use of HRP has spurred the 
development of different substrates for the same enzyme. In their simplest format, 
measurements of HRP are based on chromogenic substrates which yield in a color change in 
the presence of enzyme. Often higher sensitivity can be achieved by using fluorescent or 
chemiluminescent substrates. The latter enables the use of simple luminometers or other 
readers capable of measuring total luminescence without the need for an excitation light source. 
Such approaches might be desired for low-resource settings or devices with a limited size. To 
compare the performance of the fluorescent substrate Amplex UltraRed used in publication I to 
a chemiluminescent substrate LumiPhos-HRP (PS-atto), we performed the calibration curve with 
F. proliferatum in similar manner but using as the substrate either Amplex UltraRed or LumiPhos-
HRP, together with fluorescent (excitation at 510 nm / detection at 590 nm) or 
chemiluminescent detection (detection at 405–465 nm), respectively. Chemiluminescent 
detection showed a slightly lower detection limit (1.3 pM of synthetic target DNA) than 
fluorescent detection (1.8 pM) (Figure 47). However, the latter showed better signal-to-
background ratios and thus could be considered to result in more reliable results. 
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Figure 47. Detection of F. proliferatum using SA-HRP as a label and fluorescent (black) or 
chemiluminescent (blue) substrates. Normalized signals are depicted as the average of the 
analysis of replicate samples ± the standard error of the mean (n = 3). Allometric fits 
(OriginPro 9.0) were used to calculate the lower detection limits (blank + 3 × SD of blank). 
 Second detection probe 
To further improve the sensitivity of the method we explored the possibility of introducing a 
second detection probe to the system. For example, a hybridization assay in the Simoa system 
has been reported to use up to three biotinylated detection probes, which resulted in dramatic 
improvements in the sensitivity.322 With a similar idea (Figure 48B), we designed a second 
biotinylated detection probe for F. proliferatum which could hybridize to the target DNA 
simultaneously with the original detection probe and the capture probe. As a result, one target 
DNA strand would be labeled with two biotins and, subsequently, two SA-HRPs instead of one. 
As expected, this approach led to further signal amplification, and higher signals were measured 
with two detection probes than with one (Figure 48A). However, no significant improvement in 
the sensitivity (in terms of lower detection limits) were observed, since the normalized signals 
with one or two detection probes resulted in similar responses (inset of Figure 48A). 
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Figure 48. Detection of F. proliferatum synthetic target using one (black) or two (orange) 
detection probes and SA-HRP with the fluorescent substrate for the detection. (A) More 
intense fluorescence signals were measured with two detection probes, but normalized 
signals (inset) did not show any improvement compared to a single detection probe. Signals 
are depicted as the average of the replicate samples ± the standard error of the mean  
(n = 3) and fitted with an allometric fit (OriginPro 9.0). (B) Scheme of the assay using two 
detection probes (green) instead of just one to bind to the target DNA (red) simultaneously 
with the capture probe (blue). 
 Fragmentation of genomic DNA 
Regardless of the sensitivity of the assay using the synthetic target DNA, analysis of the genomic 
DNA inevitably poses further challenges. First of all, in real samples, the amount of the target 
DNA is usually very small, and moreover, genomic DNA is a considerably large and highly 
structured molecule compared to the synthetic target, and therefore it is possible to obtain very 
different signals.323 Genomic double-stranded DNA, often folded in complex tertiary or 
quaternary structures resembling fairly a large polymer, might be difficult to open enough to 
allow binding of the detection probes. Moreover, steric hindrance can complicate the probe 
binding. Denaturation at high temperatures will unwind and separate the double-stranded DNA, 
but rehybridization might favor the reorganization of the double-stranded DNA rather than 
binding of the short oligonucleotide probes. 
A few attempts to apply the genosensors to analyze directly the genomic DNA extracted 
from contaminated maize samples showed that despite the excellent sensitivity achieved with 
the synthetic target DNA, poor responses were obtained with the crude genomic DNA. To 
alleviate the complexity of the genomic DNA a handful of strategies have been reported in the 
literature including, for example, specific enzymatic digestion of double-stranded DNA and RNA–
DNA heteroduplexes resulting in a sample with merely ssDNA and double-stranded RNA,324 as 
well as fragmentation of the DNA. Some have reported fragmentation of genomic DNA by 
sonication,325,326 but such harsh method will lead to physical shearing and non-specific 
fragmentation of the DNA and might be a problem if the target DNA is cut from the sequence 
between the locations where the capture and detection probes hybridize. More specific 
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fragmentation can be achieved by enzymatic digestion using specific restriction enzymes.322  
To explore this strategy (Figure 49A) we attempted to digest the crude extracted genomic DNA 
using the restriction enzyme EcoRI. Analysis of the fragmented DNA in comparison with the crude 
extract showed slightly better results; however, a high variation between replicate samples and 
inconsistent results between days were observed, which were a limitation for real sample 
analysis (Figure 49B–C). 
 
Figure 49. Analysis of fragmented genomic DNA. (A) Genomic DNA was extracted from a maize 
sample contaminated with Fusarium fungi after which the crude genomic DNA was analyzed with 
the genosensor, directly or after enzymatic digestion. (B–C) Genosensor response for different 
concentrations of the genomic DNA with (green diamonds) and without (black circles) 
fragmentation. Significant variations were observed between replicates and analyses done on 
different days (B–C). The fluorescence signals are shown as the average of the replicate analysis 
of the samples (n = 3) ± the standard error of the mean. 
 Amplification of the IGS region by PCR 
Finally, despite the previous attempts to detect the fungal genomic DNA directly without 
amplification, the final application of the genosensors for sample analysis was completed after 
DNA amplification. The complexity of the genomic DNA and the presence of fungi at low 
concentrations in clinical and natural environments could explain the challenges in direct 
detection of Fusarium, despite the aforementioned attempted amplification strategies. In fact, 
the poor sensitivity is a common failing in hybridization-based genosensors, and even the most 
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sensitive systems require target amounts in the order of 109–1010 molecules for detection.90 
Although the reported detection limits in publication I were lower than this range (1.81 × 108 
and 1.08 × 108 copies of F. proliferatum and F. verticillioides synthetic target DNA, respectively), 
after several fruitless attempts it became evident that DNA amplification was entailed before 
the analysis. 
Since the development of PCR more than 30 years ago, the application of DNA 
amplification methods has expanded enormously in the fields of clinical, veterinary, food, and 
environmental diagnostics. PCR continues to be the most widely applied amplification method, 
although years of research have introduced several exciting improvements to the technology, 
including optimized DNA polymerases and real-time PCR. Besides, isothermal amplification 
methods, such as loop-mediated isothermal amplification (LAMP) or helicase-dependent 
amplification, have gained remarkable attention as an exciting alternative for PCR because the 
amplification does not require thermal cycling but can be performed at a constant temperature. 
Several reports in the literature have shown the applicability of such methods for identifying 
foodborne bacteria and fungal pathogens.327 For the detection of some Fusarium species, LAMP 
primers have been designed, for example, based on tri5 and tri6 genes which are involved in 
the trichothecene biosynthesis,328 or using the 28S ribosomal DNA sequences as the target. 
Unfortunately, the high GC-content of the IGS regions makes this highly variable region a rather 
impossible target to develop such isothermal methods.329 
Nevertheless, standard thermal cyclers for PCR are these days rather common laboratory 
equipment, and the additional step of PCR in this work did not increase the analysis time 
extensively, as no further purification was required, and the PCR reaction could be directly used 
for the analysis. To avoid having a complex mixture of several PCR primers and having to handle 
with cross-reactivity issues in the amplification, or complicated PCR reaction optimization, we 
designed a common primer pair which could be used to amplify the IGS region of most of the 
Fusarium species within the F. fujikuroi species complex (Figure 50A). The complexity of the 
genomic DNA as a target was also noted in the PCR reaction which required optimization and a 
specific PCR polymerase optimized for the amplification of long or GC-rich DNA templates. 
Amplification with the KOD Xtreme Hot Start DNA Polymerase kit, using betaine as an enhancer, 
enabled amplification of the IGS region using contaminated maize as the sample matrix  
(Figure 50B). Analysis of samples contaminated with Fusarium or other fungal species 
demonstrated the applicability of the developed genosensors to real samples and proved that 
these devices could provide a simple and robust method for the detection of mycotoxigenic 
Fusarium species in food samples. 
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Figure 50. (A) Schematic of the IGS region with the common primer pair (orange arrows) used to 
amplify the genomic rDNA of most of the species in the Fusarium fujikuroi species complex. (B) 
Analytical gel electrophoresis was used to confirm successful PCR amplification using as a 
template a maize sample contaminated with F. proliferatum. PCR product (746 bp) was seen when 
using KOD Xtreme Hot Start DNA Polymerase (lane 1) although KAPA HiFi HotStart DNA Polymerase 
(lane 2) could not amplify the target from the same sample. Lane M shows the molecular marker, 
GeneRuler 1kb. 
4.1.3 INTEGRATION OF THE OPTICAL GENOSENSOR ON A 
MICROFLUIDIC PLATFORM 
Recently, considerable efforts have been devoted to developing integrated test platforms using 
microfluidic lab-on-a-chip technologies. In fact, microfluidics has been even described as a 
powerful tool with the potential to significantly change the way modern biology is performed.330 
These platforms can enable measuring or quantifying the target analyte in a fully automated 
fashion, and the most advanced systems include the integration of various processes, from raw 
sample pretreatment to specific biomolecular detection.331 Microfluidic chip–based approaches 
for DNA analysis have been reported to overcome some of the limitations seen in other 
applications, such as long reaction times and various manual operations which are required in 
traditional approaches.332 The advantages of using microfluidic systems with small dimensions 
for bioanalytical assays include the possibility of using only minute quantities of the reagents 
and short reaction times, because the molecular diffusion lengths are of the order of the 
microchannel dimension.331 Therefore, for example, the drawbacks of slow DNA hybridization 
can be avoided by flowing the assay components through microfluidic channels. 
A myriad of miniaturized fluidic systems has been designed with various geometrical 
microchannel designs based on different microfluidic flow patterns. In particular, microparticles 
have been combined with microfluidics systems which can be modified to generate controlled 
hydrodynamic forces acting on the particles.331 The movement of magnetic particles is often 
controlled by external magnets or electromagnets, and for optical detection the particles can be 
concentrated at a designated detection site. As the surface chemistry of the microchannels 
themselves is often irreproducible, the use of microparticles as the solid surface can circumvent 
such drawbacks because the particle surface chemistry can be controlled off-chip.331 In 
continuation with the work described in publication I, we aimed to develop an integrated 
platform for Fusarium detection using the same assay concepts reported previously but 
performing the reaction in a microfluidic chip. 
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Glass is a widely used material for microfluidics but also plastic polymers have many 
interesting properties and have the advantage of lower cost and ease of chemical 
modification.331,333 The integrated microdevice (Figure 51) for fungi detection, designed in 
collaboration with Micronit Microtechnologies (Enschede, The Netherlands), was fabricated by 
micro-milling using an optically highly transparent polymer (cyclic olefin copolymer). The Micronit 
clamping system was used to provide the connections to the syringe pump, the integrated 
heater, and the complementary metal–oxide–semiconductor (CMOS) detector. 
 
Figure 51. Chip design for the integrated genosensor. (A) Chip in the Micronit clamping 
system which provides the connections for the fluidic (syringe pump), electric (integrated 
heater), and optical (CMOS detector) structures of the system. (B) Microfluidic chip 
(dimensions 15 × 45 mm) designed for fungi detection. (C) CMOS detector (on the green 
support) placed under the capture chamber to measure the luminescence signals. Figure 
copyright: Sandro Meucci/Micronit Microtechnologies. 
More specifically, the microfluidic chip consisted of a serpentine channel for the DNA 
hybridization, a chamber for the capture of the beads, and an integrated heater (Figure 52). The 
heating element was required to achieve the temperature of +60°C for optimal DNA 
hybridization (Figure 8C). For this purpose, conductive silver paste was dispensed on top of the 
chip (at 1.1 mm distance above the channel), and a temperature sensor was placed at the 
bottom of the chip (at 0.1 mm distance below the channel). Electrical connections to the heater 
and the temperature sensor were used for the feedback-controlled temperature system. The 
detection chamber downstream of the serpentine channel was designed and optimized for the 
capture of the magnetic microparticles using an external magnet which was positioned above 
the detection chamber. After the magnetic capture, the beads were washed, followed by the 
generation of a fluorescent or chemiluminescent signal by addition of the substrate. Fluorescent 
detection using a fluorescent microscope was used in the preliminary experiments, however it 
was later replaced by a chemiluminescent detector using a simple and low-cost configuration 
without an external light source. The chemiluminescent signal was generated using luminol and 
hydrogen peroxide (PS-atto) as substrate for the enzyme HRP. As confirmed previously  
(Figure 47) the use of chemiluminescent detection could provide the required assay sensitivity. 
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The measurements in the integrated system were carried out using a small yet sensitive CMOS 
detector from Anitoa (Menlo Park, CA, USA). The CMOS sensor is ultra-sensitive, highly 
integratable and a low power detector,334 which makes it compatible with the generation of low-
cost and portable microfluidic systems platforms. 
 
Figure 52. Microfluidic approach for Fusarium detection. (A) Chip with the hybridization channel 
(blue dye solution indicates the fluidic path) with a total volume of 6 μL (300 μm × 100 μm). (B) 
Open reservoir as the inlet allowed to add each reagent manually. (C) The outlet was connected to 
a syringe pump and was preceded with the (D) detection chamber (600 μm × 600 μm) where an 
external magnet was used to capture the microbeads. An integrated heater (indicated with red 
arrows in A–B) made of conductive silver paste was used as the heating element to reach the 
required hybridization temperature. Figure copyright: Sandro Meucci/Micronit Microtechnologies. 
Preliminary experiments with fluorescent detection showed highly intense emission signals from 
the detection chamber after adding the fluorogenic substrate Amplex UltraRed (Figure 53). It is 
known that microfluidic systems benefit from the large surface-to-volume ratio of the 
microchannels, but, at the same time, often also the non-specific binding of reagents to surfaces 
increases with the surface-to-volume ratio.335 Such behavior was vastly observed in the 
integrated genosensor, and high non-specific binding of the SA-HRP was seen to the uncoated 
polymer surface. Several ways to prevent the non-specific adsorption of proteins have been 
reported, for example, covering the surfaces with PEG or copolymers, such as Pluronic.335 
Preliminary results to block the channels with casein or BSA did not have the expected effect, 
but a significant improvement in the background was observed with Pluronic-127 coating  
(Figure 53, right). The microchannels covered with the copolymer showed reduced background 
signals in the absence of the target ssDNA, and the irreproducibility was decreased in 
comparison with the uncoated chip indicating that the coating could also help to standardize 
the surface properties of the channel. 
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Figure 53. Fluorescent detection on the integrated genosensor showed intense emission from the 
detection chamber after addition of the substrate (Amplex UltraRed). High non-specific binding of 
SA-HRP to the uncoated surface was seen in the absence of the target (right graph) but coating the 
microchannels with Pluronic-127 (0.5%, w/v) was seen to improve the background and decrease 
the irreproducibility observed with the uncoated chip. 
In the preliminary experiments, the efficiency of on-chip hybridization was evaluated by flowing 
the assay components through the heated microchannel but removing the beads after the 
reaction and performing the magnetic capture and fluorescence detection outside the chip. The 
comparison was then made with a reaction done in a microcentrifuge tube in the conventional 
way (1.5 h incubation at +60°C). The on-chip hybridization produced similar results as the off-
chip protocol (Figure 54A) but notably required significantly shorter reaction times (< 20 min). 
In parallel, the chemiluminescent detection with the CMOS detector was studied by 
performing the hybridization off-chip but afterward flowing the beads onto the chip and capturing 
them in the detection chamber using a permanent magnet. The CMOS detector was then used 
to monitor the luminescence signals from the chamber upon adding the substrate (PS-atto). 
While the response from the negative control (no target ssDNA) resulted in low background 
signals, luminescence produced by the enzymatic reaction was seen in the presence of the 
target ssDNA (Figure 54). We are currently testing the fully integrated system, in collaboration 
with Dr. Meucci from Micronit Microtechnologies, to optimize the on-chip hybridization platform 
with integrated detection for Fusarium detection. 
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Figure 54. Preliminary results with the integrated approach for Fusarium detection. (A) On-chip DNA 
hybridization was tested using a direct F. proliferatum detection probe which was flowed through 
the microfluidic channel with the capture probe functionalized beads using the integrated heater 
set to +60°C. Afterward, the beads were collected from the chip, and the fluorescence signals were 
measured after adding the fluorescent substrate (Amplex UltraRed). The response of the on-chip 
hybridization was then compared to the off-chip hybridization doing the assay in microcentrifuge 
tube at +60°C. (B) Chemiluminescent measurement using the integrated CMOS detector. The 
hybridized sandwich complex was captured on the chip using an external magnet, and the CMOS 
detector was used to measure the luminescence signals from the beads in the detection chamber 
after adding the chemiluminescent substrate. Response from a control reaction without the target 
(green) was compared to the signals obtained when using 1 nM ssDNA target in the reaction (in 
two replicates; red triangles and yellow circles). The dashed line at 70 s indicates the time point 
where the flow of the substrate was stopped, and a decrease in the signals is seen. 
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4.2 Selection of mimotopes 
 
The use of mimotopes has been introduced as an interesting alternative for the detection of 
small molecule analytes in competitive immunoassays. These short peptides are capable of 
mimicking the analyte and binding to the same antibody paratope, and thus, they can replace 
the hapten-conjugates conventionally used in competitive immunoassays. In this work, we have 
used a commercial peptide library to select mimotopes for mycotoxins with the final aim of 
developing detection methods for these toxins. Remarkably, mimotopes can be selected from 
phage-displayed libraries using the analyte-specific antibody as the target, even without any 
prior knowledge about the antibody–analyte binding. The following section discusses further the 
background and selection of mimotopes for FB1 (publication II) and ZEA (publication V) together 
with unpublished results with T-2 toxin. 
4.2.1 Ph.D.-12 PEPTIDE LIBRARY 
The Ph.D. (for Phage Display) system is based on simple M13 phage vector for display of 
peptides in the N-terminus of the phage minor coat protein pIII.336 Commercially available 
libraries by New England Biolabs (Ipswich, MA, USA) based on this system are available in linear 
heptapeptide (Ph.D.-7 Library) and dodecapeptide (Ph.D.-12 Library), as well as a disulfide-
constrained heptapeptide (Ph.D.-C7C Library) formats.337 These combinatorial libraries consist 
of approximately 109 unique and random peptides fused to the N-terminus of the minor coat 
protein (pIII) of M13 phage. The library insert is preceded by the pIII signal sequence (pIII leader) 
which is essential for the secretion, and a short spacer (GGGS) is included between the 
randomized segment and the pIII to improve accessibility to the displayed peptide. The phage 
vector M13KE (Figure 55), a derivative of M13mp19, can be simply and rapidly propagated 
without the need for antibiotic selection or helper phage superinfection.336 On the other hand, 
the use of M13KE rather than the phagemid system results in a multivalent display where all 
five copies of pIII of each virion will be fused to the displayed peptide. Moreover, the vector 
contains the lacZα gene which allows identification of the phages from blue plaques on Xgal-
containing media when using an appropriate lacZα-complementing strain (for example 
ER2738).336 
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Figure 55. Map of the Ph.D. (M13KE) vector. The library insert (red; 12 amino 
acids in the case of Ph.D.-12) has been introduced as N-terminal fusion to pIII 
(yellow). A short spacer (GGGS-linker) is included between the randomized 
segment and the pIII. The lacZα in the vicinity of the (+)-origin of replication 
(M13 ori) permits blue–white screening to detect contamination with wild-type 
phages. 
Various applications using these random peptide libraries have been reported, including epitope 
mapping, vaccine development, protein–protein interaction studies, and epitope 
mimicking.224,225,336,338 Epitope mimics, also sometimes called antigenic mimics or immugenic 
mimics when used to elicit new antibodies, have an exceptional ability to mimic an epitope and 
bind to the paratope of an antibody that has been raised against another antigen. Epitope 
mimics are not necessarily true structural mimics but might bind in an entirely different way via 
different interactions than the original epitope.254 The advantages of epitope mimics over the 
natural antigen as diagnostic reagents include an easier and cheaper manufacture, and they 
can be used even when the natural antigen is unknown or undefined.254,272 For immunoassay 
development, epitope mimics are an intriguing alternative to be used as the competitor instead 
of the antigen-conjugate. In this work, epitope mimicking peptides, or mimotopes, have been 
selected for mycotoxins from phage-displayed peptide libraries. The identified mimotopes have 
then been used in competitive immunoassays to replace the use of toxin-conjugates. This 
approach not only avoids the cumbersome conjugation step but also allows developing toxin-
free assays which are easier and cheaper to manufacture and safer to the user than the 
conventional methods. 
4.2.2 PANNING SELECTIONS 
A multitude of factors can have a significant effect on the outcome of the pannings. Although 
many theoretical aspects have been described in the literature and a variety of strategies have 
been reported with excellent outcomes, often with a new target the best selection conditions 
have to be investigated by trial and error. One successful strategy for finding good binders by 
phage display has in fact been described as “try everything you can think of.”339 The 
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methodology, affinity, and avidity can be affected by selecting a library with a suitable display 
format and peptide structure. Moreover, the selection conditions including the target 
immobilization methods and a variety of elution methods also play an essential role in the quest 
for optimal binders. 
In this work, a total of five selections for mimotopes for FB1, ZEA, and T2-toxin were 
completed with minor modifications to the protocols recommended by the manufacturer.337 
Table 15 summarizes the conditions used in each of the rounds. The first screenings from the 
Ph.D.-12 library, for FB1 and T-2 toxin, were performed without major modifications. The target 
antibody for FB1 or T-2 toxin was immobilized by non-specific absorption to the plastic surface 
of the microtiter plate, and after incubation and stringent washes, the bound phages were eluted 
in acidic conditions with glycine-HCl (pH 2.2). While such an approach resulted in an excellent 
mimotope for FB1 (publication II), the selections for T-2 toxin were somewhat inconclusive. Thus, 
later experiments with ZEA and T-2 toxin were performed in modified conditions, by evaluating 
the antibody immobilization strategy, the use of alternative elutions, and the effect of the pre-
selection. 
  
Table 15. Summary of the selection condition used in this thesis for the identification of mycotoxin mimotopes using the Ph.D.-12 library. Various strategies employed 
included introducing a pre-selection step prior to the target selection, a competitive elution step with the free toxin, and a bead-based panning with oriented antibody 
immobilization. Key changes to the original protocol by the manufacturer in each protocol are indicated in bold. 
  FB1 Zearalenone (i) Zearalenone (ii) T-2 toxin (i) T-2 toxin (ii) 
1st Negative selection BSA – BSA BSA – 
 Target selection 10 μg/ml anti-FB1 10 μg/ml anti-ZEA 10 μg/ml anti-ZEA 10 μg/ml anti-T2 300 ng anti-T2 (protein G –MBs) 
 Washing 5x PBS-T(0.1%) 6x PBS-T(0.1%) 6x PBS-T(0.1%) 5x PBS-T(0.1%) 5x PBS-T(0.1%) 
 Elution Glyc-HCl Glyc-HCl Glyc-HCl Glyc-HCl Glyc-HCl 
2nd Negative selection BSA – BSA BSA MBs and anti-DON (“cross-reactant”) 
 Target selection 10 μg/ml anti-FB1 5 μg/ml anti-ZEA 5 μg/ml anti-ZEA 10 μg/ml anti-T2 300 ng anti-T2 (protein A –MBs) 
 Washing 10x PBS-T(0.1%) 10x PBS-T(0.5%) 10x PBS-T(0.5%) 10x PBS-T(0.1%) 10x PBS-T(0.1%) 
 Elution Glyc-HCl 100 ng/ml ZEA 100 ng/ml ZEA Glyc-HCl Glyc-HCl 
3rd Negative selection – – BSA BSA MBs and anti-DON (“cross-reactant”) 
 Target selection 10 μg/ml anti-FB1 2.5 μg/ml anti-ZEA 2.5 μg/ml anti-ZEA 10 μg/ml anti-T2 300 ng anti-T2 (protein G –MBs) 
 Washing 10x PBS-T(0.5%) 10x PBS-T(0.5%) 10x PBS-T(0.5%) 10x PBS-T(0.1%) 10x PBS-T(0.1%) 
 Elution Glyc-HCl 10 ng/ml ZEA 10 ng/ml ZEA Glyc-HCl 50 μg/mL T-2 toxin 
4th Negative selection –   BSA MBs and anti-DON (“cross-reactant”) 
 Target selection 10 μg/ml anti-FB1   10 μg/ml anti-T2 300 ng anti-T2 (protein G –MBs) 
 Washing 10x PBS-T(0.5%)   10x PBS-T(0.1%) 10x PBS-T(0.1%) 
 Elution Glyc-HCl   Glyc-HCl 50 μg/mL T-2 toxin 
5th Negative selection –   BSA  
 Target selection 10 μg/ml anti-FB1   10 μg/ml anti-T2  
 Washing 10x PBS-T(0.5%)   10x PBS-T(0.1%)  
 Elution Glyc-HCl   Glyc-HCl  
Abbreviations: BSA, bovine serum albumin; Glyc-HCl (0.2 M glycine-HCl, pH 2.2); MBs, magnetic beads; PBS-T, PBS with Tween-20 (percentage in parenthesis)
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 Selection of zearalenone mimotopes 
The selections of zearalenone (ZEA) mimotopes were conducted using a similar protocol applied 
for FB1.230 In the first selection round, a high concentration of the antibody was immobilized to 
guarantee the capture of the all the selective clones from the library. In the subsequent second 
and third rounds, when a preliminary enrichment had already been achieved, decreasing 
amounts of the immobilized antibody were used. Thus, the avidity effects of the multivalent 
phage display could be diminished, and peptides with better affinity could be selected. 
Moreover, in order to favor the selection of binders which are capable of competing with the free 
toxin, the elution step in the second and third rounds was performed by competition with ZEA, 
instead of the acidic elution that was used in the first round. Also, the toxin concentration was 
reduced in the third round (100 ng mL–1 and 10 ng mL–1 of ZEA in the second and third rounds, 
respectively) to favor the elution of the peptides providing the highest assay sensitivities, rather 
than those with highest affinities. Altogether, the more restricted selection conditions should 
favor enrichment of the best mimotopes. In parallel, the effect of the pre-selection step was 
studied by comparing selections where the phage pools were introduced directly to the target (i) 
with those that included a pre-selection step with the blocked plate (ii). The idea of the pre-
selection step was to remove non-specific binders which recognize the components of the solid 
surface, or the blocking agents used, from the pool before the actual selection. The risk of such 
selection is the coincidental elimination of a fraction of interesting binders. In this case, no 
significant differences were observed between the two approaches, neither in the output titers 
nor in the response in the ELISAs (Figure 56). Enrichment of specific binders was seen in both 
cases, and it was concluded that, in this case, the pre-selection step did not have any significant 
contribution on the background signal. Probably, the competitive elution step in the second and 
third rounds had an important effect in this matter, as it could provide high specificity in the 
elution step regardless of the specificity of the binding in the first place. 
 
Figure 56. Results of the ELISA with the polyclonal phage pools after each selection round for 
zearalenone (ZEA) mimotopes with (A) and without (B) a pre-selection step. Binding of the phages 
was tested to the background (blue) and the immobilized target anti-ZEA antibody (red). Likewise, 
enrichment of the phages could be depicted as increasing phage titers after each selection round 
(blue diamonds; right y-axis). 
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 Selection of T-2 toxin mimotopes 
T-2 toxin was one of the mycotoxin targets which was included in the objectives of this work 
because it is produced by the same Fusarium genus as fumonisins. However, working with this 
hydrophobic toxin proved to be challenging on several occasions, and the results were not as 
promising or straightforward as with FB1 and ZEA. Mimotope selections for T-2 toxin were 
conducted with different strategies, but in the end, none of them could provide us with a robust 
mimotope. The first selections were done in a similar way as for FB1 in publication II,230 and 
enrichment and specific binding was seen in the ELISA with the polyclonal phage pools after 
each round (Figure 57A). 
 
Figure 57. Results of the ELISA with the polyclonal phage pools after each selection round of T-2 
toxin mimotopes (A) selection on the plate (i), and (B) selection on magnetic beads (ii). Binding of 
the phages was tested to the background (blue) and the immobilized target anti-T2 antibody (red). 
Amplification and analysis of individual monoclonal phages revealed a number of clones 
capable of binding specifically to the T-2 toxin antibody (Figure 58A). However, sequencing of 
the positive clones did not reveal clearly conserved sequences or consensus motifs, and thus, 
six different monoclonal clones were tested in the competitive assay with the free toxin to 
confirm their functionality as epitope mimics. All tested clones showed competition, but the 
provided sensitivities and reproducibility varied significantly. Figure 59 shows the assays 
performed on three different days with six of the clones. Based on the competitive ELISA results, 
clones F11 and H11 showed the best performance in the competitive assay, both in terms of 
sensitivity and reproducibility, and were selected for the subsequent experiments. 
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Figure 58. Results of the ELISA with the monoclonal T-2 toxin mimotopes from the selection on (A) 
plate (i), and (B) magnetic beads (ii). Binding to the background (blue) and the anti-T2 antibody 
(red) was tested, and the clones with the best signal-to-background ratios were identified by DNA 
sequencing. 
Later, the selections for T-2 toxin mimics were repeated from scratch using magnetic beads 
functionalized with protein A or protein G as the solid surface. This strategy was thought to result 
in the selection of better mimotopes as the binding step could be performed in solution followed 
by antibody capture in an oriented manner. Moreover, a competitive elution step with the free 
toxin was used in the third and fourth rounds, instead of the treatment at low pH to release the 
bound phages. Enrichment and high specific binding to the antibody was observed already after 
one round, and the second and third rounds did not result in further enrichment, as confirmed 
in the ELISA (Figure 57B). This could probably be explained with the more stringent conditions 
used in the elution step in the third round. The fourth round showed significant further 
enrichment, and the majority of the monoclonal clones selected from the third and fourth rounds 
showed specific binding to the target (Figure 58B). 
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Figure 59. Competitive phage-based ELISA with T-2 toxin mimotopes (A) F5, (B) F11, (C) G5, (D) H5, 
(E) H9, and (F) H11 from the first (i) selections. Normalized signals are depicted as the average of 
the replicate measurements ± the standard error of the mean (n = 3) and fitted with the four-
parameter logistic fit (OriginPro 9.0). Each assay was repeated three times on different days (blue, 
green, red) to test the inter-day variation. 
Sequencing of the T-2 monoclones from the second selections (ii) revealed only one new peptide 
sequence (namely T13) which was further tested in the competitive ELISA. In comparison with 
the previously selected mimotopes (F11 and H11), T13 showed better sensitivity which perhaps 
could be attributed to the competitive elution step. The binding kinetics was not studied directly 
but based on the results of the ELISA and the cross-reactivity studies, T13 was suspected of 
having lower affinity to the antibody than F11 and H11. Lower affinity could provide better 
sensitivity as lower concentrations of the free toxin could induce competition, but at the same 
time the binding was less specific, and some non-specific binding and cross-reactivity with other 
antibodies were observed (Figure 60). 
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Figure 60. (A) Competitive phage-based ELISA with the monoclonal T-2 toxin mimotopes F11 (red), 
H11 (blue), and T13 (green). Normalized signals are depicted as the average of the replicate 
measurements ± the standard error of the mean (n = 3) and fitted with a four-parameter logistic 
fit (OriginPro 9.0). (B) Cross-reactivity with different mycotoxins (1 µg mL–1) and (C) binding to the 
background or other anti-toxin antibodies. Signals are normalized to the signal obtained in the 
absence of the toxin with the anti-T2 antibody. 
 Identification of mycotoxin mimicking peptides 
Following the pannings and the phage-based ELISAs, selected positive clones which showed 
specific binding to their target antibody were identified by DNA sequencing. Table 16 presents 
all the identified sequences from the pannings against FB1, ZEA, and T-2 toxin antibodies. Clear 
enrichment of certain peptide sequences was seen in the case of FB1 and ZEA, and among the 
ten sequenced clones, only four different sequences were observed. In both cases, two 
conserved sequences (A2 and D1 for FB1, and SF and GW for ZEA) were present in 80% of all 
the phages. Based on the sensitivity and reproducibility of the competitive assays using these 
clones, mimotopes A2 (publication II; Figure 15) and SF (publication V; Figure 44) were selected 
as the best candidates for FB1 and ZEA, respectively. 
For T-2 toxin two separate selections were conducted, but the identified sequences did 
not clearly show enriched or conserved peptides. A total of twenty clones were sequenced, 
among which 12 different sequences were observed. Some similarities were seen between 
these peptides, and short conserved motifs could be observed (Table 16). Based on the 
competitive assays clones F11 and T13 were selected for further assay development. 
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Table 16. Identified peptide sequences from the fumonisin B1 (FB1), T-2 toxin, and 
zearalenone (ZEA) mimotope pannings. The best candidates selected for the subsequent 
experiments are indicated with an asterisk after the mimotope name. The frequency (%) 
refers to the occurrence of the same sequence found among the sequenced clones 
(10 clones for FB1 and ZEA, 20 clones for T-2 toxin). Conserved amino acids or motifs are 
indicated in bold, and X refers to an unknown amino acid. 
Target toxin Mimotope name Sequence Frequency 
FB1 D1 -----RPLDLYPGSGQE--- 60% 
FB1 A2(*) VTPNDDTFDPFR-------- 20% 
FB1 C9 VXGIXNGWESYE-------- 10% 
FB1 D8 --------DMVPTFWLTEFT 10% 
ZEA SF [B1](*) SFDYFLWDSTET----- 50% 
ZEA GW [F2] ----GWWGPYGEIELL- 30% 
ZEA B2 --SMTPWHILAPRA--- 10% 
ZEA H2 -----TWGPYGEAPLWP 10% 
T-2 toxin F11(*) NVAGHSPFDYVF----------- 15% 
T-2 toxin H5 ----TPQPDYLHLLMK------- 15% 
T-2 toxin F5 ----ETAMDYLFRKPS------- 10% 
T-2 toxin G5 --------SSSLESWQHFLR--- 10% 
T-2 toxin H9 -----------YNPWQDFWSSQP 10% 
T-2 toxin H11 ---SSDPFSYLFRNA-------- 10% 
T-2 toxin H6 ---YVDPFSMVFSKW-------- 5% 
T-2 toxin T13(*) -----SGVYKVAYDWQH------ 5% 
T-2 toxin E7 --------SLVNDDWQQFWT--- 5% 
T-2 toxin G3 --------VTPNSDWEAFWA--- 5% 
T-2 toxin G11 --------YRHPSSWETFWS--- 5% 
T-2 toxin H2 ITRQADMLSQVF----------- 5% 
 
Comparison of all the peptide sequences identified as mimotopes revealed some common 
characteristics, although the targets were different. The reported frequency of each amino acid 
within the original Ph.D.-12 library338 was compared to the frequency of the amino acids among 
the clones sequenced for FB1, ZEA, and T-2 toxin (Figure 61) to determine if certain amino acids 
were favored in the selections. Most remarkably, for all the targets the fraction of aromatic and 
negatively charged amino acids was incremented in comparison with their original frequency in 
the library. Enrichment of these amino acids suggests their essential role in the binding 
interactions to the antibody paratope. Some rational can also be seen when comparing the 
amino acids content of the mimotopes for different targets, in particular in the case of FB1 which 
is more hydrophilic (log KOW = 1.84340) than the other mycotoxins (log KOW (ZEA) = 3.580;341 log 
KOW (T-2 toxin) = 2.27, est.342). Whereas the percentage of the hydrophobic amino acids (A, I, L, 
M, V, F, W, Y) amongst the mimotopes sequenced for T-2 toxin and ZEA was 43–45%, the 
sequenced FB1 mimotopes contained only 29% of the hydrophobic amino acids. The observed 
trend of an augmented fraction of aromatic and negatively charged residues, as seen in  
Figure 61, is also consistent with previous reports stating that mycotoxin mimotopes usually 
contain several charged and aromatic amino acids.193 
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Figure 61. The frequency of amino acids observed in the original Ph.D.-12 library338 
and among the sequenced clones (Table 16) after 3–5 selection rounds for fumonisin 
B1 (FB1), T-2 toxin, and zearalenone (ZEA) mimotopes. 
 Anti-immune complex peptides 
Given that theoretically the sensitivity, kinetics, and linear range of the non-competitive or 
sandwich-type immunoassays are superior to the competitive ones,93,343 one of our aims was to 
develop non-competitive assays for mycotoxin detection. The anti-immune, or anti-metatype, 
concept refers to antibodies which are capable of binding to the primary antibody only when it 
is bound to the antigen (Figure 62). Antibodies with such extraordinary characteristics were 
originally monoclonal antibodies developed by immunization,344 but later on phage-displayed 
libraries with antibodies136,345,346 and peptides347–351 have been used as well. Although the exact 
nature of the anti-immune complex interaction is controversial,344 non-competitive 
immunoassays based on such two-site format have been shown to improve the sensitivity and 
specificity in comparison with competitive assays.136,347 
 
Figure 62. Scheme of the non-competitive immunoassays with the anti-
immune complex peptide. Such antibody–analyte–peptide trivalent 
interaction allows the development of noncompetitive sandwich-type 
assays for small molecule detection. 
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With these aspects in mind, we screened the same Ph.D.-12 peptide library for anti-
immune complex binders for mycotoxin detection. Selections against FB1, T-2 toxin, and ZEA 
antibodies in the presence of the corresponding toxin were performed. In this case, a pre-
selection with the antibody alone was conducted to favor the selection of those clones 
interacting with the antibody–analyte complex. In the case of FB1 and T-2 toxin, a total of five 
selection rounds were completed. The phage-based ELISAs with the polyclonal phages after 
each round showed enrichment of antibody binding clones after the second or third rounds, and 
similar signals were observed in the presence and absence of the target toxin (Figure 63A–B). 
Thus, the selections did not seem successful as genuine anti-immune complex peptides should 
bind only to the antibody when bound to the toxin analyte. Similarly, the selection of peptides 
binding to the ZEA anti-immune complex was unsuccessful, and no enrichment was observed 
after three rounds neither in the phage-based ELISA nor in the phage titers after each round 
(Figure 63C). For ZEA, also a total of 80 monoclones from the third round were amplified and 
tested individually by ELISA, but none of them showed the expected response as an anti-immune 
complex peptide. 
It remains to be uncovered whether and how anti-immune peptides can be selected from 
the peptide library in question. The only conclusion that can be drawn from these experiments, 
and in agreement with previous reports,347 is that anti-immune complex binders are difficult to 
obtain. This could be partially explained considering that, when bound to the antibody, many 
small molecules are in fact buried rather deep in the antibody paratope. Actually, it has been 
reported that up to 85% of the accessible surface of a small molecule analyte can be buried 
when bound to the antibody,352,353 and therefore, only a small fraction of the analyte remains 
available for contributing to the formation of the immune complex.347 Moreover, nearly all the 
previously reported anti-immune complex peptides have been selected from peptide libraries 
with constrained peptides loops.347,349–351,354 In the work of Wang et al. (2013), all New England 
Biolabs libraries, Ph.D.-7, Ph.D.-12, and Ph.D.-C7C, were used to select anti-immune complex 
peptides for 2,2′,4,4′-tetrabromodiphenyl ether. The Ph.D.-C7C with cyclic heptapeptides 
showed a larger increase in titer during the selection rounds in comparison with the Ph.D.-7 and 
Ph.D.-12 libraries.355 Moreover, the best anti-immune complex peptide was found from this 
constrained library, suggesting that since cyclic peptides may have a higher affinity to the target 
than linear ones, they might present a more appropriate alternative for the selection of anti-
immune complex peptides. 
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Figure 63. Selection of anti-immune complex peptides for (A) FB1, (B) T-2 toxin, and (C) ZEA. Binding 
of the polyclonal phage pools to the background (blue), the anti-toxin antibody (red), and the anti-
immune complex (green; antibody together with the corresponding toxin, 300 ng mL–1 FB1 or T-2 
toxin, or 1000 ng mL–1 ZEA) were determined after each round. For ZEA, the phage titers after each 
round are indicated with blue diamonds in the right y-axis. 
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4.3 Phage-displayed antibody libraries 
 
All the work described in the publications and with the mimotopes was carried out using 
commercial monoclonal antibodies. These antibodies, at least in the case of FB1 and ZEA, 
provided excellent sensitivity and specificity for the detection of their target toxin. However, the 
use of commercial antibodies is subject to certain limitations. One obvious drawback is the price 
and the dependency on the commercial provider. Moreover, in some cases, the manufacturer 
provides only limited details about the product, and some commercial antibodies for mycotoxins 
have been demonstrated to have high cross-reactivity with other similar toxins.183,184 Thus, this 
work also aimed to select recombinant antibodies from a phage-displayed antibody library. 
Successful selection of mycotoxin-specific antibodies could potentially replace commercial 
monoclonal antibodies, and after identifying a good recombinant binder, it could be produced in 
bacteria in a cost-effective manner and with the desired modifications. 
4.3.1 THE DOMAIN ANTIBODY LIBRARY 
The commercial domain antibody (DAb) library used in this work is based on a single human VH 
framework (V3-23/D47) where diversity has been introduced in the antigen-binding site, i.e., 
CDRs, by PCR mutagenesis. The DAb library, with a size of 3 × 109, has been constructed in the 
phagemid format which leads to mostly monovalent display (Figure 64).356,357 Thus, the library 
has the potential for selecting high-affinity binders, as it has been reported, for example, for the 
multiple sclerosis antigenic peptide CSF114(Glc)358 and for Mycobacterium tuberculosis heat 
shock protein,359 using the same library. 
In this work, the selection of FB1 and T-2 toxin binders was conducted using immobilized 
FB1–BSA or T2–HSA -conjugates, as the target, according to the manufacturer’s protocols.356,357 
Briefly, a 1000-fold excess of the DAb-library (3 × 1012 phages) was pre-selected against 
BSA/HSA-coated wells and then incubated with the toxin-conjugate immobilized to a microtiter 
plate by non-specific absorption. After stringent washes, the phages were eluted by incubation 
with trypsin, which cuts the c-Myc tag between the VH fragment and the phage pIII thus releasing 
the bound phages. Also, during the elution step the trypsin-sensitive helper phages (KM13) are 
removed, and the background binders originating from the helper are decreased. In the case of 
FB1, alternatively competitive elution with the free toxin was used to release those bound phages 
which are capable of binding the free toxin with high affinity. The eluted phages were amplified 
in TG1 bacteria and precipitated with polyethylene glycol (PEG). The amplified phages were then 
used for the subsequent panning rounds and tested in the phage-based ELISA with the 
immobilized target and an HRP-labeled secondary antibody. 
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Figure 64. Map of the DAb phagemid vector (pR2-VH) with the most important 
features. The VH sequence (DAb, 12 kDa) has been introduced as N-terminal 
fusion to pIII. The amber stop codon located between the VH and pIII is 
suppressed by the strain used for phage amplification (TG1) and is introduced 
as a glutamine. 
4.3.2 SELECTION OF ANTIBODY FRAGMENTS FOR MYCOTOXINS 
Despite its wide use, phage display is susceptible to certain risks which can make it a 
complicated, demanding, and time-consuming technology.360,361 Although the selection of 
antibodies have been reported, for example, against mycophenolic acid, OTA,280 ABF1,311 and 
ZEA281 with excellent affinities in the nanomolar range or higher, phage display may result in the 
selection of moderate affinity binders which are not able to compete with the affinities of 
monoclonal antibodies for biosensor development. Moreover, phage display selections are 
notorious for also identifying false positive hits, and at times, instead of specific binders, panning 
selections yield phages with no actual affinity toward the target but to other components of the 
screening system, such as contaminants in the target sample, the solid phase, or blocking 
agents. For example, plastic binders with high abundance of aromatic amino acid residues and 
those against albumin are frequently selected from peptide libraries.362 Variety of strategies 
have been employed to avoid, or at least minimize, the enrichment of such binders.363 On the 
other hand, certain clones might enrich during the selections rounds, not because they exhibit 
affinity to the target but because they propagate faster than an average clone. Each replication 
step enables them to prevail in the phage pool creating bias regarding the actual target-binding 
capabilities. 
Unfortunately, the ventures with the DAb library in this work made us aware of many of 
these challenges. T-2 toxin which already proved itself a difficult toxin to mimic  
(4.2.2.2 Selection of T-2 toxin mimotopes) was not any more successful target for antibody 
selections. The three panning rounds against the T2–HSA-conjugate showed enrichment in the 
phages eluted after each round. A comparison to a control panning, without the target, in the 
second and third rounds suggested that the enrichment was specific to T2–HSA (Figure 65A). In 
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fact, binding of the polyclonal phage pools after each round showed a similar trend in the ELISAs 
(Figure 65B). However, although enrichment of the phages was seen, the extent of the 
background binding was substantial. Binding to blocked wells, and in particular to HSA-coated 
wells, showed significant non-specific binding among the phages and could not be tolerated. 
Analysis of 36 individual clones showed a similar trend in the ELISAs (Figure 65C), and the 
selections wound up fruitless. 
 
Figure 65. Selection of domain antibodies for T-2 toxin. (A) The ratio between the input phages (pfu) 
and output phages (pfu) after each selection round. Pannings against T2–HSA (red) showed 
enrichment after three selection rounds (the bar of the first round is not visible in the scale used). 
A control panning (green) against the wells without the target in the second and third round showed 
some enrichment in the background binders as well. (B) ELISAs with the polyclonal phage pools 
after each round. Binding was tested to the target T2–HSA (red), HSA (yellow), and wells blocked 
with 5% milk (green). The commercial anti-T2 monoclonal antibody (MAb) was used as a positive 
control. The signal-to-background ratios (red diamonds, right y-axis) were calculated from the signal 
from T2–HSA coating divided with the background signals from the non-coated wells. (C) ELISAs 
with monoclonal phages. Binding was tested similarly to the target T2–HSA (red), HSA (yellow), and 
wells blocked with 5% milk (green). 
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Later, for FB1 pannings an additional second pre-selection step was included in order to 
eliminate the background binders that were a problem for T-2 toxin, and thus the phage pools 
were passed through two background wells prior to the target selection. Whether this had the 
wanted effect, or the less hydrophobic nature of the target resulted in lower background, was 
not studied in further detail, but in this case, the extent of the background binders was lower 
than before. A total of three panning rounds were conducted with immobilized FB1–BSA and 
trypsin elution. In addition, another parallel third round was done with competitive elution using 
the free toxin. Comparison of the phages eluted from each round, i.e. the output phage, from 
the target selection (FB1–BSA-coating) and a control selection (BSA-coating) showed enrichment 
of specific binders. The competitive elution with the toxin showed a decrease in the background 
binders as expected (Figure 66A). The results from the ELISA were consistent with the output 
phage and showed enrichment of specific binders towards FB1–BSA. Thus, individual phages 
were amplified from the second and third rounds, and the binding was tested similarly in the 
phage-based ELISAs. Again, BSA-coated wells were used as a control and target binding was 
tested with FB1–BSA-coated wells in the absence and presence of free FB1 (Figure 67A). All of 
the 48 clones tested showed specific binding to the target FB1–BSA in comparison with the 
background binding to BSA. However, addition of the free toxin (2 µg mL–1 of FB1) did not have 
the expected effect, and no competition was observed even with such high toxin concentration. 
Further tests with increased toxin concentrations and varied assay conditions showed 
similar negative results. A final experiment, with an overnight incubation step of the phage-
displayed DAb with the toxin, resulted to some extent of competition, and slightly lower signals 
were observed in the presence of high concentration of FB1 (Figure 67B). Nevertheless, it was 
clear that the selected binders had a significantly higher affinity towards the FB1–BSA than to 
the free FB1. This could be a result of so-called bridge-effect wherein the antibody recognizes 
the hapten only in the context of the protein-conjugate and some parts of the conjugate or the 
linker have a significant contribution to the binding. Thus, the antibody does not recognize, or 
recognizes with low affinity, the free hapten which in fact would be the wanted target. Therefore, 
such binders are useless for the intended application, and thus far, also the selections for FB1-
binding antibodies were inconclusive. 
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Figure 66. Selection of domain antibodies for FB1. (A) Output phage (pfu) after each round for the 
target (FB1–BSA, yellow) and control pannings (BSA, green). (B) ELISA with the polyclonal phage 
pools after each round. Binding was tested to the target FB1–BSA (yellow), and BSA (green). In the 
first and second rounds the elution was done with trypsin, and in the third round the elution with 
trypsin and free FB1 (toxin) was compared. 
The failure to isolate target binding phages recognizing FB1 or T-2 toxin with high affinity could 
be due to the absence of such phages in the library that was used, or to the selective loss of 
suitable phages during the selection procedure. Alternative libraries could provide better 
antibodies for small targets, such as FB1 and T-2 toxin. In the literature, many of the mycotoxin-
specific antibodies discovered by phage display have been selected from immunized libraries 
which are already strongly biased towards the target.136,200,279–281 It should be also noted that 
the DAb library used in this work might not include appropriate antibodies for small molecules. 
As has been reported in the case of nanobodies,193,364 the paratope of single-domain antibodies 
consists of only three hypervariable loops, rather than six as in the intact IgG or the scFv and 
Fab fragments.93 Thus, the structure or the complexity of the antigen binding site, with a limited 
number of conformational structures, might not be suitable for small molecule recognition.365 
On the other hand, the target is evidently a crucial element of the selections, and it is 
possible that the toxin-conjugates used in this work were not optimal for the purpose. The protein 
context, as well as the used linker and degree of purity, can have significant effects on the 
antibody binding, exactly as in the case of raising hapten-specific antibodies by immunizations.93 
If the structure of the conjugate hinders binding to the toxin itself or due to steric hindrance the 
antibody is not capable of interacting with the target, the results could be similar to those seen 
in this work. As discussed already in the case of the mimotopes, the stringency of the selection 
conditions also has dramatical effects on the outcome, and even small stringency differences 
during the selection might result in the selection of a completely different phage population.361 
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Figure 67. Selection of domain antibodies for FB1. (A) ELISA with monoclonal phages from the 
second and third rounds. Binding was tested to BSA (red) and the target FB1–BSA in the absence 
(yellow) and presence of 2 µg mL–1 FB1 (green). (B) Competitive assay with selected monoclones 
with an overnight pre-incubation step with the toxin. As a control (dark green) no FB1 was used, or  
5 µg mL–1 (green), 10 µg mL–1 (light green), or 25 µg mL–1 FB1 (yellow). (C) Schematic of the 
hypothesized binding of the phage-displayed DAb which recognized the FB1–BSA only in the context 
of the protein-conjugate. 
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4.4 Mimotope-based immunoassays 
 
Despite the unsuccessful selection of mycotoxin-specific recombinant antibodies, we have 
developed various novel methods for mycotoxin detection based on the commercial antibodies 
and the newly identified mimotopes. After identifying the mimotopes for FB1, ZEA, and T-2 toxin 
from the phage-displayed peptide library, as described in the previous sections, three alternative 
strategies for immunoassay development were followed. Firstly, and perhaps most 
straightforwardly, the phage-borne peptides were directly used in the immunoassay after 
identifying the best individual clones. As it was already seen in the phage-based ELISA, which 
was used to evaluate the success of the pannings, the phage-displayed mimotopes were used 
in competitive assays, based on immobilized antibodies, and subsequent detection with an HRP-
labeled anti-phage secondary antibody. This approach was the least complicated method to 
evaluate and compare the performance of the individual clones and could be used as a means 
to select the best mimotope candidates. However, as discussed in publication IV, the phage-
borne mimotopes did not provide the best sensitivity in comparison with the alternative assay 
formats. The SPR analysis revealed that the phage-displayed mimotope possessed very slow 
binding kinetics, which was attributed to the enormous size of the phage virion. Nevertheless, 
signal amplification could be achieved using the anti-phage-HRP secondary antibody which 
binds to the major coat protein of the phage, and further improvement in the assay sensitivity 
was attained using magnetic beads as the solid phase. 
On the other hand, after identifying the mimotopes in terms of the amino acid sequence, 
they could be synthesized or produced without the phage. In our second approach, the 
mimotopes were chemically synthesized with a biotin-linker and could be used in different 
approaches. Publication II presented the microarray-based immunoassay using the synthetic 
peptide, which was immobilized on the array surface using neutravidin. Similarly, the synthetic 
peptide was later (publication IV) applied to a bead-based immunoassay that provided lower 
detection limits. The synthetic peptide proved itself as an outstanding recognition element not 
only for the excellent sensitivity that could be achieved but also owing to the versatility of the 
approach. The biotin-linker which was included to the peptide during the synthesis could be used 
to immobilize it to various solid surfaces, such as the microarray or magnetic beads which were 
used in this work, or likewise for conjugation to practically any label or other molecule modified 
with a biotin-binding protein, such as neutravidin or streptavidin. 
The third approach to use the mimotopes relied on genetically constructed recombinant 
fusion proteins for which the peptides were cloned as translational fusions with fluorescent or 
bioluminescent proteins. In this manner, the recombinant fusion protein was produced directly 
with a label and could be applied to the immunoassays without further labeling or secondary 
antibodies. Although the construction of the recombinant proteins by genetic engineering might 
be considered more laborious than peptide synthesis, the bacterial expression provided an 
exhaustive source of the protein once the translational fusion was constructed. However, at 
times, expression of heterologous proteins might turn out challenging due to problems 
associated with protein misfolding or degradation occasionally observed in their expression of 
heterologous fusion proteins.366 Publications III–V present the development of fluorescent and 
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bioluminescent fusion proteins for the detection of FB1 and ZEA. These assays provide excellent 
sensitivities and, in particular, simplified analytical methods using the mimotope-fusions as the 
tracer. The following sections discuss the background and further unpublished results obtained 
with the different mimotopes and assay formats for the detection of FB1, ZEA, and T-2 toxin. 
4.4.1 DETECTION OF ZEARALENONE ON MAGNETIC BEADS 
As discussed above, the phage-borne peptides can be directly used to develop competitive 
immunoassays to detect the target toxin. In the case of ZEA, originally two conserved peptide 
sequences were identified in the panning among which SF provided better reproducibility, 
although the sensitivity obtained with both peptides, SF and GW, seemed to be very similar 
(Figure 44D). Even though the sensitivity of the assay was excellent, the very narrow dynamic 
range obtained in the competitive phage-based assay was a matter of concern. Based on the 
thorough investigation of different assay formats in the case of FB1, the ZEA assay was also 
implemented in a bead-based format with the aim to improve the dynamic range. Similarly as 
for FB1 (publication V), the assay was based on the covalent immobilization of the anti-ZEA 
antibody on carboxylated magnetic microbeads. Competition between the toxin and the phage-
displayed mimotope (SF) was later revealed using the HRP-labeled anti-phage antibody. After 
optimizing the amount of the SF-phage in the assay (Figure 68A), calibration with ZEA was 
performed. A significant improvement in the assay sensitivity and dynamic range was observed 
using the beads in comparison with the plate-based approach (Figure 68B). The IC50 values for 
ZEA assays on magnetic microbeads and microtiter plate were 0.31 ± 0.02 ng mL–1 and 2.43 ± 
0.08 ng mL–1, respectively. The dynamic range (from IC80 to IC20) for the bead-assay was from 
0.16 to 0.61 ng mL–1 while for the plate assay the range ranged between 1.96 and  
3.01 ng mL–1. The detection limits, defined as the IC90 value, were 0.11 and 1.72 ng mL–1 for 
the bead and plate-based assays, respectively. 
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Figure 68. Competitive phage-based immunoassays for ZEA. (A) Optimization of the amount of the 
phage in the bead-based immunoassay in the absence of free ZEA (blue) and in the presence of 3 
ng mL–1 ZEA (green). Best signal-to-background ratio (red diamonds, right y-axis) was obtained with 
4 × 108 pfu mL–1, and it was used for the toxin calibration. (B) ZEA calibration using as the solid 
phase a microtiter plate (blue) or magnetic microbeads (red). Normalized signals are depicted as 
the average of the replicate samples ± the standard error of the mean (n = 3) and fitted with a four-
parameter logistic fit (OriginPro 9.0). 
 
4.4.2 DUPLEX MICROARRAY ASSAYS FOR FB1 AND T-2 TOXIN 
DETECTION 
In parallel with the work reported in publication II, we aimed to develop a microarray-based 
immunoassay for T-2 toxin analysis with the final objective of developing a duplex method for 
the simultaneous detection of FB1 and T-2 toxin. 
 Optimization of the microarray spotting 
For the duplex microarray development, immobilization of the FB1 and T-2 toxin mimotopes to 
the array was optimized in terms of the spotting buffer as well as the peptide and neutravidin 
concentrations. Moreover, direct immobilization of the peptides without neutravidin was tested 
in parallel. Tested spotting buffers were: (a) 1× PBS (pH 7.2) with 0.01% sodium-deoxycholate, 
(b) 1× PBS (pH 7.2) with 0.005% CHAPS and 0.01% BSA, and (c) 1× PBS (pH 7.2). Spotting 
buffer (b) with CHAPS and BSA provided the best spot quality (Figure 69A) and was selected for 
the subsequent experiments. Biotinylated peptides A2-bio (FB1-mimotope) and F11-bio  
(T2-mimotope) were spotted in the same array at different concentrations (0.10 mg mL–1; 
0,25 mg mL–1; or 0.75 mg mL–1) with or without neutravidin (1:8 molar ratio). Binding of the FB1 
and T-2 toxin-specific antibodies at different concentrations was then measured to both 
peptides spotted at different concentrations (Figure 69). Although some binding was observed 
at high antibody concentrations, it was clearly seen that the direct spotting of the peptides to 
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the epoxy-surface did not provide good binding. This could be due to the absence of appropriate 
reacting groups for the binding, unfavorable folding of the peptide or steric hindrance after the 
spotting which prevents antibody binding. Nevertheless, the spotting with neutravidin resulted 
in excellent signals. High concentrations of the spotted peptide resulted in some non-specific 
binding (Figure 69C–D) but could provide the required signal-to-background ratios. The 
concentration of neutravidin and both peptides were later optimized more specifically to provide 
competitive assays with the highest sensitivity for toxin detection (Figure 23, Figure 70). 
 
Figure 69. Optimization of the peptide (A2-bio and F11-bio) spotting. (A) The array was spotted with: 
(a) 1× PBS (pH 7.2), 0.01% sodium-deoxycholate; (b) 1× PBS (pH 7.2), 0.005% CHAPS, 0.01% BSA; 
or (c) 1× PBS (pH 7.2). Then, binding of different antibody concentrations to the peptides spotted 
with spotting buffer was tested (b). (B) Specific binding of anti-FB1 to A2-bio; and (C) non-specific 
binding to F11-bio. (D) Non-specific binding of anti-T2 to A2-bio; and (E) specific binding to F11-bio. 
Both peptides were spotted with (orange, purple, blue) neutravidin and without (green, red, light 
blue) in three different concentrations, 0.10  mg mL–1 (purple, green); 0,25 mg mL–1 (orange, red); 
or 0.75 mg mL–1 (blue, light blue). The fluorescence signals are depicted as the average of three 
replicate spots in three replicate arrays ± standard error of the mean (n = 9). 
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Figure 70. Optimization of the F11-bio spotting. (A) Binding inhibition curves with the peptide 
immobilized at a concentration of 0.25 mg mL–1, (blue) 0.50 mg mL–1 (orange), or 0.75 mg mL–1 
(red). (B) Binding inhibition curves with 0.25 mg mL–1 immobilized peptide F11 at different 
neutravidin concentrations, 1:4-molar ratio (blue), 1:6-molar ratio (orange) or 1:8-molar ratio (red). 
Results are shown as normalized mean signals ± the standard error of the mean (n = 9). A four-
parameter logistic fit (OriginPro 9.0) was used for the curve fitting. 
 
 T-2 toxin assay based on biotinylated F11-mimotope 
Similarly as described for FB1 in publication II, the competitive binding inhibition assay for T-2 
toxin was optimized in terms of the antibody concentration. Figure 71A shows the toxin 
calibration performed with 10–250 ng mL–1 anti-T2 antibody where it can be observed that lower 
antibody concentrations led to lower absolute signals but could provide slightly better 
sensitivities. The assay with 10 ng mL–1 antibody exhibited an IC50 value of 287 ng mL–1 and a 
limit of detection (IC90) 7.7 ng mL–1. 
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Figure 71. (A) Optimization of T-2 toxin antibody concentration in the microarray. Anti-T2 toxin was 
used at 250 ng mL–1 (red), 40 ng mL–1 (orange), and 10 ng mL–1 (blue). Results are shown as mean 
fluorescence signals ± the standard error of the mean (n = 9). A four-parameter logistic fit (OriginPro 
9.0) was used for the curve fitting. (B) Scheme of the duplex microarray where A2-bio and F11-bio 
are spotted on the same array and FB1 and T-2 toxin can be detected simultaneously using an anti-
IgG secondary antibody labeled with AlexaFluor (AF). 
 Duplex microarray assays of FB1 and T-2 toxin 
For the duplex mycotoxin assay both peptides were spotted to the same microarray (in triplicate 
spots) and the binding of one or both antibodies together with varying concentrations of one or 
both toxins, FB1 and T-2 toxin, was tested. The FB1-assay (Figure 72C; blue squares) with anti-
FB1 and FB1 as a unique target showed excellent performance in terms of sensitivity and 
reproducibility (as described in publication II). Non-specific binding to the immobilized T-2 toxin 
mimotope F11-bio was not observed (Figure 72D; blue squares). Similarly, the T-2 toxin assay, 
although significantly less sensitive and less reproducible, showed specific response in the 
presence of the anti-T2 and T-2 toxin alone (Figure 72A–B; purple squares). The simultaneous 
addition of both antibodies to the reaction increased the complexity of the assay most likely due 
to the appearance of secondary signals caused by non-specific binding and cross-reaction 
between the two antibodies. The results showed some irregular behavior and non-specific 
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binding to the non-target peptide. For example, in the presence of both antibodies, high 
concentrations of T-2 toxin and no FB1, we could also observe a change in the signals originating 
from the FB1-mimotope A2-bio spot (Figure 72B; green squares). This might originate from non-
specific binding of the anti-T2 antibody to the A2-bio to some extent, or from non-specific binding 
of the high concentrations of T-2 toxin to the anti-FB1 antibody. In either case, possibly due to 
this unwanted response, also the specific signals from the T2-mimotope F11-bio with the T-2 
toxin were somewhat unusual (Figure 72A; green squares). Similarly, in the case of FB1, some 
irregularities were seen in the non-specific signals (Figure 72D; red circles). In the duplex assay 
with both antibodies and both toxins simultaneously, the competitive response was observed 
for both toxins (Figure 72D; orange diamonds), but as the response differed from the singleplex 
assay sufficiently, we could not conclude that the duplex assay would provide reliable results. 
Further work is required, to optimize the duplex assay for the simultaneous detection of both 
mycotoxins. To begin with, the low-dose hook effect that is seen for both toxins when both 
antibodies are present (for example Figure 72A, green squares, and Figure 72C, red circles) 
might be an indication that the antibody concentration is not optimal. In fact, the antibody 
concentrations were optimized separately and might require further testing for the duplex assay. 
Also, alternative buffer compositions might improve the observed non-specific binding. 
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Figure 72. Duplex microarray assay for the detection of FB1 and T-2 toxin. A2-bio and F11-bio were 
spotted onto the same array, and the signals were measured from both spots (A and C, A2-bio 
250 µg mL–1; B and D, F11-bio 250 µg mL–1) in the presence of anti-FB1 (blue), anti-T2 (purple), or 
both antibodies (orange, red, and green). Different concentrations of one or both toxins were tested 
(blue and red, only FB1; green and purple, only T-2 toxin; orange both toxins simultaneously). 
Results are shown as the mean fluorescence signals ± the standard error of the mean (n = 9). A 
four-parameter logistic fit (OriginPro 9.0) was used for the curve fitting. 
4.4.3 FLUORESCENT FUSION PROTEINS 
As an alternative for the use of phage-borne or synthetic mimotopes, recombinant 
peptide−protein fusions have been suggested as a fascinating option for biosensor 
development. They can be produced in bacteria cost-effectively even in large quantities. 
Moreover, the countless possibilities offered by genetic engineering enable the design of 
different fusions tailored for the purpose. The fusion can be designed to consist of a protein 
such as MBP, which can be used as an affinity tag for further purification and immobilization, or 
alternatively fluorescent or luminescent proteins can be used to provide an optical signal for the 
assay. Fluorescent proteins (FPs) which are able to emit a strong and stable fluorescence signal 
present one attractive alternative for such an approach. The use of FPs as markers for gene 
expression analysis or protein tracking within cells or organelles, is often seen to have 
revolutionized molecular biology in the last decades, and simultaneously, FPs with enhanced 
fluorescence or different spectral characteristics have become an exciting alternative for 
biosensing in both in vivo and in vitro assays. 
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 Construction of fluorescent fusion proteins for FB1 and T-2 toxin 
The mimotopes for FB1 and T-2 toxin identified in the first round of selections, namely A2 and 
F11, respectively, were used as the basis to construct fluorescently tagged mimotopes. Three 
different fluorescent proteins (FPs) with a distinguishable spectrum were chosen to prepare the 
fluorescently-tagged mimotopes. ZsYellow and mOrange were both used in combination with the 
FB1-mimotope A2 whereas EmGFP was fused with the T2-mimotope F11. To construct the 
translational mimotope-FP fusion by PCR amplification, a long 5’-overhang was used in the 
forward primer to amplify the gene encoding for the FP, resulting in an N-terminal fusion with 
the mimotope. The same linker (GGGS) between the pIII and the mimotope that was present in 
the pannings was included in the fusion protein design, to ensure sufficient space between the 
mimotope and the FP. Additionally, a polyhistidine tag was added to the C-terminus of the FP for 
purification, likewise, with a 5’-overhang in the reverse primer. Table 17 summarizes the primers 
used to create the mimotope-FP fusions which were subsequently subcloned into the pQE-T7-2 
expression vector using KpnI and SacI restriction enzyme sites (Figure 73A). Successful cloning 
was confirmed by DNA sequencing, and moreover, bright fluorescence emission after inducing 
the protein expression was a clear indicative of successfull clonage. 
Table 17. Primers used to create the fluorescently-tagged mimotopes. The mimotope sequences (A2 or 
F11) are shown in bold, restriction enzyme sites in cursive, and the sequence hybridizing to the 
fluorescent protein is underlined. 
Primer name Sequence (5’→3’) 
FP-SacI-V5-ZsYellow TTCGAGCTCATGGTTACTCCGAATGATGATACGTTTGATCCTTTTCGGGGTGGAGGTTCGGCTCATTCAAAGCACGGTCTA 
RP-KpnI-6H-ZsYellow GCTGGTACCTCAGTGGTGGTGGTGGTGGTGGGCCAAGGCAGAAGGGAATGC 
FP-SacI-V5-mOrange TTCGAGCTCATGGTTACTCCGAATGATGATACGTTTGATCCTTTTCGGGGTGGAGGTTCGGTGAGCAAGGGCGAGGAGAAT 
RP-KpnI-6H-mOrange GCTGGTACCTCAGTGGTGGTGGTGGTGGTGCTTGTACAGCTCGTCCATGCC 
FP-SacI-F11-EmGFP TTCGAGCTCATGGGGTATGGGTCTATTCTTCCTTTTAATCCGGTGTTTGGTGGAGGTTCGGTGAGCAAGGGCGAGGAGCTG 
RP-KpnI-6H-EmGFP-v2 GCTGGTACCTCAGTGGTGGTGGTGGTGGTGCTTGTACAGCTCGTCCAT 
 
The FP-tagged mimotopes were then purified from the crude cell extracts by affinity 
chromatography using the C-terminal polyhistidine tag (Figure 73C). The emission spectra of the 
purified fusions proteins (Figure 73B) were very similar to those reported in the literature for the 
intact FPs. The measured emission maxima were 511 nm, 541 nm, and 566 nm for F11-EmGFP, 
A2-ZsYellow, and A2-mOrange, respectively, also similar to those reported in the literature for 
EmGFP, ZsYellow, and mOrange (511 nm, 540 nm, and 564 nm, respectively). 
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Figure 73. (A) Main features of the expression vector for fusion proteins consisting of the mimotope 
(A2 or F11) and fluorescent protein ZsYellow, mOrange, or EmGFP. (B) Fluorescence emission 
spectra and emission maxima of the purified fusion proteins, A2-ZsYellow (yellow), A2-mOrange 
(red), and F11-EmGFP (green). The dashed lines represent the emission spectra reported in the 
literature. Excitation wavelengths were 472 nm, 490 nm, and 520 nm for EmGFP, ZsYellow, and 
mOrange, respectively. (C) Purification of the F11-EmGFP by HisTrap was monitored by SDS-PAGE 
analysis. Lane 1 unpurified lysate; 2, HisTrap flow-through; 3, Elution; M, molecular marker. 
Binding of the purified fusion proteins was tested using the mycotoxin specific antibody, anti-
FB1 or anti-T2, immobilized to the microtiter well plate. Low non-specific binding to the plate 
without the antibody was seen, and in the case of A2-ZsYellow and F11-EmGFP high specific 
binding was observed to the anti-FB1 and anti-T2 antibodies, respectively (Figure 74). Curiously, 
A2-mOrange did no bind to its target antibody, but similar signals were observed in both target 
and control wells. The measured emission showed that the FP expression was successfll, but it 
was evident that the mimotope was not capable of binding its target. It is possible that despite 
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of the linker that was used, the FP might cause steric hindrance preventing the binding, or that 
protein folding in the context of this FP in particular had an unwanted effect on the mimotope 
recognition. Regardless of the negative outcome of the experiments with A2-mOrange, the 
concept of FP-tagged mimotopes was further studied using the F11-EmGFP and in particular, 
A2-ZsYellow which showed excellent performance in the immunoassays. Later, in publication III, 
a new ZsYellow-fusion, A2-YFP (PA031) was constructed, and a TEV-cleavage site was included 
before the polyhistidine tag in order to remove the tag after the purification. This fusion protein 
was used to develop heterogeneous and homogeneous immunoassays for FB1 detection, as 
discussed in publications III–IV. 
 
Figure 74. Binding of the fluorescent fusion proteins to their target antibody (200 ng of anti-FB1 or 
anti-T2 per well) and background binding (dark green) to the plate in the absence of the antibody. 
(A) A2-ZsYellow (anti-FB1-coating yellow; excitation at 490 nm), (B) A2-mOrange (anti-FB1-coating 
orange; excitation at 520 nm), (C) F11-EmGFP (anti-T2 coating green; excitation at 475 nm). 
 Fluorescent protein microarray 
The FP-tagged mimotopes were also applied in a microarray-based immunoassay format. This 
work was carried out collaboration with Dr. Ursula Sauer from Austrian Institute of Technology 
(AIT). In this case, the toxin-specific antibodies were spotted on the array and binding of the FP-
tagged mimotopes in the presence of different concentrations of the target toxins was studied. 
In comparison with the previously described microarray with the synthetic peptides, the FP-array 
could have the potential to provide shorter and simpler assay protocols since no secondary 
antibodies are required. In the preliminary experiments, the direct binding of FP-tagged 
mimotopes, A2-ZsYellow and F11-EmGFP, to the spotted anti-FB1 and anti-T2 antibodies was 
studied to confirm the functionality of the mimotopes and the specificity of the binding. Both 
mimotopes showed binding to their target antibody, although some non-specific binding was 
observed as well (Figure 75). The highest antibody concentration (500 µg mL–1) tested provided 
the best signal-to-background ratio and was chosen for the subsequent experiments. 
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Figure 75. Binding of the fluorescent fusion proteins to their target antibody in the microarray. 
Binding of different concentrations of A2-ZsYellow to (A) the target anti-FB1 antibody and (B) the 
non-target anti-T2 antibody. Binding of different concentrations of F11-EmGFP to (C) the non-target 
anti-FB1 antibody and (D) the target anti-T2 antibody. Different concentrations of the antibodies 
were spotted onto the microarray, 500 µg mL–1 (purple), 250 µg mL–1 (orange), 100 µg mL–1 (blue), 
50 µg mL–1 (green), and 20 µg mL–1 (red). The signals are depicted as the average of three replicate 
spots in three replicate arrays ± standard error of the mean (n = 9). 
Next, the competitive assay was tested with both toxins and mimotope-fusions separately. 
Competitive inhibition was observed in the presence of the toxins, but the assay sensitivity and 
reproducibility were rather poor (Figure 76). For both toxins, the use of 5 µg mL–1 FP-tagged 
mimotope showed the best response, but the results were not promising, and thus the duplex 
assay was not implemented. However, the A2-YFP was successfully applied to FB1 detection in 
heterogeneous plate- and bead-based assays as well as in homogeneous quenching 
immunoassay (publications III and IV). Ongoing work with the F11-EmGFP intends to find out if 
the fusion could provide a robust means for T-2 toxin detection. 
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Figure 76. Microarray-based competitive immunoassays using fluorescent proteins (A) A2-ZsYellow 
and (B) F11-EmGFP for the detection of FB1 and T-2 toxin, respectively. Binding of the fluorescent 
fusion proteins to their target antibody in the microarray in the presence of the target mycotoxin. 
The anti-toxin antibodies (500 ng mL–1) were spotted onto the same microarray and binding of the 
mimotope-tagged fluorescent protein (green 2.5 µg mL–1, red 5 µg mL–1, or blue 10 µg mL–1) was 
tested with different toxin concentrations. The signals are depicted as the average of three 
replicate spots in three replicate arrays ± standard error of the mean (n = 9) and fitted with a four-
parameter logistic fit (OriginPro 9.0). 
 Optimization of the homogeneous quenching immunoassay 
The homogeneous quenching immunoassay presented in publication III was based on the use 
of the fluorescent YFP-tagged mimotope A2 and AuNPs. The simple homogeneous one-step 
assay provided good sensitivity in only 20 min without the need for washing steps. Various 
parameters of the homogeneous assay were optimized, including the reaction volume, 
temperature, plate blocking, buffer, and AuNP blocking (Figure 77). The total reaction volume 
(60–100 µL) did not have significant effects on the assay sensitivity or reproducibility  
(Figure 77A). The lowest volume used provided a slightly better response, and moreover, would 
result in lower reagent consumption and was thus selected for the subsequent experiments. It 
was also concluded that neither a prior blocking of the wells nor a pre-incubation step with the 
A2-YFP and anti-FB1 before adding the AuNPs improved the results (Figure 77B). The incubation 
temperature (between +26°C and +37°C) did not have any significant effects on the sensitivity 
either (Figure 77C), whereas the assay buffer was seen to change the response considerably 
(Figure 77D). The presence of the surfactant Tween-20 in the assay buffer resulted in 
significantly lower absolute signals, as well as worse signal-to-background ratios. The best 
response was obtained 10 mM phosphate buffer (pH 8.0) supplemented with 0.1% BSA. As the 
low total reaction volume was concluded to provide the best results, the assay was also 
performed in a 384-well plate instead of the 96-well plate. However, the 96-well plate provided 
better reproducibility and signal-to-background ratios (Figure 77E). Finally, blocking of the AuNPs 
after protein G coupling was optimized. Blocking with PEG instead of BSA was tested and 
resulted in lower background signals, although at the same time, also lower maximum signals 
were observed (Figure 77F). Thus, the experiments were continued with the BSA blocking which 
was also used in the assay buffer to prevent the non-specific binding. 
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Figure 77. Optimization of the homogeneous quenching immunoassay with A2-YFP. Experiments 
were completed with (A) different reaction volumes, 60 µL (red), 80 µL (green), or 100 µL (violet), 
(B) with a prior blocking of the plate with Starting block (blue) or Protein free blocking buffer (green), 
in comparison with wells without blocking (red and violet, with and without pre-incubation before 
adding the gold, respectively), (C) at different temperatures, +26°C (red), +30°C (green), or +37°C 
(violet), (D) using different assay buffers, 10 mM phosphate buffer, pH 8, with 0.1% BSA (red), 0.5% 
BSA (violet), or 0.1% BSA and 0.05% Tween-20 (green), (E) in a 96-well plate (violet) or 384-plate 
(green) at a total reaction volume of 60 µL in both cases, and (F) alternative blockings of the 
AuNP:protGs either with 0.1% BSA (red), or 0.1% PEG-6000 (blue). 
The AuNPs used in publication III were prepared a step-by-step growing procedure, and the 
process resulted in seven generations of AuNPs with increasing sizes. Based on the plasmon 
peak, the sizes of different generations varied between 17 and 72 nm. In parallel with the 
experiments reported in publication III with generations 0, 3, and 6 (17 nm, 36 nm, and 72 nm 
AuNPs, respectively), also the in-between generations (1–4) were tested in the quenching assay. 
First, different concentration of the AuNPs coated with protein G were evaluated to confirm their 
quenching ability and determine the concentration providing the best response (Figure 78). 
Comparison of the fluorescence emission measured in the presence and absence of FB1 was 
used to calculate the signal-to-background ratios and determine the AuNP concentration of each 
generation resulting in the best sensitivity. Fluorescence quenching, as well as competition with 
the free FB1, was observed with all generations, although the best results were obtained with 
the smallest AuNPs (generation 0, 17 nm). Similar results were seen in the competitive assay 
with different FB1 concentrations (Figure 79), and it was evident that the larger the AuNP, the 
lower were the signal-to-background ratios obtained. Publication III reports the application of the 
optimized assay with the generation 0 AuNPs to the analysis of spiked wheat samples. 
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Figure 78. Fluorescence quenching with different sizes of AuNPs (A) Generation 0; 17 nm, 
(B) Generation 1; 27 nm, (C) Generation 2; 30 nm, (D) Generation 3; 36 nm, (E) Generation 
4; 54 nm, (F) Generation 6; 74 nm. Signals measured in the absence of FB1 (red) and in the 
presence 40 µg mL–1 FB1. The ratio (Max/min) between these two signals is shown in the 
right y-axis (blue diamonds). The fluorescence signals are depicted as the average of 
replicate samples ± the standard error of the mean (n = 3). 
 
Figure 79. Calibration curves with all AuNP generations, 0 (red), 1 (orange), 2 (yellow), 3 
(green), 4 (blue), and 6 (violet). The fluorescence signals are depicted as the average signal-
to-background ratio ± standard error of the mean (n = 3) and fitted with a four-parameter 
logistic fit (OriginPro 9.0). 
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4.4.4 BIOLUMINESCENT FUSION PROTEINS 
In an alternative, yet similar, approach to the FP-tagged mimotopes, the mimotopes for FB1 (A2), 
ZEA (SF and GW), and T-2 toxin (F11 and T13) were used to construct fusion proteins with a 
bioluminescent protein Gaussia luciferase (GLuc). This work was carried out in collaboration 
with the group of prof. Sylvia Daunert from University of Miami. In a similar manner to the FP, 
the bioluminescent GLuc could provide a measurable feature for the mimotope and could be 
used as the tracer in the immunoassay. Moreover, owing to the intrinsic nature of 
bioluminescence, the measurement could be accomplished without the need for an excitation 
light source and the enzymatic activity of the luciferase was thought to improve the assay 
sensitivity. In parallel with GLuc-tagged mimotopes (A2-GLuc and SF-GLuc) described in 
publication V, we constructed GLuc-fusions also of the mimotopes F11, T13, and GW to compare 
which fusion could provide the best response for the detection of ZEA and T-2 toxin. After 
expression and purification of the GLuc-tagged mimotopes, direct binding of the proteins to their 
target antibody was tested to confirm the specific binding to the antibody. Good signal-to-
background ratios were observed with different concentrations of A2-GLuc, SF-GLuc, and GW-
GLuc (Figure 80A–C), which exhibited significantly higher luminescent signals from the wells 
coated with anti-FB1, or anti-ZEA antibodies, in comparison with the background wells without 
the antibody. The persistently challenging T2-mimotopes showed some specific binding to the 
anti-T2 antibody, but the non-specific binding to the background wells was substantial for both 
F11-GLuc and T13-GLuc fusion proteins (Figure 80D–E). 
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Figure 80. Binding of the GLuc-fusion protein to their target antibody and background 
binding to BSA-coated wells (blue squares). (A) A2-GLuc binding to immobilized anti-FB1 
(red), (B) SF-GLuc and (C) GW-GLuc binding to anti-ZEA (green), (D) T13-GLuc and (E) F11-
GLuc binding to anti-T2 (orange). 
A checkerboard-type titration was performed with all the mimotope fusions in order to determine 
the optimal concentrations of the immobilized antibody and the GLuc-tagged mimotope for the 
competitive assay. For the FB1 assay, different concentrations of A2-GLuc (0.125–1 µg mL–1) 
were combined with varying concentrations of the immobilized anti-FB1 (50–400 ng per well). 
The highest concentration of A2-GLuc together with the highest amount of the antibody resulted 
in most intense bioluminescent signals, but a similar trend was also seen in the presence of 
free FB1 in the reaction (Figure 81). To obtain the best sensitivity in the competitive assay, those 
concentrations of A2-GLuc and anti-FB1 that provided the best signal-to-background ratio, in the 
absence and presence of FB1 (0.25 µg mL–1 A2-GLuc with 50 ng of anti-FB1), were selected for 
the subsequent experiments. Similarly, the concentrations of SF-GLuc and GW-GLuc were 
optimized together with the amount of anti-ZEA (Figure 82), in the presence and absence of free 
ZEA in the reaction. A further experiment with SF-GLuc, and different amounts of anti-ZEA (10–
1000 ng per well), was carried out in order to determine if the dynamic range of the assay could 
be improved with higher amounts of the immobilized antibody. The results showed that low 
amounts of the antibody (10–20 ng) could not provide sufficient signals in the absence of the 
toxin, but higher amounts showed increasing signals (Figure 83A). Although all antibody 
concentrations showed the competition with high concentrations of ZEA, the best sensitivity was 
seen with 50 ng of anti-ZEA per well. 
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Figure 81. Checkerboard titration with A2-GLuc (A) without (red) and (B) with 5 ng mL–1 FB1 (blue). 
Various concentrations of the immobilized antibody (50–400 ng/well) and A2-GLuc (0.125–1 µg 
mL–1) were tested in both conditions and those resulting in the highest signal-to-background ratios 
were selected for the subsequent experiments. 
 
Figure 82. Checkerboard titration with (A–B) GW-GLuc and (C–D) SF-GLuc without (violet) and with 
1 ng mL–1 ZEA (green). Various concentrations of the immobilized antibody (50–100 ng/well) and 
mimotope-GLucs (0.04–0.52 µg mL–1) were tested in both conditions, and those resulting in the 
highest signal-to-background ratios were selected for the subsequent experiments. 
Next, a calibration curve with 0–30 ng mL–1 of ZEA was performed using the optimized 
concentrations of the immobilized anti-ZEA and SF-GLuc, or GW-GLuc. Both assays showed good 
sensitivity for ZEA detection with similar IC50 values (0.45 ± 0.05 ng mL–1 and 0.60 ± 
0.03 ng mL–1 for GW-GLuc and SF-GLuc, respectively). Although GW-GLuc provided a slightly 
better sensitivity, the assay with SF-GLuc proved to be more reproducible in terms of intra- and 
interday variations and was thus designated as the best mimotope for ZEA detection. 
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Figure 83. Optimization of the ZEA assay. (A) Various antibody concentrations were tested 
in the assay (10–1000 ng/well) but the lowest concentrations (10–20 ng; red and orange) 
did not result in good signals. Best sensitivity was seen with 50 ng (blue) whereas higher 
concentrations resulted in higher absolute signals but lower sensitivity. (B) Comparison of 
the optimized assay with GW-GLuc (blue) and SF-GLuc (orange). The signals are depicted as 
the average of three replicate spots in three replicate arrays ± standard error of the mean 
(n = 9). A four-parameter logistic fit (OriginPro 9.0) was used to estimate the assay 
sensitivity. 
Also for the detection of T-2 toxin, the bioluminescent immunoassay was further optimized with 
F11-GLuc despite the high background signals observed. In the checkerboard titration, 
competition with a high concentration of T-2 toxin (1000 ng mL–1) was observed to some extent, 
and the antibody and F11-GLuc concentrations providing the best signal-to-background ratio 
(100 ng per well and 1 µg mL–1, respectively) were used in the further attempts to improve the 
assay performance. 
 
Figure 84. Checkerboard titration with F11-Gluc (A) without (blue) and (B) with 1000 ng mL–1 T-2 
toxin (brown). Various concentrations of the immobilized antibody (50–400 ng/well) and F11-GLuc 
(0.1–2 µg mL–1) were tested in both conditions and those resulting in the highest signal-to-
background ratios were selected for the subsequent experiments. 
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Different blocking buffers (3% BSA, 10% BSA, Protein-free blocking buffer, StartingBlock, 
Casein, and SuperBlock) were tested to determine if the extent of the non-specific binding to the 
plate could be reduced (Figure 85A). Some differences were observed in the signal levels, but 
none of the buffers tested provided significant improvements to the non-specific binding. The 
competitive assay was further tested with different concentrations of T-2 toxin  
(0–1000 ng mL–1) using alternative buffers (Figure 85B). The best results were obtained adding 
0.1% or 1% BSA in the assay buffer, but the assay did not provide enough sensitivity for the 
detection of T-2 toxin in food samples. Further optimization of the assay protocol might present 
some improvements in the response, but, unfortunately, so far, the experiments with 
bioluminescent T-2 toxin assay have been somewhat unsuccessful. 
 
Figure 85. (A) Optimization of T-2 toxin assay with the immobilized anti-T2 and F11-GLuc without 
(blue) and with 2000 ng mL–1 T-2 toxin (red) using different blocking buffers. PFBl, Protein-free 
blocking buffer, StartBl, Starting block; SuperBl, SuperBlock (all from ThermoScientific)  
(B) Competitive T-2 toxin assay with F11-GLuc in StartingBlock (green triangles), 1% BSA (red 
diamonds), or in 0.1% BSA (violet squares). 
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4.5  Discussion 
 
Fusarium genus includes more than 70 described species, many of which are common plant 
pathogens worldwide. Moreover, many species in this family are notorious producers of 
mycotoxins and owing to the natural origin of these toxins, mycotoxin contamination in both food 
and feed is often inevitable. The toxicity of these compounds even at low concentrations has 
necessitated the need for sensitive and reliable methods for their detection.222 At the same time, 
in order to detect mycotoxins or prevent mycotoxin formation, it is considered essential to 
identify the producers of these toxins. While conventional culture-based methods for fungal 
detection are time-consuming and challenging, especially if the species have similar 
morphologies, molecular methods based on highly specific DNA primers or probes are capable 
of distinguishing even closely related species. The genosensors developed in this work for the 
detection of F. proliferatum and F. verticillioides enabled detection of the synthetic target DNA 
at low pM levels and could be applied to analyze Fusarium contamination in maize after PCR 
amplification of the genomic DNA. The developed sensors could provide a valuable tool to 
evaluate the potential for mycotoxin contamination in conditions where direct detection of 
mycotoxins is challenging. Moreover, the suggested microfluidic approach, which yet remains in 
its preliminary stage, presents an interesting alternative for the development of an integrated 
method which might be able to achieve better sensitivities, faster analysis times, and lower 
reagent consumption than conventional methods. 
Another interesting approach in the future would be to combine the genosensors with the 
immunoassays described in this work, in order to investigate the simultaneous occurrence of 
mycotoxin-producing Fusarium species and fumonisins. Although some studies have reported 
this kind of correlation between the mycotoxin concentrations and the presence of the fungi,318 
it remains essential to detect also the mycotoxins themselves to determine what kind of threat 
they might pose to the consumer. The establishment of national and international regulations 
has been an important incentive for the development of new analytical methods with high 
sensitivities. However, some experts have also expressed their concern about the fact that the 
regulatory limits are set according to the toxin concentrations detected with the most 
sophisticated methodology, rather than being consistent with the toxic levels.10 
Regulations exist, not only for the presence of mycotoxins in different food commodities, 
but also for the sampling protocols, and in fact, regulatory agencies have even set improvements 
in sampling of food and feed products as one of their priorities.16,25 The wide variety of food 
matrices and the often heterogeneous distribution of the toxins within the sample makes this 
step one of the most crucial parts of the analysis and is often also associated with the largest 
source of variability.16 Sample preparation has also been reported to affect the analysis of 
toxigenic fungi in addition to the analysis of mycotoxins.367 Matrix-dependent recoveries have 
been reported, for example, for fumonisins which tend to exhibit a strong interaction with matrix 
macroconstituents.368 Another challenge for the development of new methods of analysis is the 
lack of certified reference materials for certain toxins and different food matrices.25 
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In general, the small size of mycotoxins, or equally other small molecular weight 
contaminants, has hindered the development of analytical methods for routine use. 
Conventional methods, typically based on chromatography, can provide accurate and precise 
detection but are often time-consuming, or require complex and expensive instrumentation. 
Such methods, mostly based on HPLC coupled with MS-detection, have been advocated by 
international organizations as reference methods for the analysis of these compounds,369 and 
recent research efforts have focused particularly on the development of multi-analyte 
methods.370 However, these analyses require extremely careful sample preparation to avoid any 
analyte losses during this step due to the chemical differences between the target molecules. 
For example, fumonisins have proven to be a challenging target in such approaches.371 
Biosensors and bioanalytical assays have the potential to overcome some of the 
limitations of chromatographic methods, mainly related to the cost and high throughput 
potential, and they can be regarded as valuable complements for food safety applications due 
to their merits in simplicity, rapidity and low cost while maintaining the required sensitivity and 
specificity. Evidently, molecular recognition plays a key role in biosensors, and the recognition 
element lies at the heart of all biosensing applications. One of the aims of this thesis has been 
to study alternative recognition elements which could improve mycotoxin analysis. Various 
natural and bioinspired recognition elements have been described in the literature for mycotoxin 
sensors, and although monoclonal and polyclonal antibodies still at large continue their reign as 
the recognition element of choice in many applications, alternative methods have the potential 
to overcome some of their limitations.193 At the same time, a myriad of different label 
technologies and transduction schemes have been described for mycotoxin detection, many of 
them with excellent sensitivity and performance. Moreover, owing to their unique 
physicochemical characteristics, various nanomaterials have also gained increasing attention 
for biosensor development.372,373 
Biosensors can be implemented in integrated systems which are capable of fully 
automated processes. Miniaturization enables the use of samples, or sample extracts, down to 
nanoliter volumes and often leads to an increased speed of analysis using small footprint 
devices. However, despite the technical advances of integrated systems, the challenge of 
integrating the sampling and processing of solid samples, in particular in miniaturized analytical 
systems, remains yet to be tackled.370,374 Although a variety of emerging technologies have been 
reported for rapid mycotoxin measurements, so far, they have not been implemented for 
commercial usage, and ELISA and lateral flow assays continue to be among the most popular 
methods for simple mycotoxin analysis.374 Table 18 presents examples of commercially 
available test kits for fumonisin, ZEA, and T-2 toxin detection.  
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Table 18. Examples of commercially available test kits for the detection of fumonisins, 
zearalenone, or T-2/ HT-2 toxin. 
Test 
(company) Test type Target toxin Detection range Test time Ref. 
Veratox 
(Neogen) ELISA 
FB 
T-2/HT-2 
ZEA 
50–600 ppb 
25–250 ppb 
25–500 ppb 
10–15 min 375 
Reveal Q+ 
(Neogen) LF 
FB 
T-2/HT-2 
ZEA 
0.3–6 ppm 
50–600 ppb 
50–1200 ppb 
6 min 375 
Rosa Fast 
(Charm) LF 
FB 
T-2/HT-2 
ZEA 
0.5–1.5 ppm 
25–200 ppb 
100–350 ppb 
5–10 min 376 
QuickTox Kit 
(Envirologix) LF 
FB 
T-2/HT-2 
ZEA 
0.2–20 ppm 
25–2500 ppb 
50–520 ppb 
5 min 377 
AgraQuant 
(Romer Labs) ELISA 
FB 
T-2 
ZEA 
200–5000 ppb 
10–500 ppb 
20–1000 ppb 
15 min 378 
AgraStrip 
(Romer Labs) LF 
FB 
ZEA 
150–30000 ppb 
30–1000 ppb 3 min 
378 
EuroProxima ELISA FB T-2 toxin 
LOD 1–2 ppb 
LOD 20–50 ppb 1h 30min 
379 
Abbreviations: FB, fumonisins; ELISA, enzyme-linked immunosorbent assay; LF, lateral flow; ZEA, zearalenone. 
One of the aims of this thesis was the development of methods of the detection of mycotoxins 
in food samples. The main part of this work focused on the development of mimotope-based 
immunoassays for the detection of FB1, ZEA, and T-2 toxin. Mimotopes for each toxin were 
selected by phage display from the same commercial peptide library using the toxin-specific 
antibody as the target. The degree of success in the selections varied for different toxins, ranging 
from the excellent mimotopes found for FB1 and ZEA to the mediocre or rather poor mimotopes 
identified for T-2 toxin, which could be considered as an indicator of the delicate nature of phage 
display. Despite being a robust and widely used, or even a revolutionary technology, it is 
susceptible to particular risks. The complicated and demanding side of phage display was 
uncovered in the quests of mimotopes for the T-2 toxin, as well as with the fruitless attempts to 
select anti-immune complex peptides and anti-toxin antibody fragments. At its best, the 
immense potential of phage display for different applications is undeniable, but the technology 
can also prove itself time-consuming and inconclusive. 
Nonetheless, the successful selection of mimotopes for FB1 and ZEA was followed by the 
application of these peptides to various methods developed for the detection of these toxins. 
The use of mimotopes could circumvent the conjugation of the toxins themselves to a label or a 
carrier protein, and the immunoassay could be performed using the mimotope as the 
competitor. Thus, one cumbersome and time-consuming, not to mention often expensive, step 
to prepare the mycotoxin-conjugate could be avoided, and at the same time, the mimotope 
Results and discussion 
220 
assay could be described to be more user-friendly, as it did not require toxic compounds except 
as the calibrants. 
Among the various immunoassays developed in this work, a comparison revealed that the 
synthetic peptide assay with magnetic microbeads provided the best sensitivity. This outcome 
could be traced back to the slightly lower affinity of the synthetic peptide in comparison with the 
recombinant fusion protein. Thus, the synthetic peptide could provide better sensitivity since 
lower amounts of the target was required to observe the competition. On the other, magnetic 
microbeads as the solid support could provide efficient capture of the biotinylated mimotope 
after a homogeneous pre-incubation step in solution with the target toxin and the antibody, and 
the enzymatic detection with HRP-labeled secondary antibody led to signal amplification. It will 
be curious to see if a similar behavior will be observed in the case of ZEA as future work aims to 
develop a similar assay based on the synthetic ZEA-mimotope and magnetic beads for ZEA 
detection and compare the performance to the assays described in this work using the phage-
displayed mimotope and bioluminescent fusion protein. 
The recombinant fusion proteins, consisting of the mimotope tagged with a fluorescent or 
bioluminescent protein, provided an exciting alternative for the synthetic mimotopes. After 
constructing the heterologous fusions by genetic engineering, the recombinant proteins could 
be produced cost-effectively in bacteria even in high amounts. Moreover, the recombinantly 
produced fusion proteins guaranteed a fixed stoichiometry between the fusion partners and 
could avoid issues related to batch-to-batch variations or heterogeneous conjugates that are 
often observed as the product of chemical conjugation reactions. Notably, the recombinant 
fusion proteins could then be directly used in the assays without the need for further labeling or 
secondary antibodies. Thus, the assay protocol could be simplified and shortened. Further 
simplification was achieved by implementing a homogeneous assay based on the fluorescently 
tagged mimotope and gold nanoparticles. The excellent fluorescence quenching efficiency of 
AuNPs via nanoparticle surface energy transfer was demonstrated to be an attractive feature 
for homogeneous assay development, and the use of His-tag-mediated AuNP coating provided 
a flexible and facile manner to create protein-conjugated AuNPs. Overall, the simplicity and 
analytical performance of the quenching assay provided an elaborated yet powerful tool for rapid 
analysis of mycotoxins in food samples. 
Finally, it should be noted that the aim of the work described in this thesis has been to 
develop new methods for mycotoxin analysis, and it is important to underline that, at this point, 
the majority of the analysis has been done in buffer and only a few spiked samples were tested. 
Although these preliminary experiments have shown promise as the first step towards the 
development of new analytical methods and such sample analysis can be considered as 
sufficient test for proof-of-concept analysis, in the future it must be broadened to analyze real 
samples. Moreover, within the scope of this thesis, sample extraction protocols did not receive 
particular, and perhaps sufficient, attention although undoubtedly sampling and sample 
treatment are possibly one of the most critical issues to be considered for mycotoxin analysis. 
For optimal mycotoxin extraction, appropriate extraction conditions should be optimized to 
achieve high yields and minimal interference with the detection method. Despite how sensitive 
the analytical method is, should the sample not represent correctly the real situation, everything 
else is vain. 
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5 Summary and 
conclusions    
 
Nature produces a variety of different species, among which fungi play an important yet 
somewhat unexplored role. The widespread occurrence of pathogenic or mycotoxigenic fungi 
has spurred the development of new analytical methods to detect and identify these species. 
Moreover, the toxic nature of many fungal secondary metabolites, mycotoxins, has been 
reported as a major threat to public health not to mention the massive economic losses caused 
every year due to fungal and mycotoxin contaminations. Years of research have made it evident 
that early detection of both, fungi and mycotoxin contamination, could improve the living 
conditions around the world. Moreover, an important motivation for the development of new 
methods has been the establishment of national and international regulatory limits designed to 
guarantee food safety for the consumers. 
Nowadays, biosensing methods are able to compete with traditional culture-based or 
chromatographic techniques for the detection of mycotoxigenic fungi and mycotoxins. These 
methods are often able to provide rapid, sensitive, selective, robust, and cost-effective analysis 
of these targets in food samples. Optical biosensors, in particular, can be considered ideal for 
conditions where expensive or bulky instrumentation cannot be used, or trained personnel is 
not available to perform the analysis. Biosensor technologies have been a rapidly evolving field 
during the past decades, but for environmental and food safety applications they still have been 
partly described to be in their infancy, especially for real sample analysis. The challenging 
sample matrices are complex in nature and can often interfere with the detection of the target 
analytes in biosensors. 
A wide variety of different biosensor concepts have been reported in the literature based 
on various recognition elements and transduction schemes, and it is hardly possible, nor 
necessary, to design one optimal platform for every situation. In this work, we have aimed to 
develop new biosensors for mycotoxin analysis, which could offer comparable or better 
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sensitivities, along with simplified methodologies and concepts in comparison with currently 
available devices, and that could be integrated into simple systems and transferred to low-
resource settings or conditions in the field. Saying this, it is clear that the novel methods 
presented here are far from complete as they still require laboratory expertise and equipment, 
or rely on bulky and expensive instrumentation, such as a microplate reader or a microarray 
scanner. However, notably, these biosensors show potential for further implementation into 
integrated systems. 
 
The main conclusions based on the publications presented in this thesis are summarized in the 
following section: 
 
In the first part of this thesis (publication I), we developed novel genosensors for the 
detection of two fungal species which are among the most common ones found in maize and 
are responsible for producing several mycotoxins. Fusarium proliferatum and Fusarium 
verticillioides are closely related fungi with highly similar morphologies, which makes their 
identification challenging. Based on the species-specific capture and detection probes designed 
on the intergenic spacer (IGS) region sandwich hybridization assays for both species were 
implemented. The optimized assay protocol with enzymatic detection had detection limits of  
1.8 pM and 3.0 pM for F. proliferatum and F. verticillioides, respectively, using synthetic DNA 
targets. In addition, a common primer pair was designed to amplify both Fusarium species 
simultaneously, and thus, after PCR amplification of the IGS region, the genosensors could be 
applied to the analysis of naturally contaminated maize sample. The sensors could detect the 
presence of both fungi species separately and simultaneously in contaminated maize samples, 
in consistency with previous results obtained by PCR. No cross-reactivity between 
F. verticillioides and F. proliferatum, or other fungi species tested, was observed. The developed 
sensors can provide a valuable tool to evaluate the potential for mycotoxin contamination in 
conditions where detection of mycotoxins directly is challenging. Furthermore, ongoing efforts 
aim to integrate this assay into a microfluidic platform to develop a simple, robust, and 
potentially an even fully automated method for the detection of mycotoxigenic Fusarium species 
in food samples. 
The second and major part of the thesis focused on the development of bioanalytical 
methods for the detection of mycotoxins. The first publication on fumonisin detection 
(publication II) described the discovery of the fumonisin mimotope and laid the foundation of its 
application in different biosensing schemes (publications III–V). Selection of the mimotopes for 
fumonisin (publication II), and later for zearalenone (publication V) and T-2 toxin (unpublished), 
from the commercial phage display peptide library, gives an idea about the versatility of these 
libraries and the enormous potential of phage display in the quest for new recognition elements. 
Publication II presented a novel immunoassay for fumonisin detection based on a 
microarray format. This approach based on the synthetic mimotope allowed detection of 
fumonisin B1 in ng mL–1 range and could be applied to the analysis of spiked wheat and maize 
samples at the levels set by European legislation. Perhaps the most interesting outlook of this 
approach would be to include other mycotoxins in the same array to embrace the full potential 
of microarrays for multiplexed detection. Preliminary efforts envisioned the introduction of  
T-2 toxin as a second target for duplex detection with the microarray; however, the approach 
requires still further work and optimization. 
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In publications III and V, the mimotopes for fumonisin and zearalenone were produced 
recombinantly as fusion proteins with fluorescent and bioluminescent proteins. These 
approaches allowed us, not only to have our own, in principle, unlimited source of the fusion 
protein from a bacterial expression system, but also the mimotopes were readily produced with 
a label and could be directly used in the assay, without the need for further labeling or a 
secondary antibody. The immunoassay for FB1 with the fluorescent fusion protein, A2-YFP, 
provided a limit of detection and IC50 value of 0.3 ng mL–1 and 1.7 ng mL–1, respectively, in the 
magnetic bead–based heterogeneous assay, which demonstrated not only that the YFP-tagged 
mimotope could function as the competitor in the assay but also that the assay format and the 
YFP as a label could provide good sensitivity. The bioluminescent immunoassays based the 
mimotope-GLuc fusions enabled even higher sensitivities than the fluorescence-based ones 
with limits of detection and IC50 values of 0.2 ng mL–1 and 1.3 ng mL–1, respectively, for FB1, 
and 0.09 ng mL–1 and 0.35 ng mL–1 for ZEA. On the other hand, publication IV aimed to develop 
a rapid one-step immunoassay based on the fluorescent fusion protein using functionalized gold 
nanoparticles as fluorescence quenchers. Although the sensitivity in terms of the IC50 value, 
12.9 ng mL−1, was slightly worse than for the heterogeneous formats, the simple one-step 
protocol showed excellent performance for sample analysis with a significant decrease in the 
assay time. 
Altogether these results (publications II–V) demonstrate the versatility of mimotopes for 
biosensing. Once a good mimotope had been identified it can be used directly in the phage-
displayed format, or as the synthetic peptide or as a recombinant fusion protein. Each mimotope 
format has its advantages, and the most appropriate option can be selected depending on the 
application. Whilst the phage-displayed format is perhaps the simplest one after selecting the 
mimotopes from a phage library, and in principle can be used even without actually identifying 
the peptide sequence, the phage is inherently large in size and its biologically active nature 
might be disadvantageous for analytical purposes. The well-established synthesis of short 
peptides makes them also an attractive alternative. In publications II and IV, the synthetic 
fumonisin mimotope with a biotin-linker was immobilized to the microarray or on the magnetic 
beads surface via neutravidin and was used in the immunoassay. Studies in publication IV 
demonstrated that the best sensitivity among the different mimotope assays tested could be in 
fact achieved using the synthetic mimotope. The construction of recombinant fusions is perhaps 
more cumbersome than ordering the synthetic peptide, but once constructed it can provide an 
exhaustive source of the fusion protein which can be produced readily with a label.  
Publication IV could be considered as a summary of the work done in this thesis, although 
it did not cover the later work with the bioluminescent proteins. The aim of this publication was 
to compare the different mimotope and assay formats. For a fair comparison of the mimotopes, 
we performed analysis of the binding kinetics by surface plasmon resonance (SPR). This label-
free technique enabled determination of the kinetics and direct comparison the mimotope 
binding independently of the solid phase or label used in the assay. Interestingly, the phage-
displayed peptide, which in fact can be described as the original mimotope, showed the worst 
performance in SPR. The slightly lower affinity value in terms of the KD of the synthetic peptide 
to the antibody in comparison with the recombinant fusion might be among the reasons why this 
mimotope could provide the best sensitivity in the bead-based assays. 
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APPLICATION OF BACTERIOPHAGES IN SENSOR DEVELOPMENT 
Reproduced from: Analytical and Bioanalytical Chemistry 2016, 408, 1805–1825. 
Copyright ® 2015, reprinted with permission from Springer. 
Abstract 
Bacteriophage-based bioassays are a promising alternative to traditional antibody-based 
immunoassays. Bacteriophages, shortened to phages, can be easily conjugated or genetically 
engineered. Phages are robust, ubiquitous in nature, and harmless to humans. Notably, phages 
do not usually require inoculation and killing of animals; and thus, the production of phages is 
simple and economical. In recent years, phage-based biosensors have been developed featuring 
excellent robustness, sensitivity, and selectivity in combination with the ease of integration into 
transduction devices. This review provides a critical overview of phage-based bioassays and 
biosensors developed in the last few years using different interrogation methods such as 
colorimetric, enzymatic, fluorescent, surface plasmon resonance, quartz crystal microbalance, 
magnetoelastic, Raman, or electrochemical techniques. 
Keywords 
Bacteriophage, phage display technology, biosensing, biosensor, biorecognition element 
Introduction 
Bacteriophages, as well as plants and some animal viruses, have proven to be useful tools in 
biotechnology, agricultural, and clinical medicine.1,2 Although antibodies, enzymes, or nucleic 
acids have been traditionally used for the development of sensitive and selective analytical 
methods based on different transduction mechanisms, recently, bacteriophages have recently 
become of great interest for analytical chemistry to be used as probes for biosensing and 
imaging. 
Bacteriophages or phages are viruses ubiquitous in nature but harmless to humans. Since 
in some cases phages destroy bacterial cells, they were used in the early 1900s as a medical 
therapy against some bacterial infections.3,4 However, they were later displaced by antibiotics 
in the 1940s.3,4 Phages are extremely robust and stable virus particles, which use bacterial cells 
as hosts to replicate. Phages are composed of a protein coat that encapsulates its RNA or DNA 
genome comprising four to hundreds of genes.5 Proteins of the phage coat can be easily 
conjugated or genetically engineered to display peptides, proteins, or antibodies targeting a wide 
variety of molecules, including biopolymers, toxins, proteins, or even specific contaminant 
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BIOINSPIRED RECOGNITION ELEMENTS FOR MYCOTOXIN SENSORS 
Reproduced from: Analytical and Bioanalytical Chemistry 2018, 410, 747–771. 
Copyright ® 2018, reprinted with permission from Springer. 
Abstract 
Mycotoxins are low molecular weight molecules produced as secondary metabolites by 
filamentous fungi that can be found as natural contaminants in many foods and feeds. These 
toxins have been shown to have adverse effects on both human and animal health, and are the 
cause of significant economic losses worldwide. Sensors for mycotoxin analysis have 
traditionally applied elements of biological origin for the selective recognition purposes. 
However, since the 1970s there has been an exponential growth in the use of genetically 
engineered or synthetic biomimetic recognition elements that allow some of the limitations 
associated with the use of natural receptors for the analyses of these toxins to be circumvented. 
This review provides an overview on recent advances in the application of bioinspired 
recognition elements, including recombinant antibodies, peptides, aptamers, and molecularly 
imprinted polymers, to the development of sensors for mycotoxins based on different 
transduction elements. 
Introduction 
Mycotoxins are low molecular weight (approximately 700) natural products produced as 
secondary metabolites by filamentous fungi mainly, although not exclusively, when they reach 
maturity 1. Unlike primary metabolites, these compounds are believed to have no function in the 
life cycle of the producer cell.2 They can be found as natural contaminants in many vegetal foods 
or feeds, including nuts (almonds and walnuts), cereals (rice, wheat, and maize), oilseeds 
(soybean, peanuts), fruits, dried fruits, spices, beans, forage, wines and grape juices, or in foods 
of animal origin, such as milk, eggs, or meat.1, 2 Alternatively, exposure to these toxins can be 
produced by inhalation of dust containing mycotoxigenic fungal spores.1 Regardless of the way 
they come in contact with humans, or domestic animals, including birds, they may cause lowered 
performance, sickness, or even death even at very low concentrations.3, 4 Their range of actions 
includes cytotoxic, nephrotoxic, hepatotoxic, teratogenic, mutagenic, carcinogenic, 
immunosuppressive, and estrogenic effects.1, 2 In any case, their effect on health depends on 
factors such as the concentration in the contaminated food and the exposure time, the 
synergistic effect of other mycotoxins, and environmental factors associated especially with the 
storage conditions of foodstuff.1 
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OPTICAL BIOSENSORS FOR LABEL-FREE DETECTION OF SMALL 
MOLECULES 
Reproduced from: Sensors 2018, 18, 4126 
Copyright ® 2018, reprinted with permission from MDPI. 
Abstract 
Label-free optical biosensors are an intriguing option for the analyses of many analytes, as they 
offer several advantages such as high sensitivity, direct and real-time measurement in addition 
to multiplexing capabilities. However, development of label-free optical biosensors for small 
molecules can be challenging as most of them are not naturally chromogenic or fluorescent, 
and in some cases, the sensor response is related to the size of the analyte. To overcome some 
of the limitations associated with the analysis of biologically, pharmacologically, or 
environmentally relevant compounds of low molecular weight, recent advances in the field have 
improved the detection of these analytes using outstanding methodology, instrumentation, 
recognition elements, or immobilization strategies. In this review, we aim to introduce some of 
the latest developments in the field of label-free optical biosensors with the focus on 
applications with novel innovations to overcome the challenges related to small molecule 
detection. Optical label-free methods with different transduction schemes, including evanescent 
wave and optical fiber sensors, surface plasmon resonance, surface-enhanced Raman 
spectroscopy, and interferometry, using various biorecognition elements, such as antibodies, 
aptamers, enzymes, and bioinspired molecularly imprinted polymers, are reviewed. 
Origin and occurrence of small molecules 
Small molecules can be defined as low molecular weight organic molecules which are typically 
less than 1000 Da in size. This category includes a wide variety of different chemical 
compounds, of either natural or pharmaceutical origin, many of which are biological, 
pharmacologically, or environmentally relevant, which makes detection and quantification of 
these molecules important in many disciplines. Naturally, nearly every cell contains a collection 
of 100 to 200 different low molecular weight organic molecules, including the common amino 
acids, nucleotides, sugars, and their phosphorylated derivatives. Additionally, there exists a wide 
variety of small biomolecules which are specific to certain types of cells or organisms, for 
example, many plants contain so-called secondary metabolites which include compounds that 
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give plants their characteristic scents, and compounds such as morphine, nicotine, and caffeine 
that are valued for their physiological effects on humans.1 On the other hand, small synthetic 
molecules, man-made or produced by synthetic biology,2 have been extensively applied in a 
broad variety of fields including pharmaceutical, clinical, environmental, or food analysis, to 
name a few. 
Many small molecules are well-known contaminants in food, feed, and other agricultural 
products. For example, mycotoxins, which are produced as secondary metabolites by 
filamentous fungi, include more than 500 different small molecules with different 
physicochemical properties and various effects ranging from cancer to acute toxicity and 
developmental defects. Agriculturally, the most critical mycotoxins are aflatoxins, fumonisins, 
trichothecenes, ochratoxins, and zearalenone family which are common contaminants in crops 
worldwide.3, 4 Algal toxins, phycotoxins, and cyanotoxins, in turn, are produced by toxicogenic 
microalgae and cyanobacteria, and they can enter the marine food chain via phytoplankton and 
subsequently to humans by contaminated seafood. Several small molecule toxins originating 
from seafood are known to cause severe illnesses, such as paralytic shellfish poisoning, puffer 
fish poisoning, and neurotoxic shellfish poisoning, and it has been reported that seafood 
poisonings are increasing in frequency and new intoxications are emerging.5, 6 All the 
aforementioned toxins are known to cause, besides a threat to human and animal health, but 
also substantial economic losses in aqua- and agriculture, and many of them fall under national 
and international regulations. 
Along with the naturally produced contaminants, many synthetic low molecular weight 
compounds are environmentally and pharmacologically significant. For example, biological and 
chemical warfare agents which can be lethal even at low levels are some of the most feared 
weapons of mass destruction. Nerve agents, which are usually organophosphates, have rapid 
and severe effects on human and animal health due to their ability to block acetylcholinesterase 
(AChE) that is essential for the normal functioning of the nervous systems. Also, many pesticides 
and insecticides belong to the same chemical class of organophosphates, and they possess the 
same mode of action as nerve agents but are less hazardous.7 For example, chlorpyrifos, a broad 
spectrum pesticide which belongs to the group of organophosphates and is used worldwide in 
a wide range of crops, presents a major concern for potential environmental contamination and 
overuse, improper storage or disposal of these molecules.8, 9 
Pharmaceuticals, either of natural or synthetic origin, are ubiquitous substances of 
interest not only in clinical medicine but also in drug screening and environmental safety. Small 
molecules, in particular, are of great interest in pharmaceutical research, for example, because 
they can cross the blood-brain barrier. Detection of many drugs is diagnostically and clinically 
relevant but is also of interest in pharmaceutical sciences for drug screening and development 
of new biotherapeutics, as well as for studying the activity, kinetics, and stability of 
pharmaceuticals.10 Therapeutic drug monitoring, which aims to optimize the pharmacological 
response of a drug while avoiding adverse effects, measures the drug concentrations in a 
biological matrix and with appropriate interpretation affects the prescribing procedures.11 On 
the other hand, after administration, many drugs are excreted by the patients into wastewater, 
and in fact, rather often many pharmaceutical products and residues have been found in 
wastewaters, surface waters and even drinking water.12 Pharmaceuticals vary from antibiotics 
to non-steroidal anti-inflammatory drugs, such as ibuprofen, or anti-cancer drugs which are of 
particular concern not only for human health but also for the environment due to their unique 
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properties in combination with poor biodegradability.13, 14 On the other hand, many small 
molecules can behave as endocrine disrupting chemicals (EDCs), i.e., they interfere with the 
body’s endocrine system and produce adverse developmental, reproductive, neurological, and 
immune effects in both humans and wildlife.15 According to the World Health Organization 
(WHO), EDCs and potential EDCs consist mainly of man-made compounds found in various 
materials, such as pesticides, metals, additives, or contaminants in food and personal care 
products, and they are a public health issue worldwide.16 
Conventionally, many small molecules are detected by chromatographic methods which 
usually provide high sensitivity and specificity.9 However, due to the high cost, bulky 
instrumentation, and required expertise, these methods are not suitable for every purpose; 
whereas, biosensors can offer a cheaper and faster alternative. Myriad of different biosensors 
and bioanalytical assays have been reported for the diverse group of small molecule analytes, 
ranging from traditional enzyme-linked immunosorbent assays (ELISAs)17, 18 and lateral flow 
tests19 to microarrays20 and fluorescent21 or electrochemical sensors,22 just to mention a few 
examples. Some of the advantages of biosensors over classical methods for small molecule 
detection include real-time monitoring, high specificity, fast response times, reduced 
consumption of organic solvents and sample manipulation, portability, compactness, and easy 
operation avoiding the need of skilled personnel.23 
Biosensors for small molecule detection 
Generally, biosensors consist of a bioreceptor, the recognition element responsible for capturing 
the target analyte, and a transducer, whose properties are altered upon analyte binding.24 In the 
context of this review, the majority of the methods can be defined as affinity biosensors since 
they are based on a specific biorecognition element which is capable of binding to the analyte. 
Antibodies continue to be one of the most used bioreceptors due to their exceptional specificity 
and sensitivity, but also nucleic acids, aptamers, peptides, and molecularly imprinted polymers 
(MIPs) are widely used. On the other hand, catalytic biosensors are based on a bioreceptor, such 
as an enzyme or whole cell, which is capable of recognizing the analyte and transforming them 
into a product through a chemical reaction.25 Usually, the bioreceptor is immobilized on the 
surface of a transducer where the biorecognition event can be monitored by different 
transduction schemes which measure the binding event. The binding event can produce, for 
example, an increase in mass, or a change in the electrical resistivity or refractive index of the 
surface, which can be monitored by various detection methods, such as mechanical, electrical, 
or optical signals. 
Optical transducers are based on measuring a change in the optical properties in the 
presence of the analyte, such as absorption, reflectance, emission, or interferometric pattern, 
which can be recorded by a photodetector. Many optical biosensors require the use of labels, 
for example, fluorescent dyes, enzymes, or nanoparticles, which are used as a means to 
measure the biorecognition event. Although such label-based methods are widely used and 
usually very sensitive, they inevitably require the involvement of a label and a chemical 
conjugation step to link the label to the biorecognition event. The necessity of labeling makes 
these methods limited by the success and efficiency of the conjugation step, which furthermore 
in some cases might even alter the biorecognition event. Thus, label-free biosensors can offer 
some significant advantages and better accuracy over label-based methods since label-free 
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biosensors do not require the use of a label to monitor the binding event. Advantages of label-
free methods include simplicity and speed of the measurement procedure; these methods 
enable real-time monitoring of the binding reaction, thus giving access to the kinetic and 
thermodynamic parameters of the molecular recognition process.26, 27 
Development of biosensors for small molecule detection represents particular challenges 
which might not be an issue with larger analytes. Firstly, small molecules are challenging targets 
for many recognition elements, in particular for antibodies since haptens alone fail to stimulate 
the immune system responsible for antibody production.28 Consequently, hapten-specific 
antibodies are usually selected using the hapten conjugated to a larger carrier molecule, which 
at times results in antibodies specific for the conjugate rather than for the free hapten. 
Furthermore, small molecules which are components of physiological pathways, such as amino 
acid, are not immunogenic. Recombinant antibodies have been presented as an interesting 
alternative for monoclonal and polyclonal antibodies, and several recombinant antibody-based 
immunoassays and sensors have been reported during the last two decades.29, 30 Potentially, 
recombinant antibodies can overcome some of the limitations of their conventional 
counterparts; they can be selected from naïve repertoires avoiding animal immunization and 
modified by genetic engineering to improve their binding or include reactive groups or tags 
intended for conjugation or protein purification. Because of their small size, recombinant 
antibody fragments can contribute to decreased non-specific binding and lower steric hindrance 
compared to the intact antibody. However, despite some interesting properties, recombinant 
antibodies rarely show better or even similar affinities than conventional antibodies,31 which 
limits their use for the detection of small molecules which are present at low concentrations and 
thus require recognition elements with high affinity. 
Alternatively, biosensors can be based on several other bioreceptors or bioinspired 
recognition elements. Aptamers are short synthetic DNA or RNA molecules which form a three-
dimensional structure which allows them to bind target molecules with high specificity and 
sensitivity.32 Aptamers are readily synthesized and modified for immobilization or labeling 
purposes, and owing to their small size, high chemical and thermal stability, and low price, 
aptamers can be an intriguing alternative for antibodies. Nonetheless, once again, it can be 
particularly challenging to find good aptamer binders for analytes with small size.33 Thus, 
aptamer-based label-free methods often rely on different signal amplification methods to 
compensate for the shortcomings of the recognition element.33 Enzymes which were among the 
first recognition elements used in biosensors are a rather obvious choice as a recognition 
element for targets which are known enzyme inhibitors, for example, organophosphates;9,34 
however, their use can be limited by poor stability or loss of activity as a result of the 
immobilization. Molecularly imprinted polymers (MIPs), also known as plastic antibodies, are 
artificial materials, and although strictly speaking, they do not match the description of a 
biosensor which by definition relies on biological recognition element, MIPs are an exciting 
option for biosensor development due to their high physical and chemical stability, robustness, 
low cost, and ease of preparation.35 Molecular imprinting allows the design and preparation of 
custom-made polymeric materials that contain binding sites with selective affinity to the analyte, 
similar to some biological receptors, such as antibodies, enzymes, or other protein receptors. 
For MIP synthesis, the selected print molecule, which may be the analyte or a substitute 
molecule, interacts via covalent or non-covalent bonds with functional monomers that 
polymerize in the presence of a crosslinker. Once the template molecule is removed, the 
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resulting three-dimensional supramolecular structure contains specific recognition sites that are 
complementary to the template molecule or/and target molecule. 
In their simplest format, label-free biosensors are based on direct detection of the target 
which binds to the recognition element immobilized on the sensor surface (Figure 1A). 
Compared to small molecules, binding of large molecules usually produces a larger response 
which is often roughly in proportion to the mass of the molecule. Thus, for direct detection, the 
requirement is that the analyte of interest produces a sufficient response in a required 
concentration range, which in practice means that the molecular weight of the target must be 
large enough to generate a measurable signal change. Generally speaking, the sandwich assay 
format can be used to improve the response and the assay sensitivity; however, small molecules 
which are composed of only one epitope are not suitable for this approach.36 Alternatively, small 
molecules can be measured indirectly using either a competitive or an inhibition detection 
format (Figures 1B–C). 
In the competitive format, the sensing surface is coated with the recognition element while 
the analyte and its conjugated analog compete for a limited number of binding sites on the 
surface. In the inhibition detection format, reversely, the analyte-conjugate is immobilized on 
the surface, and the recognition element is added together with the analyte in solution.25 
Regardless of the assay format, or the recognition element of choice, the immobilization step to 
the sensor surface is critically important to all biosensor configurations. The functionalized 
biosensor surface should provide high specific binding of the target analyte while maintaining 
low non-specific binding or cross-reactivity towards interfering molecules present in the same 
samples. 
The repertoire of methods based on optical label-free detection is vast and impressive. In 
this review, we aim to revise the latest developments in the field with particular attention to 
solutions that improve the methods for small molecule detection, or present innovative 
alternatives to overcome some of the limitations mentioned above. Significant research efforts 
in the field of evanescent wave and fiber optic biosensors, surface plasmon resonance (SPR) 
and localized surface plasmon resonance (LSPR) biosensors, as well as surface-enhanced 
Raman spectroscopy (SERS), and interferometry are described. 
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Figure 1. Schematic presentation of assay formats generally used for small-molecule 
detection. (A) In a direct assay, target analyte binds to the recognition element, e.g., the 
antibody which is immobilized on the sensor surface; (B) In a competitive assay, the analyte 
competes with its conjugate for the binding to the immobilized recognition element; (C) In a 
binding inhibition assay, similarly the analyte and analyte-conjugate compete for the 
binding, but the analyte-conjugate is the one immobilized on the sensor surface either 
directly via a linker or as a protein-conjugate. Also, other recognition elements besides 
antibodies are applied to biosensor development using the same assay formats. 
Fiber optic and evanescent wave biosensors 
Evanescent wave systems have found broad applicability and flexibility for biosensor design as 
they confine the interactions between light input/output and fluidics inflow/outflow to a single 
interface.37 Evanescent wave biosensors can be based on the use of cylindrical or planar 
waveguides. Several fiber optic configurations, including tapered optical fibers, photonic crystal 
fibers, hollow-core fibers, or long-period fiber gratings have been proposed to improve the 
interaction between the evanescent field and the sensing layer. In most cases, the cladding of 
the fiber is modified by a sensing layer and any change in the optical or structural properties of 
the material, such as the refractive index, thickness or absorption will change the transmission 
properties of the fiber.38 In absorption sensors, light absorption of the evanescent wave by a 
sensing layer will result in a decrease of the guided light in the fiber core. In luminescent sensors, 
the evanescent light will excite the luminescent molecules located near the waveguide surface, 
and the emitted light will be captured and guided by the waveguide. Therefore, the background 
signal from the bulk sample can be minimized, and these methods are usually very sensitive 
and selective for the detection of small molecules in comparison with label-free 
techniques.37, 39, 40 However, only a few molecules can be detected directly using this approach 
without the use of labels. 
Optical waveguide light mode spectroscopy (OWLS) is an optosensing technique that 
applies the evanescent field for the in situ and label-free study of surface processes at the 
molecular level.41 In this approach, polarized laser light is diffracted by a grating and incoupled 
into a thin waveguide. The incoupling resonance takes place at precise angles, depending on 
the characteristic optical parameters of the sensor chips and the refractive index of the external 
medium. Photodiodes detect the intensity of the incoupled light. The effective refractive index is 
determined from the resonance incoupling angle which is detected with high accuracy and 
allows the evaluation of the layer thickness and coverage (or mass) of the adsorbed or bound 
material with excellent sensitivity. OWLS has been applied for example to the analysis of 
mycotoxins ochratoxin A (OTA) and aflatoxin B1 (AFB1) in grain samples using direct and indirect 
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assay formats. Higher sensitivities were obtained using the inhibition assay with an immobilized 
antigen, and the response range was between 0.5 and 10 ng/mL for both mycotoxins. The same 
conclusion was obtained for the analysis of trifluralin and zearalenone, two environmental 
endocrine disrupters, vitellogenin, an endocrine marker42 in environmental samples and 
deoxynivalenol (DON), a mycotoxin in wheat.43 The competitive immunosensor was shown to be 
more sensitive for the target compounds than the noncompetitive ones. This behavior can be 
explained considering that the OWLS signal is sensitive to relative masses bound to the 
waveguide surface. Binding of an antibody to an immobilized antigen conjugate produces a 
higher signal than binding of small analytes, as in the case of the mycotoxins or the herbicide, 
to an immobilized antibody. The same group applied the OWLS immunosensor to the analysis 
of AFB1 in 60 spice paprika samples from different countries, finding that 16 samples were 
contaminated with AFB1, and 9 samples contained AFB1 above the official maximum residue 
level (5 μg/kg) set by the European Commission. Excellent correlation was observed with the 
results obtained by ELISA and high-performance liquid chromatography (HPLC) with fluorescent 
detection.44 
In a completely different approach, the Haupt group45 reported the development of 
disposable evanescent wave fiber optic sensors by coating 4-cm long injection-molded tapered 
polystyrene waveguides with 2,4-dichlorophenoxyacetic acid (2,4-D) (Figure 2) or citrinin 
selective MIPs containing a fluorescent signaling monomer, N-(2-(6-4-methylpiperazin-1-yl)-1,3-
dioxo-1H-benzo[de]isoquinolin-2(3H)-yl-ethyl)acrylamide, which can be excited by the 
evanescent wave. Polymer coating on the cylindrical waveguide was carried out either by in situ 
photopolymerization of the MIP on the fiber using the evanescent wave, or by dip coating with 
the MIP particles. An increase in fluorescence intensity proportional to the analyte concentration 
was observed in the presence of the target compound with a limit of quantification of 1 nM for 
2,4-D and good selectivity to the herbicide. The biomimetic sensors obtained by in situ 
polymerization of the MIP were less sensitive than those obtained using the MIP particles. 
 
Figure 2. (A) Photograph of the polystyrene evanescent wave fiber optic waveguide 
coated with fluorescent 2,4-D MIP particles using polyvinyl alcohol as glue. (B) 
Injection of the light with a fiber optic bundle and collection through the lens (λexc = 
410 nm; λem = 515 nm). (C–D) SEM micrographs of the surface of the 2,4-D-MIP-
coated optical fiber (reprinted from [46] with permission from Elsevier). 
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Barrios et al.47 demonstrated the applicability of aluminum nanohole arrays (NHAs), 
deposited onto a microscope coverslip, for sensing applications. The pre-polymerization mixture 
was deposited onto the NHAs, and the light was efficiently confined inside favoring the 
photopolymerization of submicron-sized MIP patterns selective to rhodamine 123 (R123), as a 
model template molecule. The final size could be tuned by changing the dose of green radiation 
applied during the polymerization step. Evaluation of the selective recognition of R123 by the 
imprinted polymer was carried out by fluorescence lifetime imaging microscopy with single 
photon timing measurements. A similar approach has been applied to the development of 
biosensors for the detection of biotin as a model analyte, in combination with glass, 
polycarbonate compact discs (PC CDs) or transferable aluminum NHAs onto flexible pressure-
sensitive adhesive tapes using label-free SPR measurements.47, 48 
Margheri et al.49 described the detection of heavy metal ions by self-assembling a 
monolayer of a fluorescent indicator which was quenched in the presence of Hg(II) ions on the 
external surface of an optical fiber waveguide formed by a metal (Au)-dielectric (SiO2) bilayer 
known as metal–clad optical waveguide (MCOW). The thin Au metal layer (~20 nm) guided the 
zero-order TE and TM modes with the lowest possible losses, and the thickness of the dielectric 
layer was selected to propagate the same modes. On the other hand, the fluorescent layer and 
the metal were separated by the SiO2 layer, thus avoiding the metal-induced fluorescence 
quenching. The authors estimated a limit of detection of 150 nM and response time of 
approximately 2 min which were in the same order of magnitude as the best ones reported in 
the literature for this metal ion. Further improvements were proposed by the substitution of Au 
with an Ag layer and increasing the number of sensing sites by enriching a hydrogel volumetric 
matrix. 
Genetically modified organisms have also been coupled to optical fibers for the 
development of label-free biosensors for the sensitive and selective detection of a wide range 
of compounds of interest in different fields such as food analysis, environmental monitoring, 
and clinical diagnostics, among others.50–54 Sensor performance depends on the introduction 
of a reporter gene into the host cell, whose expression is modulated by the interaction of the 
analyte with the molecular recognition element, and promoter sequences.55 Widely used 
reporter genes include lux (bacterial luciferase), Luc (firefly luciferase), GFP (green fluorescent 
protein), and lacZ (β-galactosidase). The activity of the reporter protein can be monitored upon 
the addition of the corresponding (e.g., bioluminescent, fluorescent) substrate or directly as in 
the case of the GFP.56 
In a different approach, non-genetically modified microorganisms, such as green 
microalgae based on mutant algae clones which are the result of evolutionary strategies, have 
also been applied to the development of biosensors for the analysis of pesticides or heavy 
metals. Two different approaches have been used for this purpose. The first was based on 
monitoring the variation in the algal chlorophyll fluorescence at 682 nm, as a result of the 
inhibition of the algal photosystem II by the pollutant.57, 58 Alternatively, herbicide concentration 
was evaluated by monitoring the inhibition of the photosynthetic O2 production by the target 
compound using an oxygen optode.59 
In addition, several fiber optic sensors are based on SPR which requires the use of a 
metal-dielectric interface. Different optical structures have been reported for SPR-based fiber 
optic biosensors, including D-shaped, de-cladded, end mirror or tapered fiber structures.38 Some 
Annex I: Review articles 
328 
relevant examples of fiber optic SPR sensors and the basis of SPR sensing are described in the 
following section. 
Surface plasmon resonance 
Surface plasmon resonance (SPR) is one of the most advanced and most used label-free 
detection techniques because of the high sensitivity and versatility of the method, as well as the 
possibility for a real-time read-out and direct measurement of binding kinetics. As a result of 
tremendous research on SPR during the last decades and the availability of advanced 
commercial instruments, SPR-based biosensors can be considered as a landmark label-free 
biosensing platform for characterizing and quantifying biomolecular interactions.36, 60 SPR 
sensors measure changes in the refractive index which occur at the surface of a metal film 
where electromagnetic waves, called surface plasmons, propagate upon illumination. Since 
surface plasmons are highly dependent on the geometry of the plasmonic structure and the 
environmental parameters, changes such as biomolecule binding to the surface will change the 
plasmon mode.61 Prism couplers are most commonly used, but alternatively, optical excitation 
can be based on waveguide couplers, diffraction gratings, or integrated optical fibers.62 Prism-
based coupling requires bulky instrumentation and thus is not compatible with portable 
platforms or point-of-care devices. Instead, optical fibers are low cost and ideal for 
miniaturization, which has made them as the subject of intense research.63, 64 A major 
contribution to SPR-based biosensors is the use of metal nanostructures which are smaller than 
the incident wavelength and when interacting with light waves generate a resonance 
phenomenon known as localized surface plasmon resonance (LSPR). One of the most 
interesting features of LSPR is the possibility of tuning the SPR intensity by varying the size, 
shape, composition, and environment of the nanostructures which can be for example metal 
nanoparticles, carbon nanotubes or nanowires.62 
Direct detection of small molecules by SPR is challenging due to their small size and 
subsequently the small change in the refractive index produced by analyte binding, which 
generally leads to measurements with too low signal-to-noise ratios.65 Nevertheless, direct 
detection is more straightforward and has several advantages over indirect methods, such as 
shorter assay times, lower sample volumes, no need for the conjugated analyte competitor, and 
the possibility for direct kinetic measurements.66 Advances in SPR instrumentation, such as 
detection systems with lower noise and improved fluidics as well as advanced immobilization 
methods and new sensor chips, have simultaneously decreased the total noise and improved 
the signal intensities and reproducibility.65 The most advanced commercial SPR instruments, 
such as Biacore, claim the detection of analytes down to 100 Da67 and although the early 
immunosensors for small molecule detection relied almost inevitably on the competitive assay 
formats, during the last decade several examples of direct small molecule detection have been 
reported. 
The performance of SPR sensors is highly dependent on the chemical interface and bio-
functionalization, as well as the optical, electrical and structural features of the instrument.62 
The choice of a recognition element indisputably has a direct effect on the assay sensitivity and 
specificity, but moreover, the immobilization of the interacting molecule, either the recognition 
element or the analyte-conjugate, is crucial. A robust biomolecule coating on the sensor surface 
should be stable and, in many cases, preferably regenerable. It is critical to ensure that the 
Optical biosensors for label-free detection of small molecules 
329 
surface coating and the immobilization do not degrade the biological activity of the recognition 
element or result in steric hindrance, and a sufficient number of molecules must be immobilized 
to ensure reliable signals simultaneously minimizing the non-specific binding to the surface.68 
The following sections discuss SPR-based methods reported for small molecule detection using 
different recognition elements, and Table 1 summarizes some of the most interesting 
approaches from recent years. 
Antibody-based SPR sensors 
Owing to their unique properties and an immense variety of possible specificities antibodies 
continue to be the most used recognition element in SPR sensors, although alternative options 
for small molecule detection, mostly aptamers or molecularly imprinted polymers (MIPs), have 
also been reported.36 Despite the extensive use of both SPR and antibodies, only a few examples 
of direct SPR-based immunosensors have been described, and direct SPR methods for small 
molecule detection still might suffer from poor sensitivity. For example, Tomassetti et al.69 
compared a direct-flow SPR immunosensor for ampicillin detection with a competitive 
amperometric immunosensor which showed better sensitivity and wider dynamic range than 
direct detection by SPR. SPR sensor was more selective, as well as faster and simpler in the 
analysis, compared to the amperometric method in the concentration range from 10–6 M to  
10–2 M. In comparison, an LSPR sensor composed of core-shell nanosensors for the detection 
of atrazine was prepared using polystyrene nanospheres, as the “core” of the nanochip, and a 
gold layer which was thermally deposited onto the core as the “shell”. After studying the 
response of three types of nanosensors with different Au film and shell dimensions, the authors 
biofunctionalized one of the nanosensors with an atrazine specific antibody and proved direct 
detection of atrazine at 10 ng/mL.70 
The importance of the recognition element immobilization procedure has been established in 
several applications. For example, direct detection of tetrodotoxin was performed with Biacore 
T200 instrument using CM5 and CM7 sensor chips for antibody immobilization. Introduction of 
higher conjugation substrate, CM7, provided significantly greater response compared to CM5 
substrate with a lower number of antibody binding sites, although analysis with CM5 gave better 
sensitivity than CM7 (EC50-values 2.98 ng/mL and 12.45 ng/mL, respectively) (Figure 3A). 
Compared with the inhibition assay, the direct detection method provided not only faster and 
simpler analysis, but also four times the lower limit of detection (LOD 0.091 ng/mL for direct 
assay on CM5 chip, LOD 0.38 ng/ml for inhibition assay).71 In a different approach, an SPR 
immunosensor for ochratoxin A (OTA) was constructed on a nano-size gold hollow ball with a 
dendritic surface that was used to immobilize anti-OTA monoclonal antibody. OTA detection was 
reported in the range of 0.05–7.5 ng/mL with a detection limit of 0.01 ng/mL. According to the 
authors, the three-dimensional network of the gold hallow microspheres provided more space 
for the protein adsorption and thus improved the sensitivity compared to the SPR sensor with 
gold nanoparticles.72 Direct SPR sensor for benzoylecgonine (BZE), a major cocaine metabolite, 
consisted of high-affinity monoclonal antibody immobilized with high density to a sensor chip 
which contained a polycarboxylated hydrogel as a three-dimensional immobilization matrix. 
Detection of BZE in oral fluid could be performed within 180 s with BZE concentrations as low 
as 4 μg/L in filtered oral fluid-buffer (1:4) samples.66 
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Nonetheless, the majority of antibody-based SPR sensors are based on an inhibition assay 
format where a target-conjugate is immobilized onto the sensor surface. Although direct assays 
can be considered more ideal than the competitive inhibition assays, it should be noted that the 
latter can avoid some of the drawbacks related to antibody immobilization, such as potential 
changes in the native structure, improper orientation of the immobilized antibody, or a 
deteriorated affinity, all of which have direct effects on the assay performance. Therefore, 
immobilization of the target, either directly or conjugated to a carrier molecule, might provide a 
more robust sensor surface.73 A variety of different surfaces chemistries have been used with 
different binding site densities, but probably the most used and the most versatile surface is the 
Biacore CM5 sensor chip which consists of carboxymethylated dextran covalently attached to a 
gold surface and can be used to covalently couple molecules via amine, thiol, aldehyde, or 
carboxyl groups.67 During the last 10 years, a wide range of SPR immunosensors for small 
molecules have been reported using the inhibition assay, and several of them have presented 
sub-regulatory detection limits including validation with sample analysis. A specially designed 
multi-microchannel SPR sensor for the detection of herbicide 2,4-D was based on an array of 
thin Au-films, and a multi-microchannel plate with a flow-cell and the protein-conjugate was 
immobilized merely by physical adsorption onto the sensing surface.74 Majority of reported 
methods are based on protein-conjugated target which is covalently attached to the sensor 
surface. For example, contamination of mycotoxins nivalenol (NIV) and deoxynivalenol (DON) in 
wheat was tested using a sensor chip with DON–bovine serum albumin (BSA)-conjugate 
immobilized using a conventional amine coupling method. The competitive inhibition assay with 
a monoclonal antibody that cross-reacts with NIV and DON provided IC50 values of 28.8 and 
14.9 ng/mL for NIV and DON, respectively.75 Likewise, SPR immunosensors with BSA-
conjugated domoic acid (DA) and cortisol were used to analyze DA contamination in clam 
extracts76 or cortisol levels in saliva,77 respectively, whereas others have reported sensors with 
ovalbumin (OVA)-conjugated enrofloxacin (ENRO)78 as well as patulin79 and benzylpenicillin80 
conjugated to glutamine-binding protein for target immobilization. Alternatively, protein-
conjugated small molecules have been immobilized on a sensor surface using self-assembled 
monolayers (SAMs) to obtain good stability high degree of reproducibility. SPR immunosensors 
using SAMs or mixed SAMs to immobilized protein-conjugated targets have been reported at 
least for the detection of atrazine,81 ractopamine82 and antibiotics amikacin73 and 
fluoroquinolones.83 Robustness of the SAMs has been proven as the surface could be reused at 
least 40 times over span of three days83 or even up to 150 times.82 In the work of Herranz et 
al.,84 several assay formats with different immobilization strategies were evaluated for the 
detection of microcystin-LR (MCLR). Compared to the protein-conjugated or biotinylated target, 
direct immobilization of MCLR onto an amine-SAM-functionalized chip was concluded to provide 
the best performance. Alternatively, detection of saxitoxin85, 86 and HT-2 toxin87 has been 
accomplished by directly immobilizing the target to the biosensor chip via amino-coupling. 
Recently, a self-tuning interfacial architecture for estradiol detection was described with a 
decreased detection limit and widened dynamic range.46 The novel immobilization strategy was 
based on a “charged” surface where a flexible and structurally variable architecture was created 
by a variety of weak electrostatic interactions utilizing the electrostatic levitation phenomenon 
(Figure 3B). 
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Figure 3. (A) For tetrodotoxin detection, the antibody was covalently immobilized onto 
carboxymethylated (CM) dextran surface (left). A comparison of high-density CM7 and low-density 
CM5 surfaces for antibody immobilization (right). (B) Schematic representation of the 
immobilization of estradiol(E2)-BSA conjugate within the BSA matrix utilizing the electrostatic 
levitation phenomenon for forming a “fluid”-like interfacial membrane with rotation freedom and 
in-plane mobility of membrane components ((A), reprinted from ref. [71], copyright (2014) 
American Chemical Society; (B), reprinted from ref. [46] with permission from Elsevier). 
Also, a few SPR biosensors using recombinant antibodies have been reported for small 
molecules, mainly mycotoxins and other biotoxins with sub-regulatory detection limits, but most 
SPR-based methods in the literature in combination with recombinant antibodies consists of 
examples where SPR is used as a method to characterize novel antibodies and determine the 
binding affinities.88–95 For these applications, the target is immobilized directly,88 via a biotin-
linker,89 or as a protein-conjugate90–95 to the sensor chip. It has been noted that the structural 
format of recombinant antibody fragments, as well as chip functionalization, strongly affects the 
SPR response. Townsend et al.96 concluded that direct coating and the Fab antibody format 
would be optimal since multimerization of scFvs might result in incomparable SPR sensorgrams. 
Although recombinant antibodies still often suffer from lower affinity than monoclonal 
antibodies, which consequently limits the sensitivity levels that can be reached, they offer some 
intriguing characteristics, including their small size which could provide immobilization at high 
density, and the possibility to genetically engineer specific tags or reactive groups to facilitate 
the immobilization.31, 97, 98 
Finally, numerous examples have demonstrated that nanoparticles can be used to enhance SPR 
signals and overcome the challenges related to the small molecule detection.99–104 However, it 
could be argued that after incorporating a nanoparticle label to the sensor configuration, such 
a method is no longer genuinely label-free. Also, advanced SPR instrumentation based on 
microfluidic channels105–107 or imaging surface plasmon resonance108–110 have enabled 
multiplex detection of several targets simultaneously in the inhibition assay format. 
SPR sensors based on aptamers 
Aptamers are rarely able to compete with monoclonal antibodies when it comes to affinity, but 
they show several advantages such as relatively simple synthesis without significant batch 
differences. Moreover, chemically synthesized aptamers are easily modified or extended from 
their 3’ or 5’ end, which allows designing particular immobilization strategies which do not have 
a negative influence on their recognition activity. Direct binding of thiolated aptamers to the gold 
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surface is a widely used method, although many other alternatives have been reported as well. 
As with other recognition elements, the immobilization manner of aptamers is crucial as in some 
cases immobilization at one end of the aptamer has been seen to abolish the binding.111 
First aptamer-based SPR sensors were based on the competitive assay-format. For 
example, after an unsuccessful first trial to directly detect the small molecule target binding with 
an immobilized aptamer, neomycin B was covalently immobilized onto the sensor surface, and 
detection of free neomycin B was achieved in the competitive format with a range of 
quantification between 10 nM and 100 μM.112 On the other hand, competitive replacement 
assays which take advantage of aptamers and partially complementary single-stranded DNA 
(ssDNA) have been reported as an alternative to improve the detection of small molecules. 
Hybridization of gold nanoparticle (AuNP)-tagged secondary ssDNA with the immobilized 
aptamer results in a substantial change in SPR signal, whereas upon target binding the 
secondary ssDNA is not able to hybridize with the target-bound aptamer causing a remarkable 
decrease in the signal. In this manner, adenosine was detected over the range of 10–9 to  
10–6 M using an aptamer immobilized on SPR gold film and complementary ssDNA with 
AuNPs.113 Alternatively, a double-AuNP system comprising of ATP (adenosine triphosphate) 
aptamer functionalized 39-nm-AuNPs array chip and a partially complementary ssDNA which 
was immobilized on 13-nm-AuNPs. A wall-less LSPR array chip was fabricated on a hydrophilic-
hydrophobic patterned glass slide, which enabled high throughput detection and the chip 
fabrication and sample processing could be simplified using the wall-less configuration 
(Figure 4A). The detection limit was reported down to 0.01 μM ATP which was a 5-order-of-
magnitude improvement over the non-enhanced setup.114 
Interestingly, the versatility of aptamers as recognition elements has been elaborated by 
use of two anti-cocaine aptamer subunits in an aptasensor where one subunit was assembled 
on gold surface and the second subunit was labeled with AuNPs. In the presence of cocaine, 
binding of both aptamer subunits resulted in electronic coupling between the localized plasmon 
of the AuNPs and the surface plasmon wave of the gold surface and a significant shift in the 
SPR spectrum was observed. The dissociation constant of the aptamer complex was determined 
to be (8.9 ± 0.4) × 10–6 M and a detection limit of 10–6 M for cocaine was reported.115 
Later, advances in the sensor technology and alternative immobilization methods have 
also enabled the direct detection of small molecules. For example, Zhu et al.116 reported Biacore 
aptasensor for the detection of OTA using streptavidin as a cross-linker to immobilize a 
biotinylated aptamer. Linear detection range from 0.094 to 10 ng/mL of OTA with a lower 
detection limit of 0.005 ng/mL was reported, and after liquid-liquid sample extraction spiked 
wine and peanut oil samples were analyzed with recoveries from 86.9% to 116.5%. An 
alternative immobilization strategy on the Biacore sensor was reported by Chang et al.117 who 
characterized the affinity and kinetics of a diverse panel of 12 small molecule-binding RNA and 
DNA aptamers. Instead of direct aptamer immobilization or streptavidin linker, a poly(T) DNA 
linker was covalently immobilized to a Biacore sensor chip, and the aptamer was captured 
through hybridization of a poly(A) tail, which enabled simple regeneration of the surface and 
testing different aptamers or targets on the same chip. 
Recently, direct detection of tetracycline was reported with a Biacore sensor where the 
aptamer was immobilized on the top of a tetrahedron nanostructure to provide better 
accessibility of the target. The sensor was based on the conformational reorganization of the 
aptamer which formed G-quadruplex structure upon target binding. The aptasensor was 
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validated in a real application for tetracycline screening in multiple honey samples, and the 
detection limit was calculated to be 0.0069 μg/kg, 10-fold lower than that of the aptasensor 
with the single-stranded aptamer.68 Also, an LSPR-based aptasensor based on the G-quadruplex 
structure and gold nanorods (GNRs) enabled detection of OTA in nM-range.118 Later, an 
enhancement in a similar approach was achieved using G-quadruplex (GQx) binders to increase 
the signal change upon target binding (Figure 4B). Addition of berberine as GQx binder improved 
the detection limits for OTA, ATP, aflatoxin B1 (AFB1), and potassium ions 1000-fold.119 Recently, 
the same group reported another aptasensor for OTA detection based on an optical fiber coated 
with aptamer-modified GNRs which enabled in situ detection of OTA by simply dipping the fiber 
into a solution. Linear range was determined from 10 pM to 100 nM with a detection limit of 
12.0 pM, and OTA-spiked samples were analyzed from 50% grape juice with recoveries from 
85.5% to 116.9% (1–100 nM OTA).120 
 
Figure 4. (A) Wall-less LSPR array chip for detection of adenosine triphosphate (ATP) using 
a normal microplate reader. Plasmonic nanoparticles (NPs) are immobilized on hydrophilic–
hydrophobic patterned glass slide and a double-gold NPs system constitute a competitive 
replacement assay for signal amplification. (B) LSPR sensor for small molecule detection 
based on (1) aptamer-modified gold nanorods (GNRs), (2) addition of the G-quadruplex (GQx) 
binder, (3) addition of a target that induces GQx structure, and (4) addition of the target and 
GQx binder; interaction between the GQx binder and GQx occurs. GQx binder provides signal 
enhancement and enables a broad dynamic range. (A, reprinted from ref. [114]; B, reprinted 
from ref. [119], both with permission from Elsevier).  
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Examples of instrumental advances in aptasensors include the development of a lab-
made plasmonic sensing platform based on sinusoidal gratings and the azimuthally-controlled 
SPR under phase interrogation which leads to enhanced refractive index compared to the classic 
grating-based SPR setup. After optimization of the aptamer immobilization strategy, the 
biosensor was demonstrated to detect down to 0.2 ng/mL of OTA with a detection limit of 
0.005 ng/mL.121 In a different approach, a portable, palm-sized transmission-localized surface 
plasmon resonance setup with aptamer-functionalized gold nanoislands deposited on a glass 
slide was reported for the detection of tobramycin, measuring concentrations down to 0.5 μM 
in buffer and down to 10 μM in filtered undiluted blood serum with a theoretical detection limit 
of 3.4 μM.122 
SPR sensors using molecularly imprinted polymers 
In recent years, MIPs have been rather widely used in SPR sensors for small molecule 
detection.32 The interaction of the target molecule with the active sites of the polymer causes a 
change in the dielectric nature of the sensing layer which can be detected by SPR. Compared to 
antibodies, MIPs can provide a more robust surface as they can withstand better harsh 
regeneration conditions and are less susceptible to lose their binding capability.123 Several 
methods to prepare a selective MIP layer on SPR sensor chips have been described, and they 
are either based on physical deposition or covalent coupling of the MIP film or particles onto the 
chip or, alternatively, involve in situ polymerization directly onto the sensor surface. For example, 
the spin coating has been used to create the recognition layer for SPR sensors with imprinted 
nanofilms or -gels for the detection amoxicillin,124 citrinin,125 and pesticides.126 A recent report 
showed that an enhancement in the SPR signals was achieved using a nano-hybrid film for the 
detection of ractopamine.127 In this work, MIP particles were synthesized by precipitation 
polymerization and coated with AuNPs and reduced graphene oxide to improve the SPR signals. 
The novel SPR sensor with the nano-hybrid film for ractopamine detection had a wide linear 
range from 20 to 1000 ng/mL with a detection limit of 5 ng/mL. Another recent work reported 
the use of atrazine imprinted nanoparticles which were deposited and dried onto the SPR chip. 
Attachment of the nanoparticles was confirmed by scanning electron microscopy, and the SPR 
measurements showed the linear response from 0.5 ng/mL to 15 ng/mL with a detection limit 
of 0.7134 ng/mL of atrazine.128 
Alternatively, imprinting can be performed directly in situ on the sensor surface thus 
avoiding a separate MIP immobilization, which is the approach that the majority of reported SPR 
sensors for small molecules rely on. Various methods for creating imprinted films have been 
reported, including thermal-initiated polymerization, photo-initiated polymerization, and 
electrical polymerization. For example, molecularly imprinted polypyrrole films were prepared via 
electropolymerization onto bare gold chips for the detection of zearalenone129 and DON.95 
Likewise, π-conjugated MIP with nanopatterns for T-2 toxin was prepared on SPR chip by in situ 
electropolymerizations. Kinetic measurements showed excellent affinity with a KD-value of 
12.7 fM, and the sensor had a linear response for T-2 toxin from 2.1 fM to 33.6 fM with a 
detection limit of 0.1 fM (0.05 pg/mL). Interference was studied with high concentrations of 
other toxic small molecules which showed less than 10% selectivity efficiencies; however, the 
response using other toxins with similar structures was not tested.130 By surface-initiated 
polymerization, where the initiator is immobilized to the sensor surface prior to the 
Optical biosensors for label-free detection of small molecules 
335 
polymerization, ultrathin MIP films have been prepared, for example, for DA,123 malachite 
green,131 acephate,132 ametryn,133 and profenofos134 detection showing the potential of MIPs 
for selective and sensitive analysis of small molecules. Another SPR sensor based on nanoscale 
MIP film as recognition element was developed for selective detection of the antibiotic 
ciprofloxacin (CIP). The MIP film was prepared by in situ photo-initiated polymerization method, 
and the sensor had good linear relation with CIP concentration over the range 10–11–10–7 M 
and the detection limit was determined to be ~0.08 μg/L. Furthermore, using the MIP-modified 
SPR imaging (SPRi) chip with separate sensing spots, the SPR response for two different types 
of antibiotics (CIP and azithromycin) could be measured simultaneously.135 
MIPs are also able to provide a three-dimensional binding matrix which can improve the 
sensitivity due to higher binding capacity. For this purpose, a water-compatible macroporous 
molecularly imprinted film (MIF) was synthesized by photo copolymerization of monomers, cross-
linker and polystyrene nanoparticles in the presence of testosterone as the template 
molecule.136 After removal of the template and the polystyrene nanoparticles, a macroporous 
MIF was formed. By in situ polymerization, the thickness of the film could be observed as the 
shift in the SPR resonant angle and the UV radiation was stopped when, approximately, 177 nm 
thick film was observed, a thickness comparable to the penetration depth of SPR. SPR-based 
MIF sensor was applied to testosterone detection in buffer and artificial urine with a detection 
limit down to 10−15 g/mL (i.e., 3.5 fM) which is among the lowest values reported for small 
molecule detection by SPR. Conventional MIF showed 30-fold lower response compared to the 
macroporous MIF indicating improved accessibility and sensitivity for testosterone due to the 
high porosity. High stability of the MIF was proved as the sensor chips could be stored at room 
temperature for 8 months and, approximately, 84% of their affinity was retained, whereas 
conventional antibody-based biosensors survive storage at room temperature only for days, 
which highlights one of the most remarkable advantages of MIPs as recognition elements. 
Additionally, MIPs have been used to create a sensing layer in fiber optic SPR sensors for 
which the cladding of a small part of the optical fiber is replaced by a thin metal film on top of 
which a sensing layer is constructed, and the evanescent waves generated at the core–metal 
interface are then used to excite surface plasmons at the sensing interface.63 Application of 
MIPs to fiber optic SPR sensors has been reported to enhance their sensing ability for the 
detection of selected small molecules. For example for 2,4,6-trinitrotoluene (TNT) detection, an 
unclad plastic optical fiber was coated with a thin gold film where the selective MIP film was 
deposited and based on the changes in the obtained SPR transmission spectra, a detection limit 
of 5.1 × 10−5 M was established.137 Similarly, a sensing probes for tetracycline,138 melamine,139 
atrazine,140 profenofos,141 and erythromycin142 detection were fabricated by coating the unclad 
core of an optical fiber with a 40 nm thick silver film which was further coated with the target-
specific MIP by dip coating (Figure 5). A red shift in resonance wavelength indicated target 
recognition, and excellent detection limits for atrazine (LOD = 1.92 × 10−14 M), profenofos (LOD 
= 2.5 × 10−6 μg/L) and erythromycin (LOD = 1.62 × 10−3 μM) were reported. To improve the 
sensitivity, a 10 nm thick aluminum layer was added between silver and MIP layer and slightly 
lower limit of detection for atrazine was measured.140 Erythromycin sensor was additionally 
applied to the analysis of spiked milk and honey samples, and excellent recoveries were 
reported for micromolar erythromycin concentrations.142 
Alternatively, enhancement in the sensitivity of MIP-based detection has been achieved 
by incorporating gold nanostars in LSPR sensor for the detection of TNT143 and L-nicotine.144 
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TNT-specific MIPs, identical to the previously reported,137 were used with five-branched gold 
nanostars and three times better sensitivity was obtained (LOD = 2.4 × 10−6 M). Further 
enhancement of the sensitivity was achieved using tapered optical fibers (LOD = 7.2 × 10−7 M), 
which was attributed to the reduction of incidence angles of the guided rays in the fiber close to 
the critical angle of the unclad uniform tapered region.143 For ascorbic acid (vitamin C) detection, 
enhancement in the sensitivity of a polyaniline MIP-based optical fiber SPR sensor145 was 
achieved by employing both SPR and LSPR techniques.146 In situ molecularly imprinted 
polyaniline-Ag nanocomposite was coated on the Ag layer on the optical fiber core thus 
combining LSPR of the Ag nanoparticles and SPR of the Ag thin film. Compared to the LSPR 
probe without the Ag film (LOD = 1.117 × 10−10 M), lower detection limit could be achieved with 
the LSPR+SPR probe (LOD = 7.383 × 10−11 M) and ascorbic acid contents of commercial vitamin 
C tablets could be analyzed with good recoveries.146 
 
Figure 5. Schematic of (A) fabricated sensing probe for the detection of erythromycin (ERY) 
using the fiber optic core decorated with the coatings of silver and a layer of ERY imprinted 
nanoparticles (B) experimental set-up and (C) sensing mechanism. Figure reprinted from ref. 
[142] with permission from Elsevier. 
Enzyme-based SPR sensors 
Although for certain sensor applications enzymes are the most extensively studied recognition 
elements, only a few examples of enzyme-based SPR sensors have been described.147 In some 
recent strategies acetylcholinesterase (AchE), a key enzyme in neurotransmission, which is 
inhibited by organophosphorus compounds such as nerve agents, pesticides and several toxins, 
has been used in SPR sensors for the detection of these inhibitors.148 Fiber-based LSPR-sensor 
for pesticide detection using AChE covalently coupled to AuNPs was based on the change of the 
light attenuation in the presence of pesticides which inhibited the activity of AChE to hydrolyze 
acetylcholine chloride (ACh). In optimized conditions, the detection limit of the sensor was 
0.234 µg/L and using a powerful nucleophilic agent the sensor surface could be reactivated 
with 94% recovery rate after six cycles of inhibition.149 Based on the same principle, AChE was 
used in a fiber-optic sensor based on silver coated core of a plastic-cladding silica fiber. AChE 
was immobilized using gel entrapment, and detection of chlorpyrifos pesticide (CPF) was 
reported in the micromolar range.150 More recently, Milkani et al.151 reported direct detection of 
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AChE inhibitors used for Alzheimer’s disease therapy by immobilizing AChE covalently to a self-
assembled monolayer on the gold surface of a commercial SPR sensor. The reversible 
carbamate inhibitors, neostigmine and serine, could be detected at micromolar concentrations, 
and considering the small target size, a relatively large change observed in the refractive index 
was attributed to the conformational changes in AChE as a result of inhibitor binding to the 
enzyme’s active site. It has also been reported that conjugation of the target molecule to a 
carrier protein does not significantly alter the AChE recognition but could be used to increase 
the SPR signals. In the AChE-based SPR sensor by Puiu et al.152 the target AFB1 alone did not 
give a detectable SPR signal but using AFB1–horseradish peroxidase (HRP)-conjugate in a 
competitive approach a detection limit of 0.003 μM (0.94 ng/mL) for AFB1 was reported. 
Enhancement in AChE-based detection has been achieved using magnetic MIPs with 
recognition sites for pesticide CPF, which enabled enrichment of the target to the sensor surface. 
Magnetic MIPs were synthesized by self-polymerization of dopamine on the surface of Fe3O4 
nanoparticles in the presence of the template CPF. Rebinding of the target and analysis of these 
CPF-imprinted nanoparticles by AChE-based SPR showed a low detection limit of 0.76 nM due 
to the significant signal amplification caused by the high molecular weight of the MIPs. 
Compared to direct analysis of CPF, approximately 64 times higher SPR angle shift could be 
observed with CPF-imprinted nanoparticles (Figure 6). Although CPF rebinding to MIPs required 
12 h incubation, which can be considered as a limiting aspect, the MIP-based method showed 
excellent selectivity against other pesticides tested.153 
 
Figure 6. (A) Preparation of magnetic MIPs for chlorpyrifos (CPF) recognition and (B) 
schematic illustration of the stepwise preparation process of the sensor surface with 
immobilized AChE. (C) SPR response curve with 10 μM CPF using direct detection of free 
CPF in PBS (red) and amplification with magnetic MIPs (black). Figure reprinted from ref. 
[153], copyright (2013) American Chemical Society.
  
Table 1. Examples of SPR- and LSPR-based methods using different recognition elements. The limit of detection (LOD), calculated as the blank response plus three 
times the standard deviation, is reported. Alternatively, the measured concentration range is shown between brackets. 
Analyte Recognition element Assay format Immobilization LOD Sample matrix Ref. 
Tetrodotoxin MAb Direct Covalent amine coupling on CM5/CM7 sensor chip 0.091 ng/mL – [71] 
Benzoylecgonine MAb Direct Covalent amine coupling on a polycarboxylated hydrogel matrix 6.7 nM (=2 μg/L) Oral fluid [66] 
Estradiol MAb Competitive inhibition 
E2-BSA on the SCN-modified 
“charged” Au surface weak 
electrostatic interactions 
[0.1–1000 ng/mL] – [46] 
Tetracycline Aptamer Direct DNA nanostructure 0.0069 μg/kg Honey [68] 
OTA, AFB1, ATP Aptamer 
Direct, signal 
enhancement with 
berberine 
Thiol modified aptamer on GNR 
0.56 pM (OTA), 
0.63 pM (AFB1), 
0.87 pM (ATP) 
– [119] 
Ractopamine MIP/GNPs/rGO  nano-hybrid Direct Deposition by spin-coating 
5 ng/mL 
(LR 20–1000 ng/mL) – [127] 
T-2 toxin MIP Direct In situ electropolymerization 0.1 fM (=0.05 pg/mL) (LR 2.1–33.6 fM)  – [130] 
Testosterone Macroporous MIF Direct In situ photo copolymerization 10–15 g/mL Urine [136] 
TNT GNS-MIPs Direct Polymerization on exposed POF core 7.2 × 10−7 M – [143] 
Neostigmine 
Eserine AChE Direct 
Covalent attachment of AChE to 
COOH-terminated SAM on Au 
surface 
[10–1000 μM] – [151] 
Chlorpyrifos AChE/MIP Direct after MIP capture 
Covalent attachment of AChE to 
COOH-terminated SAM on Au 
surface 
0.76 nM 
(LR 0.001–10 μM) – [153] 
Abbreviations: AChE, acetylcholinesterase; AFB1, aflatoxin B1; ATP, adenosine triphosphate; DR, dynamic range; GNP, gold nanoparticle; GNR, gold nanorod; GNS, gold nanostar; LOD, 
limit of detection; LR, linear range; MAb, monoclonal antibody; MIF, molecularly imprinted film; MIP, molecularly imprinted polymer; OTA, ochratoxin A; POF, plastic optical fiber; rGO, 
reduced graphene oxide; SAM, self-assembled monolayer; TNT, 2,4,6-trinitrotoluene. 
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Surface-enhanced Raman spectroscopy 
Surface-enhanced Raman spectroscopy (SERS) is a powerful vibrational spectroscopy technique 
that has unique features compared to other sensor devices using various kinds of signal 
readouts, including colorimetry, fluorescence, surface plasmon resonance, and 
electrochemistry.154–156 SERS is a vibrational spectroscopy technique that can be used to 
identify unknown compounds since it provides structural information of the target molecule as 
a “fingerprint,” similar to that derived from infrared spectroscopy. Also, SERS sensors can be 
used to analyze aqueous-rich samples and complex matrices, such as food samples, because 
water does not interfere in SERS signals and it has deep penetration depth. 
 
Figure 7. SEM images of different types of SERS substrates. (A) Spherical gold nanoparticles, 
(B) gold nanorods, (C) silver nanobar, (D) silver plasmonic nanodome array, (E) gold 
nanocluster, (F) gold nanoholes, (G) silver nanovoids, (H) silver nanocolumnar film, and (I) 
silver nano-pillars. Reprinted with permission from ref. [157], copyright (2017) De Gruyter. 
Generally speaking, Raman scattering is tremendously inefficient due to the small scattering 
cross section of ca. 10–30 cm2/molecule, which is about 14 orders of magnitude lower than 
the cross sections of fluorescent dye molecules.158 Therefore, it is fundamental the use of SERS 
reporters or substrates that, similarly to SPR-based sensors, enhance the Raman signal to 
improve the sensitivity. Mostly all SERS reporters are plasmonic nanostructures, such as gold, 
silver, copper, or aluminum nanoparticles with dimensions lower than the wavelength of the 
incident light (Figure 7). 
In these particular cases, the electronic oscillations are confined within a small volume, 
resulting in a specific type of surface plasmon called localized surface plasmon (LSPR). The 
excitation of LSPR plasmons produces a strongly amplified electromagnetic (EM) field because 
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of the collectivity oscillation of the conductive electrons on the nanoparticle surface. The basic 
concept of surface-enhanced Raman spectroscopy is that the Raman scattering signal of 
molecules at or close to the metallic surface can be enhanced to a factor of 1010–1011.156 There 
are at least two enhancement mechanisms in SERS:159, 160 (1) electromagnetic, referring to the 
electromagnetic effect that occurs near to the particle surface and is associated with long-range 
enhancement; (2) chemical effect, induced by the charged transfer between the metal 
nanoparticle and the molecule chemically adsorbed. 
Several factors significantly influence SERS, such as the type and energy of the bond 
between the molecule and the nanoparticle (NP), the surface roughness of the NP, light 
excitation wavelength and media conditions (e.g., pH, buffer nature). Interestingly, a significant 
enhancement has been observed when the analyte molecules are located in the gap between 
two or more nanoparticles, or are situated at sharp angles or tips of anisotropic plasmonic NPs 
(e.g., rods, stars, prisms). These areas are known as SERS “hot spots” and maximization of their 
number is desirable (Figure 8). Although aggregation of metal NPs in liquid induces “hot spots”, 
reproducibility during measurements is challenging and a real disadvantage in sensing 
applications. Thus, some of the current focuses on material science is to create SERS reporters 
with three-dimensional large-ordered nanostructures to achieve signal uniformity and 
reproducibility. Some examples include rods, holes, clusters, domes 3D nanostructures which 
have been successfully fabricated (Figure 7).157 Moreover, the use of coating nanomaterials to 
improve the chemical stability of the metal structures and to preserve the SERS signal is under 
investigation. For example, graphene, mesoporous silica, polymers, and even proteins are 
starting to be widely used in the fabrication of SERS reporters.161 
Benchtop Raman microscopes have been the gold standard platform for analytical 
methods based on SERS.162 However, the large size and high cost restrict their use to the 
laboratory, although the transition to the field as portable SERS sensors is a reality proved by 
the arrival of affordable small portable Raman spectrometers with dimensions similar to a 
smartphone, such as FirstDefenderTM RMX (Thermo Fisher Scientific, Inc., Waltham, MA, US).163 
The diversity of SERS-active platforms offers sufficient choices for analyzing proteins, disease 
biomarkers, ions, toxins, bacteria, viruses, etc. 
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Figure 8. Schematic of SERS effect for a small molecule on gold nanoparticles 
(AuNPs). (1) Analyte outside the enhanced magnetic field (red dotted lines), no 
Raman signal is observed; (2) analyte located within the enhanced magnetic field but 
at long-distance, and (3) analyte located within a “hot spot”. Reprinted with 
permission from ref. [159]. Copyright 2015 The Royal Society of Chemistry. 
In contrast to label-based SERS devices, in which the accuracy depends on the selective binding 
of the label to the target analyte, in label-free SERS methods the signal is directly dependent on 
either the analyte or the recognition element–analyte complex; thus understanding intra- and 
intermolecular interactions of the analyte is feasible. Direct recognition of the analyte by its 
characteristic Raman vibration bands when it is adsorbed, chemically or physically, on the SERS 
reporter surface is the most straightforward approach for detecting and quantifying small 
molecules. For example, dithiocarbamate pesticides thiram, ferbam, and ziram were detected 
individually using a gold nanoparticle colloid as SERS reporter.164, 165 The three organic 
pollutants were adsorbed firmly on the plasmonic surface through their sulfur groups allowing 
detection limits as low as 34 nM, 26 nM and 23 nM, respectively. Using a different SERS reporter 
type, Meng et al.164 prepared a self-assembled layer of silver nanocubes on a flexible 
polyethylene film. Direct deposition of SERS sensor pieces on contaminated oranges 
demonstrated the presence of 10 nM of thiram, 1 μM of 3-chlorobiphenyl, and 10 nM of 
parathion. 
A critical factor in label-free detection using SERS sensors is that the analyte should be 
confined inside the enhanced EM field of the SERS reporter. This issue is a significant challenge 
for SERS sensing since high non-polar or small hydrophobic molecules present low affinity for 
hydrophilic SERS reporters (Ag, Au, etc.), which prevents their detection at low concentrations. 
In this context, (bio)recognition elements can provide a set of analytical strengths that add value 
to SERS sensor platforms. For example, they can provide a degree of selectivity and an increase 
in the sensitivity by concentrating the analyte at the sensing surface. Most of the (bio)recognition 
elements used in label-free SERS sensors are antibodies, aptamers, molecularly imprinted 
polymers, and small molecules affinity agents. The following sections highlight label-free SERS 
sensor approaches reported for small molecule detection using the aforementioned 
(bio)recognition elements. Table 2 summaries some of the most interesting approaches from 
recent years. 
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SERS sensors based on antibodies 
The first report that described the use of antibodies as the biorecognition element in SERS was 
a label-based “sandwich” immunoassay. The target, thyroid stimulating hormone (TSH), was 
detected using anti-TSH capture antibodies bound to silver surfaces to form SERS probes and a 
detection antibody labeled with p-dimethylaminoazobencene, a well-known SERS reporter. The 
intensity of the resultant Raman scattering signal and the TSH concentration had a linear 
relationship ranging from 4 to 60 μIU/mL.166 
It is worth noting that, as in the case of SPR sensor platforms, the number of direct SERS 
methods for small molecule detection using antibodies is limited. This is likely due to the large 
size of the antibody (ca. 150 kDa) that occupies the volume just above of the SERS substrate 
area and thus, is in the most active region of the enhancing EM field.167 Antibodies, which are 
composed of amino acids, produce a significant SERS signal particularly from the side chains of 
phenylalanine, tyrosine, and tryptophan residues,168 and thus, a discrepancy between the 
antibody and small molecule signal is produced. As a consequence, spectral information of the 
target small molecules can only be obtained under two particular circumstances: (1) binding of 
the small molecule to the antibody paratope triggers a structural change in the latter, or (2) the 
small target features a large scattering cross-section. 
A representative example of a direct SERS-based immunoassay for the detection of small 
molecule targets is the work of Sanles-Sobrido et al.169 The authors demonstrated that BZE 
could be detected and quantified by simple comparison of the antibody-BZE complex Raman 
spectra, enhanced by the use of silver-coated carbon nanotubes, with the spectrum of the 
antibody alone. For supporting this strategy, structural information of the anti-BZE antibody was 
illustrated through the study by single-crystal X-ray diffraction and computational modeling of 
the modifications in the fragment antigen binding (Fab) region upon binding to BZE (Figure 9). 
The detection limit for BZE was in the range of 1 ng/mL (ca. 1 nM), which was in the same order 
of magnitude than using other immunological methods. Moreover, the reported SERS-sensor 
could be suitable for in situ detection of BZE even in complex biological fluids, similarly as was 
reported later with the antibody-based SPR-sensor for the same analyte.66 
An exciting alternative to minimize the strong SERS signal produced by the antibody is the 
use of recombinant antibody fragments. Up to now, the most used antibody fragment type is 
scFv (single chain fragment variable, 25 kDa) which consists only of the VH and VL domains, 
joined by a peptide linker. Surprisingly, to the best of our knowledge, no reports have been 
published based on the combination of label-free SERS-based immunoassays and recombinant 
antibodies for small molecule detection. 
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Figure 9. Schematic representation of benzoylecgonine (BZE) detection by SERS using silver-
coated carbon nanotubes (CNT@Ag). Direct binding of BZE to AgNPs (green spheres) (A), 
label-free indirect detection of BZE on CNT@Ag coated with BZE-specific antibody fragment 
alone (B) and in complex with BZE (C). Corresponding SERS spectra are depicted in the graph 
on top. Figure reprinted from ref. [169] with permission from The Royal Society of Chemistry. 
SERS sensors based on aptamers 
Aptamers are small (usually from 15 to 60 nucleotides, or 5–20 kDa) DNA or RNA 
oligonucleotides that have specific affinity for a target molecule. Since 1996, when the first 
aptasensors were published, their sensing applications are on the rise with particular emphasis 
in SERS-based aptasensors.170 Despite their simplicity, aptamers feature excellent binding 
constants, resulting from the three-dimensional architecture acquired upon binding to the target 
molecule through hydrogen bonding, Van der Waals, and/or electrostatic interactions. Aptamer 
immobilization onto SERS substrates does not result in random orientation since there are only 
two ends, 5’ and 3’, in its structure. The most popular immobilization approaches are based 
on:171, 172 (1) the use of thiolated aptamers which behave as ligands to form metal-thiolated 
complexes; (2) adsorption or π-π stacking interactions between the oligonucleotide bases of the 
aptamer and graphene-modified SERS reporters; (3) covalent linkage of amino-functionalized 
aptamers to carboxylic acid groups present on a particular substrate. 
Mostly all label-free SERS platforms based on aptamers, detect small molecules using either 
the direct signal from the target or the target/aptamer complex. The latter approach is relatively 
simple to analyze since the assignment of the SERS vibration peaks of the DNA bases is fully 
covered in the literature.173 One of the first reports combining aptamers and SERS detection 
demonstrated a label-free optical method for monitoring cocaine and platelet-derived grow 
factor.174 Similarly to work presented by Sanles-Sobrido et al.169 SERS spectra of the DNA 
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aptamer, acquired before and after exposure to the target analyte, enabled detection of the 
conformational changes in the oligonucleotide induced by the formation of the aptamer–analyte 
complex. This observation was well correlated with circular dichroism spectroscopy. Direct 
monitoring of the target molecule using a SERS device was described by Barahona et al.175 The 
approach presented an aptasensor for monitoring the pesticide malathion using polymeric 
microspheres that were prepared with methacrylic acid and ethylene glycol dimethacrylated. 
Then, the beads were activated with 2-aminoethanethiol and decorated with AuNPs in which 
thiolated anti-malathion aptamers were immobilized. Characteristic peaks of malathion were 
observed in a region of the spectra free of DNA signal, and finally, 495 cm–1 (shift assigned to 
P-S stretching) was selected for quantification of the pesticide. The linear range was established 
between 3.3–33 μg/mL and the detection limit was 3.3 μg/mL with an RSD < 14%. 
SERS sensors based on molecularly imprinted polymers 
To solve some of the problems that prevented the use of molecularly imprinted polymers in SERS 
sensing platforms,35 homogeneous MIP films with controlled thickness have been synthesized 
using methods like atom transfer radical polymerization133 and reversible addition-
fragmentation chain transfer (RAFT).123 Moreover, the development of core-shell nanocomposite 
imprinted polymers is of high interest when the material includes additional benefits, such as 
magnetic, luminescent, or metal core nanoparticles.176 AuNPs are the most widely used noble 
metal colloid in the manufacture of sensors based on core-shell structures (Au@MIP) thanks to 
the advantages it offers, such as optimal electro-optical properties, biocompatibility, and ease 
of fabrication and functionalization. 
Wulff and coworkers reported one of the first approaches of SERS chemosensor based on 
MIPs.177 Imprinted polymer layers were prepared on SERS archive surfaces built with either gold 
or silver deposited films. As a proof of concept, (2S,3S)-(+)-di-O-benzoyltartaric acid or N-
benzyloxy-carbonyl-(L)-aspartic acid were selected as templates. The functional monomer and 
crosslinker used were N,N′-diethyl-4-vinylbenzamidine and ethylenglycol dimethacrylate, 
respectively. The rebinding of the target molecules was performed with a 10 mM solution of the 
aspartic acid derivative in 0.1 M HEPES at pH 7.3 during 15 min. Under these conditions, the 
uptake was followed at 1007 cm–1 and normalized with the polymer band at 1615 cm–1. As the 
authors mentioned, this method was not suitable for direct monitoring of the target molecules, 
pointing out the need for robust methods to anchor MIP layers onto metal surfaces without 
losing the SERS enhancement. Nevertheless, the work definitively opened the door to the use 
of MIPs for the development of SERS chemosensors as have been demonstrated in recent 
years.178–180 
To circumvent the aforementioned problem, Carrasco et al.181 prepared selective 
Au@MIPs for ENRO using multibranched AuNPs as cores to act as intrinsic hot spots. The 
optimized nanostructures were obtained through a multistep synthetic approach that involved: 
(1) the growth of nanometric mesoporous silica layer, (2) formation of gold branches inside the 
silica, (3) functionalization with RAFT agent and (4) polymerization of the selective MIP 
(Figure 10). The use of this material resulted in a significant enhancement of the Raman 
scattering of ENRO upon binding to the selective sites of the MIP and improved sensitivity with 
a detection limit of 1.5 nM and minimal cross-reactivity toward potential interfering species 
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Figure 10. (A) Schematic representation of the nanocomposite fabricated in this work for 
the development of a SERS–MIP sensor, using Au@mSiO2 nanoparticles and a 
branching−functionalization−polymerization approach to produce branched 
Au@mSiO2@MIP/CIP (molecularly imprinted/control imprinted polymer) nanoparticles; (B) 
Schematic overview of the rebinding features towards the target molecule. Reprinted with 
permission from ref. [181]. Copyright 2016 American Chemical Society. 
In contrast to the numerous examples of MIP-metal composites prepared by core–shell 
approaches, Kamra et al.182 prepared MIP microspheres by RAFT polymerization, templated to 
the target nicotine and decorated with terminal thiol groups to increase the adsorption to gold-
based substrates. Raman signal of nicotine was enhanced by positioning the SERS substrates 
near the specific sites of the MIP by three different strategies: (1) coating MIP microspheres with 
gold colloids, (2) sputtering of AuNPs onto the MIP surfaces, and (3) measuring the MIP 
microspheres trapped on a commercial SERS-active substrate. All the approaches tested 
transformed the MIP microspheres into SERS-active substrates although gold colloidal coating 
yielded the strongest signal when nicotine was detected. 
In a different strategy, Ashley et al.183 combined the separation properties of magnetic 
molecularly imprinted polymer (MMIP)-based sample pretreatment with SERS detection for 
quantitative analysis of cloxacillin in pig serum. Magnetic FeOx nanospheres were synthesized 
and coated with mesoporous silica and metacryloxy propyl trimethoxyl silane to allow the 
polymerization of the MIP layer directly attached to the silica surface. The target antibiotic was 
then extracted from pig serum using the MMIPs and eluted into a clean solvent. Then, the extract 
was deposited into the SERS substrates, consisting of vertical silicon nanopillars coated with 
gold, and quantitative analysis was performed using acetic acid as internal standard. The sensor 
presented good sensitivity (7.8 pmol) toward the antibiotic with recoveries ranging from 85% to 
126%. Although the results were adequate, the strategy followed for measuring rendered SERS 
redundant because of the MIP specificity and the separation of the target from the matrix by 
extraction. 
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The multiplexing ability of SERS sensing in combination with MIPs was demonstrated by 
Holthoff et al. 184 for the simultaneous analysis of TNT and their derivatives. The MIP against 
TNT, based on organosilane precursors, contained 3-mercaptopropyl trimethoxysilane to 
facilitate the adhesion of the spin-coated MIP xerogel to the SERS reporter through thiol-metal 
interactions. The MIP bound selectively dinitro species that could be differentiated by the 
molecular “fingerprint” of each analyte afforded by the SERS measurements. Quantification of 
TNT was performed at 1352 cm–1, the peak corresponding to the asymmetric stretching band 
for nitrate, presenting a detection limit of 3 μM in solution after 24 h exposure. 
SERS sensors based on molecular traps 
Small molecules are exciting alternatives to trap hydrophobic organic targets that have a very 
low affinity to SERS surfaces. The two most common molecular trap agents are partition layers 
and functional monolayers of small molecules.167 For the first type, diffusion enables the 
transport of a set of analytes that are soluble inside of them. The second interact directly through 
covalent binding, hydrogen bonding, ionic, polar, nonpolar, etc. 
For example, polychlorinated biphenyls185 and polycyclic aromatic hydrocarbons (PAHs)186 
have been detected using partition layer-functionalized SERS substrates. For instance, 
decanethiol on silver substrates could perform pM sensitivity with multiplexing analysis 
capability. PAHs are a group of small molecules intensely studied using label-free SERS sensors 
and multicycle organic compounds, such as calixarenes, viologens, and cyclodextrins, have been 
broadly used.187, 188 For example, calix[4]arene dithiocarbamate189 was able to host pyrene, 
benzo[c]phenanthrene, triphenylene, and coronene facilitating their SERS detection (LODs from 
100 pM to 10 nM) when the calixarene was linked to AgNPs. Viologen dications (VGDs) lucigerin, 
diquat, and paraquat have also been evaluated as PAHs-molecular traps after their 
immobilization onto AgNPs.188 VGDs were able to induce the formation of hot spots to locate the 
analyte yielding a significant intensification of the Raman emission of the target molecule. 
Lucigerin provided the most robust VGD–AgNPs sensor due to its bifunctional nature and its 
large aromatic character and allowed a limit of detection down to 10–9 M for pyrene detection. 
Another molecular trap used to determine PAHs (anthracene and pyrene) was reported by Xie 
et al.187 The designed system (Figure 11) used AgNPs modified with per-6-deoxy-(6-thio)-β-
cyclodextrin. The SERS signals for each PAH were easy to differentiate and were significantly 
enhanced thanks to the selective cyclodextrin cavity that hosted the hydrophobic molecules 
near to the EM field. However, the sensitivity of the sensors was not impressive, reporting a limit 
of detection for anthracene of 10 μM and 7.5 μM for pyrene. 
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Figure 11. (A) Schematic representation of the host-guest complexation mechanism for 
pyrene. (B) Top graph: SERS spectra of mixtures of 333 mM anthracene with different 
concentrations of pyrene; a–h (0, 17, 25, 33, 83, 166, 250 and 333 mM). Bottom graph: 
SERS spectra of mixtures of 333 mM pyrene with different concentrations of anthracene, 
from a–e (0, 83, 166, 250 and 333 mM). Reprinted with permission from ref. [187]. 
Copyright 2010 the Royal Society of Chemistry. 
Interferometric biosensors 
Interferometric biosensors are based on refractive index changes produced by a biorecognition 
event which takes place in the sensing area. This change is measured with the aid of two light 
beams, the sensor, and reference beams, which are combined to produce an interference 
pattern. The sensor area is functionalized with the recognition element (e.g., antibodies, 
aptamers, enzymes) which is responsible for the selective recognition of the target analyte, and 
the immobilization of the recognition element is of crucial importance for the sensor 
performance.190–192 On the other hand, a good intrinsic reference channel is necessary to obtain 
high sensitivity.190 The reference channel is designed to take into account the background 
signals derived from thermal drift, the light source stability, mechanical noise, and non-specific 
binding, i.e., all the processes that also occur in the sensing channel other than the specific 
binding event.193 
  
Table 2. Examples of SERS-based methods using different recognition elements. The limit of detection (LOD), calculated as the blank response plus three times the 
standard deviation, is reported. 
Analyte Recognition element Assay format Immobilization LOD Sample matrix Ref. 
PCB-47 Alkanethiols  (C8, C10, C16, C18) Direct SAMs of alkanethiols built over AgFON 5 mM – [185] 
PCB-3 
PCB-29 
PCB-77 
β-CD Direct β-CD adsorbed over SiO2@Au@AgNPs and immobilized on quartz slides 1 μM – [194] 
Malathion Aptamer Direct Thiol-modified aptamer on AgNPs@SP 5–100 × 10−7 M tap water [195] 
Isocarbophos (1) 
Omethoate (2) 
Phorate (3) 
Profenofos (4) 
Aptamer Direct Thiolated aptamer on Ag dendrites 
3.4 μM (1) 
24 μM (2) 
0.4 μM (3) 
14 μM (4) 
apple juice [196] 
S-propanolol MIP Direct MIP attached to the SERS-active klarite
® 
substrate 7.7 × 10
−4 M Urine [197] 
Ciprofloxacin MIP Direct Fe3O4 NPs@MIP dispersed on a silver solution 
10−9 M (1) 
10−7 M (2) 
water (1) 
serum (2) [198] 
Abbreviations: β-CD, β-cyclodextrin; AgFON, roughened silver film over nanosphere; AgNPs, silver nanoparticles; AuNPs, gold nanoparticles; C8, n-octane; C10, n-decane; C16, n-
hexadecane; C18, n-octadecano; Fe3O4, iron (II,III) oxide; MIP, molecularly imprinted polymer; PCB-3-chlorobiphenyl; PCB-29, 2,4,5-trichlorobiphenyl; PCB-47, 2,2′,4,4′-
tetrachlorobiphenyl; PCB-77, 3,3′,4,4′-tetrachlorobiphenyl; SAM, self assembled monolayer; SiO2, silicon dioxide. 
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Numerous interferometric configurations have been reported for measuring small molecules; 
the most used ones are described hereafter and shown in Figure 12. The two most commonly 
used platforms are the Mach-Zehnder (MZI) and Young’s (YI) interferometers which are both 
formed by a waveguide which splits a laser beam into the sample and reference arms and differ 
only in the way the two beams are merged to form the interference pattern. YI converges through 
natural divergence and MZI through a physically forced combination.191 Dual polarization 
interferometer (DPI) employs two stacked planar waveguides (sample and reference) that are 
illuminated by a single laser beam, and the interference pattern is formed in the far field by 
emerging light.199 Backscattering interferometry (BSI) differs from other interferometric 
techniques by its ability to measure interactions in solution within a channel or capillary.200 
Porous sensors use the Fabry-Perot interferometer principle where the interference is produced 
by reflected light from different surfaces within the sensor.201 In biolayer interferometry (BLI) the 
binding event takes place at the end of an optical fiber where the reference is formed by a 
portion of propagated light that is reflected back towards the light source as it reaches a 
polymeric layer near the tip. The interference occurs between the reference beam and a small 
amount of light reflected from the interface between the fiber and the sample.202 Along with 
these setups, there are several other interferometric configurations, such as reflectometric 
interference spectroscopy (RIfS),203 spectral-phase interferometry (SPI)204 or spectral-
correlation interferometry (SCI), among others. Moreover, some configurations can be found in 
commercial devices such as ForteBio Octet (BLI) or Optiqua MiniLab (MZI). 
Interferometric sensors can be produced in optical fibers or integrated optical 
waveguides. Generally, optical fibers can avoid problems related to channel blocking205 and 
enable manufacturing of compact and economical equipment,206 but integrated optics offer 
greater flexibility in the geometry of the design and the combination of materials, allowing 
greater complexity and ease of access to the optical path in evanescent field sensing.192 Sensing 
surfaces are generally prepared by depositing on the surface of a glass substrate an optically 
transparent thin layer of a high refractive index, such as silicon nitride (Si3N4)207, 208 or tantalum 
pentoxide (Ta2O5).209, 210 Light can be coupled into the waveguide either by prism coupling, end 
firing, or diffraction grating, the latter being the most commonly used in interferometry 
measurements due to the simple manufacturing in the waveguide by etching the surface or by 
embossing.190 
Interferometric biosensors can monitor directly small changes in the optical properties 
and allow measuring binding and dissociation events in real time. These biosensors generally 
do not require prior sample treatment or additional steps such as washing. Consequently, they 
have been used in a broad range of applications such as sensing, determination of biomolecule 
or protein-ligand interactions,211 drug discovery,212 and kinetic measurements,202, 211 among 
others. Also, multi-analyte or multi-sample analysis is possible by joining different channel pairs 
(sensing–reference) into a single waveguide.207, 213 Detection of small molecules with 
interferometric biosensors using different recognition elements is discussed in the following 
sections, and some representative examples are listed in Table 3. 
Annex I: Review articles 
350 
 
Figure 12. Schematic of the most commonly used interferometric configurations: (A) Mach–
Zehnder interferometer (MZI), (B) a Young interferometer (YI), (C) porous silicon sensor, (D) 
backscattering interferometry (BSI), (E) dual-polarization interferometer (DPI), (F) biolayer 
interferometry. ((A–D), reprinted with permission from ref. [201], copyright (2012) American 
Chemical Society; (E), reprinted with permission from ref. [214] and (F), reprinted with permission 
from ref. [215] copyrights 2004 and 2017 Elsevier. 
Antibody-based interferometric sensors 
Only a few examples of antibody-based interferometric sensors for small molecules have been 
reported using the direct assay format. A polarization interferometer biosensor based on a 
planar waveguide for the detection of mycotoxins AFB1216 and OTA217 was able to detect the 
mycotoxins at concentrations down to ppts in a direct immunoassay format. The operating mode 
was similar to MZI, but the design was simpler, and the waveguide was not split into two arms. 
The waveguides consisted of a thin Si3O4 layer (200 nm) sandwiched between thicker SiO2 layers 
(3 μm) and the light propagated in the core at an angle of 47° and experienced about 3000216 
or 800217 reflections per mm. For biosensor development, a portion of the SiO2 layer was etched, 
and a layer of positively charged poly-allylamine hydrochloride was deposited, followed by 
adsorption of protein A molecules, negatively charged, followed by immobilization of the 
monoclonal antibodies selective to the analyzed mycotoxin. The liquid sample was placed in 
contact with the sensing window using a reaction cell that included inlet and outlet tubes. Any 
changes in the refractive index or in the thickness of adsorbed molecules on the Si3O4 layer 
affected the p-component of the polarized light while the s-component was used as a reference. 
The light was collected with a charge-coupled device (CCD) array, and the phase shift between 
p- and s-components of polarized light was converted to variations of light intensity using a 
polarizer placed in front of the CCD camera. The sensor detected 0.01 ng/mL of AFB1 or OTA in 
water. 
Most commonly antibody-based interferometric sensors use the competitive 
immunoassay format with an immobilized the antibody,207 or the binding inhibition assay where 
the target218 is attached to the surface (Figure 1). In some cases, structural analogs of the target 
compound are needed for immobilization if the analyte lacks appropriate groups required for 
covalent coupling,219–223 or due to the risks associated with the analyte.224 Alternatively, a 
protein-conjugate can be immobilized on the surface. For example, Pagkali et al.225 reported 
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detection OTA in beer with an MZI where the sensing area was functionalized with OTA–OVA 
conjugate. This 10-channel sensor was based on a binding inhibition assay with signal 
amplification using a secondary antibody to form another bimolecular layer increasing the 
effective RI. The assay exhibited a LOD of 2.0 ng/mL and a dynamic range from 4.0 to 
100 ng/mL in beer samples. Later, the authors used the same platform and methodology for 
simultaneously detect AFB1, fumonisin B1, and DON, achieving LODs of 0.8, 5.6 and 24 ng/mL, 
respectively, in undiluted beer in less than 15 min.213 In a different approach, Maragos205 
applied the BLI system for the detection of DON in wheat flour with using immobilized DON–BSA 
obtaining a detection limit of 0.1 mg/kg.226 To improve the detection limit and assay time, they 
tested the use of a secondary antibody marked with HRP, as well as a primary antibody 
conjugated to colloidal gold. After signal amplification using colloidal gold, the detection limit 
was decreased to 0.09 mg/kg. 
Given the importance of the suitable surface for the covalent binding of the analyte, Krieg 
et al.210 compared the performance of amino-dextran and diamino-polyethylene glycol as 
biopolymer coatings for sensing purposes. After binding dimethylated amitriptyline, binding 
inhibitions assays were carried out with RIfS, and better results were obtained with the amino-
dextran surface. The most sensitive assay showed a limit of detection of 268 ng/L in buffer and 
540 ng/L in diluted (1:10) human serum, making it competitive even with HPLC measurements. 
Moreover, the platform showed high stability as 80 measurement cycles could be performed on 
each transducer chip after guanidine hydrochloride regeneration.220 Recently in a different 
approach, using bimodal waveguide interferometry (BiMW), Chocarro-Ruiz et al.219 employed 
several silanization protocols to evaluate the most suitable biofunctionalization procedure for 
Irgarol 1051 detection. 
To improve the analytical characteristics of a porous silicon sensor, Orlov et al.227 
described a method for enhancing the reproducibility of the assay using the specific absorption 
capacity within the sensing area. For this purpose, after obtaining the signal produced by the 
competitive assay (S), an excess of the monoclonal antibody was put in contact with the surface 
to saturate the sites not occupied in the previous stage (∆). The normalized S/∆-ratio provided 
a better reproducibility even with non-uniform surface coatings (Figure 13). OTA, zearalenone, 
and AFB1 were detected in white wine with detection limits of 0.25, 0.48 and 1 ng/mL 
respectively, with CVs less than 5% and 2–3-fold lower detection limit compared a standard 
competitive assay. Furthermore, Tinsley-Bown et al.224 develop a competitive assay for TNT 
detection which combined porous silicon interferometry with an Orthogonal Subspace Signal 
Projection Algorithm (OSPA), reaching a detection limit of 1 μg/mL. The OSPA method used 
reference reflectivity data before the sensing event to “self-calibrate” and measured any 
changes between the reference data and the test data overcoming the baseline drift, 
temperature fluctuation, and some systematic tendency such as the systematic reduction in 
optical thickness through erosion of the material. 
Interferometric sensors based on aptamers 
Since aptamers first emerged in 1990 with the SELEX (systematic evolution of ligands by 
exponential enrichment) technique,228 they became an alternative to antibodies. However, they 
are still consolidating their role as biorecognition elements. SELEX process screens random 
sequences of a fixed length of a large oligonucleotide library; sequences are exposed to the 
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target, and those with higher affinity are enriched through successive rounds. Wang’s group 
used this tool to find the aptamers with better affinity and specificity to different marine toxins, 
such as gonyautoxin 1/4 (GTX1/4),229 nodularin-R (NOD-R),230 and palytoxin (PTX),215 and 
afterward applied to BLI sensors. Aptamers against GTX1/4 and NOD-R were employed in direct 
assays with detection limits of 50 pg/mL and 167 pM, respectively. BLI biosensor for PTX 
detection was based on a binding inhibition assay with immobilized PTX and an HRP-conjugated 
aptamer. After signal amplification by submerging the sensor tip in a 3,3′-diaminobenzidine 
solution, which resulted in the formation of a precipitated polymeric product directly on the 
biosensor surface, a detection limit of 0.04 pg/mL was obtained (Figure 14). In a similar 
approach, marine toxin saxitoxin (STX) was detected with a detection limit of 0.5 ng/mL and a 
linear range from 100 to 800 ng/mL231 using a modified aptamer which had been improved via 
site-directed mutation and truncation and had a 30-fold higher affinity for STX compared with 
the parent aptamer.232, 233 
 
Figure 13. Scheme of reproducibility enhancement of label-free detection of small 
molecules. Spectral-correlation interferometry (SCI) sensograms for detection of 
ochratoxin A (OTA, 10 ng/mL) using intentionally different chip surfaces with different 
conjugates (top). Signal variations at each stage and the normalized signal (bottom). 
Reprinted with permission from ref. [227]. Copyright 2017 Elsevier. 
Unlike in SPR where thiolated aptamers are often directly immobilized to the gold surface, 
interferometric sensors usually require a modified surface for the immobilization. The most 
widely used method, and perhaps the fastest, is the use of biotinylated aptamers in combination 
with surfaces modified with streptavidin229, 230, 234 or avidin.235, 236 For example, bisphenol A 
(BPA) -specific aptamer was immobilized on the surface of a DPI sensor chip through biotin-
avidin interaction, and detection limits of 2.5 mM on the mass signals and 1.7 mM on the 
thickness signals were reported.235 In an alternative approach, adenine-rich ssDNA aptamer was 
immobilized through a preadsorbed layer of poly(ethylenimine) for the direct detection of Coralyn 
Optical biosensors for label-free detection of small molecules 
353 
on a DPI. The mass, thickness and refractive index parameters were used to establish each 
calibration equation for the biosensor, achieving detection limits of 0.22 μM, 0.14 μM, and 
0.32 μM respectively. Coralyn was detected in the range of 0.5 to 12 μM, with a high selectivity 
that was confirmed by comparison with three other common intercalators (ethidium bromide, 
daunomycin, and methylene blue).237 
An unconventional competitive assay for testosterone was described by Zhang et al.234 
who used a BLI sensor with aptamers and testosterone-binding RepA protein. RepA could bind 
the biotinylated double-stranded DNA aptamers immobilized onto a streptavidin-coated chip in 
the absence of testosterone, whereas the conformational changes in RepA upon testosterone 
binding led to the displacement of RepA from the surface-bound aptamers. Testosterone could 
be determined in 17 min with a linear range of 2.13 to 136.63 ng/mL, exhibiting a sensitivity 
comparable to that achieved by HPLC. 
Alternatively, using BSI which does not depend on surface-immobilization, Kammer et al. 
characterized interactions between small molecule and aptamers, providing KD values with 
minimal sample manipulation on small volume sample quantities and at low nanomolar 
sensitivity. For this propose they measured the aptamer affinity for BPA (20.2 ± 2.1 nM), 
tenofovir (9.0 ± 1.4 nM) and epirubicin (626 ± 121 nM); showing values reliable with those 
published previously for the same molecules. In addition, KD values for aptamers to ampicillin 
(402 ± 99 nM), tetracycline (2.94 ± 0.28 mM) and norepinephrine (188 ± 64 nM) were 
determined.202 
 
Figure 14. (A) Schematic of the working principles of the biosensor with the competitive 
assay for palytoxin (PTX) detection using horse-radish peroxidase (HRP)-modified aptamer. 
(B) Schematic of the biolayer interferometry (BLI)-based detection system and (C) the 
expected sensor response after each step: (1) baseline (1 min), (2) capture of free HRP-
aptamer (5 min), (3) washing (1 min), and (4) signal amplification (3 min). Reprinted with 
permission from ref. [215]. Copyright 2017 Elsevier. 
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Polymer-based interferometric sensors 
Also, MIPs have been described as bioinspired receptors for interferometric sensors 208. MIPs 
can be produced directly on sensor surface,238 by thermal or photochemical initiation, or be 
integrated later by dip or spin coating.208, 209 In situ polymerization circumvents a separate 
immobilization step but sometimes has the disadvantage of long response times, low 
reproducibility and long-term stability, and regeneration problems. 
Belmont et al.208 applied two different methods for the deposition of MIPs, selective to 
atrazine, on the RIfS transducer surface. The first method consisted of in situ polymerizations of 
a thin film produced after spin-coating of monomers and template. In the second method, MIP 
nanoparticles produced by mini-emulsion polymerization were auto-assembled with the aid of 
polyethyleneimine. Using the autoassembled particle film in a RIfS platform, atrazine detection 
was established at concentrations as low as 1.7 ppm which was several orders of magnitude 
lower than previously reported with the same surface using a chiral chemosensor238 for (R,R)- 
or (S,S)-2,3-di-O-benzoyltartraric acid. RIfS has also been used for the detection of L-Boc-
phenylalanine anilide through miniemulsion polymerized imprinted nanospheres which provided 
a detection limit of 60 µM, good reproducibility, and selectivity, as well as long-term stability for 
up to 1 year.209 
Also, non-imprinted polymers have been used as recognition elements in interferometric 
sensors. Porous silicon (pSi) films, which can be fabricated with the desired morphological 
structures, allows the design of a porous matrix to optimize the access of the target analyte, 
making it suitable for sensing applications.239 These surfaces can be combined with polymers 
to carry out selective recognition, as in the glucose sensor described by Krismastuti et al.240 
using phenylboronic acid polymers. Thiol-terminated poly(4-vinylphenylboronic acid) was 
covalently bound to the pores of succinimidyl 4-(p-maleimidophenyl)butyrate modified pSi. In 
the presence of glucose, the properties of the polymer changed as cyclic boronate esters were 
formed. Surface behavior was monitored by interferometric reflectance spectroscopy (IRS) 
which could detect as low as 0.15 mM glucose at physiological pH, and no interferences were 
found when measuring in wound fluid samples. 
A less common form of detection is based on measuring the decrease in surface thickness 
caused by polymer degradation. Wu et al. prepared a dithiothreitol (DTT) sensor based on an 
optical fiber Fabry-Perot interferometer (FPI). When DTT solution was in contact with the sensor, 
a cleavage in the disulfide-crosslinked PAAm hydrogel on the optical fiber was produced and 
monitored in real time as changes in the refractive index. A concentration of 50 µM DTT was 
successfully detected within 36 min,241 improving the sensitivity 2000 times compared to 
previous work.242 
Finally, there is no clear difference between interferometry and diffraction because of the 
similarity between their principles from a physical point of view.243 For example, antimicrobial 
ENRO could be detected via optical diffraction using a selective MIP on a Si3N4/SiO2 strip 
waveguide sensor. ENRO produced large signal response, saturating at 70 M and selectivity was 
evaluated with the temple analog flumequine.208 Optical diffraction in combination with MIPs 
has also been used for testosterone detection. This approximation used a holographic structure 
(diffraction grating) obtained via photopolymerization of photoinitiators and monomers with 
interfering laser beams and was able to detect testosterone between 1 and 100 µM.244 
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Protein-based interferometric sensors 
Although enzymes are used in numerous bioassay formats, there are hardly any examples in the 
case of interferometry.208 Instead, certain models of interaction between small molecules and 
proteins have been used, such as glucose and mannose with lectin concanavalin A (ConA). An 
interferometric sensor developed by Paek et al.245 used a semi-continuous determination of 
glucose in human serum by placing an optic fiber in the hollow of a syringe needle. The BLI 
glucose sensor measured glucose levels by quantifying the wavelength shifts caused by the 
binding of glucose to ConA immobilized on the tip. Direct glucose measurement was limited by 
the signal-to-noise ratios and to overcome this problem authors used a sugar-protein conjugate 
enclosed inside the needle by a semi-permeable membrane to competitively bind to the 
immobilized ConA and satisfy the clinical range of interest (70–200 mg/dL). Recently, the same 
group described a modification to the previous sensor because of considerable migration 
distance of the ligand to the sensor surface and the limited pore size of the membrane due to 
the artificial conjugates. Authors addressed these limitations by placing the sugar-protein 
conjugate outside of the membrane (Figure 15) and increasing the pore size. Results obtained 
with this platform were compared with the ideal BLI, showing high reproducibility and good 
stability over time, ascribed to the fact that the sensing zone was not directly exposed to serum 
and thereby avoided non-specific binding of other compounds.246 
BSI has also been used to study the binding affinity of mannose and glucose to ConA 
under significantly different physical conditions (tethered ConA on the surface and free solution). 
When comparing the results of the free solution with those obtained by having the ConA 
anchored at different distances from the surface, they observed that the binding affinity 
increased when the distance from the ConA to the surface decreased; thereby understanding 
how protein immobilization affects binding.211 
Alternatively, optical coherence tomography (OCT) has been used to study the viability of 
semi-noninvasive continuous monitoring sensors. The OCT sensor described by Ballerstadt 
et al.247 for glucose measurement in interstitial fluid (ISF) was established using a porous 
membrane with a suspension of macroporous hydrogel particles and ConA within. A reference 
compartment, containing buffer or ISF, was added next to the glucose-sensitive compartment 
for signal normalization. Performance of the sensor was demonstrated in vitro for 160 days with 
excellent reversibility, stability and good response over the physiological concentration range 
(2.5–20 mM glucose). Additionally, to mimic in vivo conditions and evaluate the possibility of 
using the sensor as an implant under the skin, they covered the sensor with a tissue phantom 
and were able to measure glucose changes of 10 mM. 
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Figure 15. Schematic of the needle-type sensor. A syringe needle was modified and 
covered with a semi-permeable membrane to fabricate the needle-type sensor. 
Sensor tip was modified with concanavalin A (ConA) and bovine serum albumin (BSA)-
ligand conjugate was kept outside of the semi-permeable membrane. Reprinted with 
permission from ref. [246]. Copyright 2016 MDPI. 
  
Table 3. Examples of interferometric-based methods using different recognition elements. The limit of detection (LOD), calculated as the blank response plus three 
times the standard deviation, is reported. Alternatively, the measured concentration range is shown between brackets. 
Analyte Recognition element 
Assay 
format Immobilization Sensitivity Sample matrix 
Interf. 
type Ref. 
Domoic acid PAb Inhibition Covalent binding of domoic acid by active ester chemistry 2.0 ng/mL (IC50) 
Mussel tissue 
extracts BLI [218] 
Irgarol 1051 PAb Binding inhibition 
Covalent binding of a derivative onto an 
APTES functionalized surface 3 ng/L Sea water BiMW [219] 
DON MAb Competitive Adsorption of DON–OVA on the sensor chip 128 µg/kg 737 µg/kg  
Wheat  
Wheat dust BLI [248] 
Testosterone MAb Binding inhibition 
Covalent binding by active ester chemistry of 
a derivative onto a DAPEG coated surface 94.4 ng/L Milk RIfS [223] 
AFM1 Fab′ Competitive Fab′ binding to a mercaptosilane functionalized surface 5 × 10
–7 RIU Milk aMZI [207] 
Vancomycin Peptide Direct Covalent binding of the peptide to a pSi surface via a carboxy-linker KD = 1.09 × 10
–5 mol/L – RIFTS [249] 
Testosterone Aptamer Competitive Biotinylated aptamer on streptavidin-coated chip [2.13–136.63 ng/mL] – BLI [234] 
Argininamide Aptamer Direct Biotinylated aptamer on avidin-coated chip 5 µM – DPI [236] 
Microcystin-LR 
(MC-LR) MIP Direct Dip coating of the sol–gel matrix [0.3–1.4 g/L] 
Environmental 
water FP [250] 
Melamine MIP Direct Spin coating 1251 rad/RIU – YI [251] 
Methyl-parathion AChE Direct Covalent attachment to a APTES-GLU-functionalized surface 
2.4 × 10−10 M 
(2.1 nM–47 µM) – ITFS [252] 
Abbreviations: AChE, acetylcholinesterase; AFM1, aflatoxin M1; aMZI, asymmetric Mach-Zehnder interferometer; APTES-GLU, 3-aminopropyltriethoxysilane-glutaraldehyde; BiMW, bimodal 
waveguide interferometer; BLI, biolayer interferometry; DAPEG, diamino-poly(ethylene glycol); DON, deoxynivalenol; DPI, dual polarization interferometer; Fab′, antibody fragments; FP, 
Fabry-Perot interferometer; IC50, half maximal inhibitory concentration; ITFS, interferometric tapered fiber sensor; KD, equilibrium dissociation constant; mAb, monoclonal antibody; MIP, 
molecularly imprinted polymer; OVA, ovalbumin; PAb, polyclonal antibody; pSi, porous silicon; RIFTS, reflective interferometric Fourier transform spectroscopy; RIU, refractive index unit; 
YI, Young’s interferometer  
  
Table 4. Comparative table of different optical label-free biosensors for the detection of ochratoxin A (OTA) as an example of a small molecule. 
Method Recognition element Assay format Immobilization Sensitivity Measurement Regeneration 
Assay 
time Sample Ref. 
SPR MAb Direct 
GHBs on 
electropolymerized 
thionine (PTh) film 
LOD 0.01 ng/mL ESPR with SPR sensor in a flow cell 
Up to eight times 
with glycine-HCl 
solution (pH 2.8) 
<30 min Milk [72] 
iSPR MAb Inhibition 
Covalently 
immobilized toxins 
on CMD surface 
LOD 3 ng/mL 
iSPR instrument with 
nanostructured gold 
chips 
More than 450 
times with 10 mM 
HCl 
≈15 min Beer [109] 
LSPR Aptamer Direct Aptamer with 5′ thiol on Au surface 
<1 nM 
(=0.4 ng/mL) 
Microplate reader 
with 96-well plate 
Seven times with 
10% methanol at 
+70°C 
≈15 min Corn [118] 
OWLS MAb Direct and competitive 
Covalently 
immobilized MAb 
(direct) or OTA–BSA 
(competitive) 
DR 5–10 ng/mL 
for direct, 0.5–
10 ng/mL for 
competitive 
Integrated 
OWLS sensor chips n.d. <10 min 
Barley 
and 
wheat 
[41] 
PW (PI 
principle) MAb Direct Antibody via protein A  
DR 0.01–
100 ng/mL 
PW structures on 
silicon wafers, CCD 
array and a polarizer 
n.d. n.d. – [217] 
SERS Aptamer Direct Aptamer with 5′ thiol on Au surface DR 0.05–4 μM 
SERS platform 
with microfluidic 
channel 
n.d. n.d. – [253] 
Abbreviations: BSA; bovine serum albumin, CCD; charge-coupled device (CCD), CMD; 3-dimensional carboxymethylated dextran, DON; deoxynivalenol, DR; detection range, ESPR; 
electrochemical surface plasmon resonance, GHB; gold hollow balls, LOD; limit of detection, MAb; monoclonal antibody, iSPR; imaging surface plasmon resonance, OWLS; optical 
waveguide lightmode spectroscopy, PI; polarization interferometry, PW; planar waveguide. 
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Conclusions 
During the last decades, biosensors have become an essential tool for small molecule analysis 
in different disciplines, such as drug discovery, environmental security, and food safety, 
complementing and, in some cases, even replacing the existing analytical methodologies. 
Biosensors can provide not only selective and sensitive detection but can be also portable and 
offer a rapid response in real time, which makes them ideal for many applications. The 
performance of biosensors depends on many factors including, the bioreceptor layer, the 
transducer, and the instrumentation. Therefore all these different parameters must be taken 
into account in the design of the device. 
SPR continues its reign as the most used label-free sensor configuration for small 
molecule analysis, partly due to the availability and simple use of advanced commercial devices. 
Nevertheless, significant advances in other transduction schemes have made important 
contributions to the field of label-free sensing. On the other hand, although antibodies are 
probably the most common biorecognition elements, during the last decade also several exciting 
applications using, for example, aptamers or MIPs as recognition elements have been reported. 
Table 4 collects examples of different optical label-free methods for the detection of OTA which 
has been one of the most widely used targets in the papers revised for this review. 
Nevertheless, it should also be noted that the research in many label-free methods is still 
their infancy and many reports in the literature, particularly those related to instrumental or 
material improvements, are rather fundamental including only proof-of-concept bioassays and 
are thus yet to encompass the challenges associated with the real analyte analysis. For example, 
many of the most recent biosensors reviewed here have shown excellent characteristics for 
synthetic samples, but still, lack characterization in complex matrices which better resemble the 
real applications. Moreover, many designs based on nanostructures could be able to overcome 
some of the optical and biological limitations of sensors but the inherent nanofabrication 
procedures, such as electron beam lithography and focused ion-beam milling, might limit their 
widespread application.62 In any case, as discussed in this paper, recent advances in the field 
of optical label-free methods are impressive, and new technologies and materials for improved 
detection are reported every year. 
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